Curator Name UniProt ID NCBI Gene ID Gene Name Species Name Taxonomy ID Data Type Data Value GO Term GO ID Uberon Term Uberon ID BRENDA Tissue Ontology Term BRENDA Tissue Ontology ID Anatomy Ontology Term Anatomy Ontology ID Phenotype Ontology Term Phenotype Ontology ID Developmental Stage Term (BRENDA) Developmental Stage ID (BRENDA) Cell Type Ontology Term (CTO or CL) Cell Type Ontology ID (CTO or CL) Cell Line Ontology Term (CLO) Cell Line Ontology ID (CLO) PATO Qualifier PATO ID OMIM ID Human Disease Ontology Term Human Disease Ontology ID SNOMED Term SNOMED ID ChEBI Chemical Term ChEBI Chemical ID Secondary Source IDs Secondary Source Notes Reviewed (Y/N) Use (Y/N) Evidence Code Primary Source Secondary Source PENTACON Notes Gene Set Secondary Source Version Date Secondary Source Version PENTACON Annotation No Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease 85; In 3KTD. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007497 Y Y ECO:0000311 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006019 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease A301P; In 3KTD; 5% normal activity. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007503 Y Y ECO:0000269 PubMed:7728148 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006021 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease A333P; In 3KTD; no activity. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007505 Y Y ECO:0000269 PubMed:9744475 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006023 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease A380T; In 3KTD; 7% normal activity. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007507 Y Y ECO:0000269 PubMed:1715688 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006025 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease G152A; In 3KTD. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007499 Y Y ECO:0000311 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006027 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease G183R; In 3KTD; no activity. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007501 Y Y ECO:0000269 PubMed:1346617 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006029 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease G379V; In 3KTD. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007506 Y Y ECO:0000311 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006031 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease I312T; In 3KTD; 10% activity. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007504 Y Y ECO:0000269 PubMed:9744475 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006033 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease N158D; In 3KTD; no activity. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007500 Y Y ECO:0000269 PubMed:7728148 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006035 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease N93S; In 3KTD; 10% activity. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007498 Y Y ECO:0000269 PubMed:9744475 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006037 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease T297M; In 3KTD; 10% normal activity. MIM:203750 beta-ketothiolase deficiency DOID:14723 VAR_007502 Y Y ECO:0000269 PubMed:7728148 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 141 3300006039 Katie O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity ACSL4 splice variant 1 (NM_004458) was detected in cultured aortic smooth muscle cells and was more abundantly expressed than variant 2 (long form) aortic smooth muscle BTO:0001685 vascular associated smooth muscle cell CL:0000359 Y Y PubMed:21242590 PENTACON Splice variant 1 (short) was more abundantly expressed than variant 2 (long) in aortic smooth muscle cells AAP, AAP-M, ASD 4/21/2014 3 3300006092 Mike O60488 2182 ACSL4 Homo sapiens 9606 Comment/Involvement in disease R133C; In a colorectal cancer sample; somatic mutation. colorectal cancer DOID:9256 VAR_036376 Y Y ECO:0000269 PubMed:16959974 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, AAP-M, ASD 11/28/2012 131 3300006094 Mike O60488 2182 ACSL4 Homo sapiens 9606 Comment/Involvement in disease R570S; In MRX63. MIM:300387 non-specific X-linked mental retardation DOID:0050776 VAR_013180 Y Y ECO:0000269 PubMed:11889465 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, AAP-M, ASD 11/28/2012 131 3300006096 Katie Q9ULC5 51703 ACSL5 Homo sapiens 9606 Comment/Involvement in disease G466D; In a colorectal cancer sample; somatic mutation. colorectal cancer DOID:9256 VAR_036378 Y Y ECO:0000006 PubMed:16959974 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, AAP-M 11/28/2012 121 3300006101 Katie Q9ULC5 51703 ACSL5 Homo sapiens 9606 Comment/Involvement in disease K388R; In a colorectal cancer sample; somatic mutation. colorectal cancer DOID:9256 VAR_036377 Y Y ECO:0000006 PubMed:16959974 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, AAP-M 11/28/2012 121 3300006103 Mike O15120 10555 AGPAT2 Homo sapiens 9606 Comment/Involvement in disease 140; In CGL1. MIM:608594 congenital generalized lipodystrophy DOID:0050585 VAR_017326 Y Y ECO:0000269 PubMed:11967537 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 1/9/2013 119 3300006118 Mike O15120 10555 AGPAT2 Homo sapiens 9606 Comment/Involvement in disease A239V; In CGL1. MIM:608594 congenital generalized lipodystrophy DOID:0050585 VAR_017325 Y Y ECO:0000269 PubMed:11967537 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 1/9/2013 119 3300006120 Mike O15120 10555 AGPAT2 Homo sapiens 9606 Comment/Involvement in disease G136R; In CGL1. MIM:608594 congenital generalized lipodystrophy DOID:0050585 VAR_017328 Y Y ECO:0000269 PubMed:11967537 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 1/9/2013 119 3300006122 Mike O15120 10555 AGPAT2 Homo sapiens 9606 Comment/Involvement in disease L228P; In CGL1. MIM:608594 congenital generalized lipodystrophy DOID:0050585 VAR_017327 Y Y ECO:0000269 PubMed:11967537 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 1/9/2013 119 3300006124 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/Involvement in disease H578Q; In NCIE. MIM:242100 congenital ichthyosiform erythroderma DOID:1699 VAR_015174 Y Y ECO:0000269 PubMed:11773004 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 116 3300006151 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/Involvement in disease L426P; In NCIE. MIM:242100 congenital ichthyosiform erythroderma DOID:1699 VAR_015173 Y Y ECO:0000269 PubMed:11773004 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 116 3300006153 Katie Q9BYJ1 59344 ALOXE3 Homo sapiens 9606 Comment/Involvement in disease R396S; In NCIE. MIM:242100 congenital ichthyosiform erythroderma DOID:1699 VAR_015175 Y Y ECO:0000006 PubMed:11773004 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 104 3300006194 Katie Q9BYJ1 59344 ALOXE3 Homo sapiens 9606 Comment/Involvement in disease V500F; In NCIE. MIM:242100 congenital ichthyosiform erythroderma DOID:1699 VAR_015176 Y Y ECO:0000006 PubMed:11773004 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 104 3300006196 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease A119S; In allele CYP1B1*2, allele CYP1B1*6 and allele CYP1B1*7; significantly associated with breast or lung cancer; no significant change in 17beta-estradiol 2- and 4-hydroxylation activities and 17beta-estradiol affinity; 1.5-fold reduction in testosterone affinity but nearly no change in testosterone 6beta-hydroxylation activity; 2-fold increase in progesterone 6beta- and 16alpha-hydroxylation activities and 5-fold reduction in progesterone affinity; dbSNP:rs1056827. breast cancer DOID:1612 VAR_011753 rs1056827 Y Y ECO:0000006 PubMed:10426814 PubMed:10655546 PubMed:11527932 PubMed:12036985 PubMed:14635112 PubMed:12525557 PubMed:15475877 PubMed:16688110 submission: PubMed:11854439 PubMed:10739169 UniProtKB TBD ver_2Variant has mixed effects on enzyme activity, did not change qualifier#ORIGINAL data type: Feature/sequence variant Variant has mixed effects on enzyme activity, did not change qualifier#ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006259 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease A119S; In allele CYP1B1*2, allele CYP1B1*6 and allele CYP1B1*7; significantly associated with breast or lung cancer; no significant change in 17beta-estradiol 2- and 4-hydroxylation activities and 17beta-estradiol affinity; 1.5-fold reduction in testosterone affinity but nearly no change in testosterone 6beta-hydroxylation activity; 2-fold increase in progesterone 6beta- and 16alpha-hydroxylation activities and 5-fold reduction in progesterone affinity; dbSNP:rs1056827. lung cancer DOID:1324 VAR_011753 rs1056827 Y Y ECO:0000006 PubMed:10426814 PubMed:10655546 PubMed:11527932 PubMed:12036985 PubMed:14635112 PubMed:12525557 PubMed:15475877 PubMed:16688110 submission: PubMed:11854439 PubMed:10739169 UniProtKB TBD ver_2Variant has mixed effects on enzyme activity, did not change qualifier#ORIGINAL data type: Feature/sequence variant Variant has mixed effects on enzyme activity, did not change qualifier#ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006261 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease D374N; In GLC3A; dbSNP:rs28936413. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_001246 rs28936413 Y Y ECO:0000006 PubMed:9463332 PubMed:10655546 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006266 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease R368H; In GLC3A and glaucoma; digenic early-onset; this mutation may act as a modifier of MYOC mutant phenotype; dbSNP:rs28936414. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_016034 rs28936414 Y Y ECO:0000006 PubMed:10655546 PubMed:11774072 PubMed:11980847 PubMed:12036985 PubMed:15475877 PubMed:16490498 PubMed:16735994 PubMed:16688110 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006268 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease G61E; In GLC3A and POAG; allele CYP1B1*12; reduces enzymatic activity; dbSNP:rs28936700. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_001244 rs28936700 Y Y ECO:0000006 PubMed:9463332 PubMed:9497261 PubMed:10655546 PubMed:11980847 PubMed:16490498 PubMed:16735994 PubMed:18470941 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006270 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease G61E; In GLC3A and POAG; allele CYP1B1*12; reduces enzymatic activity; dbSNP:rs28936700. MIM:137760 primary open angle glaucoma DOID:1070 VAR_001244 rs28936700 Y Y ECO:0000006 PubMed:9463332 PubMed:9497261 PubMed:10655546 PubMed:11980847 PubMed:16490498 PubMed:16735994 PubMed:18470941 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006272 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease R469W; In GLC3A; allele CYP1B1*25; dbSNP:rs28936701. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_001247 rs28936701 Y Y ECO:0000006 PubMed:9463332 PubMed:9497261 PubMed:10655546 PubMed:16735994 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006274 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease A443G; In GLC3A and POAG; allele CYP1B1*7; unproven pathogenicity; dbSNP:rs4986888. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_018774 rs4986888 Y Y ECO:0000006 PubMed:12036985 PubMed:15342693 PubMed:16862072 PubMed:11854439 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006277 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease A443G; In GLC3A and POAG; allele CYP1B1*7; unproven pathogenicity; dbSNP:rs4986888. MIM:137760 primary open angle glaucoma DOID:1070 VAR_018774 rs4986888 Y Y ECO:0000006 PubMed:12036985 PubMed:15342693 PubMed:16862072 PubMed:11854439 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006279 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease G365W; In GLC3A; allele CYP1B1*18; dbSNP:rs55771538. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_001245 rs55771538 Y Y ECO:0000006 PubMed:9497261 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006281 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease E387K; In GLC3A and POAG; allele CYP1B1*20; dbSNP:rs55989760. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_008352 rs55989760 Y Y ECO:0000006 PubMed:9497261 PubMed:10227395 PubMed:12036985 PubMed:14635112 PubMed:15342693 PubMed:16735994 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006283 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease E387K; In GLC3A and POAG; allele CYP1B1*20; dbSNP:rs55989760. MIM:137760 primary open angle glaucoma DOID:1070 VAR_008352 rs55989760 Y Y ECO:0000006 PubMed:9497261 PubMed:10227395 PubMed:12036985 PubMed:14635112 PubMed:15342693 PubMed:16735994 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006285 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease R390H; In GLC3A; allele CYP1B1*21; dbSNP:rs56010818. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_008353 rs56010818 Y Y ECO:0000006 PubMed:9497261 PubMed:15342693 PubMed:15475877 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006287 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease P437L; In GLC3A; allele CYP1B1*23; dbSNP:rs56175199. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_008354 rs56175199 Y Y ECO:0000006 PubMed:9497261 PubMed:12036985 PubMed:15475877 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006289 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease E229K; In GLC3A and POAG; juvenile-onset; hypomorphic allele; reduces the abundance of the enzyme; dbSNP:rs57865060. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054243 rs57865060 Y Y ECO:0000006 PubMed:11980847 PubMed:14635112 PubMed:15342693 PubMed:15475877 PubMed:16735994 PubMed:18470941 PubMed:16688110 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006292 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease E229K; In GLC3A and POAG; juvenile-onset; hypomorphic allele; reduces the abundance of the enzyme; dbSNP:rs57865060. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054243 rs57865060 Y Y ECO:0000006 PubMed:11980847 PubMed:14635112 PubMed:15342693 PubMed:15475877 PubMed:16735994 PubMed:18470941 PubMed:16688110 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006294 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease V198I; In GLC3A; dbSNP:rs59472972. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054240 rs59472972 Y Y ECO:0000006 PubMed:11527932 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006296 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease Y81N; In POAG; adult-onset; hypomorphic allele; reduces the abundance of the enzyme; dbSNP:rs9282671. MIM:137760 primary open angle glaucoma DOID:1070 VAR_028736 rs9282671 Y Y ECO:0000006 PubMed:15342693 PubMed:16735994 PubMed:18470941 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006299 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease 269-271; In GLC3A and POAG. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054246 Y Y ECO:0000311 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006303 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease 269-271; In GLC3A and POAG. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054246 Y Y ECO:0000311 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006305 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease 355-358; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054252 Y Y ECO:0000311 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006307 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease 343; In GLC3A; reduces enzymatic activity and also the abundance of the enzyme. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054250 Y Y ECO:0000006 PubMed:16735994 PubMed:18470941 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006309 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease A115P; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054230 Y Y ECO:0000006 PubMed:15475877 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006311 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease A189P; Associated with ocular hypertension susceptibility. ocular hypertension DOID:9282 VAR_054237 Y Y ECO:0000006 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006313 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease A330F; In GLC3A; requires 2 nucleotide substitutions; uncertain pathogenicity. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054248 Y Y ECO:0000006 PubMed:11527932 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006315 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease A330S; Associated with ocular hypertension susceptibility. ocular hypertension DOID:9282 VAR_054249 Y Y ECO:0000006 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006317 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease A388T; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054254 Y Y ECO:0000006 PubMed:16490498 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006319 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease D192V; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054238 Y Y ECO:0000006 PubMed:11527932 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006321 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease D530G; In POAG. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054268 Y Y ECO:0000006 PubMed:16688110 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006323 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease E499G; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054264 Y Y ECO:0000006 PubMed:11527932 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006325 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease F445C; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054262 Y Y ECO:0000006 PubMed:14640115 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006327 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease G232R; In GLC3A and POAG; adult-onset. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054244 Y Y ECO:0000006 PubMed:14635112 PubMed:15342693 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006330 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease G232R; In GLC3A and POAG; adult-onset. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054244 Y Y ECO:0000006 PubMed:14635112 PubMed:15342693 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006332 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease G466D; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054263 Y Y ECO:0000006 PubMed:15475877 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006334 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease I399S; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054257 Y Y ECO:0000006 PubMed:14635112 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006336 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease L345F; In POAG. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054251 Y Y ECO:0000006 PubMed:11774072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006338 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease L77P; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054229 Y Y ECO:0000006 PubMed:10655546 PubMed:15475877 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006340 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease M132R; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054231 Y Y ECO:0000006 PubMed:15475877 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006342 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease N203S; In GLC3A; reduces enzymatic activity. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054241 Y Y ECO:0000006 PubMed:18470941 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006344 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease N423Y; In GLC3A and POAG; juvenile-onset. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054260 Y Y ECO:0000006 PubMed:14635112 PubMed:15342693 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006346 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease N423Y; In GLC3A and POAG; juvenile-onset. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054260 Y Y ECO:0000006 PubMed:14635112 PubMed:15342693 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006348 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease P193L; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054239 Y Y ECO:0000006 PubMed:11980847 PubMed:15475877 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006350 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease Q144P; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054233 Y Y ECO:0000006 PubMed:15475877 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006354 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease Q144R; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054234 Y Y ECO:0000006 PubMed:14640115 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006356 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease R145W; In POAG. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054235 Y Y ECO:0000006 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006358 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease R390C; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054255 Y Y ECO:0000006 PubMed:15475877 PubMed:15255109 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006360 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease R390S; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054256 Y Y ECO:0000006 PubMed:10655546 PubMed:14635112 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006362 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease R444Q; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054261 Y Y ECO:0000006 PubMed:11527932 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006364 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease R523T; In POAG; juvenile-onset. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054267 Y Y ECO:0000006 PubMed:16688110 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006366 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease S215I; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054242 Y Y ECO:0000006 PubMed:12525557 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006368 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease S239R; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054245 Y Y ECO:0000006 PubMed:15475877 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006370 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease S28W; In POAG. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054227 Y Y ECO:0000006 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006372 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease S515L; In POAG; uncertain pathogenicity. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054265 Y Y ECO:0000006 PubMed:16688110 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006374 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease V320L; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054247 Y Y ECO:0000006 PubMed:11527932 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006376 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease V364M; In GLC3A. MIM:231300 primary congenital glaucoma DOID:0050593 VAR_054253 Y Y ECO:0000006 PubMed:11184479 PubMed:11527932 PubMed:12525557 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006378 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease V409F; In POAG. MIM:137760 primary open angle glaucoma DOID:1070 VAR_054258 Y Y ECO:0000006 PubMed:16862072 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006380 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease W57C; In POAG; juvenile onset; allele CYP1B1*11. MIM:137760 primary open angle glaucoma DOID:1070 VAR_008350 Y Y ECO:0000006 PubMed:9497261 PubMed:16688110 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 148 3300006384 Faith Q02928 1579 CYP4A11 Homo sapiens 9606 Comment/Involvement in disease F434S; Associated with hypertension; significantly reduced arachidonic acid and lauric acid metabolizing activity; dbSNP:rs1126742. hypertension DOID:10763 VAR_019160 rs1126742 Y Y ECO:0000006 PubMed:15611369 PubMed:8363569 PubMed:15895287 PubMed:8274222 submission: UniProtKB May want to change to Decrease#ORIGINAL data type: Feature/sequence variant May want to change to Decrease#ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 121 3300006526 Faith Q6NT55 126410 CYP4F22 Homo sapiens 9606 Comment/Involvement in disease F59L; In LI3. MIM:604777 ichthyosis DOID:1697 VAR_037441 Y Y ECO:0000006 PubMed:16436457 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 84 3300006558 Faith Q6NT55 126410 CYP4F22 Homo sapiens 9606 Comment/Involvement in disease H435Y; In LI3. MIM:604777 ichthyosis DOID:1697 VAR_037444 Y Y ECO:0000006 PubMed:16436457 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 84 3300006560 Faith Q6NT55 126410 CYP4F22 Homo sapiens 9606 Comment/Involvement in disease H436D; In LI3. MIM:604777 ichthyosis DOID:1697 VAR_037445 Y Y ECO:0000006 PubMed:16436457 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 84 3300006562 Faith Q6NT55 126410 CYP4F22 Homo sapiens 9606 Comment/Involvement in disease R243H; In LI3. MIM:604777 ichthyosis DOID:1697 VAR_037442 Y Y ECO:0000006 PubMed:16436457 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 84 3300006564 Faith Q6NT55 126410 CYP4F22 Homo sapiens 9606 Comment/Involvement in disease R372W; In LI3. MIM:604777 ichthyosis DOID:1697 VAR_037443 Y Y ECO:0000006 PubMed:16436457 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 84 3300006566 Katie P16444 1800 DPEP1 Homo sapiens 9606 Comment/Involvement in disease R246H; In a colorectal cancer sample; somatic mutation. colorectal cancer DOID:9256 VAR_036496 Y Y ECO:0000006 PubMed:16959974 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 2/6/2013 143 3300006580 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity P19440-3;Isoform 3 lung BTO:0000763 VSP_008132 Produced by alternative promoter usage. Y Y ECO:0000311 UniProtKB Isoform 3 lung specific (see tissue comment).#ORIGINAL data type: Comment/alternative products/isoform Isoform 3 lung specific (see tissue comment).#ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 11/28/2012 148 3300006611 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity P19440-3;Isoform 3 lung UBERON:0002048 VSP_008132 Produced by alternative promoter usage. Y Y ECO:0000311 UniProtKB Isoform 3 lung specific (see tissue comment).#ORIGINAL data type: Comment/alternative products/isoform Isoform 3 lung specific (see tissue comment).#ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 11/28/2012 148 3300006612 Katie P36969 2879 GPX4 Homo sapiens 9606 Comment/Involvement in disease A120T; In a patient affected by cryptorchidism. cryptorchidism DOID:11383 VAR_017064 Y Y ECO:0000006 PubMed:12606444 UniProtKB TBD ver_2Reviewed by Faith#ORIGINAL data type: Feature/sequence variant Reviewed by Faith#ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 137 3300006675 Katie P15428 3248 HPGD Homo sapiens 9606 Comment/Involvement in disease A140P; In COA; inactive. MIM:259100 primary hypertrophic osteoarthropathy DOID:14283 VAR_046209 Y Y ECO:0000006 PubMed:18500342 UniProtKB Normal -> abolished#ORIGINAL data type: Feature/sequence variant Normal -> abolished#ORIGINAL data type: Feature/sequence variant AAP, ASD 2/6/2013 135 3300006694 Katie P15428 3248 HPGD Homo sapiens 9606 Comment/Involvement in disease S193P; In ICNC. MIM:119900 skin disease DOID:37 VAR_060792 Y Y ECO:0000006 PubMed:18805827 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 2/6/2013 135 3300006696 Katie P15428 3248 HPGD Homo sapiens 9606 Comment/Involvement in disease S193P; In ICNC. MIM:119900 Hereditary clubbing SNOMEDCT:239055005 VAR_060792 Y Y ECO:0000006 PubMed:18805827 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 2/6/2013 135 3300006698 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease A117T; In LCATD; dbSNP:rs28940886. MIM:245900 Norum disease DOID:1391 VAR_004255 rs28940886 Y Y ECO:0000006 PubMed:8432868 PubMed:8318557 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006713 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease R159W; In LCATD; dbSNP:rs28940887. MIM:245900 Norum disease DOID:1391 VAR_004257 rs28940887 Y Y ECO:0000006 PubMed:8432868 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006715 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease T345M; In LCATD; dbSNP:rs28940888. MIM:245900 Norum disease DOID:1391 VAR_004266 rs28940888 Y Y ECO:0000006 PubMed:8432868 PubMed:12957688 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006717 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease L233P; In LCATD; dbSNP:rs28942087. MIM:245900 Norum disease DOID:1391 VAR_004262 rs28942087 Y Y ECO:0000006 PubMed:8432868 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006719 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease F406V; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039038 Y Y ECO:0000006 PubMed:12957688 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006724 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease G54S; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_004253 Y Y ECO:0000006 PubMed:8807342 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006726 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease G57R; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_004254 Y Y ECO:0000006 PubMed:7711728 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006728 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease K242N; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039031 Y Y ECO:0000006 PubMed:15994445 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006731 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease L17LLLPPAAPFWL; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_004251 Y Y ECO:0000311 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006733 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease L338F; In FED; results in reduced protein secretion and activity. MIM:136120 corneal dystrophy DOID:2566 VAR_066867 Y Y ECO:0000006 PubMed:21901787 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006735 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease L396R; In a patient with LCATD. MIM:245900 Norum disease DOID:1391 VAR_039037 Y Y ECO:0000006 PubMed:15994445 PubMed:16874701 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006737 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease M276K; In FED. MIM:136120 corneal dystrophy DOID:2566 VAR_004264 Y Y ECO:0000006 PubMed:1516702 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006739 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease M317I; In LCATD; partially defective enzyme. MIM:245900 Norum disease DOID:1391 VAR_004265 Y Y ECO:0000006 PubMed:1681161 PubMed:1859405 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006741 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease N252K; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_004263 Y Y ECO:0000006 PubMed:1681161 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006743 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease N29I; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039020 Y Y ECO:0000006 PubMed:9007616 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006745 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease P331S; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039035 Y Y ECO:0000006 PubMed:9741700 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006747 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease P34L; In FED. MIM:136120 corneal dystrophy DOID:2566 VAR_004252 Y Y ECO:0000006 PubMed:1571050 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006749 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease P34Q; In FED. MIM:136120 corneal dystrophy DOID:2566 VAR_039021 Y Y ECO:0000006 PubMed:8620346 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006751 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease R123C; In FED. MIM:136120 corneal dystrophy DOID:2566 VAR_039026 Y Y ECO:0000006 PubMed:9261271 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006753 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease R159Q; In FED. MIM:136120 corneal dystrophy DOID:2566 VAR_039027 Y Y ECO:0000006 PubMed:8620346 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006755 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease R164C; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039028 Y Y ECO:0000006 PubMed:15994445 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006757 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease R164H; In LCATD; also in a compound heterozygote carrying R-95 with intermediate phenotype between LCATD and FED; loss of activity. MIM:245900 Norum disease DOID:1391 VAR_004258 Y Y ECO:0000006 PubMed:7607641 PubMed:16216249 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006759 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease R171W; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_004259 Y Y ECO:0000006 PubMed:2370048 PubMed:15994445 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006761 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease R268H; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039032 Y Y ECO:0000006 PubMed:15994445 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006765 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease R347C; In FED; results in reduced activity. MIM:136120 corneal dystrophy DOID:2566 VAR_066868 Y Y ECO:0000006 PubMed:21901787 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006768 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease S205N; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039030 Y Y ECO:0000006 PubMed:15994445 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006771 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease T147I; In FED. MIM:136120 corneal dystrophy DOID:2566 VAR_004256 Y Y ECO:0000006 PubMed:1737840 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006773 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease T298A; In FED and LCATD. MIM:136120 corneal dystrophy DOID:2566 VAR_039033 Y Y ECO:0000006 PubMed:11423760 PubMed:15994445 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006775 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease T298A; In FED and LCATD. MIM:245900 Norum disease DOID:1391 VAR_039033 Y Y ECO:0000006 PubMed:11423760 PubMed:15994445 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006777 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease T298I; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039034 Y Y ECO:0000006 PubMed:15994445 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006779 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease T371M; In FED. MIM:136120 corneal dystrophy DOID:2566 VAR_004267 Y Y ECO:0000006 PubMed:1737840 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006781 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease T37M; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039022 Y Y ECO:0000006 PubMed:9741700 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006783 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease V333M; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_039036 Y Y ECO:0000006 PubMed:15994445 PubMed:16051254 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006786 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease V70E; In FED. MIM:136120 corneal dystrophy DOID:2566 VAR_039023 Y Y ECO:0000006 PubMed:15994445 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006788 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease W99S; In FED; loss of activity. MIM:136120 corneal dystrophy DOID:2566 VAR_066862 Y Y ECO:0000006 PubMed:21901787 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006790 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease Y180N; In LCATD. MIM:245900 Norum disease DOID:1391 VAR_004260 Y Y ECO:0000311 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA 11/28/2012 141 3300006792 Rose P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease H129P; In CESD. MIM:278000 Wolman disease DOID:14497 VAR_004248 Y Y ECO:0000006 PubMed:9633819 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 128 3300006798 Rose P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease H129P; In CESD. MIM:278000 Wolman's disease SNOMEDCT:82500001 VAR_004248 Y Y ECO:0000006 PubMed:9633819 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 128 3300006800 Rose P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease H129R; In CESD. MIM:278000 Wolman disease DOID:14497 VAR_004249 Y Y ECO:0000006 PubMed:9633819 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 128 3300006802 Rose P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease H129R; In CESD. MIM:278000 Wolman's disease SNOMEDCT:82500001 VAR_004249 Y Y ECO:0000006 PubMed:9633819 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 128 3300006804 Rose P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease L200P; In CESD and WOD. MIM:278000 Wolman disease DOID:14497 VAR_004250 Y Y ECO:0000006 PubMed:8146180 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 128 3300006806 Rose P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease L200P; In CESD and WOD. MIM:278000 Wolman's disease SNOMEDCT:82500001 VAR_004250 Y Y ECO:0000006 PubMed:8146180 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP 11/28/2012 128 3300006808 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/tissue specificity Q05469-1;Isoform 1;Testicular testis BTO:0001363 Y Y ECO:0000311 UniProtKB TBD ver_2full length#ORIGINAL data type: Comment/alternative products/isoform full length#ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 11/28/2012 118 3300006811 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/tissue specificity Q05469-1;Isoform 1;Testicular testis UBERON:0000473 Y Y ECO:0000311 UniProtKB TBD ver_2full length#ORIGINAL data type: Comment/alternative products/isoform full length#ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 11/28/2012 118 3300006812 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/Involvement in disease P146Q; In a breast cancer sample; somatic mutation. breast cancer DOID:1612 VAR_036539 Y Y ECO:0000006 PubMed:16959974 UniProtKB TBD ver_2breast cancer sample#ORIGINAL data type: Feature/sequence variant breast cancer sample#ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 11/28/2012 118 3300006823 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006838 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. fibroblast BTO:0000452 fibroblast CL:0000057 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006839 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. lymphocyte BTO:0000775 lymphocyte CL:0000542 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006840 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. monocyte BTO:0000876 monocyte CL:0000576 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006841 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. neutrophil BTO:0000130 neutrophil CL:0000775 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006842 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. reticulocyte BTO:0001173 reticulocyte CL:0000558 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006843 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006844 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. fibroblast BTO:0000452 fibroblast CL:0000057 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006845 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. lymphocyte BTO:0000775 lymphocyte CL:0000542 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006846 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. monocyte BTO:0000876 monocyte CL:0000576 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006847 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. neutrophil BTO:0000130 neutrophil CL:0000775 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006848 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity Isoform 1 and isoform 2 are expressed in monocytes, lymphocytes, neutrophils, reticulocytes, platelets and fibroblasts. reticulocyte BTO:0001173 reticulocyte CL:0000558 Y Y ECO:0000311 UniProtKB AAP, ASD 2/6/2013 161 3300006849 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/Involvement in disease H442Q; In a breast cancer sample; somatic mutation. breast cancer DOID:1612 VAR_035826 Y Y ECO:0000006 PubMed:16959974 UniProtKB #ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 140 3300006960 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/Involvement in disease G45C; In FRFB. MIM:228980 retinal disease DOID:5679 VAR_067343 Y Y ECO:0000006 PubMed:22137173 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 123 3300007008 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/Involvement in disease G45C; In FRFB. MIM:228980 Retinal flecking SNOMEDCT:247138002 VAR_067343 Y Y ECO:0000006 PubMed:22137173 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 123 3300007010 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/Involvement in disease G49S; In FRFB. MIM:228980 retinal disease DOID:5679 VAR_067344 Y Y ECO:0000006 PubMed:22137173 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 123 3300007012 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/Involvement in disease G49S; In FRFB. MIM:228980 Retinal flecking SNOMEDCT:247138002 VAR_067344 Y Y ECO:0000006 PubMed:22137173 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, ASD 11/28/2012 123 3300007014 Mike O60733 8398 PLA2G6 Homo sapiens 9606 Comment/miscellaneous 691; In NBIA2A. MIM:256600 VAR_029374 Y Y ECO:0000006 PubMed:16783378 PubMed:17033970 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 1/9/2013 128 3300007022 Mike O60733 8398 PLA2G6 Homo sapiens 9606 Comment/miscellaneous K545T; In NBIA2B. MIM:610217 VAR_029372 Y Y ECO:0000006 PubMed:16783378 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 1/9/2013 128 3300007024 Mike O60733 8398 PLA2G6 Homo sapiens 9606 Comment/miscellaneous R632W; In NBIA2B. MIM:610217 VAR_029373 Y Y ECO:0000006 PubMed:16783378 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 1/9/2013 128 3300007026 Mike O60733 8398 PLA2G6 Homo sapiens 9606 Comment/Involvement in disease R741Q; In PARK14. MIM:612953 Parkinson's disease DOID:14330 VAR_062530 Y Y ECO:0000006 PubMed:18570303 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 1/9/2013 128 3300007028 Mike O60733 8398 PLA2G6 Homo sapiens 9606 Comment/Involvement in disease R747W; In PARK14. MIM:612953 Parkinson's disease DOID:14330 VAR_062531 Y Y ECO:0000006 PubMed:18570303 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 1/9/2013 128 3300007030 Mike O60733 8398 PLA2G6 Homo sapiens 9606 Comment/miscellaneous V310E; In NBIA2A. MIM:256600 VAR_029371 Y Y ECO:0000006 PubMed:16783378 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 1/9/2013 128 3300007032 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-1;Isoform 1 heart BTO:0000562 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007100 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-1;Isoform 1 heart UBERON:0000948 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007101 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-1;Isoform 1 placenta BTO:0001078 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007102 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-1;Isoform 1 placenta UBERON:0001987 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007103 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-2;Isoform 2;FP(S) heart BTO:0000562 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007104 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-2;Isoform 2;FP(S) heart UBERON:0000948 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007105 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-2;Isoform 2;FP(S) placenta BTO:0001078 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007106 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-2;Isoform 2;FP(S) placenta UBERON:0001987 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007107 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-2;Isoform 2;FP(S) skeletal muscle BTO:0001103 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007108 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-2;Isoform 2;FP(S) skeletal muscle tissue UBERON:0001134 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007109 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity P43088-2;Isoform 2;FP(S) HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y PubMed:14984197 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, ASD 4/21/2014 3 3300007110 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha placenta BTO:0001078 Y Y PubMed:8034687 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007152 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha placenta UBERON:0001987 Y Y PubMed:8034687 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007153 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha blood platelet BTO:0000132 platelet CL:0000233 Y Y PubMed:8613548 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007154 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha HEL 92.1.7 cell CLO:0003682 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007155 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha aortic smooth muscle cell BTO:0004577 immortal smooth muscle cell line cell CLO:0000078 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007156 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha aortic smooth muscle cell BTO:0004577 fetus BTO:0000449 immortal smooth muscle cell line cell CLO:0000078 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007157 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha uterus BTO:0001424 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007158 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha uterus UBERON:0000995 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007159 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha HUVEC cell BTO:0001949 Y Y PubMed:9838218 PENTACON Does not agree with 8034687#ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007160 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha brain BTO:0000142 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007161 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha brain UBERON:0000955 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007162 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha brain BTO:0000142 fetus BTO:0000449 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007163 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha brain UBERON:0000955 fetus BTO:0000449 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007164 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha thymus BTO:0001374 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007165 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha thymus UBERON:0002370 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007166 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha small intestine BTO:0000651 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007167 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha small intestine UBERON:0002108 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007168 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha liver BTO:0000759 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007169 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha liver UBERON:0002107 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007170 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-3;Isoform 1;Alpha bronchial smooth muscle cell BTO:0004402 bronchial smooth muscle cell CL:0002598 Y Y PubMed:12921856 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007171 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta HUVEC cell BTO:0001949 Y Y PubMed:8034687 PubMed:9838218 PENTACON down regulated when stimulated with endoperoxide analog U46619#ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007172 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta placenta BTO:0001078 Y Y PubMed:8034687 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007173 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta placenta UBERON:0001987 Y Y PubMed:8034687 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007174 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta blood platelet BTO:0000132 platelet CL:0000233 Y Y PubMed:8613548 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007175 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta HEL 92.1.7 cell CLO:0003682 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007176 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta aortic smooth muscle cell BTO:0004577 immortal smooth muscle cell line cell CLO:0000078 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007177 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta aortic smooth muscle cell BTO:0004577 fetus BTO:0000449 immortal smooth muscle cell line cell CLO:0000078 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007178 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta uterus BTO:0001424 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007179 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta uterus UBERON:0000995 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007180 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta brain BTO:0000142 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007181 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta brain UBERON:0000955 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007182 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta brain BTO:0000142 fetus BTO:0000449 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007183 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta brain UBERON:0000955 fetus BTO:0000449 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007184 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta thymus BTO:0001374 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007185 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta thymus UBERON:0002370 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007186 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta small intestine BTO:0000651 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007187 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta small intestine UBERON:0002108 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007188 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta liver BTO:0000759 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007189 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta liver UBERON:0002107 Y Y PubMed:9838218 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007190 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity P21731-2;Isoform 2;Beta bronchial smooth muscle cell BTO:0004402 bronchial smooth muscle cell CL:0002598 Y Y PubMed:12921856 PENTACON #ORIGINAL data type: Comment/alternative products/isoform AAP, DGA, ASD 4/21/2014 3 3300007191 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/Involvement in disease G481W; In GHDD. MIM:231095 bone disease DOID:0080001 VAR_044389 Y Y ECO:0000006 PubMed:18264100 UniProtKB TBD ver_2HDO term more general than OMIM.#ORIGINAL data type: Feature/sequence variant HDO term more general than OMIM.#ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 2/6/2013 147 3300007226 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/Involvement in disease L487P; In GHDD. MIM:231095 bone disease DOID:0080001 VAR_044390 Y Y ECO:0000006 PubMed:18264100 UniProtKB TBD ver_2HDO term more general than OMIM.#ORIGINAL data type: Feature/sequence variant HDO term more general than OMIM.#ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 2/6/2013 147 3300007228 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/Involvement in disease L82P; In GHDD. MIM:231095 bone disease DOID:0080001 VAR_044386 Y Y ECO:0000006 PubMed:18264100 UniProtKB TBD ver_2HDO term more general than OMIM.#ORIGINAL data type: Feature/sequence variant HDO term more general than OMIM.#ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 2/6/2013 147 3300007230 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/Involvement in disease R412Q; In GHDD. MIM:231095 bone disease DOID:0080001 VAR_044388 Y Y ECO:0000006 PubMed:18264100 UniProtKB TBD ver_2HDO term more general than OMIM.#ORIGINAL data type: Feature/sequence variant HDO term more general than OMIM.#ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 2/6/2013 147 3300007233 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/Involvement in disease R85W; In a breast cancer sample; somatic mutation. breast cancer DOID:1612 VAR_036294 Y Y ECO:0000006 PubMed:16959974 UniProtKB TBD ver_2#ORIGINAL data type: Feature/sequence variant #ORIGINAL data type: Feature/sequence variant AAP, DGA, ASD 2/6/2013 147 3300007237 Faith P33527 4363 ABCC1 Homo sapiens 9606 Comment/tissue specificity Lung, testis and peripheral blood mononuclear cells. peripheral blood mononuclear cell BTO:0001025 mononuclear cell CL:0000842 Y Y UniProtKB no PBMC in CL AAP, DGA, AAP-M, ASD 5/1/2013 139 3300007239 Faith P33527 4363 ABCC1 Homo sapiens 9606 Comment/function Mediates export of organic anions and drugs from the cytoplasm. Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o-glucuronide, methotrexate, antiviral drugs and other xenobiotics. Confers resistance to anticancer drugs. Hydrolyzes ATP with low efficiency. Y Y ECO:0000269 PubMed:10064732 PubMed:11114332 PubMed:16230346 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, AAP-M, ASD 5/1/2013 139 3300007240 Faith P33527 4363 ABCC1 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB linked to Reactome and GO Ref in GO AAP, DGA, AAP-M, ASD 5/1/2013 139 3300007241 Faith P33527 4363 ABCC1 Homo sapiens 9606 Comment/tissue specificity Lung, testis and peripheral blood mononuclear cells. lung BTO:0000763 Y Y UniProtKB AAP, DGA, AAP-M, ASD 5/1/2013 139 3300007242 Faith P33527 4363 ABCC1 Homo sapiens 9606 Comment/tissue specificity Lung, testis and peripheral blood mononuclear cells. lung UBERON:0002048 Y Y UniProtKB AAP, DGA, AAP-M, ASD 5/1/2013 139 3300007243 Faith P33527 4363 ABCC1 Homo sapiens 9606 Comment/tissue specificity Lung, testis and peripheral blood mononuclear cells. testis BTO:0001363 Y Y UniProtKB AAP, DGA, AAP-M, ASD 5/1/2013 139 3300007244 Faith P33527 4363 ABCC1 Homo sapiens 9606 Comment/tissue specificity Lung, testis and peripheral blood mononuclear cells. testis UBERON:0000473 Y Y UniProtKB AAP, DGA, AAP-M, ASD 5/1/2013 139 3300007245 Faith O15439 10257 ABCC4 Homo sapiens 9606 Comment/function May be an organic anion pump relevant to cellular detoxification. Y Y UniProtKB AAP, AAP-M, ASD 5/1/2013 126 3300007246 Faith O15439 10257 ABCC4 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with particularly high levels in prostate, but is barely detectable in liver. prostate gland BTO:0001129 Y Y UniProtKB AAP, AAP-M, ASD 5/1/2013 126 3300007249 Faith O15439 10257 ABCC4 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with particularly high levels in prostate, but is barely detectable in liver. prostate gland UBERON:0002367 Y Y UniProtKB AAP, AAP-M, ASD 5/1/2013 126 3300007250 Faith O15439 10257 ABCC4 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with particularly high levels in prostate, but is barely detectable in liver. liver BTO:0000759 Y Y UniProtKB barely detectable AAP, AAP-M, ASD 5/1/2013 126 3300007251 Faith O15439 10257 ABCC4 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with particularly high levels in prostate, but is barely detectable in liver. liver UBERON:0002107 Y Y UniProtKB barely detectable AAP, AAP-M, ASD 5/1/2013 126 3300007252 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. brain BTO:0000142 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007258 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. brain UBERON:0000955 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007259 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. heart BTO:0000562 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007260 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. heart UBERON:0000948 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007261 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. kidney BTO:0000671 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007262 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007263 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. liver BTO:0000759 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007264 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. liver UBERON:0002107 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007265 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007266 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/tissue specificity Ubiquitously expressed in most normal human tissues and cancer cell lines with high level of expression in heart, skeletal muscles, brain, kidney and liver. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:12359260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 109 3300007267 Katie Q9H845 28976 ACAD9 Homo sapiens 9606 EC 1.3.99.- Y Y ECO:0000311 EC number UniProtKB AAP 2/6/2013 109 3300007268 Rose P24752 38 ACAT1 Homo sapiens 9606 Comment/function Plays a major role in ketone body metabolism. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 141 3300007269 Rose P24752 38 ACAT1 Homo sapiens 9606 EC 2.3.1.9 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 141 3300007272 Faith Q86TX2 641371 ACOT1 Homo sapiens 9606 EC 3.1.2.2 Y Y EC number UniProtKB AAP 5/1/2013 87 3300007273 Faith Q86TX2 641371 ACOT1 Homo sapiens 9606 Comment/function Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH. Active towards fatty acyl-CoA with chain-lengths of C12-C16 (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 87 3300007274 Faith Q8WXI4 26027 ACOT11 Homo sapiens 9606 EC 3.1.2.- Y Y EC number UniProtKB AAP 5/1/2013 113 3300007276 Faith Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/function Has acyl-CoA thioesterase activity towards medium (C12) and long-chain (C18) fatty acyl-CoA substrates. Y Y UniProtKB AAP 5/1/2013 113 3300007277 Faith Q9NPJ3 55856 ACOT13 Homo sapiens 9606 EC 3.1.2.- Y Y EC number UniProtKB AAP, ASD 5/29/2013 101 3300007281 Faith P49753 10965 ACOT2 Homo sapiens 9606 EC 3.1.2.2 Y Y EC number UniProtKB AAP 5/29/2013 127 3300007285 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/function Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH. Displays high levels of activity on medium- and long chain acyl CoAs. Y Y ECO:0000269 PubMed:10944470 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007286 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. heart BTO:0000562 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007289 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. heart UBERON:0000948 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007290 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. liver BTO:0000759 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007291 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. liver UBERON:0002107 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007292 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. muscle BTO:0000887 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007293 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. musculature UBERON:0001015 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007294 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. kidney BTO:0000671 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007295 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007296 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. placenta BTO:0001078 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007297 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007298 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007299 Faith P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity Strongest expression in heart, liver, muscle and kidney. Weak in placenta and pancreas. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 127 3300007300 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 EC 3.1.2.2 Y Y EC number UniProtKB AAP 5/1/2013 92 3300007302 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/function Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH (By similarity). Succinyl-CoA thioesterase that also hydrolyzes long chain saturated and unsaturated monocarboxylic acyl-CoAs. Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007303 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. liver BTO:0000759 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007306 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. liver UBERON:0002107 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007307 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. kidney BTO:0000671 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007308 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007309 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. placenta BTO:0001078 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007310 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007311 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. heart BTO:0000562 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007312 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. heart UBERON:0000948 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007313 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. muscle BTO:0000887 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007314 Faith Q8N9L9 122970 ACOT4 Homo sapiens 9606 Comment/tissue specificity Strongest expression in liver and kidney and weaker expression in placenta, heart, and muscle. musculature UBERON:0001015 Y Y ECO:0000269 PubMed:16940157 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/1/2013 92 3300007315 Faith O00154 11332 ACOT7 Homo sapiens 9606 EC 3.1.2.2 Y Y EC number UniProtKB AAP, ASD 6/26/2013 124 3300007316 Faith O00154 11332 ACOT7 Homo sapiens 9606 Comment/function Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH. May play an important physiological function in brain. May play a regulatory role by modulating the cellular levels of fatty acyl-CoA ligands for certain transcription factors as well as the substrates for fatty acid metabolizing enzymes, contributing to lipid homeostasis. Has broad specificity, active towards fatty acyl-CoAs with chain-lengths of C8-C18. Has a maximal activity toward palmitoyl-CoA. Y Y UniProtKB AAP, ASD 6/26/2013 124 3300007317 Faith O14734 10005 ACOT8 Homo sapiens 9606 EC 3.1.2.27 Y Y EC number UniProtKB AAP 5/29/2013 124 3300007320 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity heart BTO:0000562 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007325 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity heart UBERON:0000948 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007326 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity brain BTO:0000142 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007327 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity brain UBERON:0000955 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007328 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity placenta BTO:0001078 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007329 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity placenta UBERON:0001987 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007330 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity lung BTO:0000763 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007331 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity lung UBERON:0002048 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007332 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity liver BTO:0000759 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007333 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity liver UBERON:0002107 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007334 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity skeletal muscle BTO:0001103 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007335 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity skeletal muscle tissue UBERON:0001134 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007336 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity kidney BTO:0000671 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007337 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity kidney UBERON:0002113 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007338 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity pancreas BTO:0000988 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007339 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity pancreas UBERON:0001264 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007340 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity spleen BTO:0001281 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007341 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity spleen UBERON:0002106 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007342 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity thymus BTO:0001374 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007343 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity thymus UBERON:0002370 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007344 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity prostate gland BTO:0001129 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007345 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity prostate gland UBERON:0002367 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007346 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity testis BTO:0001363 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007347 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity testis UBERON:0000473 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007348 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity ovary BTO:0000975 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007349 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity female gonad UBERON:0000992 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007350 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity small intestine BTO:0000651 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007351 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity small intestine UBERON:0002108 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007352 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity colon BTO:0000269 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007353 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity colon UBERON:0001155 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007354 Faith O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity peripheral blood lymphocyte BTO:0004729 Y Y ECO:0000006 PubMed:9299485 PENTACON Found when looking for the T-cell line name AAP 4/21/2014 3 3300007355 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/developmental stage Expressed during the early stages of erythroid development while expression is very low in reticulocytes and young erythrocytes. erythrocyte BTO:0000424 erythrocyte CL:0000232 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID no Uberon term AAP, AAP-M, ASD 1/9/2013 123 3300007356 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/developmental stage Expressed during the early stages of erythroid development while expression is very low in reticulocytes and young erythrocytes. erythroid cell BTO:0002731 erythroid lineage cell CL:0000764 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID no Uberon term AAP, AAP-M, ASD 1/9/2013 123 3300007357 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. erythroid cell BTO:0002731 erythroid lineage cell CL:0000764 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID no Uberon term AAP, AAP-M, ASD 1/9/2013 123 3300007358 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/developmental stage Expressed during the early stages of erythroid development while expression is very low in reticulocytes and young erythrocytes. reticulocyte BTO:0001173 reticulocyte CL:0000558 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID no Uberon term AAP, AAP-M, ASD 1/9/2013 123 3300007359 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/function Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses palmitoleate, oleate and linoleate. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007360 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. brain BTO:0000142 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007366 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007367 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. heart BTO:0000562 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007368 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. heart UBERON:0000948 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007369 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. kidney BTO:0000671 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007370 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007371 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. liver BTO:0000759 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007372 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007373 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. lung BTO:0000763 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007374 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. lung UBERON:0002048 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007375 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007376 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007377 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. placenta BTO:0001078 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007378 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007379 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007380 Rose P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, heart, skeletal muscle, kidney and erythroid cells, and to a lesser extent in brain, lung, placenta and pancreas. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 1/9/2013 123 3300007381 Rose P33121 2180 ACSL1 Homo sapiens 9606 EC 6.2.1.3 Y Y ECO:0000311 EC number UniProtKB AAP, AAP-M, ASD 1/9/2013 123 3300007382 Mike O95573 2181 ACSL3 Homo sapiens 9606 Comment/function Acyl-CoA synthetases (ACSL) activates long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL3 mediates hepatic lipogenesis (By similarity). Preferentially uses myristate, laurate, arachidonate and eicosapentaenoate as substrates (By similarity). Has mainly an anabolic role in energy metabolism. Required for the incorporation of fatty acids into phosphatidylcholine, the major phospholipid located on the surface of VLDL (very low density lipoproteins). Y Y ECO:0000269 ECO:0000250 : PubMed:18003621 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, AAP-M, ASD 1/9/2013 115 3300007383 Mike O95573 2181 ACSL3 Homo sapiens 9606 EC 6.2.1.3 Y Y ECO:0000311 EC number UniProtKB AAP, AAP-M, ASD 1/9/2013 115 3300007388 Mike O60488 2182 ACSL4 Homo sapiens 9606 Comment/function Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses arachidonate and eicosapentaenoate as substrates. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 11/28/2012 131 3300007389 Mike O60488 2182 ACSL4 Homo sapiens 9606 EC 6.2.1.3 Y Y ECO:0000311 EC number UniProtKB AAP, AAP-M, ASD 11/28/2012 131 3300007396 Katie Q9ULC5 51703 ACSL5 Homo sapiens 9606 Comment/function Acyl-CoA synthetases (ACSL) activate long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. ACSL5 may activate fatty acids from exogenous sources for the synthesis of triacylglycerol destined for intracellular storage (By similarity). Utilizes a wide range of saturated fatty acids with a preference for C16-C18 unsaturated fatty acids (By similarity). It was suggested that it may also stimulate fatty acid oxidation (By similarity). At the villus tip of the crypt-villus axis of the small intestine may sensitize epithelial cells to apoptosis specifically triggered by the death ligand TRAIL. May have a role in the survival of glioma cells. Y Y ECO:0000269 ECO:0000250 : PubMed:17681178 PubMed:18806831 PubMed:19459852 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, AAP-M 11/28/2012 121 3300007397 Katie Q9ULC5 51703 ACSL5 Homo sapiens 9606 EC 6.2.1.3 Y Y ECO:0000311 EC number UniProtKB AAP, AAP-M 11/28/2012 121 3300007403 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derived from fetal liver, hemopoietic stem cells from cord blood, bone marrow and brain. K-562 cell BTO:0000664 K-562 cell CLO:0007059 Y Y ECO:0000006 PubMed:10548543 PENTACON From publication AAP, AAP-M, ASD 4/21/2014 3 3300007404 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derived from fetal liver, hemopoietic stem cells from cord blood, bone marrow and brain. reticulocyte BTO:0001173 reticulocyte CL:0000558 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 6/26/2013 124 3300007405 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 EC 6.2.1.3 Y Y EC number UniProtKB AAP, AAP-M, ASD 6/26/2013 124 3300007406 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/function Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Plays an important role in fatty acid metabolism in brain and the acyl-CoAs produced may be utilized exclusively for the synthesis of the brain lipid. Y Y UniProtKB AAP, AAP-M, ASD 6/26/2013 124 3300007407 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derived from fetal liver, hemopoietic stem cells from cord blood, bone marrow and brain. reticulocyte BTO:0001173 reticulocyte CL:0000558 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID Erythrocyte precursors AAP, AAP-M, ASD 6/26/2013 124 3300007412 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derived from fetal liver, hemopoietic stem cells from cord blood, bone marrow and brain. hematopoietic cell BTO:0000574 fetus BTO:0000449 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID From liver AAP, AAP-M, ASD 6/26/2013 124 3300007413 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derived from fetal liver, hemopoietic stem cells from cord blood, bone marrow and brain. hematopoietic stem cell BTO:0000725 umbilical cord blood cell BTO:0004054 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 6/26/2013 124 3300007414 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derived from fetal liver, hemopoietic stem cells from cord blood, bone marrow and brain. bone marrow BTO:0000141 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 6/26/2013 124 3300007415 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derived from fetal liver, hemopoietic stem cells from cord blood, bone marrow and brain. bone marrow UBERON:0002371 Y Y ECO:0000269 PubMed:10548543 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 6/26/2013 124 3300007416 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derived from fetal liver, hemopoietic stem cells from cord blood, bone marrow and brain. brain BTO:0000142 Y Y ECO:0000006 PubMed:10548543 PENTACON From publication AAP, AAP-M, ASD 4/21/2014 3 3300007417 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in erythrocyte precursors, in particular in reticulocytes, fetal blood cells derived from fetal liver, hemopoietic stem cells from cord blood, bone marrow and brain. brain UBERON:0000955 Y Y ECO:0000006 PubMed:10548543 PENTACON From publication AAP, AAP-M, ASD 4/21/2014 3 3300007418 Faith Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/Sequence caution The sequence BAA74860.1 (EMBL-CDS). Reason: erroneous initiation. Translation N-terminally shortened. Y Y ECO:0000305 UniProtKB UPDATE ver_2 Changes in: EVID AAP, AAP-M, ASD 6/26/2013 124 3300007427 Mike O15120 10555 AGPAT2 Homo sapiens 9606 Comment/function Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. lysophosphatidic acid acyltransferase activity GO:0042171 Y Y ECO:0000269 PubMed:15629135 PubMed:21873652 PubMed:9242711 UniProtKB UPDATE ver_2 Changes in: GO,EVID1,EVID GO MF Use=Y AAP 1/9/2013 119 3300007428 Mike O15120 10555 AGPAT2 Homo sapiens 9606 Comment/pathway Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3. CDP-diacylglycerol biosynthetic process GO:0016024 UER00613 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 119 3300007430 Mike O15120 10555 AGPAT2 Homo sapiens 9606 EC 2.3.1.51 Y Y ECO:0000311 EC number UniProtKB AAP 1/9/2013 119 3300007437 Mike Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/function Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone (By similarity). Y Y by similarity UniProtKB TBD ver_2 AAP 1/9/2013 102 3300007438 Katie Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/pathway Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3. CDP-diacylglycerol biosynthetic process GO:0016024 UER00613 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 102 3300007439 Katie Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/pathway Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3. phospholipid metabolic process GO:0006644 UER00613 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 102 3300007440 Katie Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 EC 2.3.1.51 Y Y ECO:0000311 EC number UniProtKB AAP 1/9/2013 102 3300007442 Katie Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/pathway Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3. CDP-diacylglycerol biosynthetic process GO:0016024 UER00613 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 97 3300007445 Katie Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/pathway Phospholipid metabolism; CDP-diacylglycerol biosynthesis; CDP-diacylglycerol from sn-glycerol 3-phosphate: step 2/3. phospholipid metabolic process GO:0006644 UER00613 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 97 3300007446 Katie Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 EC 2.3.1.51 Y Y ECO:0000311 EC number UniProtKB AAP 1/9/2013 97 3300007449 Mike P15121 231 AKR1B1 Homo sapiens 9606 Comment/function Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols with a broad range of catalytic efficiencies. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 157 3300007450 Mike P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in embryonic epithelial cells (EUE) in response to osmotic stress. EUE cell BTO:0000430 Y Y ECO:0000269 PubMed:8435445 UniProtKB UPDATE ver_2 Changes in: EVID BRENDA term is perfect match to description. AAP, DGA, ASD 11/28/2012 157 3300007452 Mike P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity Highly expressed in embryonic epithelial cells (EUE) in response to osmotic stress. epithelium UBERON:0000483 Y Y ECO:0000269 PubMed:8435445 UniProtKB UPDATE ver_2 Changes in: EVID BRENDA term is perfect match to description. AAP, DGA, ASD 11/28/2012 157 3300007453 Mike P15121 231 AKR1B1 Homo sapiens 9606 EC 1.1.1.21 Y Y ECO:0000311 EC number UniProtKB This EC number describes many reactions. AAP, DGA, ASD 11/28/2012 157 3300007454 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/function Catalyzes the conversion of aldehydes and ketones to alcohols. Catalyzes the reduction of prostaglandin (PG) D2, PGH2 and phenanthrenequinone (PQ) and the oxidation of 9-alpha,11-beta-PGF2 to PGD2. Functions as a bi-directional 3-alpha-, 17-beta- and 20-alpha HSD. Can interconvert active androgens, estrogens and progestins with their cognate inactive metabolites. Preferentially transforms androstenedione (4-dione) to testosterone. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007455 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. medulla oblongata BTO:0000041 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID Need to double-check AAP, ASD 2/6/2013 142 3300007458 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. medulla oblongata UBERON:0001896 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID Need to double-check AAP, ASD 2/6/2013 142 3300007459 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. adrenal gland BTO:0000047 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007461 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. adrenal gland UBERON:0002369 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007462 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. amygdala BTO:0001042 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007463 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. amygdala UBERON:0001876 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007464 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. brain BTO:0000142 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007465 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007466 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. caudate nucleus BTO:0000211 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007467 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. caudate nucleus UBERON:0001873 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007468 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. colon BTO:0000269 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007469 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. colon UBERON:0001155 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007470 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. hippocampus BTO:0000601 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007471 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. hippocampal formation UBERON:0002421 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007472 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. kidney BTO:0000671 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007473 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007474 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. liver BTO:0000759 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007475 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007476 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. lung BTO:0000763 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007477 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. lung UBERON:0002048 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007478 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. mammary gland BTO:0000817 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007479 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. mammary gland UBERON:0001911 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007480 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. placenta BTO:0001078 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007481 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007482 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007483 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007484 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. prostate gland epithelium BTO:0002397 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007485 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. prostate epithelium UBERON:0000428 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007486 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007487 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007488 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. spinal cord BTO:0001279 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007489 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. spinal cord UBERON:0002240 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007490 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. spleen BTO:0001281 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007491 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007492 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. substantia nigra BTO:0000143 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007493 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. substantia nigra UBERON:0002038 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007494 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. temporal lobe BTO:0001355 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007495 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. temporal lobe UBERON:0001871 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007496 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. testis BTO:0001363 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007497 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. testis UBERON:0000473 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007498 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. thalamic nucleus BTO:0002452 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007499 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. nucleus of thalamus UBERON:0007692 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007500 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. thalamus BTO:0001365 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007501 Rose P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues including adrenal gland, brain, kidney, liver, lung, mammary gland, placenta, small intestine, colon, spleen, prostate and testis. The dominant HSD in prostate and mammary gland. In the prostate, higher levels in epithelial cells than in stromal cells. In the brain, expressed in medulla, spinal cord, frontotemporal lobes, thalamus, subthalamic nuclei and amygdala. Weaker expression in the hippocampus, substantia nigra and caudate. dorsal plus ventral thalamus UBERON:0001897 Y Y ECO:0000269 PubMed:10557352 PubMed:10622721 PubMed:11165022 PubMed:7650035 PubMed:9415401 PubMed:9927279 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 142 3300007502 Rose P42330 8644 AKR1C3 Homo sapiens 9606 EC 1.-.-.- Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 142 3300007503 Rose P18054 239 ALOX12 Homo sapiens 9606 EC 1.13.11.31 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, AAP-M 1/9/2013 143 3300007507 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/tissue specificity Expressed in B-cells, hair follicles, foreskin keratinocytes and adult skin. Also expressed in psoriatic tissue. B-lymphocyte BTO:0000776 B cell CL:0000236 Y Y ECO:0000269 PubMed:9618483 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 116 3300007508 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/tissue specificity Expressed in B-cells, hair follicles, foreskin keratinocytes and adult skin. Also expressed in psoriatic tissue. prepuce BTO:0001113 keratinocyte CL:0000312 Y Y ECO:0000269 PubMed:9618483 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 116 3300007509 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/tissue specificity Expressed in B-cells, hair follicles, foreskin keratinocytes and adult skin. Also expressed in psoriatic tissue. skin of prepuce of penis UBERON:0001471 keratinocyte CL:0000312 Y Y ECO:0000269 PubMed:9618483 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 116 3300007510 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/tissue specificity Expressed in B-cells, hair follicles, foreskin keratinocytes and adult skin. Also expressed in psoriatic tissue. skin BTO:0001253 psoriasis DOID:8893 Y Y ECO:0000269 PubMed:9618483 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 116 3300007514 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/tissue specificity Expressed in B-cells, hair follicles, foreskin keratinocytes and adult skin. Also expressed in psoriatic tissue. skin of body UBERON:0002097 psoriasis DOID:8893 Y Y ECO:0000269 PubMed:9618483 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 116 3300007515 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/tissue specificity Expressed in B-cells, hair follicles, foreskin keratinocytes and adult skin. Also expressed in psoriatic tissue. hair follicle BTO:0000554 Y Y ECO:0000269 PubMed:9618483 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 116 3300007516 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/tissue specificity Expressed in B-cells, hair follicles, foreskin keratinocytes and adult skin. Also expressed in psoriatic tissue. hair follicle UBERON:0002073 Y Y ECO:0000269 PubMed:9618483 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 116 3300007517 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/tissue specificity Expressed in B-cells, hair follicles, foreskin keratinocytes and adult skin. Also expressed in psoriatic tissue. skin BTO:0001253 Y Y ECO:0000269 PubMed:9618483 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 116 3300007518 Mike O75342 242 ALOX12B Homo sapiens 9606 Comment/tissue specificity Expressed in B-cells, hair follicles, foreskin keratinocytes and adult skin. Also expressed in psoriatic tissue. skin of body UBERON:0002097 Y Y ECO:0000269 PubMed:9618483 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 116 3300007519 Mike O75342 242 ALOX12B Homo sapiens 9606 EC 1.13.11.- Y Y ECO:0000311 EC number UniProtKB Note: 1.13.11.31 refers to the S-enantiomer. AAP 11/28/2012 116 3300007520 Mike P16050 246 ALOX15 Homo sapiens 9606 EC 1.13.11.33 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 139 3300007524 Mike O15296 247 ALOX15B Homo sapiens 9606 EC 1.13.11.33 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 125 3300007537 Mike P09917 240 ALOX5 Homo sapiens 9606 Comment/function Catalyzes the first step in leukotriene biosynthesis, and thereby plays a role in inflammatory processes. inflammatory response GO:0006954 Y Y ECO:0000269 PubMed:21233389 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, DGA, AAP-M, ASD 11/28/2012 143 3300007538 Mike P09917 240 ALOX5 Homo sapiens 9606 Comment/function Catalyzes the first step in leukotriene biosynthesis, and thereby plays a role in inflammatory processes. leukotriene A4 biosynthetic process GO:1901753 Y Y ECO:0000269 PubMed:21233389 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, DGA, AAP-M, ASD 11/28/2012 143 3300007539 Mike P09917 240 ALOX5 Homo sapiens 9606 Comment/subcellular location Nucleus membrane;Peripheral membrane protein nuclear membrane GO:0031965 SL-0182 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, AAP-M, ASD 11/28/2012 143 3300007543 Mike P09917 240 ALOX5 Homo sapiens 9606 EC 1.13.11.34 Y Y ECO:0000311 EC number UniProtKB EC number specifies synthesis of leukotriene A4 from Arachidonic acid AAP, DGA, AAP-M, ASD 11/28/2012 143 3300007545 Rose P20292 241 ALOX5AP Homo sapiens 9606 Comment/function Required for leukotriene biosynthesis by ALOX5 (5-lipoxygenase). Anchors ALOX5 to the membrane. Binds arachidonic acid, and could play an essential role in the transfer of arachidonic acid to ALOX5. Binds to MK-886, a compound that blocks the biosynthesis of leukotrienes. Y Y ECO:0000269 PubMed:2300173 PubMed:8440384 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 113 3300007546 Rose P20292 241 ALOX5AP Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Multi-pass membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 113 3300007549 Katie Q9BYJ1 59344 ALOXE3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in skin. skin BTO:0001253 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 104 3300007555 Katie Q9BYJ1 59344 ALOXE3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in skin. skin of body UBERON:0002097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 104 3300007556 Katie Q9BYJ1 59344 ALOXE3 Homo sapiens 9606 EC 1.13.11.- Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 104 3300007557 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/function Acyltransferase that predominantly esterify long chain (wax) alcohols with acyl-CoA-derived fatty acids to produce wax esters. Wax esters are enriched in sebum, suggesting that it plays a central role in lipid metabolism in skin. Has no activity using decyl alcohol and significantly prefers the C16 and C18 alcohols. May also have 2-acylglycerol O-acyltransferase (MGAT) and acyl-CoA:retinol acyltransferase (ARAT) activities, to catalyze the synthesis of diacylglycerols and retinyl esters; however this activity is unclear in vivo. Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID AAP 10/31/2012 72 3300007558 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Multi-pass membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 10/31/2012 72 3300007559 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity adipose tissue BTO:0001487 Y Y ECO:0000006 PubMed:16106050 PENTACON Added from publication AAP 4/21/2014 3 3300007560 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity adipose tissue UBERON:0001013 Y Y ECO:0000006 PubMed:16106050 PENTACON Added from publication AAP 4/21/2014 3 3300007561 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity Abundant in tissues rich in sebaceous glands such as the preputial gland and eyelid. Highly expressed in skin, where it is primarily restricted to undifferentiated peripheral sebocytes. Also expressed at lower level in other tissues except pancreas. skin BTO:0001253 Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP 10/31/2012 72 3300007562 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity Abundant in tissues rich in sebaceous glands such as the preputial gland and eyelid. Highly expressed in skin, where it is primarily restricted to undifferentiated peripheral sebocytes. Also expressed at lower level in other tissues except pancreas. epidermis UBERON:0001003 Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP 10/31/2012 72 3300007563 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity Abundant in tissues rich in sebaceous glands such as the preputial gland and eyelid. Highly expressed in skin, where it is primarily restricted to undifferentiated peripheral sebocytes. Also expressed at lower level in other tissues except pancreas. sebocyte BTO:0004613 Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID I could not find undifferentiated peripheral sebocyte. http://www.karger.com/Article/Fulltext/17860 suggests that there are three types of sebocytes. I could not find a descriptive term in CL. AAP 10/31/2012 72 3300007564 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity Abundant in tissues rich in sebaceous glands such as the preputial gland and eyelid. Highly expressed in skin, where it is primarily restricted to undifferentiated peripheral sebocytes. Also expressed at lower level in other tissues except pancreas. sebaceous gland BTO:0001980 Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID replace with sebaceous gland? AAP 10/31/2012 72 3300007565 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity Abundant in tissues rich in sebaceous glands such as the preputial gland and eyelid. Highly expressed in skin, where it is primarily restricted to undifferentiated peripheral sebocytes. Also expressed at lower level in other tissues except pancreas. sebaceous gland UBERON:0001821 Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID replace with sebaceous gland? AAP 10/31/2012 72 3300007566 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity Abundant in tissues rich in sebaceous glands such as the preputial gland and eyelid. Highly expressed in skin, where it is primarily restricted to undifferentiated peripheral sebocytes. Also expressed at lower level in other tissues except pancreas. eyelid BTO:0002241 Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID this was in mice AAP 10/31/2012 72 3300007567 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity Abundant in tissues rich in sebaceous glands such as the preputial gland and eyelid. Highly expressed in skin, where it is primarily restricted to undifferentiated peripheral sebocytes. Also expressed at lower level in other tissues except pancreas. eyelid UBERON:0001711 Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID this was in mice AAP 10/31/2012 72 3300007568 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity Abundant in tissues rich in sebaceous glands such as the preputial gland and eyelid. Highly expressed in skin, where it is primarily restricted to undifferentiated peripheral sebocytes. Also expressed at lower level in other tissues except pancreas. preputial gland BTO:0001111 Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID this was in mice AAP 10/31/2012 72 3300007569 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity Abundant in tissues rich in sebaceous glands such as the preputial gland and eyelid. Highly expressed in skin, where it is primarily restricted to undifferentiated peripheral sebocytes. Also expressed at lower level in other tissues except pancreas. preputial gland UBERON:0000359 Y Y ECO:0000269 PubMed:15220349 PubMed:15671038 PubMed:16106050 UniProtKB UPDATE ver_2 Changes in: EVID this was in mice AAP 10/31/2012 72 3300007570 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity brain BTO:0000142 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007572 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity brain UBERON:0000955 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007573 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity colon BTO:0000269 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007574 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity colon UBERON:0001155 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007575 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity heart BTO:0000562 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007576 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity heart UBERON:0000948 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007577 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity kidney BTO:0000671 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007578 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity kidney UBERON:0002113 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007579 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity liver BTO:0000759 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007580 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity liver UBERON:0002107 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007581 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity lung BTO:0000763 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007582 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity lung UBERON:0002048 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007583 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity ovary BTO:0000975 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007584 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity female gonad UBERON:0000992 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007585 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity pancreas BTO:0000988 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007586 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity pancreas UBERON:0001264 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007587 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity prostate gland BTO:0001129 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007588 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity prostate gland UBERON:0002367 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007589 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity small intestine BTO:0000651 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007590 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity small intestine UBERON:0002108 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007591 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity spleen BTO:0001281 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007592 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity spleen UBERON:0002106 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007593 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity testis BTO:0001363 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007594 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity testis UBERON:0000473 Y Y ECO:0000006 PubMed:15671038 PubMed:16106050 PENTACON AAP 4/21/2014 3 3300007595 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity thymus BTO:0001374 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007596 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity thymus UBERON:0002370 Y Y ECO:0000006 PubMed:15671038 PENTACON AAP 4/21/2014 3 3300007597 Faith Q6E213 158835 AWAT2 Homo sapiens 9606 EC 2.3.1.75 Y Y ECO:0000311 EC number UniProtKB AAP 10/31/2012 72 3300007598 Faith Q14032 570 BAAT Homo sapiens 9606 EC 2.3.1.65 Y Y EC number UniProtKB AAP, ASD 5/1/2013 102 3300007599 Faith Q14032 570 BAAT Homo sapiens 9606 Comment/function Involved in bile acid metabolism. In liver hepatocytes catalyzes the second step in the conjugation of C24 bile acids (choloneates) to glycine and taurine before excretion into bile canaliculi. The major components of bile are cholic acid and chenodeoxycholic acid. In a first step the bile acids are converted to an acyl-CoA thioester, either in peroxisomes (primary bile acids deriving from the cholesterol pathway), or cytoplasmic at the endoplasmic reticulum (secondary bile acids). May catalyze the conjugation of primary or secondary bile acids, or both. The conjugation increases the detergent properties of bile acids in the intestine, which facilitates lipid and fat-soluble vitamin absorption. In turn, bile acids are deconjugated by bacteria in the intestine and are recycled back to the liver for reconjugation (secondary bile acids). May also act as an acyl-CoA thioesterase that regulates intracellular levels of free fatty acids. In vitro, catalyzes the hydrolysis of long- and very long-chain saturated acyl-CoAs to the free fatty acid and coenzyme A (CoASH), and conjugates glycine to these acyl-CoAs. Y Y ECO:0000269 PubMed:12810727 PubMed:8034703 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 5/1/2013 102 3300007600 Faith Q14032 570 BAAT Homo sapiens 9606 Comment/tissue specificity Expressed in liver, gallbladder mucosa and pancreas. liver BTO:0000759 Y Y ECO:0000269 PubMed:12810727 PubMed:2037576 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 5/1/2013 102 3300007603 Faith Q14032 570 BAAT Homo sapiens 9606 Comment/tissue specificity Expressed in liver, gallbladder mucosa and pancreas. liver UBERON:0002107 Y Y ECO:0000269 PubMed:12810727 PubMed:2037576 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 5/1/2013 102 3300007604 Faith Q14032 570 BAAT Homo sapiens 9606 Comment/tissue specificity Expressed in liver, gallbladder mucosa and pancreas. mucosa of gallbladder UBERON:0005033 Y Y ECO:0000269 PubMed:12810727 PubMed:2037576 UniProtKB UPDATE ver_2 Changes in: EVID BRENDA has gall bladder and mucosa, but not this term. AAP, ASD 5/1/2013 102 3300007605 Faith Q14032 570 BAAT Homo sapiens 9606 Comment/tissue specificity Expressed in liver, gallbladder mucosa and pancreas. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:12810727 PubMed:2037576 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 5/1/2013 102 3300007606 Faith Q14032 570 BAAT Homo sapiens 9606 Comment/tissue specificity Expressed in liver, gallbladder mucosa and pancreas. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:12810727 PubMed:2037576 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 5/1/2013 102 3300007607 Mike P16152 873 CBR1 Homo sapiens 9606 Comment/function NADPH-dependent reductase with broad substrate specificity. Catalyzes the reduction of a wide variety of carbonyl compounds including quinones, prostaglandins, menadione, plus various xenobiotics. Catalyzes the reduction of the antitumor anthracyclines doxorubicin and daunorubicin to the cardiotoxic compounds doxorubicinol and daunorubicinol. Can convert prostaglandin E2 to prostaglandin F2-alpha. Can bind glutathione, which explains its higher affinity for glutathione-conjugated substrates. Catalyzes the reduction of S-nitrosoglutathione. prostaglandin metabolic process GO:0006693 Y Y ECO:0000269 PubMed:15799708 PubMed:17912391 PubMed:18449627 PubMed:18826943 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, ASD 11/28/2012 147 3300007609 Mike P16152 873 CBR1 Homo sapiens 9606 Comment/subcellular location Cytoplasm cytoplasm GO:0005737 SL-0086 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 11/28/2012 147 3300007610 Mike P16152 873 CBR1 Homo sapiens 9606 EC 1.1.1.184 Y Y ECO:0000311 EC number UniProtKB This EC number refers to a wide range of substrates. AAP, ASD 11/28/2012 147 3300007611 Mike P16152 873 CBR1 Homo sapiens 9606 EC 1.1.1.197 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 147 3300007612 Mike P16152 873 CBR1 Homo sapiens 9606 EC 1.1.1.189 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 147 3300007613 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. leukocyte BTO:0000751 leukocyte CL:0000738 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007614 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/function Has low NADPH-dependent oxidoreductase activity towards 4-benzoylpyridine and menadione (in vitro). Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID not intended to be recorded as a major function of this enzyme AAP, ASD 11/28/2012 115 3300007615 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. brain BTO:0000142 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007617 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. brain UBERON:0000955 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007618 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. colon BTO:0000269 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007619 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. colon UBERON:0001155 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007620 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. heart BTO:0000562 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007621 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. heart UBERON:0000948 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007622 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. intestine BTO:0000648 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007623 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. intestine UBERON:0000160 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007624 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. kidney BTO:0000671 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007625 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007626 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. liver BTO:0000759 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007627 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. liver UBERON:0002107 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007628 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. lung BTO:0000763 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007629 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. lung UBERON:0002048 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007630 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. ovary BTO:0000975 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007631 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. female gonad UBERON:0000992 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007632 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007633 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007634 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007635 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007636 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. spleen BTO:0001281 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007637 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007638 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. testis BTO:0001363 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007639 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. testis UBERON:0000473 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007640 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. thymus BTO:0001374 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007641 Mike O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity Detected in ovary, pancreas, intestine, colon, kidney, brain, thymus, lung, heart, liver, spleen, leukocyte, prostate and testis. thymus UBERON:0002370 Y Y ECO:0000269 PubMed:18493841 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 115 3300007642 Mike O75828 874 CBR3 Homo sapiens 9606 EC 1.1.1.184 Y Y ECO:0000311 EC number UniProtKB This EC code applies to a broad range of reactions. AAP, ASD 11/28/2012 115 3300007643 Katie P04798 1543 CYP1A1 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. liver BTO:0000759 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 152 3300007644 Katie P04798 1543 CYP1A1 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 152 3300007645 Katie P04798 1543 CYP1A1 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 1/9/2013 152 3300007647 Katie P04798 1543 CYP1A1 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Peripheral membrane protein intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 1/9/2013 152 3300007648 Katie P04798 1543 CYP1A1 Homo sapiens 9606 Comment/tissue specificity Lung, lymphocytes and placenta. lymphocyte BTO:0000775 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 1/9/2013 152 3300007649 Katie P04798 1543 CYP1A1 Homo sapiens 9606 Comment/tissue specificity Lung, lymphocytes and placenta. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 152 3300007650 Katie P04798 1543 CYP1A1 Homo sapiens 9606 Comment/tissue specificity Lung, lymphocytes and placenta. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 152 3300007651 Katie P04798 1543 CYP1A1 Homo sapiens 9606 Comment/tissue specificity Lung, lymphocytes and placenta. placenta BTO:0001078 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 152 3300007652 Katie P04798 1543 CYP1A1 Homo sapiens 9606 Comment/tissue specificity Lung, lymphocytes and placenta. placenta UBERON:0001987 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 152 3300007653 Katie P04798 1543 CYP1A1 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 1/9/2013 152 3300007654 Mike P05177 1544 CYP1A2 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin. aflatoxin B1 metabolic process GO:0043390 Y Y ECO:0000269 PubMed:14725854 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, DGA, ASD 11/28/2012 140 3300007655 Mike P05177 1544 CYP1A2 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin. fatty acid metabolic process GO:0006631 Y Y ECO:0000269 PubMed:14725854 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, DGA, ASD 11/28/2012 140 3300007657 Mike P05177 1544 CYP1A2 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Most active in catalyzing 2-hydroxylation. Caffeine is metabolized primarily by cytochrome CYP1A2 in the liver through an initial N3-demethylation. Also acts in the metabolism of aflatoxin B1 and acetaminophen. Participates in the bioactivation of carcinogenic aromatic and heterocyclic amines. Catalizes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin. xenobiotic metabolic process GO:0006805 Y Y ECO:0000269 PubMed:14725854 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, DGA, ASD 11/28/2012 140 3300007658 Mike P05177 1544 CYP1A2 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein extrinsic component of endoplasmic reticulum membrane GO:0042406 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 140 3300007660 Mike P05177 1544 CYP1A2 Homo sapiens 9606 Comment/tissue specificity Liver. liver BTO:0000759 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 140 3300007662 Mike P05177 1544 CYP1A2 Homo sapiens 9606 Comment/tissue specificity Liver. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 140 3300007663 Mike P05177 1544 CYP1A2 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB This EC code covers many different reactions. AAP, DGA, ASD 11/28/2012 140 3300007664 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 11/28/2012 148 3300007677 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Peripheral membrane protein intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, ASD 11/28/2012 148 3300007678 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. leukocyte BTO:0000751 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 11/28/2012 148 3300007679 Katie Q16678 1545 CYP1B1 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 148 3300007680 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,4-cineole 2-exo-monooxygenase. liver BTO:0000759 Y Y ECO:0000269 PubMed:11695850 PubMed:20061448 PubMed:21875942 PubMed:22909231 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Tissue info not necessariy linked to PMID source. AAP, ASD 11/28/2012 143 3300007682 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,4-cineole 2-exo-monooxygenase. liver UBERON:0002107 Y Y ECO:0000269 PubMed:11695850 PubMed:20061448 PubMed:21875942 PubMed:22909231 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Tissue info not necessariy linked to PMID source. AAP, ASD 11/28/2012 143 3300007683 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 11/28/2012 143 3300007686 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Peripheral membrane protein intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS Microsome obsolete GO term AAP, ASD 11/28/2012 143 3300007687 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, lung and heart right ventricle. liver BTO:0000759 Y Y ECO:0000269 PubMed:10768437 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 143 3300007688 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, lung and heart right ventricle. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10768437 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 143 3300007689 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, lung and heart right ventricle. lung BTO:0000763 Y Y ECO:0000269 PubMed:10768437 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 143 3300007690 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, lung and heart right ventricle. lung UBERON:0002048 Y Y ECO:0000269 PubMed:10768437 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 143 3300007691 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, lung and heart right ventricle. right ventricle BTO:0001630 Y Y ECO:0000269 PubMed:10768437 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 143 3300007692 Rose P20813 1555 CYP2B6 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, lung and heart right ventricle. heart right ventricle UBERON:0002080 Y Y ECO:0000269 PubMed:10768437 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 143 3300007693 Rose P20813 1555 CYP2B6 Homo sapiens 9606 EC 1.14.13.- Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 143 3300007694 Rose P33260 1562 CYP2C18 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. liver BTO:0000759 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 116 3300007695 Rose P33260 1562 CYP2C18 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 116 3300007696 Rose P33260 1562 CYP2C18 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 11/28/2012 116 3300007698 Rose P33260 1562 CYP2C18 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Peripheral membrane protein intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS Microsome obsolete GO term AAP, ASD 11/28/2012 116 3300007699 Rose P33260 1562 CYP2C18 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 116 3300007700 Rose P33261 1557 CYP2C19 Homo sapiens 9606 Comment/function Responsible for the metabolism of a number of therapeutic agents such as the anticonvulsant drug S-mephenytoin, omeprazole, proguanil, certain barbiturates, diazepam, propranolol, citalopram and imipramine. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID drug info AAP, DGA, ASD 11/28/2012 125 3300007702 Rose P33261 1557 CYP2C19 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 125 3300007706 Rose P33261 1557 CYP2C19 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Peripheral membrane protein intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS Microsome obsolete GO term AAP, DGA, ASD 11/28/2012 125 3300007707 Rose P33261 1557 CYP2C19 Homo sapiens 9606 EC 1.14.13.- Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 125 3300007708 Mike P10632 1558 CYP2C8 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol). fatty acid metabolic process GO:0006631 Y Y ECO:0000269 PubMed:26427316 PubMed:7574697 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 150 3300007711 Mike P10632 1558 CYP2C8 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol). paclitaxel metabolic process GO:0042616 Y Y ECO:0000269 PubMed:26427316 PubMed:7574697 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 150 3300007712 Mike P10632 1558 CYP2C8 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol). steroid metabolic process GO:0008202 Y Y ECO:0000269 PubMed:26427316 PubMed:7574697 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 150 3300007713 Mike P10632 1558 CYP2C8 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol). liver BTO:0000759 Y Y ECO:0000269 PubMed:26427316 PubMed:7574697 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 150 3300007714 Mike P10632 1558 CYP2C8 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. In the epoxidation of arachidonic acid it generates only 14,15- and 11,12-cis-epoxyeicosatrienoic acids. It is the principal enzyme responsible for the metabolism the anti-cancer drug paclitaxel (taxol). liver UBERON:0002107 Y Y ECO:0000269 PubMed:26427316 PubMed:7574697 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 150 3300007715 Mike P10632 1558 CYP2C8 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein extrinsic component of endoplasmic reticulum membrane GO:0042406 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 150 3300007717 Mike P10632 1558 CYP2C8 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 150 3300007719 Mike P11712 1559 CYP2C9 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein extrinsic component of endoplasmic reticulum membrane GO:0042406 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 1/9/2013 152 3300007725 Mike P11712 1559 CYP2C9 Homo sapiens 9606 EC 1.14.13.- Y Y ECO:0000311 EC number UniProtKB This EC number describes a class of reactions. This enzyme is also annotated with other, more specific, EC numbers. AAP, DGA, ASD 1/9/2013 152 3300007727 Mike P11712 1559 CYP2C9 Homo sapiens 9606 EC 1.14.13.80 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 1/9/2013 152 3300007728 Mike P11712 1559 CYP2C9 Homo sapiens 9606 EC 1.14.13.48 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 1/9/2013 152 3300007729 Mike P11712 1559 CYP2C9 Homo sapiens 9606 EC 1.14.13.49 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 1/9/2013 152 3300007730 Mike P10635 1565 CYP2D6 Homo sapiens 9606 Comment/function Responsible for the metabolism of many drugs and environmental chemicals that it oxidizes. It is involved in the metabolism of drugs such as antiarrhythmics, adrenoceptor antagonists, and tricyclic antidepressants. drug metabolic process GO:0017144 Y Y ECO:0000269 PubMed:16352597 UniProtKB UPDATE ver_2 Changes in: GO,EVID New reference for this annotation. AAP, DGA, ASD 1/9/2013 146 3300007731 Mike P10635 1565 CYP2D6 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein extrinsic component of endoplasmic reticulum membrane GO:0042406 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 1/9/2013 146 3300007735 Mike P10635 1565 CYP2D6 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 1/9/2013 146 3300007737 Mike P05181 1571 CYP2E1 Homo sapiens 9606 Comment/function Metabolizes several precarcinogens, drugs, and solvents to reactive metabolites. Inactivates a number of drugs and xenobiotics and also bioactivates many xenobiotic substrates to their hepatotoxic or carcinogenic forms. xenobiotic metabolic process GO:0006805 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, DGA, ASD 1/9/2013 144 3300007738 Mike P05181 1571 CYP2E1 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein extrinsic component of endoplasmic reticulum membrane GO:0042406 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 1/9/2013 144 3300007740 Mike P05181 1571 CYP2E1 Homo sapiens 9606 EC 1.14.13.- Y Y ECO:0000311 EC number UniProtKB This EC code refers to oxidoreductases; it covers a wide range of reactions. Also annotated to 1.14.13.n7 . AAP, DGA, ASD 1/9/2013 144 3300007742 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/function This enzyme metabolizes arachidonic acid predominantly via a NADPH-dependent olefin epoxidation to all four regioisomeric cis-epoxyeicosatrienoic acids. One of the predominant enzymes responsible for the epoxidation of endogenous cardiac arachidonic acid pools. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 121 3300007743 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 121 3300007744 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Peripheral membrane protein intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 121 3300007745 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. colon BTO:0000269 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007746 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. colon UBERON:0001155 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007747 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. ileum BTO:0000620 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007748 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. ileum UBERON:0002116 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007749 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. jejunum BTO:0000657 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007750 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. jejunum UBERON:0002115 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007751 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. kidney BTO:0000671 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007752 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. kidney UBERON:0002113 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007753 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. liver BTO:0000759 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007754 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID expressed lower than in heart AAP, DGA, ASD 11/28/2012 121 3300007755 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. heart BTO:0000562 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP, DGA, ASD 11/28/2012 121 3300007756 Faith P51589 1573 CYP2J2 Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart, present at lower levels in liver, ileum, jejunum, colon, and kidney. heart UBERON:0000948 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP, DGA, ASD 11/28/2012 121 3300007757 Faith P51589 1573 CYP2J2 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 121 3300007758 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/developmental stage Expressed in fetal thymus. thymus BTO:0001374 fetus BTO:0000449 Y Y ECO:0000269 PubMed:14660610 PubMed:15752708 UniProtKB UPDATE ver_2 Changes in: EVID fetus; Rose removed ""thymus"" human developmental anatomy ontology term AAP 11/28/2012 94 3300007759 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/developmental stage Expressed in fetal thymus. thymus UBERON:0002370 fetus BTO:0000449 Y Y ECO:0000269 PubMed:14660610 PubMed:15752708 UniProtKB UPDATE ver_2 Changes in: EVID fetus; Rose removed ""thymus"" human developmental anatomy ontology term AAP 11/28/2012 94 3300007760 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/function Catalyzes the hydroxylation of arachidonic acid, docosahexaenoic acid and other long chain fatty acids. May modulate the arachidonic acid signaling pathway and play a role in other fatty acid signaling processes. Y Y ECO:0000269 PubMed:14660610 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 94 3300007761 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Multi-pass membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 94 3300007762 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/subcellular location Microsome membrane intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 11/28/2012 94 3300007763 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with stronger expression in thymus, heart and cerebellum. cerebellum BTO:0000232 Y Y ECO:0000269 PubMed:14660610 PubMed:14975754 PubMed:15752708 UniProtKB UPDATE ver_2 Changes in: EVID stronger expression AAP 11/28/2012 94 3300007764 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with stronger expression in thymus, heart and cerebellum. cerebellum UBERON:0002037 Y Y ECO:0000269 PubMed:14660610 PubMed:14975754 PubMed:15752708 UniProtKB UPDATE ver_2 Changes in: EVID stronger expression AAP 11/28/2012 94 3300007765 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with stronger expression in thymus, heart and cerebellum. heart BTO:0000562 Y Y ECO:0000269 PubMed:14660610 PubMed:14975754 PubMed:15752708 UniProtKB UPDATE ver_2 Changes in: EVID stronger expression AAP 11/28/2012 94 3300007766 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with stronger expression in thymus, heart and cerebellum. heart UBERON:0000948 Y Y ECO:0000269 PubMed:14660610 PubMed:14975754 PubMed:15752708 UniProtKB UPDATE ver_2 Changes in: EVID stronger expression AAP 11/28/2012 94 3300007767 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with stronger expression in thymus, heart and cerebellum. thymus BTO:0001374 Y Y ECO:0000269 PubMed:14660610 PubMed:14975754 PubMed:15752708 UniProtKB UPDATE ver_2 Changes in: EVID Widely expressed; stronger expression AAP 11/28/2012 94 3300007768 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with stronger expression in thymus, heart and cerebellum. thymus UBERON:0002370 Y Y ECO:0000269 PubMed:14660610 PubMed:14975754 PubMed:15752708 UniProtKB UPDATE ver_2 Changes in: EVID Widely expressed; stronger expression AAP 11/28/2012 94 3300007769 Faith Q7Z449 113612 CYP2U1 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 94 3300007770 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). parathyroid hormone secreting cell BTO:0004712 chief cell of parathyroid gland CL:0000446 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID Best match is from ""other ontology"" AAP, DGA, ASD 11/28/2012 154 3300007771 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). parathyroid gland UBERON:0001132 chief cell of parathyroid gland CL:0000446 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID Best match is from ""other ontology"" AAP, DGA, ASD 11/28/2012 154 3300007772 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Single-pass membrane protein integral component of endoplasmic reticulum membrane GO:0030176 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 154 3300007776 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Single-pass membrane protein integral component of membrane GO:0016021 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS microsome has been deprecated. AAP, DGA, ASD 11/28/2012 154 3300007777 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). gastric mucosa BTO:0001308 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID intestinal metaplasia AAP, DGA, ASD 11/28/2012 154 3300007779 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). epithelium of stomach UBERON:0001276 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID intestinal metaplasia AAP, DGA, ASD 11/28/2012 154 3300007780 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). pancreas BTO:0000988 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is more specific than BRENDA term. AAP, DGA, ASD 11/28/2012 154 3300007781 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). pancreatic duct UBERON:0007329 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is more specific than BRENDA term. AAP, DGA, ASD 11/28/2012 154 3300007782 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). adrenal cortex BTO:0000045 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007783 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). adrenal cortex UBERON:0001235 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007784 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). bile duct BTO:0000122 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007785 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). bile duct UBERON:0002394 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007786 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). brain BTO:0000142 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007787 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). brain UBERON:0000955 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007788 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). corpus luteum BTO:0000292 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007789 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). corpus luteum UBERON:0002512 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007790 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). gall bladder BTO:0000493 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007791 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). gallbladder UBERON:0002110 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007792 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). kidney BTO:0000671 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007793 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). kidney UBERON:0002113 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007794 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). large intestine BTO:0000706 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007795 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). large intestine UBERON:0000059 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007796 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). liver BTO:0000759 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007797 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). liver UBERON:0002107 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007798 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). nasal mucosa BTO:0000912 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007799 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). nasal cavity mucosa UBERON:0001826 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007800 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007801 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007802 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). small intestine epithelium BTO:0001258 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007803 Mike P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity Expressed in prostate and liver. According to some authors, it is not expressed in brain (PubMed:19094056). According to others, weak levels of expression are measured in some brain locations (PubMed:19359404 and PubMed:18545703). Also expressed in epithelium of the small intestine and large intestine, bile duct, nasal mucosa, kidney, adrenal cortex, epithelium of the gastric mucosa with intestinal metaplasia, gallbladder, intercalated ducts of the pancreas, chief cells of the parathyroid and the corpus luteum of the ovary (at protein level). epithelium of small intestine UBERON:0001902 Y Y ECO:0000269 PubMed:18545703 PubMed:19094056 PubMed:19359404 PubMed:2732228 PubMed:7894497 PubMed:8035341 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 154 3300007804 Mike P08684 1576 CYP3A4 Homo sapiens 9606 EC 1.14.13.- Y Y ECO:0000311 EC number UniProtKB This EC number refers to a class of reactions. This protein has other EC numbers, too. AAP, DGA, ASD 11/28/2012 154 3300007805 Mike P08684 1576 CYP3A4 Homo sapiens 9606 EC 1.14.13.157 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 154 3300007806 Mike P08684 1576 CYP3A4 Homo sapiens 9606 EC 1.14.13.32 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 154 3300007807 Mike P08684 1576 CYP3A4 Homo sapiens 9606 EC 1.14.13.67 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 154 3300007808 Mike P08684 1576 CYP3A4 Homo sapiens 9606 EC 1.14.13.97 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 154 3300007809 Faith Q02928 1579 CYP4A11 Homo sapiens 9606 Comment/function Catalyzes the omega- and (omega-1)-hydroxylation of various fatty acids such as laurate, myristate and palmitate. Has little activity toward prostaglandins A1 and E1. Oxidizes arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE). Y Y ECO:0000269 PubMed:15611369 PubMed:1739747 PubMed:7679927 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 121 3300007810 Faith Q02928 1579 CYP4A11 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 121 3300007811 Faith Q02928 1579 CYP4A11 Homo sapiens 9606 Comment/tissue specificity Kidney and liver. kidney BTO:0000671 Y Y ECO:0000269 PubMed:7679927 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 121 3300007813 Faith Q02928 1579 CYP4A11 Homo sapiens 9606 Comment/tissue specificity Kidney and liver. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:7679927 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 121 3300007814 Faith Q02928 1579 CYP4A11 Homo sapiens 9606 Comment/tissue specificity Kidney and liver. liver BTO:0000759 Y Y ECO:0000269 PubMed:7679927 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 121 3300007815 Faith Q02928 1579 CYP4A11 Homo sapiens 9606 Comment/tissue specificity Kidney and liver. liver UBERON:0002107 Y Y ECO:0000269 PubMed:7679927 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 11/28/2012 121 3300007816 Faith Q5TCH4 284541 CYP4A22 Homo sapiens 9606 Comment/function Catalyzes the omega- and (omega-1)-hydroxylation of various fatty acids such as laurate and palmitate. Shows no activity towards arachidonic acid and prostaglandin A1. Lacks functional activity in the kidney and does not contribute to renal 20-hydroxyeicosatetraenoic acid (20-HETE) biosynthesis. Y Y ECO:0000269 PubMed:10860550 PubMed:15611369 UniProtKB UPDATE ver_2 Changes in: EVID not functional in kidney AAP 11/28/2012 75 3300007818 Katie Q9HBI6 57834 CYP4F11 Homo sapiens 9606 Comment/tissue specificity Expressed mainly in human liver, followed by kidney, heart, and skeletal muscle. heart BTO:0000562 Y Y ECO:0000269 PubMed:10964514 PubMed:24138531 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 11/28/2012 112 3300007824 Katie Q9HBI6 57834 CYP4F11 Homo sapiens 9606 Comment/tissue specificity Expressed mainly in human liver, followed by kidney, heart, and skeletal muscle. heart UBERON:0000948 Y Y ECO:0000269 PubMed:10964514 PubMed:24138531 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 11/28/2012 112 3300007825 Katie Q9HBI6 57834 CYP4F11 Homo sapiens 9606 Comment/tissue specificity Expressed mainly in human liver, followed by kidney, heart, and skeletal muscle. kidney BTO:0000671 Y Y ECO:0000269 PubMed:10964514 PubMed:24138531 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 11/28/2012 112 3300007826 Katie Q9HBI6 57834 CYP4F11 Homo sapiens 9606 Comment/tissue specificity Expressed mainly in human liver, followed by kidney, heart, and skeletal muscle. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:10964514 PubMed:24138531 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 11/28/2012 112 3300007827 Katie Q9HBI6 57834 CYP4F11 Homo sapiens 9606 Comment/tissue specificity Expressed mainly in human liver, followed by kidney, heart, and skeletal muscle. liver BTO:0000759 Y Y ECO:0000269 PubMed:10964514 PubMed:24138531 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 11/28/2012 112 3300007828 Katie Q9HBI6 57834 CYP4F11 Homo sapiens 9606 Comment/tissue specificity Expressed mainly in human liver, followed by kidney, heart, and skeletal muscle. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10964514 PubMed:24138531 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 11/28/2012 112 3300007829 Katie Q9HBI6 57834 CYP4F11 Homo sapiens 9606 Comment/tissue specificity Expressed mainly in human liver, followed by kidney, heart, and skeletal muscle. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:10964514 PubMed:24138531 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 11/28/2012 112 3300007830 Katie Q9HBI6 57834 CYP4F11 Homo sapiens 9606 Comment/tissue specificity Expressed mainly in human liver, followed by kidney, heart, and skeletal muscle. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:10964514 PubMed:24138531 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 11/28/2012 112 3300007831 Katie Q9HBI6 57834 CYP4F11 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 112 3300007832 Faith P78329 8529 CYP4F2 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 125 3300007834 Faith P78329 8529 CYP4F2 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Peripheral membrane protein intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 125 3300007835 Faith P78329 8529 CYP4F2 Homo sapiens 9606 EC 1.14.13.30 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 125 3300007838 Faith Q6NT55 126410 CYP4F22 Homo sapiens 9606 EC 1.14.14.- Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 84 3300007843 Faith Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/pathway Lipid metabolism; leukotriene B4 degradation. lipid metabolic process GO:0006629 UPA00883 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 11/28/2012 129 3300007846 Faith Q08477 4051 CYP4F3 Homo sapiens 9606 EC 1.14.13.30 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 129 3300007851 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/function Hydroxylates arachidonic acid (20:4n-6) to (18R)-hydroxyarachidonate. Shows little activity against prostaglandin (PG) D2, PGE1, PGE2, PGF2alpha, and leukotriene B4. Catalyzes omega-2 and omega-3-hydroxylation of PGH1 and PGH2. Catalyzes epoxidation of 4,7,10,13,16,19-(Z)-docosahexaenoic acid (22:6n-3) and 7,10,13,16,19-(Z)-docosapentaenoic acid (22:5n-3) and omega-3-hydroxylation of 4,7,10,13,16-(Z)-docosapentaenoic acid (22:5n-6). Catalyzes hydroxylation of PGI2 and carbaprostacyclin. Y Y ECO:0000269 PubMed:10791960 PubMed:15789615 PubMed:16112640 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007852 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/subcellular location Microsome membrane intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 2/6/2013 106 3300007854 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. epidermis BTO:0000404 psoriasis DOID:8893 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID upregulated, NOT in normal skin AAP 2/6/2013 106 3300007855 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. epidermis UBERON:0001003 psoriasis DOID:8893 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID upregulated, NOT in normal skin AAP 2/6/2013 106 3300007856 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. liver BTO:0000759 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID adult AAP 2/6/2013 106 3300007857 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID adult AAP 2/6/2013 106 3300007858 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. stratum basale BTO:0004680 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID expanded to represent text AAP 2/6/2013 106 3300007859 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. stratum basale of epidermis UBERON:0002025 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID expanded to represent text AAP 2/6/2013 106 3300007860 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. stratum granulosum BTO:0000361 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID expanded to represent text AAP 2/6/2013 106 3300007861 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. stratum granulosum of epidermis UBERON:0002069 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID expanded to represent text AAP 2/6/2013 106 3300007862 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. stratum spinosum BTO:0000435 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID expanded to represent text AAP 2/6/2013 106 3300007863 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. stratum spinosum of epidermis UBERON:0002026 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID expanded to represent text AAP 2/6/2013 106 3300007864 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. corneal epithelium BTO:0000287 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID expressed in all cell layers AAP 2/6/2013 106 3300007865 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. corneal epithelium UBERON:0001772 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID expressed in all cell layers AAP 2/6/2013 106 3300007866 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. liver BTO:0000759 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID fetal AAP 2/6/2013 106 3300007867 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID fetal AAP 2/6/2013 106 3300007868 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. small intestine epithelium BTO:0001258 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Or 'epithelial lining of small intestine' AAP 2/6/2013 106 3300007869 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. epithelium of small intestine UBERON:0001902 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Or 'epithelial lining of small intestine' AAP 2/6/2013 106 3300007870 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. seminal vesicle BTO:0001234 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is more specific. AAP 2/6/2013 106 3300007871 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. seminal vesicle epithelium UBERON:0004805 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is more specific. AAP 2/6/2013 106 3300007872 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. vas deferens BTO:0001427 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is more specific. AAP 2/6/2013 106 3300007873 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. vas deferens epithelium UBERON:0004806 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is more specific. AAP 2/6/2013 106 3300007874 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. uroepithelium BTO:0003906 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Uroepithelium exist in BRENDA, but does have bladder-specific AAP 2/6/2013 106 3300007875 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. urinary bladder urothelium UBERON:0004645 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Uroepithelium exist in BRENDA, but does have bladder-specific AAP 2/6/2013 106 3300007876 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. urothelium of ureter UBERON:0001254 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Uroepithelium exist in BRENDA, but does have bladder-specific AAP 2/6/2013 106 3300007877 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. gastric epithelium BTO:0000500 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Use 'epithelium of stomach'? AAP 2/6/2013 106 3300007878 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. epithelium of stomach UBERON:0001276 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID Use 'epithelium of stomach'? AAP 2/6/2013 106 3300007879 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. corneal epithelium BTO:0000287 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007880 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. corneal epithelium UBERON:0001772 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007881 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. epidermis BTO:0000404 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007882 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. epidermis UBERON:0001003 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007883 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. hair follicle BTO:0000554 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007884 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. hair follicle UBERON:0002073 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007885 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007886 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007887 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. renal cortex BTO:0001166 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007888 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. cortex of kidney UBERON:0001225 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007889 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. sweat gland BTO:0001331 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007890 Faith P98187 11283 CYP4F8 Homo sapiens 9606 Comment/tissue specificity Expressed in the epithelium of seminal vesicles, in renal cortex, in adult and fetal liver, in epidermis, in corneal epithelium, in sweat glands, hair follicles, epithelial linings of the ampulla of vas deferens and of the stomach and small intestine, as well as in the transitional epithelium of the bladder and ureter (at protein level). In the epidermis, expressed from the basal cell to the granular cell layers. In the corneal epithelium, expressed in all cell layers. Also detected in prostate. Up-regulated in the epidermis of psoriatic lesions. sweat gland UBERON:0001820 Y Y ECO:0000269 PubMed:10405341 PubMed:12464258 PubMed:15789615 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300007891 Faith P98187 11283 CYP4F8 Homo sapiens 9606 EC 1.14.14.1 Y Y ECO:0000311 EC number UniProtKB AAP 2/6/2013 106 3300007892 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/function Receptor for cysteinyl leukotrienes mediating bronchoconstriction of individuals with and without asthma. Stimulation by LTD4 results in the contraction and proliferation of smooth muscle, edema, eosinophil migration and damage to the mucus layer in the lung. This response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTD4 >> LTE4 = LTC4 >> LTB4. cysteinyl leukotriene receptor activity GO:0001631 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID GO MF Use=Y AAP, DGA, ASD 1/9/2013 103 3300007893 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 1/9/2013 103 3300007897 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. alveolar macrophage BTO:0000802 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term; alveolar macrophages AAP, DGA, ASD 1/9/2013 103 3300007899 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. leukocyte BTO:0000751 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term; peripheral blood leukocytes AAP, DGA, ASD 1/9/2013 103 3300007900 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. colon BTO:0000269 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007902 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. colon UBERON:0001155 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007903 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. heart BTO:0000562 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007904 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. heart UBERON:0000948 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007905 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007906 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007907 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. pancreas BTO:0000988 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007908 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. pancreas UBERON:0001264 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007909 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. placenta BTO:0001078 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007910 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. placenta UBERON:0001987 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007911 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. small intestine BTO:0000651 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007912 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. small intestine UBERON:0002108 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007913 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. spleen BTO:0001281 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007914 Katie Q9Y271 10800 CYSLTR1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in spleen and peripheral blood leukocytes. Lower expression in several tissues, such as lung (mostly in smooth muscle bundles and alveolar macrophages), placenta, small intestine, pancreas, colon and heart. spleen UBERON:0002106 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 103 3300007915 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/function Receptor for cysteinyl leukotrienes. The response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. Stimulation by BAY u9773, a partial agonist, induces specific contractions of pulmonary veins and might also have an indirect role in the relaxation of the pulmonary vascular endothelium. The rank order of affinities for the leukotrienes is LTC4 = LTD4 >> LTE4. cysteinyl leukotriene receptor activity GO:0001631 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID GO MF Use=Y AAP, ASD 1/9/2013 107 3300007916 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 1/9/2013 107 3300007917 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. macrophage BTO:0000801 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term; expressed in the interstitial macrophages AAP, ASD 1/9/2013 107 3300007918 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. leukocyte BTO:0000751 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term; peripheral blood leukocytes AAP, ASD 1/9/2013 107 3300007919 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. adrenal gland BTO:0000047 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007921 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. adrenal gland UBERON:0002369 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007922 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. heart BTO:0000562 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007923 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. heart UBERON:0000948 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007924 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007925 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007926 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. placenta BTO:0001078 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007927 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. placenta UBERON:0001987 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007928 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. smooth muscle BTO:0001260 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007929 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. smooth muscle tissue UBERON:0001135 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007930 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. spleen BTO:0001281 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007931 Katie Q9NS75 57105 CYSLTR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in the heart, placenta, spleen, peripheral blood leukocytes and adrenal gland. In lung, expressed in the interstitial macrophages, and slightly in smooth muscle cells. spleen UBERON:0002106 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 107 3300007932 Katie P16444 1800 DPEP1 Homo sapiens 9606 Comment/function Hydrolyzes a wide range of dipeptides. Implicated in the renal metabolism of glutathione and its conjugates. Converts leukotriene D4 to leukotriene E4; it may play an important role in the regulation of leukotriene activity. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 143 3300007933 Katie P16444 1800 DPEP1 Homo sapiens 9606 Comment/subcellular location Apical cell membrane;GPI-anchor apical plasma membrane GO:0016324 SL-0015 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 2/6/2013 143 3300007934 Katie P16444 1800 DPEP1 Homo sapiens 9606 Comment/subcellular location Brush border membrane. brush border membrane GO:0031526 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, ASD 2/6/2013 143 3300007935 Katie P16444 1800 DPEP1 Homo sapiens 9606 Comment/subcellular location Microvillus membrane;GPI-anchor microvillus membrane GO:0031528 SL-0294 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 2/6/2013 143 3300007936 Katie P16444 1800 DPEP1 Homo sapiens 9606 EC 3.4.13.19 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 143 3300007937 Katie Q9H4A9 64174 DPEP2 Homo sapiens 9606 EC 3.4.13.19 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 83 3300007941 Faith Q9NXB9 54898 ELOVL2 Homo sapiens 9606 EC 2.3.1.199 Y Y EC number UniProtKB AAP, ASD 4/3/2013 90 3300007942 Faith Q9NXB9 54898 ELOVL2 Homo sapiens 9606 Comment/tissue specificity Liver and testis. liver BTO:0000759 Y Y ECO:0000269 PubMed:20937905 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 90 3300007946 Faith Q9NXB9 54898 ELOVL2 Homo sapiens 9606 Comment/tissue specificity Liver and testis. liver UBERON:0002107 Y Y ECO:0000269 PubMed:20937905 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 90 3300007947 Faith Q9NXB9 54898 ELOVL2 Homo sapiens 9606 Comment/tissue specificity Liver and testis. testis BTO:0001363 Y Y ECO:0000269 PubMed:20937905 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 90 3300007948 Faith Q9NXB9 54898 ELOVL2 Homo sapiens 9606 Comment/tissue specificity Liver and testis. testis UBERON:0000473 Y Y ECO:0000269 PubMed:20937905 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 90 3300007949 Faith Q9NYP7 60481 ELOVL5 Homo sapiens 9606 EC 2.3.1.199 Y Y EC number UniProtKB AAP 4/3/2013 94 3300007950 Rose P34913 2053 EPHX2 Homo sapiens 9606 Comment/function Bifunctional enzyme. The C-terminal domain has epoxide hydrolase activity and acts on epoxides (alkene oxides, oxiranes) and arene oxides. Plays a role in xenobiotic metabolism by degrading potentially toxic epoxides. Also determines steady-state levels of physiological mediators. The N-terminal domain has lipid phosphatase activity, with the highest activity towards threo-9,10-phosphonooxy-hydroxy-octadecanoic acid, followed by erythro-9,10-phosphonooxy-hydroxy-octadecanoic acid, 12-phosphonooxy-octadec-9Z-enoic acid, 12-phosphonooxy-octadec-9E-enoic acid, and p-nitrophenyl phospate. Y Y ECO:0000269 PubMed:12574508 PubMed:12574510 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 131 3300007966 Faith O60427 3992 FADS1 Homo sapiens 9606 EC 1.14.19.- Y Y EC number UniProtKB AAP, ASD 5/1/2013 108 3300007970 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/function Isoform 2 does not exhibit any catalytic activity toward 20:3n-6, but it may enhance FADS2 activity (By similarity). Isoform 1 is a component of a lipid metabolic pathway that catalyzes biosynthesis of highly unsaturated fatty acids (HUFA) from precursor essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3). Catalyzes the desaturation of dihomo-gamma-linoleic acid (DHGLA) (20:3n-6) and eicosatetraenoic acid (20:4n-3) to generate arachidonic acid (AA) (20:4n-6) and eicosapentaenoic acid (EPA)(20:5n-3), respectively. linoleic acid CHEBI:17351 Y Y ECO:0000250 ECO:0000269 PubMed:10601301 PubMed:10769175 UniProtKB N ver_2 AAP, ASD 5/1/2013 108 3300007971 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/pathway Lipid metabolism; polyunsaturated fatty acid biosynthesis. lipid metabolic process GO:0006629 UPA00658 Y Y UniProtKB UPDATE ver_2 Changes in: GO,SEC_IDS AAP, ASD 5/1/2013 108 3300007976 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB ver_2 AAP, ASD 5/1/2013 108 3300007987 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000006 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB TBD ver_2 AAP, ASD 5/1/2013 108 3300007988 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. lung BTO:0000763 Y Y ECO:0000006 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB TBD ver_2 AAP, ASD 5/1/2013 108 3300007989 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. lung UBERON:0002048 Y Y ECO:0000006 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB TBD ver_2 AAP, ASD 5/1/2013 108 3300007990 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. placenta BTO:0001078 Y Y ECO:0000006 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB TBD ver_2 AAP, ASD 5/1/2013 108 3300007991 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. placenta UBERON:0001987 Y Y ECO:0000006 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB TBD ver_2 AAP, ASD 5/1/2013 108 3300007992 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. kidney BTO:0000671 Y Y ECO:0000006 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB TBD ver_2 AAP, ASD 5/1/2013 108 3300007993 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. kidney UBERON:0002113 Y Y ECO:0000006 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB TBD ver_2 AAP, ASD 5/1/2013 108 3300007994 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. pancreas BTO:0000988 Y Y ECO:0000006 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB TBD ver_2 AAP, ASD 5/1/2013 108 3300007995 Faith O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues, it is most abundant in the liver, brain, adrenal gland and heart. Found as well in skeletal muscle, lung, placenta, kidney, pancreas and retina. pancreas UBERON:0001264 Y Y ECO:0000006 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB TBD ver_2 AAP, ASD 5/1/2013 108 3300007996 Faith O95864 9415 FADS2 Homo sapiens 9606 EC 1.14.19.- Y Y EC number UniProtKB AAP, DGA, ASD 5/1/2013 101 3300008002 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/function Component of a lipid metabolic pathway that catalyzes biosynthesis of highly unsaturated fatty acids (HUFA) from precursor essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3). Catalyzes the first and rate limiting step in this pathway which is the desaturation of LA (18:2n-6) and ALA (18:3n-3) into gamma-linoleic acid (GLA) (18:3n-6) and stearidonic acid (18:4n-3) respectively and other desaturation steps. Highly unsaturated fatty acids (HUFA) play pivotal roles in many biological functions. It catalizes as well the introduction of a cis double bond in palmitate to produce the mono-unsaturated fatty acid sapienate, the most abundant fatty acid in sebum. linoleic acid CHEBI:17351 Y Y ECO:0000269 PubMed:12713571 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008003 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/function Component of a lipid metabolic pathway that catalyzes biosynthesis of highly unsaturated fatty acids (HUFA) from precursor essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3). Catalyzes the first and rate limiting step in this pathway which is the desaturation of LA (18:2n-6) and ALA (18:3n-3) into gamma-linoleic acid (GLA) (18:3n-6) and stearidonic acid (18:4n-3) respectively and other desaturation steps. Highly unsaturated fatty acids (HUFA) play pivotal roles in many biological functions. It catalizes as well the introduction of a cis double bond in palmitate to produce the mono-unsaturated fatty acid sapienate, the most abundant fatty acid in sebum. alpha-linolenic acid CHEBI:27432 Y Y ECO:0000269 PubMed:12713571 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008004 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/pathway Lipid metabolism; polyunsaturated fatty acid biosynthesis. lipid metabolic process GO:0006629 UPA00658 Y Y UniProtKB UPDATE ver_2 Changes in: GO,SEC_IDS AAP, DGA, ASD 5/1/2013 101 3300008005 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. liver BTO:0000759 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008008 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008009 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. brain BTO:0000142 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008010 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008011 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. lung BTO:0000763 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008012 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. lung UBERON:0002048 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008013 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. heart BTO:0000562 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008014 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. heart UBERON:0000948 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008015 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. retina BTO:0001175 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008016 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. retina UBERON:0000966 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 5/1/2013 101 3300008017 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. breast cancer DOID:1612 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID lower levels in breast tumor AAP, DGA, ASD 5/1/2013 101 3300008018 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/tissue specificity Expressed in a wide array of tissues, highest expression is found in liver followed by brain, lung, heart, and retina. A lower level is found in breast tumor when compared with normal tissues; lowest levels were found in patients with poor prognostic index. Neoplasm of breast SNOMEDCT:126926005 Y Y ECO:0000269 PubMed:10860662 PubMed:12851727 PubMed:9867867 UniProtKB UPDATE ver_2 Changes in: EVID lower levels in breast tumor AAP, DGA, ASD 5/1/2013 101 3300008019 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/developmental stage Found in fetal heart. heart BTO:0000562 fetus BTO:0000449 Y Y UniProtKB AAP, DGA, ASD 5/1/2013 101 3300008020 Faith O95864 9415 FADS2 Homo sapiens 9606 Comment/developmental stage Found in fetal heart. heart UBERON:0000948 fetus BTO:0000449 Y Y UniProtKB AAP, DGA, ASD 5/1/2013 101 3300008021 Mike Q8TBF2 127281 FAM213B Homo sapiens 9606 Comment/function Catalyzes the reduction of prostaglandin-ethanolamide H(2) (prostamide H(2)) to prostamide F(2alpha) with NADPH as proton donor. Also able to reduce prostaglandin H(2) to prostaglandin F(2alpha) (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 83 3300008023 Faith Q8TBF2 127281 FAM213B Homo sapiens 9606 Comment/subcellular location Cytosol cytosol GO:0005829 SL-0091 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 2/6/2013 83 3300008024 Faith Q8TBF2 127281 FAM213B Homo sapiens 9606 EC 1.11.1.20 Y Y ECO:0000311 EC number UniProtKB AAP 2/6/2013 83 3300008025 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. kidney BTO:0000671 adult BTO:0001043 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008026 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. kidney UBERON:0002113 adult BTO:0001043 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008027 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. liver BTO:0000759 adult BTO:0001043 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008028 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. liver UBERON:0002107 adult BTO:0001043 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008029 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. kidney BTO:0000671 fetus BTO:0000449 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008030 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. kidney UBERON:0002113 fetus BTO:0000449 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008031 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. liver BTO:0000759 fetus BTO:0000449 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008032 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. liver UBERON:0002107 fetus BTO:0000449 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008033 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/pathway Sulfur metabolism; glutathione metabolism. glutathione metabolic process GO:0006749 UPA00204 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 148 3300008038 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/pathway Sulfur metabolism; glutathione metabolism. sulfur compound metabolic process GO:0006790 UPA00204 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 148 3300008039 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. intestine BTO:0000648 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008044 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. intestine UBERON:0000160 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008045 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008046 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008047 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. pancreas BTO:0000988 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008048 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. pancreas UBERON:0001264 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008049 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. placenta BTO:0001078 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008050 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. placenta UBERON:0001987 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008051 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. stomach BTO:0001307 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008052 Rose P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity Detected in fetal and adult kidney and liver, adult pancreas, stomach, intestine, placenta and lung. Isoform 3 is lung-specific. There are several other tissue-specific forms that arise from alternative promoter usage but that produce the same protein. stomach UBERON:0000945 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 148 3300008053 Rose P19440 2678 GGT1 Homo sapiens 9606 EC 2.3.2.2 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 148 3300008054 Rose P36269 2687 GGT5 Homo sapiens 9606 Comment/function Cleaves the gamma-glutamyl peptide bond of glutathione conjugates, but maybe not glutathione itself. Converts leukotriene C4 (LTC4) to leukotriene D4 (LTD4). Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 124 3300008055 Rose P36269 2687 GGT5 Homo sapiens 9606 Comment/pathway Lipid metabolism; leukotriene D4 biosynthesis. leukotriene biosynthetic process GO:0019370 UPA00880 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 2/6/2013 124 3300008056 Rose P36269 2687 GGT5 Homo sapiens 9606 Comment/pathway Lipid metabolism; leukotriene D4 biosynthesis. lipid metabolic process GO:0006629 UPA00880 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 2/6/2013 124 3300008057 Rose P36269 2687 GGT5 Homo sapiens 9606 EC 2.3.2.2 Y Y ECO:0000311 EC number UniProtKB AAP 2/6/2013 124 3300008060 Faith Q6P531 124975 GGT6 Homo sapiens 9606 Comment/pathway Sulfur metabolism; glutathione metabolism. sulfur compound metabolic process GO:0006790 UPA00204 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 11/28/2012 69 3300008062 Faith Q6P531 124975 GGT6 Homo sapiens 9606 EC 2.3.2.2 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 69 3300008064 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/pathway Sulfur metabolism; glutathione metabolism. glutathione metabolic process GO:0006749 UPA00204 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 101 3300008066 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/pathway Sulfur metabolism; glutathione metabolism. sulfur compound metabolic process GO:0006790 UPA00204 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 101 3300008067 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. respiratory epithelium cell BTO:0004533 respiratory epithelial cell CL:0002368 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID except in the airway epithelial cells AAP 1/9/2013 101 3300008071 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. brain BTO:0000142 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008073 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. brain UBERON:0000955 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008074 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. heart BTO:0000562 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008075 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. heart UBERON:0000948 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008076 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. kidney BTO:0000671 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008077 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. kidney UBERON:0002113 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008078 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. liver BTO:0000759 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008079 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008080 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008081 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008082 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. spleen BTO:0001281 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008083 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. spleen UBERON:0002106 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008084 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. testis BTO:0001363 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008085 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. testis UBERON:0000473 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008086 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. trachea BTO:0001388 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008087 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity Widely expressed, but at low level, except in the airway epithelial cells. Detected in brain, heart, kidney, liver, lung, spleen, testis and trachea. trachea UBERON:0003126 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 101 3300008088 Katie Q9UJ14 2686 GGT7 Homo sapiens 9606 EC 2.3.2.2 Y Y ECO:0000311 EC number UniProtKB AAP 1/9/2013 101 3300008089 Faith Q13304 2840 GPR17 Homo sapiens 9606 Comment/tissue specificity Expressed in brain, kidney, heart and umbilical vein endothelial cells. Highest level in brain. HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y ECO:0000269 PubMed:16990797 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 104 3300008090 Faith Q13304 2840 GPR17 Homo sapiens 9606 Comment/function Dual specificity receptor for uracil nucleotides and cysteinyl leukotrienes (CysLTs). Signals through G(i) and inhibition of adenylyl cyclase. May mediate brain damage by nucleotides and CysLTs following ischemia. Y Y ECO:0000269 PubMed:16990797 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 104 3300008091 Faith Q13304 2840 GPR17 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB AAP, ASD 4/3/2013 104 3300008092 Faith Q13304 2840 GPR17 Homo sapiens 9606 Comment/tissue specificity Expressed in brain, kidney, heart and umbilical vein endothelial cells. Highest level in brain. brain BTO:0000142 Y Y ECO:0000269 PubMed:16990797 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 104 3300008093 Faith Q13304 2840 GPR17 Homo sapiens 9606 Comment/tissue specificity Expressed in brain, kidney, heart and umbilical vein endothelial cells. Highest level in brain. brain UBERON:0000955 Y Y ECO:0000269 PubMed:16990797 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 104 3300008094 Faith Q13304 2840 GPR17 Homo sapiens 9606 Comment/tissue specificity Expressed in brain, kidney, heart and umbilical vein endothelial cells. Highest level in brain. kidney BTO:0000671 Y Y ECO:0000269 PubMed:16990797 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 104 3300008095 Faith Q13304 2840 GPR17 Homo sapiens 9606 Comment/tissue specificity Expressed in brain, kidney, heart and umbilical vein endothelial cells. Highest level in brain. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:16990797 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 104 3300008096 Faith Q13304 2840 GPR17 Homo sapiens 9606 Comment/tissue specificity Expressed in brain, kidney, heart and umbilical vein endothelial cells. Highest level in brain. heart BTO:0000562 Y Y ECO:0000269 PubMed:16990797 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 104 3300008097 Faith Q13304 2840 GPR17 Homo sapiens 9606 Comment/tissue specificity Expressed in brain, kidney, heart and umbilical vein endothelial cells. Highest level in brain. heart UBERON:0000948 Y Y ECO:0000269 PubMed:16990797 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 104 3300008098 Mike P07203 2876 GPX1 Homo sapiens 9606 Comment/function Protects the hemoglobin in erythrocytes from oxidative breakdown. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 2/6/2013 155 3300008099 Mike P07203 2876 GPX1 Homo sapiens 9606 EC 1.11.1.9 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 2/6/2013 155 3300008101 Rose P18283 2877 GPX2 Homo sapiens 9606 Comment/function Could play a major role in protecting mammals from the toxicity of ingested organic hydroperoxides. Tert-butyl hydroperoxide, cumene hydroperoxide and linoleic acid hydroperoxide but not phosphatidycholine hydroperoxide, can act as acceptors. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 127 3300008102 Rose P18283 2877 GPX2 Homo sapiens 9606 Comment/tissue specificity Mostly in liver and gastrointestinal tract, not found in heart or kidney. gastrointestinal tract BTO:0000511 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 127 3300008106 Rose P18283 2877 GPX2 Homo sapiens 9606 Comment/tissue specificity Mostly in liver and gastrointestinal tract, not found in heart or kidney. digestive tract UBERON:0001555 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 127 3300008107 Rose P18283 2877 GPX2 Homo sapiens 9606 Comment/tissue specificity Mostly in liver and gastrointestinal tract, not found in heart or kidney. liver BTO:0000759 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 127 3300008108 Rose P18283 2877 GPX2 Homo sapiens 9606 Comment/tissue specificity Mostly in liver and gastrointestinal tract, not found in heart or kidney. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 127 3300008109 Rose P18283 2877 GPX2 Homo sapiens 9606 EC 1.11.1.9 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 127 3300008110 Rose P22352 2878 GPX3 Homo sapiens 9606 Comment/function Protects cells and enzymes from oxidative damage, by catalyzing the reduction of hydrogen peroxide, lipid peroxides and organic hydroperoxide, by glutathione. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 138 3300008111 Rose P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity Secreted in plasma. blood plasma BTO:0000131 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 138 3300008113 Rose P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity Secreted in plasma. blood plasma UBERON:0001969 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 138 3300008114 Rose P22352 2878 GPX3 Homo sapiens 9606 EC 1.11.1.9 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 1/9/2013 138 3300008115 Mike P36969 2879 GPX4 Homo sapiens 9606 Comment/function Protects cells against membrane lipid peroxidation and cell death. Required for normal sperm development and male fertility. Could play a major role in protecting mammals from the toxicity of ingested lipid hydroperoxides. Essential for embryonic development. Protects from radiation and oxidative damage (By similarity). Y Y by similarity UniProtKB TBD ver_2 AAP, DGA, ASD 11/28/2012 137 3300008116 Katie P36969 2879 GPX4 Homo sapiens 9606 Comment/subcellular location Cytoplasm cytoplasm GO:0005737 SL-0086 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 137 3300008117 Katie P36969 2879 GPX4 Homo sapiens 9606 Comment/tissue specificity Present primarily in testis. testis BTO:0001363 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 137 3300008118 Katie P36969 2879 GPX4 Homo sapiens 9606 Comment/tissue specificity Present primarily in testis. testis UBERON:0000473 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 137 3300008119 Katie P36969 2879 GPX4 Homo sapiens 9606 EC 1.11.1.12 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 137 3300008120 Mike O75715 2880 GPX5 Homo sapiens 9606 Comment/function Protects cells and enzymes from oxidative damage, by catalyzing the reduction of hydrogen peroxide, lipid peroxides and organic hydroperoxide, by glutathione. May constitute a glutathione peroxidase-like protective system against peroxide damage in sperm membrane lipids. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID covered by EC code AAP, ASD 11/28/2012 110 3300008121 Mike O75715 2880 GPX5 Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 11/28/2012 110 3300008122 Mike O75715 2880 GPX5 Homo sapiens 9606 Comment/tissue specificity Epididymis. epididymis BTO:0000408 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 110 3300008123 Mike O75715 2880 GPX5 Homo sapiens 9606 Comment/tissue specificity Epididymis. epididymis UBERON:0001301 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 110 3300008124 Mike O75715 2880 GPX5 Homo sapiens 9606 EC 1.11.1.9 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 110 3300008125 Faith P59796 257202 GPX6 Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 2/6/2013 84 3300008126 Faith P59796 257202 GPX6 Homo sapiens 9606 Comment/tissue specificity Expressed in olfactory epithelium and embryos. embryo BTO:0000379 Y Y ECO:0000269 PubMed:12775843 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 84 3300008127 Faith P59796 257202 GPX6 Homo sapiens 9606 Comment/tissue specificity Expressed in olfactory epithelium and embryos. embryo UBERON:0000922 Y Y ECO:0000269 PubMed:12775843 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 84 3300008128 Faith P59796 257202 GPX6 Homo sapiens 9606 Comment/tissue specificity Expressed in olfactory epithelium and embryos. olfactory epithelium BTO:0000108 Y Y ECO:0000269 PubMed:12775843 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 84 3300008129 Faith P59796 257202 GPX6 Homo sapiens 9606 Comment/tissue specificity Expressed in olfactory epithelium and embryos. olfactory epithelium UBERON:0001997 Y Y ECO:0000269 PubMed:12775843 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 84 3300008130 Faith P59796 257202 GPX6 Homo sapiens 9606 EC 1.11.1.9 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 84 3300008131 Faith Q96SL4 2882 GPX7 Homo sapiens 9606 Comment/function It protects esophageal epithelia from hydrogen peroxide-induced oxidative stress. It suppresses acidic bile acid-induced reactive oxigen species (ROS) and protects against oxidative DNA damage and double-strand breaks. Y Y ECO:0000269 PubMed:22157330 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 105 3300008132 Faith Q96SL4 2882 GPX7 Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 11/28/2012 105 3300008136 Faith Q96SL4 2882 GPX7 Homo sapiens 9606 Comment/tissue specificity Expressed in esophageal epithelial cells; expression is up-regulated after exposure to acidic bile acids. esophageal epithelium BTO:0001578 Y Y ECO:0000269 PubMed:22157330 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 105 3300008138 Faith Q96SL4 2882 GPX7 Homo sapiens 9606 Comment/tissue specificity Expressed in esophageal epithelial cells; expression is up-regulated after exposure to acidic bile acids. epithelium of esophagus UBERON:0001976 Y Y ECO:0000269 PubMed:22157330 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 105 3300008139 Faith Q96SL4 2882 GPX7 Homo sapiens 9606 EC 1.11.1.9 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 105 3300008140 Katie P15428 3248 HPGD Homo sapiens 9606 Comment/function Prostaglandin inactivation. Contributes to the regulation of events that are under the control of prostaglandin levels. Catalyzes the NAD-dependent dehydrogenation of lipoxin A4 to form 15-oxo-lipoxin A4. Inhibits in vivo proliferation of colon cancer cells. Y Y ECO:0000269 PubMed:10837478 PubMed:15574495 PubMed:16828555 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 135 3300008141 Katie P15428 3248 HPGD Homo sapiens 9606 Comment/induction Down-regulated by cortisol, dexamethasone and betamethasone. Down-regulated in colon cancer. Up-regulated by TGFB1. colon BTO:0000269 colon cancer DOID:219 Y Y ECO:0000269 PubMed:12788907 PubMed:15574495 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 135 3300008142 Katie P15428 3248 HPGD Homo sapiens 9606 Comment/induction Down-regulated by cortisol, dexamethasone and betamethasone. Down-regulated in colon cancer. Up-regulated by TGFB1. colon UBERON:0001155 colon cancer DOID:219 Y Y ECO:0000269 PubMed:12788907 PubMed:15574495 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 135 3300008143 Katie P15428 3248 HPGD Homo sapiens 9606 Comment/tissue specificity Detected in colon epithelium (at protein level). colon BTO:0000269 Y Y ECO:0000269 PubMed:15574495 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 135 3300008153 Katie P15428 3248 HPGD Homo sapiens 9606 Comment/tissue specificity Detected in colon epithelium (at protein level). colonic epithelium UBERON:0000397 Y Y ECO:0000269 PubMed:15574495 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 135 3300008154 Katie P15428 3248 HPGD Homo sapiens 9606 EC 1.1.1.141 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 135 3300008155 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. macrophage BTO:0000801 macrophage CL:0000235 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008156 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. liver BTO:0000759 fetus BTO:0000449 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID Note that the liver is specified to be fetal, hence the use of the ""fetal organ"" term. AAP, ASD 2/6/2013 124 3300008157 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. liver UBERON:0002107 fetus BTO:0000449 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID Note that the liver is specified to be fetal, hence the use of the ""fetal organ"" term. AAP, ASD 2/6/2013 124 3300008158 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/function Bifunctional enzyme which catalyzes both the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation, and the conjugation of glutathione with a wide range of aryl halides and organic isothiocyanates. Also exhibits low glutathione-peroxidase activity towards cumene hydroperoxide. Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:12627223 PubMed:15113825 PubMed:16547010 PubMed:19939518 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID PGD synthesis is covered in GO annotations; remaining info not mappable. AAP, ASD 2/6/2013 124 3300008160 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. adipose tissue BTO:0001487 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008163 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. adipose tissue UBERON:0001013 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008164 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. bone marrow BTO:0000141 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008165 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. bone marrow UBERON:0002371 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008166 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. heart BTO:0000562 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008167 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. heart UBERON:0000948 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008168 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. lung BTO:0000763 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008169 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. lung UBERON:0002048 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008170 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. lymph node BTO:0000784 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008171 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. lymph node UBERON:0000029 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008172 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. megakaryocyte BTO:0000843 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008173 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. placenta BTO:0001078 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008174 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008175 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. vermiform appendix BTO:0000084 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008176 Mike O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity Expressed in a number of megakaryocytic cell lines but not in platelets. Highly expressed in adipose tissue, macrophages and placenta. Also expressed at lower levels in lung, heart, lymph nodes, appendix, bone marrow and fetal liver. vermiform appendix UBERON:0001154 Y Y ECO:0000269 PubMed:10824118 PubMed:11672424 PubMed:9353279 PubMed:9425264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008177 Mike O60760 27306 HPGDS Homo sapiens 9606 EC 5.3.99.2 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 124 3300008178 Mike P04180 3931 LCAT Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA 11/28/2012 141 3300008184 Mike P04180 3931 LCAT Homo sapiens 9606 EC 2.3.1.43 Y Y ECO:0000311 EC number UniProtKB AAP, DGA 11/28/2012 141 3300008196 Rose P38571 3988 LIPA Homo sapiens 9606 Comment/function Crucial for the intracellular hydrolysis of cholesteryl esters and triglycerides that have been internalized via receptor-mediated endocytosis of lipoprotein particles. Important in mediating the effect of LDL (low density lipoprotein) uptake on suppression of hydroxymethylglutaryl-CoA reductase and activation of endogenous cellular cholesteryl ester formation. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 128 3300008197 Rose P38571 3988 LIPA Homo sapiens 9606 Comment/subcellular location Lysosome lysosome GO:0005764 SL-0158 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 128 3300008202 Rose P38571 3988 LIPA Homo sapiens 9606 EC 3.1.1.13 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 128 3300008203 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/function In adipose tissue and heart, it primarily hydrolyzes stored triglycerides to free fatty acids, while in steroidogenic tissues, it principally converts cholesteryl esters to free cholesterol for steroid hormone production. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID tissue information extracted into other rows AAP, DGA, ASD 11/28/2012 118 3300008204 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/pathway Glycerolipid metabolism; triacylglycerol degradation. glycerolipid metabolic process GO:0046486 UPA00256 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 118 3300008205 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/subcellular location Caveola caveola GO:0005901 SL-0035 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 118 3300008206 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/subcellular location Cytosol cytosol GO:0005829 SL-0091 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 118 3300008207 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/subcellular location Cell membrane plasma membrane GO:0005886 SL-0039 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 118 3300008208 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/subcellular location Found in the high-density caveolae. Translocates to the cytoplasm from the caveolae upon insulin stimulation. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 118 3300008209 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/tissue specificity In adipose tissue and heart, it primarily hydrolyzes stored triglycerides to free fatty acids, while in steroidogenic tissues, it principally converts cholesteryl esters to free cholesterol for steroid hormone production. adipose tissue BTO:0001487 Y Y ECO:0000311 UniProtKB TBD ver_2steroidogenic tissues; Info extracted from Comment/fuction. I'm not sure how to represent this Info extracted from Comment/fuction AAP, DGA, ASD 11/28/2012 118 3300008210 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/tissue specificity In adipose tissue and heart, it primarily hydrolyzes stored triglycerides to free fatty acids, while in steroidogenic tissues, it principally converts cholesteryl esters to free cholesterol for steroid hormone production. adipose tissue UBERON:0001013 Y Y ECO:0000311 UniProtKB TBD ver_2steroidogenic tissues; Info extracted from Comment/fuction. I'm not sure how to represent this Info extracted from Comment/fuction AAP, DGA, ASD 11/28/2012 118 3300008211 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/tissue specificity In adipose tissue and heart, it primarily hydrolyzes stored triglycerides to free fatty acids, while in steroidogenic tissues, it principally converts cholesteryl esters to free cholesterol for steroid hormone production. heart BTO:0000562 Y Y ECO:0000311 UniProtKB TBD ver_2steroidogenic tissues; Info extracted from Comment/fuction. I'm not sure how to represent this Info extracted from Comment/fuction AAP, DGA, ASD 11/28/2012 118 3300008212 Faith Q05469 3991 LIPE Homo sapiens 9606 Comment/tissue specificity In adipose tissue and heart, it primarily hydrolyzes stored triglycerides to free fatty acids, while in steroidogenic tissues, it principally converts cholesteryl esters to free cholesterol for steroid hormone production. heart UBERON:0000948 Y Y ECO:0000311 UniProtKB TBD ver_2steroidogenic tissues; Info extracted from Comment/fuction. I'm not sure how to represent this Info extracted from Comment/fuction AAP, DGA, ASD 11/28/2012 118 3300008213 Faith Q05469 3991 LIPE Homo sapiens 9606 EC 3.1.1.79 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 118 3300008215 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/function Has phospholipase and triglyceride lipase activities. Hydrolyzes high density lipoproteins (HDL) more efficiently than other lipoproteins. Binds heparin. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008216 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 117 3300008218 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. coronary artery endothelial cell BTO:0004096 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 117 3300008219 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. hepatocyte BTO:0000575 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 117 3300008220 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. osteosarcoma cell line BTO:0000407 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 117 3300008221 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. umbilical vein endothelial cell BTO:0004296 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 117 3300008222 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. corpus luteum BTO:0000292 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008224 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. corpus luteum UBERON:0002512 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008225 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. kidney BTO:0000671 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008226 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. kidney UBERON:0002113 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008227 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. liver BTO:0000759 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008228 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008229 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008230 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008231 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. placenta BTO:0001078 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008232 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. placenta UBERON:0001987 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008233 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. testis BTO:0001363 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008234 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. testis UBERON:0000473 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008235 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. thyroid gland BTO:0001379 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008236 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 Comment/tissue specificity High level of expression in the liver, placenta, lung, thyroid, kidney, testis and in the corpus luteum of the ovary. Expressed also in coronary artery endothelial cells, umbilical vein endothelial cells and in hepatocytes and osteosarcoma cell lines. Not detected in heart, brain and muscle. thyroid gland UBERON:0002046 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 117 3300008237 Katie Q9Y5X9 9388 LIPG Homo sapiens 9606 EC 3.1.1.3 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 117 3300008238 Faith Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/pathway Lipid metabolism; phospholipid metabolism. lipid metabolic process GO:0006629 UPA00085 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 86 3300008240 Faith Q8NF37 79888 LPCAT1 Homo sapiens 9606 EC 2.3.1.- Y Y ECO:0000311 EC number UniProtKB AAP 1/9/2013 86 3300008244 Faith Q7L5N7 54947 LPCAT2 Homo sapiens 9606 Comment/pathway Lipid metabolism; phospholipid metabolism. lipid metabolic process GO:0006629 UPA00085 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 84 3300008246 Mike Q7L5N7 54947 LPCAT2 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Single-pass type II membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000006 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 1/9/2013 84 3300008248 Faith Q7L5N7 54947 LPCAT2 Homo sapiens 9606 EC 2.3.1.- Y Y ECO:0000311 EC number UniProtKB AAP 1/9/2013 84 3300008250 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. neutrophil BTO:0000130 neutrophil CL:0000775 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP 1/9/2013 82 3300008251 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/function Acyltransferase which mediates the conversion of lysophosphatidylcholine (1-acyl-sn-glycero-3-phosphocholine or LPC) into phosphatidylcholine (1,2-diacyl-sn-glycero-3-phosphocholine or PC) (LPCAT activity). Catalyzes also the conversion of lysophosphatidylserine (1-acyl-2-hydroxy-sn-glycero-3-phospho-L-serine or LPS) into phosphatidylserine (1,2-diacyl-sn-glycero-3-phospho-L-serine or PS) (LPSAT activity). Has also weak lysophosphatidylethanolamine acyltransferase activity (LPEAT activity). Favors polyunsaturated fatty acyl-CoAs as acyl donors compared to saturated fatty acyl-CoAs. Seems to be the major enzyme contributing to LPCAT activity in the liver. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle. Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 82 3300008252 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/pathway Lipid metabolism; phospholipid metabolism. lipid metabolic process GO:0006629 UPA00085 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP 1/9/2013 82 3300008253 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Multi-pass membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 1/9/2013 82 3300008255 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. adipose tissue BTO:0001487 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP 1/9/2013 82 3300008256 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. adipose tissue UBERON:0001013 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP 1/9/2013 82 3300008257 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. liver BTO:0000759 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP 1/9/2013 82 3300008258 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. liver UBERON:0002107 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP 1/9/2013 82 3300008259 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP 1/9/2013 82 3300008260 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID highly expressed AAP 1/9/2013 82 3300008261 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. heart BTO:0000562 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID very low expression AAP 1/9/2013 82 3300008262 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. heart UBERON:0000948 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID very low expression AAP 1/9/2013 82 3300008263 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID very low expression AAP 1/9/2013 82 3300008264 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Highly expressed in liver, pancreas and adipose tissue. Very low expression in skeletal muscle and heart. Detected in neutrophils. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:18195019 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID very low expression AAP 1/9/2013 82 3300008265 Faith Q6P1A2 10162 LPCAT3 Homo sapiens 9606 EC 2.3.1.- Y Y ECO:0000311 EC number UniProtKB AAP 1/9/2013 82 3300008266 Mike P09960 4048 LTA4H Homo sapiens 9606 Comment/function Epoxide hydrolase that catalyzes the final step in the biosynthesis of the proinflammatory mediator leukotriene B4. Has also aminopeptidase activity. leukotriene-A4 hydrolase activity GO:0004463 Y Y ECO:0000269 PubMed:11917124 PubMed:12207002 PubMed:15078870 PubMed:18804029 PubMed:1897988 PubMed:1975494 PubMed:2244921 UniProtKB UPDATE ver_2 Changes in: GO,EVID GO MF Use=Y; Provides additional refererences beyond what is found in the GO annotation. AAP, ASD 2/6/2013 161 3300008267 Mike P09960 4048 LTA4H Homo sapiens 9606 EC 3.3.2.6 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 161 3300008270 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/function Receptor for extracellular ATP > UTP and ADP. The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. May be the cardiac P2Y receptor involved in the regulation of cardiac muscle contraction through modulation of L-type calcium currents. Is a receptor for leukotriene B4, a potent chemoattractant involved in inflammation and immune response. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 123 3300008271 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 1/9/2013 123 3300008273 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. brain BTO:0000142 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Expressed at lower levels in the brain and liver AAP, DGA, ASD 1/9/2013 123 3300008274 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. brain UBERON:0000955 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Expressed at lower levels in the brain and liver AAP, DGA, ASD 1/9/2013 123 3300008275 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. liver BTO:0000759 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Expressed at lower levels in the brain and liver AAP, DGA, ASD 1/9/2013 123 3300008276 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Expressed at lower levels in the brain and liver AAP, DGA, ASD 1/9/2013 123 3300008277 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. heart BTO:0000562 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Expressed in highest levels in heart and skeletal muscle AAP, DGA, ASD 1/9/2013 123 3300008278 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. heart UBERON:0000948 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Expressed in highest levels in heart and skeletal muscle AAP, DGA, ASD 1/9/2013 123 3300008279 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. skeletal muscle BTO:0001103 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Expressed in highest levels in heart and skeletal muscle AAP, DGA, ASD 1/9/2013 123 3300008280 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Expressed in highest levels in heart and skeletal muscle AAP, DGA, ASD 1/9/2013 123 3300008281 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. lymphoid tissue BTO:0000753 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 123 3300008282 Faith Q15722 1241 LTB4R Homo sapiens 9606 Comment/tissue specificity Expressed at highest levels in heart, skeletal muscle and at lower levels in brain and liver. High level of expression in lymphoid tissues. lymphoid tissue UBERON:0001744 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 1/9/2013 123 3300008283 Katie Q9NPC1 56413 LTB4R2 Homo sapiens 9606 Comment/function Low-affinity receptor for leukotrienes including leukotriene B4. Mediates chemotaxis of granulocytes and macrophages. The response is mediated via G-proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of affinities for the leukotrienes is LTB4 > 12-epi-LTB4 > LTB5 > LTB3. leukotriene receptor activity GO:0004974 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID GO MF Use=Y AAP, ASD 2/6/2013 107 3300008285 Katie Q9NPC1 56413 LTB4R2 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 2/6/2013 107 3300008287 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. basophil BTO:0000129 basophil CL:0000767 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 116 3300008289 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. endothelial cell BTO:0001176 endothelial cell CL:0000115 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 116 3300008290 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. eosinophil BTO:0000399 eosinophil CL:0000771 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 116 3300008291 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. mast cell BTO:0000830 mast cell CL:0000097 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 116 3300008292 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. mononuclear phagocyte BTO:0001433 mononuclear phagocyte CL:0000113 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term; 'certain' suggest that it is not present in all mononuclear phagocytes AAP, DGA, ASD 11/28/2012 116 3300008293 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. KG-1 cell BTO:0000670 myeloid cell CL:0000763 KG-1 cell CLO:0007094 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 116 3300008294 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 116 3300008295 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/function Catalyzes the conjugation of leukotriene A4 with reduced glutathione to form leukotriene C4. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 116 3300008296 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/subcellular location Nucleus outer membrane;Multi-pass membrane protein nuclear outer membrane GO:0005640 SL-0183 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 116 3300008300 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. vascular smooth muscle cell BTO:0004578 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 116 3300008301 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. blood vessel smooth muscle UBERON:0004237 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 116 3300008302 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. lung BTO:0000763 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 116 3300008303 Faith Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity Detected in lung, platelets and the myelogenous leukemia cell line KG-1 (at protein level). LTC4S activity is present in eosinophils, basophils, mast cells, certain phagocytic mononuclear cells, endothelial cells, vascular smooth muscle cells and platelets. lung UBERON:0002048 Y Y ECO:0000269 PubMed:7599836 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 116 3300008304 Faith Q16873 4056 LTC4S Homo sapiens 9606 EC 4.4.1.20 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 116 3300008305 Katie P49137 9261 MAPKAPK2 Homo sapiens 9606 Comment/function Stress-activated serine/threonine-protein kinase involved in cytokines production, endocytosis, reorganization of the cytoskeleton, cell migration, cell cycle control, chromatin remodeling, DNA damage response and transcriptional regulation. Following stress, it is phosphorylated and activated by MAP kinase p38-alpha/MAPK14, leading to phosphorylation of substrates. Phosphorylates serine in the peptide sequence, Hyd-X-R-X(2)-S, where Hyd is a large hydrophobic residue. Phosphorylates ALOX5, CDC25B, CDC25C, ELAVL1, HNRNPA0, HSF1, HSP27/HSPB1, KRT18, KRT20, LIMK1, LSP1, PABPC1, PARN, PDE4A, RCSD1, RPS6KA3, TAB3 and TTP/ZFP36. Mediates phosphorylation of HSP27/HSPB1 in response to stress, leading to dissociate HSP27/HSPB1 from large small heat-shock protein (sHsps) oligomers and impair their chaperone activities and ability to protect against oxidative stress effectively. Involved in inflammatory response by regulating tumor necrosis factor (TNF) and IL6 production post-transcriptionally: acts by phosphorylating AU-rich elements (AREs)-binding proteins ELAVL1, HNRNPA0, PABPC1 and TTP/ZFP36, leading to regulate the stability and translation of TNF and IL6 mRNAs. Phosphorylation of TTP/ZFP36, a major post-transcriptional regulator of TNF, promotes its binding to 14-3-3 proteins and reduces its ARE mRNA affinity leading to inhibition of dependent degradation of ARE-containing transcript. Also involved in late G2/M checkpoint following DNA damage through a process of post-transcriptional mRNA stabilization: following DNA damage, relocalizes from nucleus to cytoplasm and phosphorylates HNRNPA0 and PARN, leading to stabilize GADD45A mRNA. Involved in toll-like receptor signaling pathway (TLR) in dendritic cells: required for acute TLR-induced macropinocytosis by phosphorylating and activating RPS6KA3. Y Y ECO:0000269 PubMed:10383393 PubMed:11844797 PubMed:12456657 PubMed:12565831 PubMed:14499342 PubMed:14517288 PubMed:15014438 PubMed:15629715 PubMed:16278218 PubMed:16456544 PubMed:17481585 PubMed:18021073 PubMed:20932473 PubMed:8093612 PubMed:8280084 PubMed:8774846 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 134 3300008306 Katie P49137 9261 MAPKAPK2 Homo sapiens 9606 EC 2.7.11.1 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 134 3300008311 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/function Acyltransferase which mediates the conversion of lysophosphatidylinositol (1-acylglycerophosphatidylinositol or LPI) into phosphatidylinositol (1,2-diacyl-sn-glycero-3-phosphoinositol or PI) (LPIAT activity). Prefers arachidonoyl-CoA as the acyl donor. Lysophospholipid acyltransferases (LPLATs) catalyze the reacylation step of the phospholipid remodeling pathway also known as the Lands cycle. Y Y ECO:0000269 PubMed:18094042 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 74 3300008312 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/pathway Lipid metabolism; phospholipid metabolism. lipid metabolic process GO:0006629 UPA00085 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, ASD 11/28/2012 74 3300008313 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/tissue specificity Overexpressed in metastatic breast and bladder carcinomas relative to normal breast epithelium and urothelium. breast epithelium BTO:0001428 breast carcinoma DOID:3459 Carcinoma of breast SNOMEDCT:254838004 Y Y ECO:0000269 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID PubMed:18772128 (ref 7 in UniProt) is linked to this information in UniProt, but is not correct. I've added the correct reference, and I'll email them. SNOMED has attributes 'metastatic to' and 'metastatic from'. OVEREXPRESSED AAP, ASD 11/28/2012 74 3300008316 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/tissue specificity Overexpressed in metastatic breast and bladder carcinomas relative to normal breast epithelium and urothelium. breast epithelium UBERON:0008367 breast carcinoma DOID:3459 Carcinoma of breast SNOMEDCT:254838004 Y Y ECO:0000269 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID PubMed:18772128 (ref 7 in UniProt) is linked to this information in UniProt, but is not correct. I've added the correct reference, and I'll email them. SNOMED has attributes 'metastatic to' and 'metastatic from'. OVEREXPRESSED AAP, ASD 11/28/2012 74 3300008317 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/tissue specificity Overexpressed in metastatic breast and bladder carcinomas relative to normal breast epithelium and urothelium. uroepithelium BTO:0003906 bladder carcinoma DOID:4007 Carcinoma of bladder SNOMEDCT:255108000 Y Y ECO:0000269 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID PubMed:18772128 (ref 7 in UniProt) is linked to this information in UniProt, but is not correct. I've added the correct reference, and I'll email them. OVEREXPRESSED AAP, ASD 11/28/2012 74 3300008318 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/tissue specificity Overexpressed in metastatic breast and bladder carcinomas relative to normal breast epithelium and urothelium. urothelium UBERON:0000365 bladder carcinoma DOID:4007 Carcinoma of bladder SNOMEDCT:255108000 Y Y ECO:0000269 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID PubMed:18772128 (ref 7 in UniProt) is linked to this information in UniProt, but is not correct. I've added the correct reference, and I'll email them. OVEREXPRESSED AAP, ASD 11/28/2012 74 3300008319 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/tissue specificity Overexpressed in metastatic breast and bladder carcinomas relative to normal breast epithelium and urothelium. breast epithelium BTO:0001428 Y Y ECO:0000269 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID PubMed:18772128 (ref 7 in UniProt) is linked to this information in UniProt, but is not correct. I've added the correct reference, and I'll email them. AAP, ASD 11/28/2012 74 3300008320 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/tissue specificity Overexpressed in metastatic breast and bladder carcinomas relative to normal breast epithelium and urothelium. breast epithelium UBERON:0008367 Y Y ECO:0000269 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID PubMed:18772128 (ref 7 in UniProt) is linked to this information in UniProt, but is not correct. I've added the correct reference, and I'll email them. AAP, ASD 11/28/2012 74 3300008321 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/tissue specificity Overexpressed in metastatic breast and bladder carcinomas relative to normal breast epithelium and urothelium. uroepithelium BTO:0003906 Y Y ECO:0000269 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID PubMed:18772128 (ref 7 in UniProt) is linked to this information in UniProt, but is not correct. I've added the correct reference, and I'll email them. AAP, ASD 11/28/2012 74 3300008322 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/tissue specificity Overexpressed in metastatic breast and bladder carcinomas relative to normal breast epithelium and urothelium. urothelium UBERON:0000365 Y Y ECO:0000269 PubMed:18772128 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID PubMed:18772128 (ref 7 in UniProt) is linked to this information in UniProt, but is not correct. I've added the correct reference, and I'll email them. AAP, ASD 11/28/2012 74 3300008323 Faith Q96N66 79143 MBOAT7 Homo sapiens 9606 EC 2.3.1.- Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 74 3300008324 Faith Q99735 4258 MGST2 Homo sapiens 9606 EC 2.5.1.18 Y Y EC number UniProtKB AAP, ASD 4/3/2013 110 3300008325 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/function Can catalyze the production of LTC4 from LTA4 and reduced glutathione. Can catalyze the conjugation of 1-chloro-2,4-dinitrobenzene with reduced glutathione. Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008326 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. liver BTO:0000759 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008329 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. liver UBERON:0002107 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008330 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. spleen BTO:0001281 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008331 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. spleen UBERON:0002106 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008332 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. skeletal muscle BTO:0001103 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008333 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. skeletal muscle tissue UBERON:0001134 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008334 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. heart BTO:0000562 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008335 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. heart UBERON:0000948 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008336 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. adrenal gland BTO:0000047 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008337 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. adrenal gland UBERON:0002369 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008338 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. pancreas BTO:0000988 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008339 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. pancreas UBERON:0001264 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008340 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. prostate gland BTO:0001129 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008341 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. prostate gland UBERON:0002367 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008342 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. testis BTO:0001363 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008343 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. testis UBERON:0000473 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008344 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. liver BTO:0000759 fetus BTO:0000449 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008345 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. liver UBERON:0002107 fetus BTO:0000449 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008346 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. lung BTO:0000763 Y Y UniProtKB very low expression AAP, ASD 4/3/2013 110 3300008347 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. lung UBERON:0002048 Y Y UniProtKB very low expression AAP, ASD 4/3/2013 110 3300008348 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. brain BTO:0000142 Y Y UniProtKB very low expression AAP, ASD 4/3/2013 110 3300008349 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. brain UBERON:0000955 Y Y UniProtKB very low expression AAP, ASD 4/3/2013 110 3300008350 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. placenta BTO:0001078 Y Y UniProtKB very low expression AAP, ASD 4/3/2013 110 3300008351 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. placenta UBERON:0001987 Y Y UniProtKB very low expression AAP, ASD 4/3/2013 110 3300008352 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. bone marrow BTO:0000141 Y Y UniProtKB very low expression AAP, ASD 4/3/2013 110 3300008353 Faith Q99735 4258 MGST2 Homo sapiens 9606 Comment/tissue specificity Liver, spleen, skeletal muscle, heart, adrenals, pancreas, prostate, testis, fetal liver, and fetal spleen. Very low expression in lung, brain, placenta and bone marrow. bone marrow UBERON:0002371 Y Y UniProtKB very low expression AAP, ASD 4/3/2013 110 3300008354 Faith O14880 4259 MGST3 Homo sapiens 9606 EC 2.5.1.18 Y Y EC number UniProtKB AAP, ASD 4/3/2013 110 3300008355 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/function Also functions as a glutathione peroxidase. Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008356 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. heart BTO:0000562 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008360 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. heart UBERON:0000948 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008361 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. skeletal muscle BTO:0001103 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008362 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. skeletal muscle tissue UBERON:0001134 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008363 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. adrenal cortex BTO:0000045 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008364 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. adrenal cortex UBERON:0001235 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008365 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. brain BTO:0000142 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008366 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. brain UBERON:0000955 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008367 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. placenta BTO:0001078 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008368 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. placenta UBERON:0001987 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008369 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. liver BTO:0000759 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008370 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. liver UBERON:0002107 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008371 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. kidney BTO:0000671 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008372 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. kidney UBERON:0002113 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008373 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. pancreas BTO:0000988 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008374 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. pancreas UBERON:0001264 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008375 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. thyroid gland BTO:0001379 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008376 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. thyroid gland UBERON:0002046 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008377 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. testis BTO:0001363 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008378 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. testis UBERON:0000473 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008379 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. ovary BTO:0000975 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008380 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. female gonad UBERON:0000992 Y Y UniProtKB AAP, ASD 4/3/2013 110 3300008381 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. lung BTO:0000763 Y Y UniProtKB Almost absent AAP, ASD 4/3/2013 110 3300008382 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. lung UBERON:0002048 Y Y UniProtKB Almost absent AAP, ASD 4/3/2013 110 3300008383 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. thymus BTO:0001374 Y Y UniProtKB Almost absent AAP, ASD 4/3/2013 110 3300008384 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. thymus UBERON:0002370 Y Y UniProtKB Almost absent AAP, ASD 4/3/2013 110 3300008385 Faith O14880 4259 MGST3 Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in heart, skeletal muscle, and adrenal cortex. Also found in brain, placenta, liver, kidney, pancreas, thyroid, testis and ovary. Almost absent in lung, thymus and peripheral blood leukocytes. leukocyte BTO:0000751 Y Y UniProtKB Almost absent AAP, ASD 4/3/2013 110 3300008386 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. alveolar macrophage BTO:0000802 alveolar macrophage CL:0000583 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID lung macrophage AAP, ASD 4/3/2013 92 3300008387 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. eosinophil BTO:0000399 eosinophil CL:0000771 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008388 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. leukocyte BTO:0000751 leukocyte CL:0000738 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID peripheral leukocyte AAP, ASD 4/3/2013 92 3300008389 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. neutrophil BTO:0000130 neutrophil CL:0000775 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008390 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/function Receptor for eicosanoids and polyunsaturated fatty acids such as 5-oxo-6E,8Z,11Z,14Z-eicosatetraenoic acid (5-OXO-ETE), 5(S)-hydroperoxy-6E,8Z,11Z,14Z-eicosatetraenoic acid (5(S)-HPETE) and arachidonic acid. Seems to be coupled to the G(i)/G(o), families of heteromeric G proteins. Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008391 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB UPDATE ver_2 Changes in: NOTE,SEC_IDS AAP, ASD 4/3/2013 92 3300008392 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. liver BTO:0000759 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008394 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. liver UBERON:0002107 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008395 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. kidney BTO:0000671 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008396 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008397 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. lung BTO:0000763 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008398 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. lung UBERON:0002048 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008399 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. spleen BTO:0001281 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008400 Faith Q8TDS5 165140 OXER1 Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues except brain. Expression is more intense in liver, kidney, peripheral leukocyte, lung, and spleen than in other tissues. Highly expressed in eosinophils, neutrophils, and lung macrophages. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:12065583 PubMed:12606753 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 4/3/2013 92 3300008401 Faith Q99487 5051 PAFAH2 Homo sapiens 9606 Comment/tissue specificity Broadly expressed in different tissues, but high in B- and T-lymphocytes. In brain, expression is restricted to amygdala and frontal cortex. B-lymphocyte BTO:0000776 B cell CL:0000236 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 114 3300008403 Faith Q99487 5051 PAFAH2 Homo sapiens 9606 Comment/tissue specificity Broadly expressed in different tissues, but high in B- and T-lymphocytes. In brain, expression is restricted to amygdala and frontal cortex. T-lymphocyte BTO:0000782 T cell CL:0000084 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 114 3300008404 Faith Q99487 5051 PAFAH2 Homo sapiens 9606 Comment/function Has a marked selectivity for phospholipids with short acyl chains at the sn-2 position. May share a common physiologic function with the plasma-type enzyme. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 1/9/2013 114 3300008405 Faith Q99487 5051 PAFAH2 Homo sapiens 9606 Comment/subcellular location Cytoplasm cytoplasm GO:0005737 SL-0086 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 1/9/2013 114 3300008406 Faith Q99487 5051 PAFAH2 Homo sapiens 9606 Comment/tissue specificity Broadly expressed in different tissues, but high in B- and T-lymphocytes. In brain, expression is restricted to amygdala and frontal cortex. amygdala BTO:0001042 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID In brain, expression restricted to amygdala and frontal cortex AAP 1/9/2013 114 3300008408 Faith Q99487 5051 PAFAH2 Homo sapiens 9606 Comment/tissue specificity Broadly expressed in different tissues, but high in B- and T-lymphocytes. In brain, expression is restricted to amygdala and frontal cortex. amygdala UBERON:0001876 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID In brain, expression restricted to amygdala and frontal cortex AAP 1/9/2013 114 3300008409 Faith Q99487 5051 PAFAH2 Homo sapiens 9606 Comment/tissue specificity Broadly expressed in different tissues, but high in B- and T-lymphocytes. In brain, expression is restricted to amygdala and frontal cortex. frontal lobe BTO:0000484 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID In brain, expression restricted to amygdala and frontal cortex AAP 1/9/2013 114 3300008410 Faith Q99487 5051 PAFAH2 Homo sapiens 9606 Comment/tissue specificity Broadly expressed in different tissues, but high in B- and T-lymphocytes. In brain, expression is restricted to amygdala and frontal cortex. frontal cortex UBERON:0001870 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID In brain, expression restricted to amygdala and frontal cortex AAP 1/9/2013 114 3300008411 Faith Q99487 5051 PAFAH2 Homo sapiens 9606 EC 3.1.1.47 Y Y ECO:0000311 EC number UniProtKB AAP 1/9/2013 114 3300008412 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/function PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Has a powerful potency for releasing arachidonic acid from cell membrane phospholipids. Prefers phosphatidylethanolamine and phosphatidylcholine liposomes to those of phosphatidylserine. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID covered by EC code AAP, DGA, ASD 11/28/2012 125 3300008413 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 125 3300008414 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. colon BTO:0000269 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008415 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. colon UBERON:0001155 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008416 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. leukocyte BTO:0000751 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008417 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008418 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008419 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. pancreas BTO:0000988 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008420 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. pancreas UBERON:0001264 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008421 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. spleen BTO:0001281 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008422 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. spleen UBERON:0002106 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008423 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. thymus BTO:0001374 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008424 Mike O15496 8399 PLA2G10 Homo sapiens 9606 Comment/tissue specificity Found in spleen, thymus, peripheral blood leukocytes, pancreas, lung, and colon. thymus UBERON:0002370 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 125 3300008425 Mike O15496 8399 PLA2G10 Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 125 3300008426 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/function PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Does not exhibit detectable activity toward sn-2-arachidonoyl- or linoleoyl-phosphatidylcholine or -phosphatidylethanolamine. phospholipid metabolic process GO:0006644 Y Y ECO:0000269 PubMed:12522102 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP 11/28/2012 114 3300008427 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/subcellular location Cytoplasm cytoplasm GO:0005737 SL-0086 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 114 3300008428 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 114 3300008429 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. heart BTO:0000562 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008430 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. heart UBERON:0000948 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008431 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. kidney BTO:0000671 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008432 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. kidney UBERON:0002113 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008433 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. liver BTO:0000759 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008434 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008435 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. pancreas BTO:0000988 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008436 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. pancreas UBERON:0001264 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008437 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. skeletal muscle BTO:0001103 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008438 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 Comment/tissue specificity Abundantly expressed in heart, skeletal muscle, kidney, liver and pancreas. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 114 3300008439 Katie Q9BZM1 81579 PLA2G12A Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 114 3300008440 Katie Q9BX93 84647 PLA2G12B Homo sapiens 9606 Comment/function Not known; does not seem to have catalytic activity. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 99 3300008441 Katie Q9BX93 84647 PLA2G12B Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 99 3300008442 Katie Q9BX93 84647 PLA2G12B Homo sapiens 9606 Comment/tissue specificity Strong expression in liver, small intestine and kidney. kidney BTO:0000671 Y Y ECO:0000269 PubMed:14516201 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 99 3300008443 Katie Q9BX93 84647 PLA2G12B Homo sapiens 9606 Comment/tissue specificity Strong expression in liver, small intestine and kidney. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:14516201 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 99 3300008444 Katie Q9BX93 84647 PLA2G12B Homo sapiens 9606 Comment/tissue specificity Strong expression in liver, small intestine and kidney. liver BTO:0000759 Y Y ECO:0000269 PubMed:14516201 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 99 3300008445 Katie Q9BX93 84647 PLA2G12B Homo sapiens 9606 Comment/tissue specificity Strong expression in liver, small intestine and kidney. liver UBERON:0002107 Y Y ECO:0000269 PubMed:14516201 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 99 3300008446 Katie Q9BX93 84647 PLA2G12B Homo sapiens 9606 Comment/tissue specificity Strong expression in liver, small intestine and kidney. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:14516201 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 99 3300008447 Katie Q9BX93 84647 PLA2G12B Homo sapiens 9606 Comment/tissue specificity Strong expression in liver, small intestine and kidney. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:14516201 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 99 3300008448 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. hematopoietic cell BTO:0000574 hematopoietic cell CL:0000988 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID low expression, if any AAP 5/29/2013 109 3300008449 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. spermatid BTO:0001274 spermatid CL:0000018 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID confined to round spermatids in testis AAP 5/29/2013 109 3300008450 Faith P53816 11145 PLA2G16 Homo sapiens 9606 EC 3.1.1.4 Y Y EC number UniProtKB AAP 5/29/2013 109 3300008451 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/function Exhibits PLA1/2 activity, catalyzing the calcium-independent hydrolysis of acyl groups in various phosphatidylcholines (PC) and phosphatidylethanolamine (PE). For most substrates, PLA1 activity is much higher than PLA2 activity. Specifically catalyzes the release of fatty acids from phospholipids in adipose tissue (By similarity). N- and O-acylation activity is hardly detectable. Might decrease protein phosphatase 2A (PP2A) activity. Y Y ECO:0000269 ECO:0000250 : PubMed:17374643 PubMed:19615464 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 5/29/2013 109 3300008452 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/subcellular location Perinuclear region perinuclear region of cytoplasm GO:0048471 SL-0198 Y Y UniProtKB AAP 5/29/2013 109 3300008454 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. thymus BTO:0001374 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID low expression, if any AAP 5/29/2013 109 3300008457 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. thymus UBERON:0002370 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID low expression, if any AAP 5/29/2013 109 3300008458 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. ovary epithelium BTO:0003661 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 109 3300008459 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. epithelium of female gonad UBERON:0004911 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 109 3300008460 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. ovary epithelium BTO:0003661 ovarian carcinoma DOID:4001 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID Down regulated AAP 5/29/2013 109 3300008461 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. epithelium of female gonad UBERON:0004911 ovarian carcinoma DOID:4001 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID Down regulated AAP 5/29/2013 109 3300008462 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. spermatid BTO:0001274 testicular germ cell cancer DOID:5557 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 109 3300008463 Faith P53816 11145 PLA2G16 Homo sapiens 9606 Comment/tissue specificity Widely expressed. low expression, if any, in hematopoietic cells and thymus. In testis, confined to round spermatids. Expressed in normal ovarian epithelial cells. Down-regulated in some ovarian carcinomas and testicular germ cell tumors. spermatid BTO:0001274 Y Y ECO:0000269 PubMed:11526504 PubMed:11973642 PubMed:19615464 PubMed:9771974 UniProtKB UPDATE ver_2 Changes in: EVID AAP 5/29/2013 109 3300008464 Mike P04054 5319 PLA2G1B Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 2/6/2013 140 3300008467 Mike P04054 5319 PLA2G1B Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 140 3300008468 Mike P14555 5320 PLA2G2A Homo sapiens 9606 Comment/function Thought to participate in the regulation of the phospholipid metabolism in biomembranes including eicosanoid biosynthesis. Catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID covered by GO annotation AAP, DGA, ASD 1/9/2013 154 3300008469 Mike P14555 5320 PLA2G2A Homo sapiens 9606 Comment/subcellular location Membrane;Peripheral membrane protein extrinsic component of membrane GO:0019898 SL-0162 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS AAP, DGA, ASD 1/9/2013 154 3300008471 Mike P14555 5320 PLA2G2A Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 1/9/2013 154 3300008472 Katie Q9UNK4 26279 PLA2G2D Homo sapiens 9606 Comment/function PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. L-alpha-1-palmitoyl-2-linoleoyl phosphatidylethanolamine is more efficiently hydrolyzed than the other phospholipids examined. phospholipid metabolic process GO:0006644 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, ASD 2/6/2013 115 3300008473 Katie Q9UNK4 26279 PLA2G2D Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 2/6/2013 115 3300008474 Katie Q9UNK4 26279 PLA2G2D Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 115 3300008476 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/function PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Has a preference for arachidonic-containing phospholipids. phospholipid metabolic process GO:0006644 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, ASD 2/6/2013 102 3300008477 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 2/6/2013 102 3300008478 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/tissue specificity Restricted to the brain, heart, lung, and placenta. brain BTO:0000142 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 102 3300008479 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/tissue specificity Restricted to the brain, heart, lung, and placenta. brain UBERON:0000955 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 102 3300008480 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/tissue specificity Restricted to the brain, heart, lung, and placenta. heart BTO:0000562 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 102 3300008481 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/tissue specificity Restricted to the brain, heart, lung, and placenta. heart UBERON:0000948 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 102 3300008482 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/tissue specificity Restricted to the brain, heart, lung, and placenta. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 102 3300008483 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/tissue specificity Restricted to the brain, heart, lung, and placenta. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 102 3300008484 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/tissue specificity Restricted to the brain, heart, lung, and placenta. placenta BTO:0001078 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 102 3300008485 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 Comment/tissue specificity Restricted to the brain, heart, lung, and placenta. placenta UBERON:0001987 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 102 3300008486 Katie Q9NZK7 30814 PLA2G2E Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 102 3300008487 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/function PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Hydrolyzes phosphatidylglycerol versus phosphatidylcholine with a 15-fold preference. phospholipid metabolic process GO:0006644 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP 11/28/2012 100 3300008488 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 100 3300008489 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. heart BTO:0000562 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008490 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. heart UBERON:0000948 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008491 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. kidney BTO:0000671 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008492 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008493 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. liver BTO:0000759 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008494 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. liver UBERON:0002107 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008495 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. placenta BTO:0001078 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008496 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008497 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008498 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008499 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. testis BTO:0001363 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008500 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. testis UBERON:0000473 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008501 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. thymus BTO:0001374 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008502 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 Comment/tissue specificity Expressed at high levels in placenta, testis, thymus and at lower levels in heart, kidney, liver and prostate. thymus UBERON:0002370 Y Y ECO:0000269 PubMed:11112443 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 100 3300008503 Katie Q9BZM2 64600 PLA2G2F Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 100 3300008504 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/function PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. Shows an 11-fold preference for phosphatidylglycerol over phosphatidylcholine (PC). Preferential cleavage: 1-palmitoyl-2-linoleoyl-phosphatidylethanolamine (PE) > 1-palmitoyl-2-linoleoyl-PC > 1-palmitoyl-2-arachidonoyl-PC > 1-palmitoyl-2-arachidonoyl-PE. Plays a role in ciliogenesis. phospholipid metabolic process GO:0006644 Y Y ECO:0000269 PubMed:12522102 PubMed:20393563 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP, DGA, ASD 11/28/2012 110 3300008505 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 11/28/2012 110 3300008509 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). microvascular endothelium BTO:0003122 breast cancer DOID:1612 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). AAP, DGA, ASD 11/28/2012 110 3300008511 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). microvascular endothelium UBERON:0008339 breast cancer DOID:1612 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). AAP, DGA, ASD 11/28/2012 110 3300008512 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). breast cancer cell BTO:0000150 breast cancer DOID:1612 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term; In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). AAP, DGA, ASD 11/28/2012 110 3300008513 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). microvascular endothelium BTO:0003122 colon cancer DOID:219 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). AAP, DGA, ASD 11/28/2012 110 3300008514 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). microvascular endothelium UBERON:0008339 colon cancer DOID:219 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). AAP, DGA, ASD 11/28/2012 110 3300008515 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). colonic cancer cell BTO:0000586 colon cancer DOID:219 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term; In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). AAP, DGA, ASD 11/28/2012 110 3300008516 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). microvascular endothelium BTO:0003122 uterine cancer DOID:363 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). AAP, DGA, ASD 11/28/2012 110 3300008517 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). microvascular endothelium UBERON:0008339 uterine cancer DOID:363 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). AAP, DGA, ASD 11/28/2012 110 3300008518 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). uterine cancer cell BTO:0000257 uterine cancer DOID:363 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term; In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). AAP, DGA, ASD 11/28/2012 110 3300008519 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). vascular endothelial cell BTO:0001854 myocardial infarction DOID:5844 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation AAP, DGA, ASD 11/28/2012 110 3300008520 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). endothelium UBERON:0001986 myocardial infarction DOID:5844 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation AAP, DGA, ASD 11/28/2012 110 3300008521 Rose Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). joint BTO:0001686 rheumatoid arthritis DOID:7148 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008522 Rose Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). skeletal joint UBERON:0000982 rheumatoid arthritis DOID:7148 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008523 Rose Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). joint BTO:0001686 osteoarthritis DOID:8398 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008524 Rose Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). skeletal joint UBERON:0000982 osteoarthritis DOID:8398 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008525 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). alveolar macrophage BTO:0000802 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 110 3300008528 Rose Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). endothelial cell BTO:0001176 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 110 3300008529 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). leukocyte BTO:0000751 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 11/28/2012 110 3300008530 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). blood vessel BTO:0001102 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008533 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). blood vessel UBERON:0001981 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008534 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). bronchial epithelium BTO:0001845 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008535 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). epithelium of bronchus UBERON:0002031 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008536 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). heart BTO:0000562 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008537 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). heart UBERON:0000948 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008538 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). kidney BTO:0000671 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008539 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). kidney UBERON:0002113 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008540 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). liver BTO:0000759 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008541 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). liver UBERON:0002107 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008542 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). placenta BTO:0001078 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008543 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). placenta UBERON:0001987 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008544 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008545 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney, heart, liver, and skeletal muscle. Also present in placenta and peripheral blood leukocytes. Not detected in brain, colon, thymus, spleen and small intestine. In lung, expressed in bronchial epithelial cells and alveolar macrophages, but scarcely detected in alveolar epithelium, arterial walls and interstitial fibroblasts (at protein level). In joints of osteoarthritis and rheumatoid arthritis, expressed in endothelial cells (at protein level). In normal heart, detected in some vessels. In myocardial tissues with acute infarction, expressed in vascular endothelial cells adjacent to cardiomyocytes and those in lesions with granulation. Expression in cardiomyocytes is scarce (at protein level). In uterus, breast and colon cancers, detected in tumor cells and neighboring microvascular endothelium, but not in normal glandular tissues (at protein level). skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:15863501 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 11/28/2012 110 3300008546 Katie Q9NZ20 50487 PLA2G3 Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 11/28/2012 110 3300008547 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/function Selectively hydrolyzes arachidonyl phospholipids in the sn-2 position releasing arachidonic acid. Together with its lysophospholipid activity, it is implicated in the initiation of the inflammatory response. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID inflammatory response AAP, ASD 11/28/2012 140 3300008548 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/subcellular location Cytoplasm cytoplasm GO:0005737 SL-0086 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 11/28/2012 140 3300008549 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/subcellular location Cytoplasmic vesicle cytoplasmic membrane-bounded vesicle GO:0016023 SL-0088 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 11/28/2012 140 3300008550 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues such as macrophages, platelets, neutrophils, fibroblasts and lung endothelium. blood platelet BTO:0000132 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, ASD 11/28/2012 140 3300008552 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues such as macrophages, platelets, neutrophils, fibroblasts and lung endothelium. fibroblast BTO:0000452 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, ASD 11/28/2012 140 3300008553 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues such as macrophages, platelets, neutrophils, fibroblasts and lung endothelium. macrophage BTO:0000801 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, ASD 11/28/2012 140 3300008554 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues such as macrophages, platelets, neutrophils, fibroblasts and lung endothelium. neutrophil BTO:0000130 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, ASD 11/28/2012 140 3300008555 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues such as macrophages, platelets, neutrophils, fibroblasts and lung endothelium. lung endothelium BTO:0004128 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 140 3300008556 Rose P47712 5321 PLA2G4A Homo sapiens 9606 Comment/tissue specificity Expressed in various tissues such as macrophages, platelets, neutrophils, fibroblasts and lung endothelium. lung endothelium UBERON:0013479 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 140 3300008557 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/function Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position with a preference for arachidonoyl phospholipids. Has a much weaker activity than PLA2G4A. Isoform 3 has calcium-dependent activity against palmitoyl-arachidonyl-phosphatidylethanolamine and low level lysophospholipase activity but no activity against phosphatidylcholine. Isoform 5 does have activity against phosphatidylcholine. Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008559 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/subcellular location Early endosome membrane;Peripheral membrane protein early endosome membrane GO:0031901 SL-0093 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 45 3300008561 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/subcellular location Mitochondrion membrane;Peripheral membrane protein mitochondrial membrane GO:0031966 SL-0171 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 45 3300008562 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. brain BTO:0000142 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008566 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008567 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. cerebellum BTO:0000232 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008568 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. cerebellum UBERON:0002037 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008569 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. heart BTO:0000562 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008570 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. heart UBERON:0000948 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008571 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. liver BTO:0000759 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008572 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008573 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008574 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed at higher level in brain, heart, liver, cerebellum and pancreas. Isoform 3 is widely expressed. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:10085124 PubMed:10358058 PubMed:16617059 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 45 3300008575 Mike P0C869 100137049 PLA2G4B Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 45 3300008576 Katie Q9UP65 8605 PLA2G4C Homo sapiens 9606 Comment/function Has a preference for arachidonic acid at the sn-2 position of phosphatidylcholine as compared with palmitic acid. phospholipid metabolic process GO:0006644 Y Y ECO:0000269 PubMed:10085124 UniProtKB UPDATE ver_2 Changes in: GO,EVID AAP 11/28/2012 93 3300008577 Katie Q9UP65 8605 PLA2G4C Homo sapiens 9606 Comment/subcellular location Membrane;Lipid-anchor membrane GO:0016020 SL-0162 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 93 3300008578 Katie Q9UP65 8605 PLA2G4C Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart and skeletal muscle. heart BTO:0000562 Y Y ECO:0000269 PubMed:10085124 PubMed:9705332 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 93 3300008579 Katie Q9UP65 8605 PLA2G4C Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart and skeletal muscle. heart UBERON:0000948 Y Y ECO:0000269 PubMed:10085124 PubMed:9705332 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 93 3300008580 Katie Q9UP65 8605 PLA2G4C Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart and skeletal muscle. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:10085124 PubMed:9705332 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 93 3300008581 Katie Q9UP65 8605 PLA2G4C Homo sapiens 9606 Comment/tissue specificity Highly expressed in heart and skeletal muscle. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:10085124 PubMed:9705332 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 93 3300008582 Katie Q9UP65 8605 PLA2G4C Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 93 3300008583 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/function Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position. Not arachidonic acid-specific but has linoleic acid-specific activity. May play a role in inflammation in psoriatic lesions. psoriasis DOID:8893 Y Y ECO:0000269 PubMed:14709560 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 82 3300008584 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/subcellular location Cytoplasmic vesicle membrane;Peripheral membrane protein cytoplasmic vesicle membrane GO:0030659 SL-0089 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 82 3300008586 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/subcellular location Cytosol cytosol GO:0005829 SL-0091 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 82 3300008587 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/tissue specificity Expressed in stratified squamous epithelia, such as those in skin and cervix, but not in other tissues. Strongly expressed in the upper spinous layer of the psoriatic epidermis, expressed weakly and discontinuously in atopic dermatitis and mycosis fungoides, and not detected in the epidermis of normal skin. atopic dermatitis DOID:3310 Y Y ECO:0000269 PubMed:14709560 UniProtKB UPDATE ver_2 Changes in: EVID discontinuously in atopic dermatitis; expressed weakly and discontinuously AAP 11/28/2012 82 3300008589 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/tissue specificity Expressed in stratified squamous epithelia, such as those in skin and cervix, but not in other tissues. Strongly expressed in the upper spinous layer of the psoriatic epidermis, expressed weakly and discontinuously in atopic dermatitis and mycosis fungoides, and not detected in the epidermis of normal skin. mycosis fungoides DOID:8691 Y Y ECO:0000269 PubMed:14709560 UniProtKB UPDATE ver_2 Changes in: EVID expressed weakly and discontinuously; mycosis fungoides AAP 11/28/2012 82 3300008590 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/tissue specificity Expressed in stratified squamous epithelia, such as those in skin and cervix, but not in other tissues. Strongly expressed in the upper spinous layer of the psoriatic epidermis, expressed weakly and discontinuously in atopic dermatitis and mycosis fungoides, and not detected in the epidermis of normal skin. stratum spinosum BTO:0000435 psoriasis DOID:8893 Y Y ECO:0000269 PubMed:14709560 UniProtKB UPDATE ver_2 Changes in: EVID strongly expressed AAP 11/28/2012 82 3300008591 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/tissue specificity Expressed in stratified squamous epithelia, such as those in skin and cervix, but not in other tissues. Strongly expressed in the upper spinous layer of the psoriatic epidermis, expressed weakly and discontinuously in atopic dermatitis and mycosis fungoides, and not detected in the epidermis of normal skin. stratum spinosum of epidermis UBERON:0002026 psoriasis DOID:8893 Y Y ECO:0000269 PubMed:14709560 UniProtKB UPDATE ver_2 Changes in: EVID strongly expressed AAP 11/28/2012 82 3300008592 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/tissue specificity Expressed in stratified squamous epithelia, such as those in skin and cervix, but not in other tissues. Strongly expressed in the upper spinous layer of the psoriatic epidermis, expressed weakly and discontinuously in atopic dermatitis and mycosis fungoides, and not detected in the epidermis of normal skin. squamous epithelium BTO:0002072 Y Y ECO:0000269 PubMed:14709560 UniProtKB UPDATE ver_2 Changes in: EVID Did not find 'stratified' in BRENDA AAP 11/28/2012 82 3300008593 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/tissue specificity Expressed in stratified squamous epithelia, such as those in skin and cervix, but not in other tissues. Strongly expressed in the upper spinous layer of the psoriatic epidermis, expressed weakly and discontinuously in atopic dermatitis and mycosis fungoides, and not detected in the epidermis of normal skin. stratified squamous epithelium UBERON:0006915 Y Y ECO:0000269 PubMed:14709560 UniProtKB UPDATE ver_2 Changes in: EVID Did not find 'stratified' in BRENDA AAP 11/28/2012 82 3300008594 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/tissue specificity Expressed in stratified squamous epithelia, such as those in skin and cervix, but not in other tissues. Strongly expressed in the upper spinous layer of the psoriatic epidermis, expressed weakly and discontinuously in atopic dermatitis and mycosis fungoides, and not detected in the epidermis of normal skin. cervical epithelium BTO:0000241 Y Y ECO:0000269 PubMed:14709560 UniProtKB UPDATE ver_2 Changes in: EVID In Uberon, did not find 'stratified'. In BRENDA: cervical endothelium and cervical squamous epithelial cell AAP 11/28/2012 82 3300008596 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 Comment/tissue specificity Expressed in stratified squamous epithelia, such as those in skin and cervix, but not in other tissues. Strongly expressed in the upper spinous layer of the psoriatic epidermis, expressed weakly and discontinuously in atopic dermatitis and mycosis fungoides, and not detected in the epidermis of normal skin. cervix squamous epithelium UBERON:0006922 Y Y ECO:0000269 PubMed:14709560 UniProtKB UPDATE ver_2 Changes in: EVID In Uberon, did not find 'stratified'. In BRENDA: cervical endothelium and cervical squamous epithelial cell AAP 11/28/2012 82 3300008597 Faith Q86XP0 283748 PLA2G4D Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 82 3300008601 Faith Q3MJ16 123745 PLA2G4E Homo sapiens 9606 Comment/subcellular location Cytosol cytosol GO:0005829 SL-0091 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 70 3300008603 Faith Q3MJ16 123745 PLA2G4E Homo sapiens 9606 Comment/subcellular location Lysosome membrane;Peripheral membrane protein lysosomal membrane GO:0005765 SL-0157 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 70 3300008604 Faith Q3MJ16 123745 PLA2G4E Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 70 3300008606 Mike Q68DD2 255189 PLA2G4F Homo sapiens 9606 Comment/function Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position. Has higher enzyme activity for phosphatidylethanolamine than phosphatidylcholine (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 72 3300008607 Faith Q68DD2 255189 PLA2G4F Homo sapiens 9606 Comment/subcellular location Cytosol cytosol GO:0005829 SL-0091 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 72 3300008608 Faith Q68DD2 255189 PLA2G4F Homo sapiens 9606 Comment/subcellular location Lysosome membrane;Peripheral membrane protein lysosomal membrane GO:0005765 SL-0157 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 11/28/2012 72 3300008609 Faith Q68DD2 255189 PLA2G4F Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP 11/28/2012 72 3300008611 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/function PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides. This isozyme hydrolyzes more efficiently L-alpha-1-palmitoyl-2-oleoyl phosphatidylcholine than L-alpha-1-palmitoyl-2-arachidonyl phosphatidylcholine, L-alpha-1-palmitoyl-2-arachidonyl phosphatidylethanolamine, or L-alpha-1-stearoyl-2-arachidonyl phosphatidylinositol. May be involved in the production of lung surfactant, the remodeling or regulation of cardiac muscle. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 123 3300008612 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 11/28/2012 123 3300008615 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/tissue specificity Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). heart BTO:0000562 Y Y ECO:0000269 PubMed:22137173 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 123 3300008618 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/tissue specificity Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). heart UBERON:0000948 Y Y ECO:0000269 PubMed:22137173 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 123 3300008619 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/tissue specificity Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). lung BTO:0000763 Y Y ECO:0000269 PubMed:22137173 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 123 3300008620 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/tissue specificity Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). lung UBERON:0002048 Y Y ECO:0000269 PubMed:22137173 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 123 3300008621 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/tissue specificity Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). placenta BTO:0001078 Y Y ECO:0000269 PubMed:22137173 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 123 3300008622 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/tissue specificity Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). placenta UBERON:0001987 Y Y ECO:0000269 PubMed:22137173 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 123 3300008623 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/tissue specificity Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). retina BTO:0001175 Y Y ECO:0000269 PubMed:22137173 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 123 3300008624 Rose P39877 5322 PLA2G5 Homo sapiens 9606 Comment/tissue specificity Heart, placenta and less abundantly, in lung. Detected in the outer and inner plexiform layers of the retina (at protein level). retina UBERON:0000966 Y Y ECO:0000269 PubMed:22137173 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 11/28/2012 123 3300008625 Rose P39877 5322 PLA2G5 Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 11/28/2012 123 3300008626 Mike O60733 8398 PLA2G6 Homo sapiens 9606 Comment/function Catalyzes the release of fatty acids from phospholipids. It has been implicated in normal phospholipid remodeling, nitric oxide-induced or vasopressin-induced arachidonic acid release and in leukotriene and prostaglandin production. May participate in fas mediated apoptosis and in regulating transmembrane ion flux in glucose-stimulated B-cells. Has a role in cardiolipin (CL) deacylation. Required for both speed and directionality of monocyte MCP1/CCL2-induced chemotaxis through regulation of F-actin polymerization at the pseudopods. Y Y ECO:0000006 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 1/9/2013 128 3300008627 Mike O60733 8398 PLA2G6 Homo sapiens 9606 Comment/function Isoform ankyrin-iPLA2-1 and isoform ankyrin-iPLA2-2, which lack the catalytic domain, are probably involved in the negative regulation of iPLA2 activity. Y Y ECO:0000006 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 1/9/2013 128 3300008628 Mike O60733 8398 PLA2G6 Homo sapiens 9606 EC 3.1.1.4 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 1/9/2013 128 3300008634 Mike Q6P1J6 151056 PLB1 Homo sapiens 9606 Comment/function Membrane-associated phospholipase. Exhibits a calcium-independent broad substrate specificity including phospholipase A2/lysophospholipase activity. Preferential hydrolysis at the sn-2 position of diacylphospholipids and diacyglycerol, whereas it shows no positional specificity toward triacylglycerol. Exhibits also esterase activity toward p-nitrophenyl. May act on the brush border membrane to facilitate the absorption of digested lipids (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP 11/28/2012 77 3300008635 Faith Q6P1J6 151056 PLB1 Homo sapiens 9606 Comment/tissue specificity Expressed in the epidermis (at protein level). epidermis BTO:0000404 Y Y ECO:0000269 PubMed:12150957 UniProtKB UPDATE ver_2 Changes in: EVID protein level AAP 11/28/2012 77 3300008639 Faith Q6P1J6 151056 PLB1 Homo sapiens 9606 Comment/tissue specificity Expressed in the epidermis (at protein level). epidermis UBERON:0001003 Y Y ECO:0000269 PubMed:12150957 UniProtKB UPDATE ver_2 Changes in: EVID protein level AAP 11/28/2012 77 3300008640 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/developmental stage Induced during differentiation of primary preadipocytes to adipocytes. Expression increased from fetal to adult in retinal pigment epithelium. preadipocyte BTO:0001107 preadipocyte CL:0002334 Y Y ECO:0000269 PubMed:16249444 PubMed:16705060 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID Difficult to capture developmental information. AAP 6/26/2013 87 3300008641 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 EC 3.1.1.3 Y Y EC number UniProtKB AAP 6/26/2013 87 3300008642 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). adipose tissue BTO:0001487 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID Highest expression AAP 6/26/2013 87 3300008647 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). adipose tissue UBERON:0001013 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID Highest expression AAP 6/26/2013 87 3300008648 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). heart BTO:0000562 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID AAP 6/26/2013 87 3300008649 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). heart UBERON:0000948 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID AAP 6/26/2013 87 3300008650 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID AAP 6/26/2013 87 3300008651 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID AAP 6/26/2013 87 3300008652 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). gastrointestinal tract BTO:0000511 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID Is there a more specific location in one of the publications? AAP 6/26/2013 87 3300008653 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). digestive tract UBERON:0001555 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID Is there a more specific location in one of the publications? AAP 6/26/2013 87 3300008654 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). retina BTO:0001175 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID AAP 6/26/2013 87 3300008655 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). retina UBERON:0000966 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID AAP 6/26/2013 87 3300008656 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). retinoblastoma cell BTO:0001178 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID AAP 6/26/2013 87 3300008657 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). retinal pigment epithelium BTO:0001177 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID AAP 6/26/2013 87 3300008658 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). pigmented layer of retina UBERON:0001782 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID AAP 6/26/2013 87 3300008659 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). photoreceptor BTO:0001060 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID expressed at lower intensity AAP 6/26/2013 87 3300008660 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). photoreceptor inner segment layer UBERON:0003925 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID expressed at lower intensity AAP 6/26/2013 87 3300008661 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). ganglion cell layer BTO:0003398 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID expressed at lower intensity AAP 6/26/2013 87 3300008662 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/tissue specificity Highest expression in adipose tissue. Also detected in heart, skeletal muscle, and portions of the gastrointestinal tract. Detected in normal retina and retinoblastoma cells. Detected in retinal pigment epithelium and, at lower intensity, in the inner segments of photoreceptors and in the ganglion cell layer of the neural retina (at protein level). ganglionic layer of retina UBERON:0001792 Y Y ECO:0000269 PubMed:15550674 PubMed:16150821 PubMed:16249444 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID expressed at lower intensity AAP 6/26/2013 87 3300008663 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/developmental stage Induced during differentiation of primary preadipocytes to adipocytes. Expression increased from fetal to adult in retinal pigment epithelium. adipocyte BTO:0000443 Y Y ECO:0000269 PubMed:16249444 PubMed:16705060 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID Difficult to capture developmental information. AAP 6/26/2013 87 3300008664 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/developmental stage Induced during differentiation of primary preadipocytes to adipocytes. Expression increased from fetal to adult in retinal pigment epithelium. retinal pigment epithelium BTO:0001177 fetus BTO:0000449 Y Y ECO:0000269 PubMed:16249444 PubMed:16705060 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID Difficult to capture developmental information. AAP 6/26/2013 87 3300008665 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/developmental stage Induced during differentiation of primary preadipocytes to adipocytes. Expression increased from fetal to adult in retinal pigment epithelium. pigmented layer of retina UBERON:0001782 fetus BTO:0000449 Y Y ECO:0000269 PubMed:16249444 PubMed:16705060 PubMed:17032652 UniProtKB UPDATE ver_2 Changes in: EVID Difficult to capture developmental information. AAP 6/26/2013 87 3300008666 Faith Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/Involvement in disease Neutral lipid storage disease with myopathy (NLSDM): Neutral lipid storage disorder (NLSD) with myopathy but without ichthyosis. NLSDs are characterized by the presence of triglyceride-containing cytoplasmic droplets in leukocytes and in other tissues, including bone marrow, skin, and muscle. Individuals with NLSDM did not show obesity, in spite of a defect in triglyceride degradation in fibroblasts and in marked triglyceride storage in liver, muscles, and other visceral cells. MIM:610717 neutral lipid storage disease DOID:0050729 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:17187067 UniProtKB N ver_2 AAP 6/26/2013 87 3300008674 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID could not find platelet membrane AAP, ASD 1/9/2013 116 3300008676 Mike Q13258 5729 PTGDR Homo sapiens 9606 Comment/function Receptor for prostaglandin D2 (PGD2). The activity of this receptor is mainly mediated by G(s) proteins that stimulate adenylate cyclase, resulting in an elevation of intracellular cAMP. A mobilization of calcium is also observed, but without formation of inositol 1,4,5-trisphosphate (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 116 3300008677 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/Involvement in disease Asthma-related traits 1 (ASRT1): Asthma-related traits include clinical symptoms of asthma, such as coughing, wheezing, dyspnea, bronchial hyperresponsiveness as assessed by methacholine challenge test, serum IgE levels, atopy and atopic dermatitis. MIM:607277 asthma DOID:2841 Disease susceptibility is associated with variations affecting the gene represented in this entry. Y Y ECO:0000006 PubMed:15496624 UniProtKB SNOMED has various types of asthma and has the qualifier 'susceptible' SNOMED has various types of asthma and has the qualifier 'susceptible' AAP, ASD 5/1/2013 119 3300008678 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/Involvement in disease Asthma-related traits 1 (ASRT1): Asthma-related traits include clinical symptoms of asthma, such as coughing, wheezing, dyspnea, bronchial hyperresponsiveness as assessed by methacholine challenge test, serum IgE levels, atopy and atopic dermatitis. MIM:607277 Asthma SNOMEDCT:195967001 Disease susceptibility is associated with variations affecting the gene represented in this entry. Y Y ECO:0000006 PubMed:15496624 UniProtKB SNOMED has various types of asthma and has the qualifier 'susceptible' SNOMED has various types of asthma and has the qualifier 'susceptible' AAP, ASD 5/1/2013 119 3300008679 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. ciliary muscle BTO:0000654 Longitudinal fiber of ciliary muscle SNOMEDCT:280863004 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID I find ciliary muscle, but not longitudinal. Does exist in SNOMED; ; Non-disease term from SNOMED AAP, ASD 1/9/2013 116 3300008681 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. ciliary muscle UBERON:0001605 Longitudinal fiber of ciliary muscle SNOMEDCT:280863004 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID I find ciliary muscle, but not longitudinal. Does exist in SNOMED; ; Non-disease term from SNOMED AAP, ASD 1/9/2013 116 3300008682 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. ciliary muscle BTO:0000654 Entire circular fibers of ciliary muscle SNOMEDCT:280866007 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID circular not captured by Uberon or BRENDA; Non-disease term from SNOMED AAP, ASD 1/9/2013 116 3300008683 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. ciliary muscle UBERON:0001605 Entire circular fibers of ciliary muscle SNOMEDCT:280866007 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID circular not captured by Uberon or BRENDA; Non-disease term from SNOMED AAP, ASD 1/9/2013 116 3300008684 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. choroid BTO:0001829 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 116 3300008685 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. optic choroid UBERON:0001776 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 116 3300008686 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. ciliary epithelium BTO:0001770 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 116 3300008687 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. ciliary epithelium UBERON:0001778 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 116 3300008688 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. iris BTO:0000653 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 116 3300008689 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. iris UBERON:0001769 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 116 3300008690 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 116 3300008691 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity Expressed in retinal choroid, ciliary epithelium, longitudinal and circular ciliary muscles, iris, small intestine and platelet membranes. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:11082108 PubMed:6302737 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 116 3300008692 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/function Receptor for prostaglandin D2 (PGD2). Coupled to the G(i)-protein. Receptor activation may result in pertussis toxin-sensitive decreases in cAMP levels and Ca(2+) mobilization. PI3K signaling is also implicated in mediating PTGDR2 effects. PGD2 induced receptor internalization. CRTH2 internalization can be regulated by diverse kinases such as, PKC, PKA, ADRBK1/GRK2, GPRK5/GRK5 and GRK6. Receptor activation is responsible, at least in part, in immune regulation and allergic/inflammation responses. prostaglandin D receptor activity GO:0004956 Y Y ECO:0000269 PubMed:11208866 PubMed:11535533 PubMed:17196174 UniProtKB UPDATE ver_2 Changes in: GO,EVID GO MF Use=N AAP, ASD 1/9/2013 102 3300008693 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. basophil BTO:0000129 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID No Uberon term AAP, ASD 1/9/2013 102 3300008697 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. TC2 cell BTO:0004794 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID No Uberon term AAP, ASD 1/9/2013 102 3300008698 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. Th2-cell BTO:0001679 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID No Uberon term AAP, ASD 1/9/2013 102 3300008699 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. peripheral blood BTO:0000553 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Uberon term more general AAP, ASD 1/9/2013 102 3300008700 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. blood UBERON:0000178 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Uberon term more general AAP, ASD 1/9/2013 102 3300008701 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. brain BTO:0000142 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008703 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. brain UBERON:0000955 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008704 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. colon BTO:0000269 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008705 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. colon UBERON:0001155 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008706 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. heart BTO:0000562 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008707 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. heart UBERON:0000948 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008708 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008709 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008710 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008711 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008712 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. spinal cord BTO:0001279 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008713 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. spinal cord UBERON:0002240 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008714 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. spleen BTO:0001281 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008715 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008716 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. stomach BTO:0001307 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008717 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. stomach UBERON:0000945 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008718 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. thymus BTO:0001374 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008719 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. thymus UBERON:0002370 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 1/9/2013 102 3300008720 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/developmental stage Expression in the amniotic fluid increases dramatically during weeks 12 to 25 of pregnancy. Levels decrease slowly after 25 weeks. amniotic fluid BTO:0000068 Y Y ECO:0000269 PubMed:8674187 UniProtKB UPDATE ver_2 Changes in: EVID Can't really capture development info easily; Non-disease term from SNOMED AAP, DGA 2/6/2013 132 3300008721 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/developmental stage Expression in the amniotic fluid increases dramatically during weeks 12 to 25 of pregnancy. Levels decrease slowly after 25 weeks. amniotic fluid UBERON:0000173 Y Y ECO:0000269 PubMed:8674187 UniProtKB UPDATE ver_2 Changes in: EVID Can't really capture development info easily; Non-disease term from SNOMED AAP, DGA 2/6/2013 132 3300008722 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/function Catalyzes the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation. Involved in a variety of CNS functions, such as sedation, NREM sleep and PGE2-induced allodynia, and may have an anti-apoptotic role in oligodendrocytes. Binds small non-substrate lipophilic molecules, including biliverdin, bilirubin, retinal, retinoic acid and thyroid hormone, and may act as a scavenger for harmful hydrophopic molecules and as a secretory retinoid and thyroid hormone transporter. Possibly involved in development and maintenance of the blood-brain, blood-retina, blood-aqueous humor and blood-testis barrier. It is likely to play important roles in both maturation and maintenance of the central nervous system and male reproductive system. Y Y ECO:0000269 PubMed:20667974 PubMed:9475419 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008723 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/miscellaneous It has been proposed that the urinary and serum levels may provide a sensitive indicator of renal damage in diabetes mellitus and hypertension. Elevated levels in the coronary circulation may also be associated with angina. Changes in charge and molecular weight microheterogeneity, due to modification of the N-linked oligosaccharides, may be associated with neurodegenerative disease and multiple sclerosis. Detected in meningioma but not in other brain tumors and may be considered a specific cell marker for meningioma. Expression levels in amniotic fluid are altered in abnormal pregnancies. Levels are lower in pregnancies with trisomic fetuses and fetuses with renal abnormalities. meningioma DOID:3565 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008725 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/miscellaneous It has been proposed that the urinary and serum levels may provide a sensitive indicator of renal damage in diabetes mellitus and hypertension. Elevated levels in the coronary circulation may also be associated with angina. Changes in charge and molecular weight microheterogeneity, due to modification of the N-linked oligosaccharides, may be associated with neurodegenerative disease and multiple sclerosis. Detected in meningioma but not in other brain tumors and may be considered a specific cell marker for meningioma. Expression levels in amniotic fluid are altered in abnormal pregnancies. Levels are lower in pregnancies with trisomic fetuses and fetuses with renal abnormalities. amniotic fluid BTO:0000068 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008726 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/miscellaneous It has been proposed that the urinary and serum levels may provide a sensitive indicator of renal damage in diabetes mellitus and hypertension. Elevated levels in the coronary circulation may also be associated with angina. Changes in charge and molecular weight microheterogeneity, due to modification of the N-linked oligosaccharides, may be associated with neurodegenerative disease and multiple sclerosis. Detected in meningioma but not in other brain tumors and may be considered a specific cell marker for meningioma. Expression levels in amniotic fluid are altered in abnormal pregnancies. Levels are lower in pregnancies with trisomic fetuses and fetuses with renal abnormalities. amniotic fluid UBERON:0000173 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008727 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/miscellaneous It has been proposed that the urinary and serum levels may provide a sensitive indicator of renal damage in diabetes mellitus and hypertension. Elevated levels in the coronary circulation may also be associated with angina. Changes in charge and molecular weight microheterogeneity, due to modification of the N-linked oligosaccharides, may be associated with neurodegenerative disease and multiple sclerosis. Detected in meningioma but not in other brain tumors and may be considered a specific cell marker for meningioma. Expression levels in amniotic fluid are altered in abnormal pregnancies. Levels are lower in pregnancies with trisomic fetuses and fetuses with renal abnormalities. urine BTO:0001419 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008728 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/miscellaneous It has been proposed that the urinary and serum levels may provide a sensitive indicator of renal damage in diabetes mellitus and hypertension. Elevated levels in the coronary circulation may also be associated with angina. Changes in charge and molecular weight microheterogeneity, due to modification of the N-linked oligosaccharides, may be associated with neurodegenerative disease and multiple sclerosis. Detected in meningioma but not in other brain tumors and may be considered a specific cell marker for meningioma. Expression levels in amniotic fluid are altered in abnormal pregnancies. Levels are lower in pregnancies with trisomic fetuses and fetuses with renal abnormalities. urine UBERON:0001088 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008729 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/subcellular location Golgi apparatus Golgi apparatus GO:0005794 SL-0132 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA 2/6/2013 132 3300008731 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/subcellular location Nucleus membrane nuclear membrane GO:0031965 SL-0182 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA 2/6/2013 132 3300008732 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/subcellular location Perinuclear region perinuclear region of cytoplasm GO:0048471 SL-0198 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA 2/6/2013 132 3300008733 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/subcellular location Detected on rough endoplasmic reticulum of arachnoid and menigioma cells. Localized to the nuclear envelope, Golgi apparatus, secretory vesicles and spherical cytoplasmic structures in arachnoid trabecular cells, and to circular cytoplasmic structures in meningeal macrophages and perivascular microglial cells. In oligodendrocytes, localized to the rough endoplasmic reticulum and nuclear envelope. In retinal pigment epithelial cells, localized to distinct cytoplasmic domains including the perinuclear region. Also secreted. arachnoid mater BTO:0001636 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Maybe meningothelial cell (cell type ontology) AAP, DGA 2/6/2013 132 3300008735 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/subcellular location Detected on rough endoplasmic reticulum of arachnoid and menigioma cells. Localized to the nuclear envelope, Golgi apparatus, secretory vesicles and spherical cytoplasmic structures in arachnoid trabecular cells, and to circular cytoplasmic structures in meningeal macrophages and perivascular microglial cells. In oligodendrocytes, localized to the rough endoplasmic reticulum and nuclear envelope. In retinal pigment epithelial cells, localized to distinct cytoplasmic domains including the perinuclear region. Also secreted. arachnoid mater UBERON:0002362 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Maybe meningothelial cell (cell type ontology) AAP, DGA 2/6/2013 132 3300008736 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. leukocyte BTO:0000751 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA 2/6/2013 132 3300008738 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. anterior chamber of the eye BTO:0002084 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is a better match. AAP, DGA 2/6/2013 132 3300008739 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. aqueous humor of eyeball UBERON:0001796 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is a better match. AAP, DGA 2/6/2013 132 3300008740 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. arachnoid barrier layer BTO:0002498 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008741 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. blood brain barrier UBERON:0000120 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008742 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. ascites BTO:0000091 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008743 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. ascitic fluid UBERON:0007795 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008744 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. brain BTO:0000142 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008745 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008746 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. central nervous system BTO:0000227 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008747 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. central nervous system UBERON:0001017 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008748 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. cerebrospinal fluid BTO:0000237 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008749 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. cerebrospinal fluid UBERON:0001359 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008750 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. epididymis BTO:0000408 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008751 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. epididymis UBERON:0001301 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008752 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. eye BTO:0000439 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008753 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. eye UBERON:0000970 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008754 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. heart BTO:0000562 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008755 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. heart UBERON:0000948 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008756 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. kidney BTO:0000671 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008757 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008758 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. ovary BTO:0000975 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008759 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. female gonad UBERON:0000992 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008760 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. oviduct BTO:0000980 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008761 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. fallopian tube UBERON:0003889 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008762 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008763 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008764 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. seminal vesicle fluid BTO:0002053 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008765 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. seminal fluid UBERON:0006530 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008766 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. serum BTO:0001239 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008767 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. serum UBERON:0001977 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008768 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. tear BTO:0001499 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008769 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. lacrimal gland secretion UBERON:0001827 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008770 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. testis BTO:0001363 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008771 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. testis UBERON:0000473 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008772 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. urine BTO:0001419 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008773 Rose P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Abundant in the brain and CNS, where it is expressed in tissues of the blood-brain barrier and secreted into the cerebro-spinal fluid. Abundantly expressed in the heart. In the male reproductive system, it is expressed in the testis, epididymis and prostate, and is secreted into the seminal fluid. Expressed in the eye and secreted into the aqueous humor. Lower levels detected in various tissue fluids such as serum, normal urine, ascitic fluid and tear fluid. Also found in a number of other organs including ovary, fimbriae of the fallopian tubes, kidney, leukocytes. urine UBERON:0001088 Y Y ECO:0000269 PubMed:10462696 PubMed:11882588 PubMed:7692978 PubMed:8599604 PubMed:8761996 PubMed:9065498 PubMed:9405674 PubMed:9475419 PubMed:9844724 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA 2/6/2013 132 3300008774 Rose P41222 5730 PTGDS Homo sapiens 9606 EC 5.3.99.2 Y Y ECO:0000311 EC number UniProtKB AAP, DGA 2/6/2013 132 3300008775 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/function Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(q) proteins which activate a phosphatidylinositol-calcium second messenger system. May play a role as an important modulator of renal function. Implicated the smooth muscle contractile response to PGE2 in various tissues. smooth muscle BTO:0001260 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008776 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/function Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(q) proteins which activate a phosphatidylinositol-calcium second messenger system. May play a role as an important modulator of renal function. Implicated the smooth muscle contractile response to PGE2 in various tissues. smooth muscle tissue UBERON:0001135 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008777 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 1/9/2013 112 3300008779 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. kidney BTO:0000671 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008783 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. kidney UBERON:0002113 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008784 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008785 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008786 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. skeletal muscle BTO:0001103 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008787 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008788 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. spleen BTO:0001281 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008789 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. spleen UBERON:0002106 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008790 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. testis BTO:0001363 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008791 Rose P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity Abundant in kidney. Lower level expression in lung, skeletal muscle and spleen, lowest expression in testis and not detected in liver brain and heart. testis UBERON:0000473 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008792 Rose P43116 5732 PTGER2 Homo sapiens 9606 Comment/function Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. The subsequent raise in intracellular cAMP is responsible for the relaxing effect of this receptor on smooth muscle. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008793 Rose P43116 5732 PTGER2 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 1/9/2013 112 3300008794 Rose P43116 5732 PTGER2 Homo sapiens 9606 Comment/tissue specificity Placenta and lung. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008795 Rose P43116 5732 PTGER2 Homo sapiens 9606 Comment/tissue specificity Placenta and lung. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008796 Rose P43116 5732 PTGER2 Homo sapiens 9606 Comment/tissue specificity Placenta and lung. placenta BTO:0001078 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008797 Rose P43116 5732 PTGER2 Homo sapiens 9606 Comment/tissue specificity Placenta and lung. placenta UBERON:0001987 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 112 3300008798 Mike P43115 5733 PTGER3 Homo sapiens 9606 Comment/function Receptor for prostaglandin E2 (PGE2); the EP3 receptor may be involved in inhibition of gastric acid secretion, modulation of neurotransmitter release in central and peripheral neurons, inhibition of sodium and water reabsorption in kidney tubulus and contraction in uterine smooth muscle. The activity of this receptor can couple to both the inhibition of adenylate cyclase mediated by G-I proteins, and to an elevation of intracellular calcium. The various isoforms have identical ligand binding properties but can interact with different second messenger systems (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008799 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. artery BTO:0000573 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID mammary artery term (or synonym) not available AAP, ASD 1/9/2013 131 3300008801 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. artery UBERON:0001637 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID mammary artery term (or synonym) not available AAP, ASD 1/9/2013 131 3300008802 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. fundic mucosa BTO:0004109 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008803 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. gastrointestinal system mucosa UBERON:0004786 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008804 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. gastric mucosa BTO:0001308 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008805 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. heart BTO:0000562 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008806 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. heart UBERON:0000948 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008807 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008808 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008809 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. pulmonary vein BTO:0001799 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008810 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. lung blood vessel UBERON:0003512 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008811 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008812 Rose P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, heart, pancreas, gastric fundic mucosa, mammary artery and pulmonary vessels. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:18023986 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 131 3300008813 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/function Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. Has a relaxing effect on smooth muscle. May play an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function. smooth muscle BTO:0001260 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Tissue info not necessariy linked to PMID source. AAP, ASD 2/6/2013 124 3300008815 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/function Receptor for prostaglandin E2 (PGE2). The activity of this receptor is mediated by G(s) proteins that stimulate adenylate cyclase. Has a relaxing effect on smooth muscle. May play an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function. smooth muscle tissue UBERON:0001135 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID Tissue info not necessariy linked to PMID source. AAP, ASD 2/6/2013 124 3300008816 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 2/6/2013 124 3300008817 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. brain BTO:0000142 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008822 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. brain UBERON:0000955 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008823 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. hematopoietic cell BTO:0000574 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008824 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. blood UBERON:0000178 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008825 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. intestine BTO:0000648 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008826 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. intestine UBERON:0000160 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008827 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. kidney BTO:0000671 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008828 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. kidney UBERON:0002113 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008829 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008830 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008831 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. thymus BTO:0001374 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008832 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. thymus UBERON:0002370 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008833 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. uterus BTO:0001424 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008834 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. uterus UBERON:0000995 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008835 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. vasculature BTO:0003718 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008836 Rose P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity High in intestine and in peripheral blood mononuclear cells; low in lung, kidney, thymus, uterus, vasculature and brain. Not found in liver, heart, retina oe skeletal muscle. vasculature UBERON:0002049 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 2/6/2013 124 3300008837 Mike O14684 9536 PTGES Homo sapiens 9606 Comment/function Catalyzes the oxidoreduction of prostaglandin endoperoxide H2 (PGH2) to prostaglandin E2 (PGE2). prostaglandin-E synthase activity GO:0050220 Y Y ECO:0000269 PubMed:18682561 UniProtKB UPDATE ver_2 Changes in: NOTE,GO,EVID GO MF Use=N; already in GO AAP, DGA 2/6/2013 100 3300008838 Mike O14684 9536 PTGES Homo sapiens 9606 EC 5.3.99.3 Y Y ECO:0000311 EC number UniProtKB AAP, DGA 2/6/2013 100 3300008841 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. heart BTO:0000562 fetus BTO:0000449 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008842 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. heart UBERON:0000948 fetus BTO:0000449 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008843 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/pathway Lipid metabolism; prostaglandin biosynthesis. lipid metabolic process GO:0006629 UPA00662 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 2/6/2013 110 3300008845 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/pathway Lipid metabolism; prostaglandin biosynthesis. prostaglandin biosynthetic process GO:0001516 UPA00662 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 2/6/2013 110 3300008846 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/subcellular location Perinuclear region perinuclear region of cytoplasm GO:0048471 SL-0198 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP 2/6/2013 110 3300008848 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. colon BTO:0000269 colorectal cancer DOID:9256 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID Overexpressed in colorectal cancer AAP 2/6/2013 110 3300008850 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. colon UBERON:0001155 colorectal cancer DOID:9256 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID Overexpressed in colorectal cancer AAP 2/6/2013 110 3300008851 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. colon BTO:0000269 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID Overexpressed in colorectal cancer AAP 2/6/2013 110 3300008852 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. colon UBERON:0001155 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID Overexpressed in colorectal cancer AAP 2/6/2013 110 3300008853 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. heart BTO:0000562 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is more specific. AAP 2/6/2013 110 3300008856 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. apex of heart UBERON:0002098 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID Uberon term is more specific. AAP 2/6/2013 110 3300008857 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. atrium BTO:0000903 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008859 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. cardiac atrium UBERON:0002081 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008860 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. brain BTO:0000142 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008861 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. brain UBERON:0000955 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008862 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. cerebellum BTO:0000232 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008863 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. cerebellum UBERON:0002037 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008864 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. frontal lobe BTO:0000484 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008865 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. frontal cortex UBERON:0001870 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008866 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. heart BTO:0000562 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008867 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. heart UBERON:0000948 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008868 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. heart ventricle BTO:0000862 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008869 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. cardiac ventricle UBERON:0002082 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008870 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. interventricular septum BTO:0002483 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008871 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. septum UBERON:0003037 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008872 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. kidney BTO:0000671 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008873 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008874 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. lymph node BTO:0000784 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008875 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. lymph node UBERON:0000029 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008876 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. occipital lobe BTO:0000293 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008877 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. occipital lobe UBERON:0002021 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008878 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. parietal lobe BTO:0001001 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008879 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. parietal lobe UBERON:0001872 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008880 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008881 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008882 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. trachea BTO:0001388 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008883 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Expressed in the heart, including apex, inter-ventricular septum, both atria and ventricles, but not in the aorta. Also expressed in fetal heart. Detected in various regions of the brain: cerebellum; occipital, frontal and parietal lobes. Also expressed in the lymph nodes, skeletal muscle, kidney and trachea, but not in the thymus or lung. Overexpressed in colorectal cancer. trachea UBERON:0003126 Y Y ECO:0000269 PubMed:11866447 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 110 3300008884 Katie Q9H7Z7 80142 PTGES2 Homo sapiens 9606 EC 5.3.99.3 Y Y ECO:0000311 EC number UniProtKB AAP 2/6/2013 110 3300008885 Faith Q15185 10728 PTGES3 Homo sapiens 9606 EC 5.3.99.3 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 125 3300008889 Rose P43119 5739 PTGIR Homo sapiens 9606 Comment/function Receptor for prostacyclin (prostaglandin I2 or PGI2). The activity of this receptor is mediated by G(s) proteins which activate adenylate cyclase. Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 125 3300008892 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/function Catalyzes the isomerization of prostaglandin H2 to prostacyclin (= prostaglandin I2). Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008894 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. heart BTO:0000562 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008896 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. heart UBERON:0000948 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008897 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008898 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008899 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. ovary BTO:0000975 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008900 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. female gonad UBERON:0000992 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008901 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. prostate gland BTO:0001129 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008902 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. prostate gland UBERON:0002367 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008903 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. skeletal muscle BTO:0001103 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008904 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Widely expressed; particularly abundant in ovary, heart, skeletal muscle, lung and prostate. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID particularly abundant AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008905 Faith Q16647 5740 PTGIS Homo sapiens 9606 EC 5.3.99.4 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, AAP-M, ASD 2/6/2013 129 3300008907 Mike Q14914 22949 PTGR1 Homo sapiens 9606 Comment/function Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-oxo-PGE1, 15-oxo-PGE2 and 15-oxo-PGE2-alpha. Has no activity towards PGE1, PGE2 and PGE2-alpha (By similarity). Catalyzes the conversion of leukotriene B4 into its biologically less active metabolite, 12-oxo-leukotriene B4. This is an initial and key step of metabolic inactivation of leukotriene B4. Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 125 3300008908 Katie Q14914 22949 PTGR1 Homo sapiens 9606 Comment/subcellular location Cytoplasm cytoplasm GO:0005737 SL-0086 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, ASD 1/9/2013 125 3300008909 Katie Q14914 22949 PTGR1 Homo sapiens 9606 Comment/tissue specificity High expression in the kidney, liver, and intestine but not in leukocytes. intestine BTO:0000648 Y Y ECO:0000269 PubMed:8576264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 125 3300008911 Katie Q14914 22949 PTGR1 Homo sapiens 9606 Comment/tissue specificity High expression in the kidney, liver, and intestine but not in leukocytes. intestine UBERON:0000160 Y Y ECO:0000269 PubMed:8576264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 125 3300008912 Katie Q14914 22949 PTGR1 Homo sapiens 9606 Comment/tissue specificity High expression in the kidney, liver, and intestine but not in leukocytes. kidney BTO:0000671 Y Y ECO:0000269 PubMed:8576264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 125 3300008913 Katie Q14914 22949 PTGR1 Homo sapiens 9606 Comment/tissue specificity High expression in the kidney, liver, and intestine but not in leukocytes. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:8576264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 125 3300008914 Katie Q14914 22949 PTGR1 Homo sapiens 9606 Comment/tissue specificity High expression in the kidney, liver, and intestine but not in leukocytes. liver BTO:0000759 Y Y ECO:0000269 PubMed:8576264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 125 3300008915 Katie Q14914 22949 PTGR1 Homo sapiens 9606 Comment/tissue specificity High expression in the kidney, liver, and intestine but not in leukocytes. liver UBERON:0002107 Y Y ECO:0000269 PubMed:8576264 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 1/9/2013 125 3300008916 Katie Q14914 22949 PTGR1 Homo sapiens 9606 EC 1.3.1.- Y Y ECO:0000311 EC number UniProtKB AAP, ASD 1/9/2013 125 3300008917 Rose P23219 5742 PTGS1 Homo sapiens 9606 Comment/pathway Lipid metabolism; prostaglandin biosynthesis. lipid metabolic process GO:0006629 UPA00662 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, AAP-M, ASD 2/6/2013 151 3300008921 Rose P23219 5742 PTGS1 Homo sapiens 9606 Comment/pathway Lipid metabolism; prostaglandin biosynthesis. prostaglandin biosynthetic process GO:0001516 UPA00662 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, AAP-M, ASD 2/6/2013 151 3300008922 Rose P23219 5742 PTGS1 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, AAP-M, ASD 2/6/2013 151 3300008924 Rose P23219 5742 PTGS1 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Peripheral membrane protein intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS Microsome obsolete GO term AAP, DGA, AAP-M, ASD 2/6/2013 151 3300008925 Rose P23219 5742 PTGS1 Homo sapiens 9606 EC 1.14.99.1 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, AAP-M, ASD 2/6/2013 151 3300008926 Rose P35354 5743 PTGS2 Homo sapiens 9606 Comment/pathway Lipid metabolism; prostaglandin biosynthesis. lipid metabolic process GO:0006629 UPA00662 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, AAP-M, ASD 2/6/2013 143 3300008931 Rose P35354 5743 PTGS2 Homo sapiens 9606 Comment/pathway Lipid metabolism; prostaglandin biosynthesis. prostaglandin biosynthetic process GO:0001516 UPA00662 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, AAP-M, ASD 2/6/2013 143 3300008932 Rose P35354 5743 PTGS2 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, AAP-M, ASD 2/6/2013 143 3300008933 Rose P35354 5743 PTGS2 Homo sapiens 9606 Comment/subcellular location Microsome membrane;Peripheral membrane protein intracellular membrane-bounded organelle GO:0043231 SL-0165 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS Microsome obsolete GO term AAP, DGA, AAP-M, ASD 2/6/2013 143 3300008934 Rose P35354 5743 PTGS2 Homo sapiens 9606 EC 1.14.99.1 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, AAP-M, ASD 2/6/2013 143 3300008935 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/function Acyl-CoA synthetase probably involved in bile acid metabolism. Proposed to activate C27 precurors of bile acids to their CoA thioesters derivatives before side chain cleavage via peroxisomal beta-oxidation occurs. In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol. Does not utilize C24 bile acids as substrates. In vitro, also activates long- and branched-chain fatty acids and may have additional roles in fatty acid metabolism. May be involved in translocation of long-chain fatty acids (LFCA) across membranes (By similarity). Y Y ECO:0000269 ECO:0000250 : PubMed:11980911 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID nothing specific enough to capture AAP 2/6/2013 106 3300008936 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/subcellular location Peripheral membrane associated with the lumenal side of peroxisomes. extrinsic component of intraperoxisomal membrane GO:0005780 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID more specific than existing GO term AAP 2/6/2013 106 3300008937 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Multi-pass membrane protein integral component of endoplasmic reticulum membrane GO:0030176 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: GO,EVID,SEC_IDS more specific than existing GO term AAP 2/6/2013 106 3300008938 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, kidney, placenta and pancreas. kidney BTO:0000671 Y Y ECO:0000269 PubMed:10198260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300008940 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, kidney, placenta and pancreas. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:10198260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300008941 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, kidney, placenta and pancreas. liver BTO:0000759 Y Y ECO:0000269 PubMed:10198260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300008942 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, kidney, placenta and pancreas. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10198260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300008943 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, kidney, placenta and pancreas. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:10198260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300008944 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, kidney, placenta and pancreas. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:10198260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300008945 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, kidney, placenta and pancreas. placenta BTO:0001078 Y Y ECO:0000269 PubMed:10198260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300008946 Mike O14975 11001 SLC27A2 Homo sapiens 9606 Comment/tissue specificity Expressed in liver, kidney, placenta and pancreas. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:10198260 UniProtKB UPDATE ver_2 Changes in: EVID AAP 2/6/2013 106 3300008947 Mike O14975 11001 SLC27A2 Homo sapiens 9606 EC 6.2.1.- Y Y ECO:0000311 EC number UniProtKB This EC code describes a class of reactions. AAP 2/6/2013 106 3300008948 Rose P35610 6646 SOAT1 Homo sapiens 9606 EC 2.3.1.26 Y Y ECO:0000311 EC number UniProtKB AAP, ASD 2/6/2013 124 3300008952 Rose P21731 6915 TBXA2R Homo sapiens 9606 Comment/function Receptor for thromboxane A2 (TXA2), a potent stimulator of platelet aggregation. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system. In the kidney, the binding of TXA2 to glomerular TP receptors causes intense vasoconstriction. Activates phospholipase C. Isoform 1 activates adenylyl cyclase. Isoform 2 inhibits adenylyl cyclase. kidney BTO:0000671 Y Y ECO:0000269 PubMed:8613548 UniProtKB UPDATE ver_2 Changes in: EVID Tissue info not necessariy linked to PMID source. AAP, DGA, ASD 1/9/2013 138 3300008953 Rose P21731 6915 TBXA2R Homo sapiens 9606 Comment/function Receptor for thromboxane A2 (TXA2), a potent stimulator of platelet aggregation. The activity of this receptor is mediated by a G-protein that activates a phosphatidylinositol-calcium second messenger system. In the kidney, the binding of TXA2 to glomerular TP receptors causes intense vasoconstriction. Activates phospholipase C. Isoform 1 activates adenylyl cyclase. Isoform 2 inhibits adenylyl cyclase. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:8613548 UniProtKB UPDATE ver_2 Changes in: EVID Tissue info not necessariy linked to PMID source. AAP, DGA, ASD 1/9/2013 138 3300008954 Rose P21731 6915 TBXA2R Homo sapiens 9606 Comment/Involvement in disease Bleeding disorder, platelet-type 13 (BDPLT13): A disorder characterized by reduced platelet aggregation and a tendency to mild mucocutaneous bleeding. MIM:614009 blood platelet disease DOID:2218 Disease susceptibility is associated with variations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:8613548 PubMed:7929844 UniProtKB AAP, DGA, ASD 5/1/2013 141 3300008955 Rose P21731 6915 TBXA2R Homo sapiens 9606 Comment/Involvement in disease Bleeding disorder, platelet-type 13 (BDPLT13): A disorder characterized by reduced platelet aggregation and a tendency to mild mucocutaneous bleeding. MIM:614009 Platelet disorder SNOMEDCT:22716005 Disease susceptibility is associated with variations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:8613548 PubMed:7929844 UniProtKB AAP, DGA, ASD 5/1/2013 141 3300008956 Rose P21731 6915 TBXA2R Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 1/9/2013 138 3300008958 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/Involvement in disease Ghosal hematodiaphyseal dysplasia (GHDD): Rare autosomal recessive disorder characterized by increased bone density with predominant diaphyseal involvement and aregenerative corticosteroid-sensitive anemia. Aregenerative anemia is characterized by bone marrow failure, so that functional marrow cells are regenerated slowly or not at all. MIM:231095 bone disease DOID:0080001 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:6101498 PubMed:18264100 UniProtKB N ver_2HDO term more general than OMIM. HDO term more general than OMIM. AAP, DGA, ASD 5/1/2013 150 3300008960 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/Involvement in disease Thromboxane synthetase deficiency has been detected in some patients with a bleeding disorder due to platelet dysfunction. MIM:274180 blood platelet disease DOID:2218 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:6101498 UniProtKB N ver_2 AAP, DGA, ASD 5/1/2013 150 3300008961 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/Involvement in disease Thromboxane synthetase deficiency has been detected in some patients with a bleeding disorder due to platelet dysfunction. MIM:274180 Thromboxane synthetase deficiency SNOMEDCT:234477002 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:6101498 UniProtKB N ver_2 AAP, DGA, ASD 5/1/2013 150 3300008962 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Multi-pass membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID,SEC_IDS AAP, DGA, ASD 2/6/2013 147 3300008964 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. lung fibroblast BTO:0000764 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 2/6/2013 147 3300008965 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. macrophage BTO:0000801 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term AAP, DGA, ASD 2/6/2013 147 3300008966 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. blood platelet BTO:0000132 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term (only parent term blood) AAP, DGA, ASD 2/6/2013 147 3300008967 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. blood UBERON:0000178 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID No Uberon term (only parent term blood) AAP, DGA, ASD 2/6/2013 147 3300008968 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. kidney BTO:0000671 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 2/6/2013 147 3300008969 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. kidney UBERON:0002113 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 2/6/2013 147 3300008970 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. lung BTO:0000763 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 2/6/2013 147 3300008971 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 2/6/2013 147 3300008972 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. spleen BTO:0001281 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 2/6/2013 147 3300008973 Rose P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity Platelets, lung, kidney, spleen, macrophages and lung fibroblasts. spleen UBERON:0002106 Y Y ECO:0000311 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, ASD 2/6/2013 147 3300008974 Rose P24557 6916 TBXAS1 Homo sapiens 9606 EC 5.3.99.5 Y Y ECO:0000311 EC number UniProtKB AAP, DGA, ASD 2/6/2013 147 3300008975 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 protein and mRNA was detected in normal tissue with vascular EC and SMC (isolated from saphenous vein) vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008976 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Within the atherosclerotic lesion, PTGS1 and PTGS2 protein and mRNA colocalized with endothelial cells, smooth muscle cells (isolated from saphenous vein), and macrophages. Protein staining signal was brightest macrophage. By western blot, PTGS2 was not detectable in EC or SMC. vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008977 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Within the atherosclerotic lesion, PTGS1 and PTGS2 protein and mRNA colocalized with endothelial cells, smooth muscle cells (isolated from saphenous vein), and macrophages. Protein staining signal was brightest macrophage. By western blot, PTGS2 was not detectable in EC or SMC. vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008978 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Within the atherosclerotic lesion, PTGS1 and PTGS2 protein and mRNA colocalized with endothelial cells, smooth muscle cells (isolated from saphenous vein), and macrophages. Protein staining signal was brightest macrophage. By western blot, PTGS2 was not detectable in EC or SMC. macrophage BTO:0000801 macrophage CL:0000235 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008979 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Within the atherosclerotic lesion, PTGS1 and PTGS2 protein and mRNA colocalized with endothelial cells, smooth muscle cells (isolated from saphenous vein), and macrophages. Protein staining signal was brightest macrophage. By western blot, PTGS2 was not detectable in EC or SMC. vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008980 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Within the atherosclerotic lesion, PTGS1 and PTGS2 protein and mRNA colocalized with endothelial cells, smooth muscle cells (isolated from saphenous vein), and macrophages. Protein staining signal was brightest macrophage. By western blot, PTGS2 was not detectable in EC or SMC. vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008981 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Within the atherosclerotic lesion, PTGS1 and PTGS2 protein and mRNA colocalized with endothelial cells, smooth muscle cells (isolated from saphenous vein), and macrophages. Protein staining signal was brightest macrophage. By western blot, PTGS2 was not detectable in EC or SMC. macrophage BTO:0000801 macrophage CL:0000235 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008982 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein expression was induced in vascular endothelial cells (isolated from athersclerotic lesions) cultured for 24 hours in the presence of recombinant human CD 40 ligand (10 ug/ml) vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345; inducible:recombinant human CD 40 ligand AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008983 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein expression was induced in vascular endothelial cells (isolated from athersclerotic lesions) cultured for 24 hours in the presence of IL-1beta (10 ng/ml) and TNFalpha (50 ng/ml) vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 inducible:IL-1beta, TNFalpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008984 Katie/Faith P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity AKR1C3 mRNA was detected in HAECs, HUVECs, and HMVECs aortic endothelial cell BTO:0003245 aortic endothelial cell CL:0002544 Y Y PubMed:19442656 PENTACON AAP, ASD 4/21/2014 3 3300008985 Katie/Faith P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity AKR1C3 mRNA was detected in HAECs, HUVECs, and HMVECs HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y PubMed:19442656 PENTACON AAP, ASD 4/21/2014 3 3300008986 Katie/Faith P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity AKR1C3 mRNA was detected in HAECs, HUVECs, and HMVECs microvascular endothelial cell BTO:0003123 blood vessel endothelial cell CL:0000071 Y Y PubMed:19442656 PENTACON AAP, ASD 4/21/2014 3 3300008987 Katie/Faith P18054 239 ALOX12 Homo sapiens 9606 Comment/tissue specificity 12-LOX mRNA and protein was detected in HUVECs and HMVECs HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y Pubmed:10733500 PENTACON AAP, DGA, AAP-M 4/21/2014 3 3300008988 Katie/Faith P18054 239 ALOX12 Homo sapiens 9606 Comment/tissue specificity 12-LOX mRNA and protein was detected in HUVECs and HMVECs microvascular endothelial cell BTO:0003123 blood vessel endothelial cell CL:0000071 Y Y Pubmed:10733500 PENTACON AAP, DGA, AAP-M 4/21/2014 3 3300008989 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta is present in platelet blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000006 PubMed:8613548 PENTACON from review:PubMed:20059330; from review:PubMed:19095631; from review:PubMed:15369681 AAP, DGA, ASD 4/21/2014 3 3300008990 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha is present in platelet blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000006 PubMed:8613548 PENTACON from review:PubMed:20059330; from review:PubMed:19095631; from review:PubMed:15369681 AAP, DGA, ASD 4/21/2014 3 3300008991 Katie P24752 38 ACAT1 Homo sapiens 9606 Comment/tissue specificity ACAT1 is expressed in macrophages in atherosclerotic lesions and in cultured monocytes-macrophages macrophage BTO:0000801 macrophage CL:0000235 Y Y PubMed:9763528 PENTACON AAP, DGA, ASD 4/21/2014 3 3300008992 Katie P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity Expressed in macrophages and upregulated by M1 polarization macrophage BTO:0000801 macrophage CL:0000235 Y Y PubMed:22308341 PENTACON AAP, AAP-M, ASD 4/21/2014 3 3300008993 Katie P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity ACSL1 mRNA and protein was detected in human macrophages macrophage BTO:0000801 macrophage CL:0000235 Y Y Pubmed:17259370 PENTACON AAP, AAP-M, ASD 4/21/2014 3 3300008994 Katie O95573 2181 ACSL3 Homo sapiens 9606 Comment/tissue specificity ACSL3 mRNA was detected in human macrophages macrophage BTO:0000801 macrophage CL:0000235 Y Y Pubmed:17259370 PENTACON AAP, AAP-M, ASD 4/21/2014 3 3300008995 Katie/Faith Q9ULC5 51703 ACSL5 Homo sapiens 9606 Comment/tissue specificity ACSL5 mRNA was detected at a low level in human macrophages macrophage BTO:0000801 macrophage CL:0000235 Y Y Pubmed:17259370 PENTACON AAP, AAP-M 4/21/2014 3 3300008996 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity PTGES expression (mRNA and protein) was induced by all-trans retinoic acid in macrophages derived from isolated CD14++ monocytes by treatment with macrophage colony stimulation factor macrophage BTO:0000801 macrophage CL:0000235 Y Y PubMed:22204820 PENTACON inducible:all-trans retinoic acid AAP, DGA 4/21/2014 3 3300008997 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity PTGES expression (protein) was induced by all-trans retinoic acid + LPS in macrophages derived from isolated CD14++ monocytes by treatment with macrophage colony stimulation factor macrophage BTO:0000801 macrophage CL:0000235 Y Y PubMed:22204820 PENTACON inducible:all-trans retinoic acid + LPS AAP, DGA 4/21/2014 3 3300008998 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 protein was detected in macrophage (derived from peripheral blood monocytes, 1, 3,9 days culture). After 3 and, more markedly, after 9 days of in vitro culture, a constitutively expressed second Cox-1 protein was detected with an molecular weight of approximately 50 kd macrophage BTO:0000801 macrophage CL:0000235 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300008999 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein was induced in macrophage (derived from peripheral blood monocytes, 1, 3,9 days culture) cultured in the presence of LPS (100 ng/ml). Inducibility of the 70-kd form diminishes with increased time in culture of the macrophage. The lower molecular weight form rose with time of culture (but does not appear to be inducible) macrophage BTO:0000801 macrophage CL:0000235 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345; inducible:LPS AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009000 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein expression was induced in macrophage (isolated from athersclerotic lesions) cultured for 24 hours in the presence of recombinant human CD 40 ligand (10 ug/ml) macrophage BTO:0000801 macrophage CL:0000235 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345; inducible:recombinant human CD 40 ligand AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009001 Katie/Faith O15439 10257 ABCC4 Homo sapiens 9606 Comment/tissue specificity Protein detected in endothelial cells and vascular smooth muscle cells of human coronary arteries coronary artery smooth muscle cell BTO:0005101 smooth muscle cell of the coronary artery CL:0002592 Y Y PubMed:15297306 PENTACON AAP, AAP-M, ASD 4/21/2014 3 3300009002 Katie/Faith P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity ACSL1 mRNA and protein was detected in human aortic smooth muscle cells aortic smooth muscle BTO:0001685 aortic smooth muscle cell CL:0002539 Y Y Pubmed:21242590 Pubmed:17259370 PENTACON AAP, AAP-M, ASD 4/21/2014 3 3300009003 Katie/Faith O95573 2181 ACSL3 Homo sapiens 9606 Comment/tissue specificity ACSL3 mRNA was detected in human aortic smooth muscle cells aortic smooth muscle BTO:0001685 aortic smooth muscle cell CL:0002539 Y Y Pubmed:17259370 PENTACON AAP, AAP-M, ASD 4/21/2014 3 3300009004 Katie/Faith O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity ACSL4 splice variant 1 (NM_004458) was detected in cultured aortic smooth muscle cells aortic smooth muscle BTO:0001685 aortic smooth muscle cell CL:0002539 Y Y Pubmed:21242590 PENTACON Splice variant 1 (short) was more abundantly expressed than variant 2 (long) in aortic smooth muscle cells, also noted in IVM tab AAP, AAP-M, ASD 4/21/2014 3 3300009005 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 protein and mRNA was detected in normal tissue with vascular EC and SMC (isolated from saphenous vein) vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009006 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity There was a modest induction of PTGS1 mRNA [in human vascular smooth muscle cells treated with phorbol 12-myristate 13-acetate (20 ng/ml) for 4 h] vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y PubMed:1380156 PENTACON inducible: phorbol 12-myristate 13-acetate AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009007 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein expression was induced in vascular smooth muscle cells (isolated from athersclerotic lesions) cultured for 24 hours in the presence of recombinant human CD 40 ligand (10 ug/ml) vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 atherosclerosis DOID: 1936 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; From review: Pubmed:21508345; inducible:recombinant human CD 40 ligand AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009008 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was induced in human vascular smooth muscle cells treated with phorbol 12-myristate 13-acetate (20 ng/ml) for 4 h vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y PubMed:1380156 PENTACON inducible: phorbol 12-myristate 13-acetate AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009009 Faith O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity HPGDS protein was detected on lymphocytes lymphocyte BTO:0000775 lymphocyte CL:0000542 Y Y PubMed:10679060 PENTACON AAP, ASD 4/21/2014 3 3300009010 Katie Q7L5N7 54947 LPCAT2 Homo sapiens 9606 Comment/tissue specificity Expression detected in human peripheral blood monocytes monocyte BTO:0000876 monocyte CL:0000576 Y Y Pubmed:20018618 PENTACON AAP 4/21/2014 3 3300009011 Katie Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity Expression detected in human peripheral blood monocytes monocyte BTO:0000876 monocyte CL:0000576 Y Y Pubmed:20018618 PENTACON AAP 4/21/2014 3 3300009012 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA and protein (PubMed:10514410) was detected in monocytes (isolated from leukocyte-rich elutriates in PubMed:1380156) monocyte BTO:0000876 monocyte CL:0000576 Y Y PubMed:1380156 PubMed:8282809 PubMed:10514410 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009013 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA expression was induced in monocytes (isolated from leukocyte-rich elutriates) by treatment with PMA (20 ng/ml) for 5 h monocyte BTO:0000876 monocyte CL:0000576 Y Y PubMed:1380156 PENTACON inducible: phorbol 12-myristate 13-acetate; cells assayed were separated from leukocytes AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009014 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA expression was induced in monocytes (isolated from leukocyte-rich elutriates) by treatment with LPS (10 ug/ml) for 5 h monocyte BTO:0000876 monocyte CL:0000576 Y Y PubMed:1380156 PENTACON inducible: LPS; cells assayed were separated from leukocytes AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009015 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity 24 h exposure to LPS (10 ug/ml) increased PTGS2 mRNA and protein expression in monocytes. monocyte BTO:0000876 monocyte CL:0000576 Y Y PubMed:8282809 PubMed:7929310 PENTACON inducible: LPS AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009016 Faith Q13258 5729 PTGDR Homo sapiens 9606 Comment/tissue specificity mRNA detected by means of RT-PCR/Southern hybridization eosinophil BTO:0000399 eosinophil CL:0000771 Y Y PubMed:11742277 PENTACON AAP, ASD 4/21/2014 3 3300009017 Katie Q96N66 79143 MBOAT7 Homo sapiens 9606 Comment/tissue specificity Detected in human neutrophils neutrophil BTO:0000130 neutrophil CL:0000775 Y Y PubMed:18772128 PENTACON PubMed:18772128 also provides data regarding expression and activity of MBOAT5 in human neutrophils AAP, ASD 4/21/2014 3 3300009018 Faith O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity HPGDS mRNA and protein was detected in Th2 cells generated from PBMCs of healthy adults Th2-cell BTO:0001679 Tc2 cell CL:0000918 Y Y PubMed:10679060 PENTACON constitutive AAP, ASD 4/21/2014 3 3300009019 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 was detected in Th2 cells generated from PBMCs of healthy adults after stimulation with immobilized OKT3 and KOLT-2 (time course) Th2-cell BTO:0001679 Tc2 cell CL:0000918 Y Y PubMed:10679060 PENTACON inducible:OKT3,KOLT-2 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009020 Faith P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Immunoreactivity was localized in both atrial and ventricular myocardial cells in immunostaining of human autopsy specimens with monoclonal or polyclonal antibodies against human L-PGDS parenchyma BTO:0001539 regular atrial cardiac myocyte CL:0002129 Y Y PubMed:9405674 PENTACON AAP, DGA 4/21/2014 3 3300009021 Faith P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Immunoreactivity was localized in both atrial and ventricular myocardial cells in immunostaining of human autopsy specimens with monoclonal or polyclonal antibodies against human L-PGDS parenchyma BTO:0001539 regular ventricular cardiac myocyte CL:0002131 Y Y PubMed:9405674 PENTACON AAP, DGA 4/21/2014 3 3300009022 Faith P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity In high magnification, immunoreactivity of L-PGDS was detected in the cytoplasm of endocardial cells heart endothelial cell BTO:0004294 endocardial cell CL:0002350 Y Y PubMed:9405674 PENTACON early arteriosclerotic plaque in intima of coronary artery, ventricular endocardium, left & right coronary arteries, right ventricle, L-PGDS accumulates in the plasma during coronary circulation in patients with stable angina. AAP, DGA 4/21/2014 3 3300009023 Katie P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity AKR1B1 mRNA was detected in HAECs aortic endothelial cell BTO:0003245 aortic endothelial cell CL:0002544 Y Y PubMed:19442656 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009024 Katie P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity CBR1 mRNA was detected in HAECs aortic endothelial cell BTO:0003245 aortic endothelial cell CL:0002544 Y Y PubMed:19442656 PENTACON AAP, ASD 4/21/2014 3 3300009025 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in umbilical smooth muscle cells vascular smooth muscle cell BTO:0004578 smooth muscle cell of the umbilical artery CL:0002594 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009026 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in umbilical smooth muscle cells vascular smooth muscle cell BTO:0004578 smooth muscle cell of the umbilical artery CL:0002594 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009027 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-2;Isoform 2;FP(S) HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009028 Katie/Faith O15439 10257 ABCC4 Homo sapiens 9606 Comment/tissue specificity Protein detected in endothelial cells and vascular smooth muscle cells of human coronary arteries arterial endothelial cell BTO:0004758 endothelial cell of artery CL:1000413 Y Y PubMed:15297306 PENTACON AAP, AAP-M, ASD 4/21/2014 3 3300009029 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta placenta BTO:0001078 Y Y PubMed:8034687 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009030 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta placenta UBERON:0001987 Y Y PubMed:8034687 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009031 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha placenta BTO:0001078 Y Y PubMed:8034687 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009032 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha placenta UBERON:0001987 Y Y PubMed:8034687 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009033 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity PGIS was detected by immunofluorescence in cryostat sections of human liver smooth muscle cells of blood vessels from liver vascular smooth muscle cell BTO:0004578 Y Y PubMed:8034007 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009034 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity PGIS was detected by immunofluorescence in cryostat sections of human liver smooth muscle cells of blood vessels from liver vasculature of liver UBERON:0006877 Y Y PubMed:8034007 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009035 Katie/Faith P24752 38 ACAT1 Homo sapiens 9606 Comment/tissue specificity ACAT1 is upregulated in atherosclerotic plaque compared to healthy arteries. Pubmed:9763528 suggests that this is due to high expression in infiltrating macrophages. artery BTO:0000573 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:15961705 PubMed:9763528 PENTACON Upregulated in atherosclerotic plaque AAP, DGA, ASD 4/21/2014 3 3300009036 Katie/Faith P24752 38 ACAT1 Homo sapiens 9606 Comment/tissue specificity ACAT1 is upregulated in atherosclerotic plaque compared to healthy arteries. Pubmed:9763528 suggests that this is due to high expression in infiltrating macrophages. artery UBERON:0001637 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:15961705 PubMed:9763528 PENTACON Upregulated in atherosclerotic plaque AAP, DGA, ASD 4/21/2014 3 3300009037 Katie/Faith P24752 38 ACAT1 Homo sapiens 9606 Comment/tissue specificity ACAT1 is upregulated in atherosclerotic plaque compared to healthy arteries. Pubmed:9763528 suggests that this is due to high expression in infiltrating macrophages. artery BTO:0000573 Y Y PubMed:15961705 PubMed:9763528 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009038 Katie/Faith P24752 38 ACAT1 Homo sapiens 9606 Comment/tissue specificity ACAT1 is upregulated in atherosclerotic plaque compared to healthy arteries. Pubmed:9763528 suggests that this is due to high expression in infiltrating macrophages. artery UBERON:0001637 Y Y PubMed:15961705 PubMed:9763528 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009039 Faith P09917 240 ALOX5 Homo sapiens 9606 Comment/tissue specificity ALOX5 mRNA was detected in tunica mediae of umbilical cord artery umbilical artery BTO:0000841 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009040 Faith P09917 240 ALOX5 Homo sapiens 9606 Comment/tissue specificity ALOX5 mRNA was detected in tunica mediae of umbilical cord artery umbilical artery UBERON:0001310 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009041 Faith P09917 240 ALOX5 Homo sapiens 9606 Comment/tissue specificity ALOX5 mRNA was detected in tunica mediae of umbilical cord vein umbilical vein BTO:0001509 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009042 Faith P09917 240 ALOX5 Homo sapiens 9606 Comment/tissue specificity ALOX5 mRNA was detected in tunica mediae of umbilical cord vein umbilical vein UBERON:0002066 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009043 Rose Q96P68 27199 OXGR1 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB AAP, ASD 9/18/2013 100 3300009044 Rose Q96P68 27199 OXGR1 Homo sapiens 9606 Comment/tissue specificity Detected in kidney and, to a lower extend, in placenta. Not detected in brain tissues including the frontal cortex, caudate putamen, thalamus, hypothalamus, hippocampus or pons. kidney BTO:0000671 Y Y UniProtKB AAP, ASD 9/18/2013 100 3300009045 Rose Q96P68 27199 OXGR1 Homo sapiens 9606 Comment/tissue specificity Detected in kidney and, to a lower extend, in placenta. Not detected in brain tissues including the frontal cortex, caudate putamen, thalamus, hypothalamus, hippocampus or pons. kidney UBERON:0002113 Y Y UniProtKB AAP, ASD 9/18/2013 100 3300009046 Rose/Faith Q96P68 27199 OXGR1 Homo sapiens 9606 Comment/tissue specificity Detected in kidney and, to a lower extend, in placenta. Not detected in brain tissues including the frontal cortex, caudate putamen, thalamus, hypothalamus, hippocampus or pons. placenta BTO:0001078 Y Y UniProtKB AAP, ASD 9/18/2013 100 3300009047 Rose/Faith Q96P68 27199 OXGR1 Homo sapiens 9606 Comment/tissue specificity Detected in kidney and, to a lower extend, in placenta. Not detected in brain tissues including the frontal cortex, caudate putamen, thalamus, hypothalamus, hippocampus or pons. placenta UBERON:0001987 Y Y UniProtKB AAP, ASD 9/18/2013 100 3300009048 Rose Q96P68 27199 OXGR1 Homo sapiens 9606 Comment/tissue specificity Detected in kidney and, to a lower extend, in placenta. Not detected in brain tissues including the frontal cortex, caudate putamen, thalamus, hypothalamus, hippocampus or pons. Y Y UniProtKB AAP, ASD 9/18/2013 100 3300009049 Katie Q9Y5Y4 11251 PTGDR2 Homo sapiens 9606 Comment/tissue specificity Widespread expression. High expression in stomach, small intestine, heart and thymus. Intermediate expression in colon, spinal cord and peripheral blood and low expression in brain, skeletal muscle and spleen. Expressed also on Th2- and Tc2- type cells, eosinophils and basophils. eosinophil BTO:0000399 Y Y ECO:0000269 PubMed:11168006 PubMed:11208866 PubMed:12466225 PubMed:9973380 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID No Uberon term AAP, ASD 1/9/2013 102 3300009050 Faith P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Immunoreactivity for L-PGDS was also observed in the endocardium and diffusely found in the extracellular matrix of the endocardium endocardium BTO:0000387 Y Y PubMed:9405674 PENTACON AAP, DGA 4/21/2014 3 3300009051 Faith P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Immunoreactivity for L-PGDS was also observed in the endocardium and diffusely found in the extracellular matrix of the endocardium endocardium UBERON:0002165 Y Y PubMed:9405674 PENTACON AAP, DGA 4/21/2014 3 3300009052 Faith P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGDS expression (mRNA) was induced by 7beta-hydroxy-DHEA (1 nM after 24 h and 100 nM after 4 and 24 h) peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7beta-hydroxy-DHEA AAP, DGA 4/21/2014 3 3300009053 Faith P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGDS expression (mRNA) was induced by 7beta-hydroxy-EpiA (1 and 10 nM) after 4 h peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7beta-hydroxy-EpiA AAP, DGA 4/21/2014 3 3300009054 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity A low hybridization signal was detected in heart by Northern dot blot analysis heart BTO:0000562 Y Y PubMed:10377395 PENTACON This paper looked at many tissues AAP, DGA 4/21/2014 3 3300009055 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity A low hybridization signal was detected in heart by Northern dot blot analysis heart UBERON:0000948 Y Y PubMed:10377395 PENTACON This paper looked at many tissues AAP, DGA 4/21/2014 3 3300009056 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity IL-1beta up-regulated PTGES expression in terms of mRNA and protein in microvascular endothelial cells released from human foreskin (up-regulation as a function of time was studied). PTGES was detected by histology in microvascular endothelium. microvascular endothelial cell BTO:0003123 Y Y PubMed:21277871 PENTACON inducible:IL-1beta AAP, DGA 4/21/2014 3 3300009057 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity Tumor cells conditioned media induced PTGES mRNA and protein levels in a time-dependent manner microvascular endothelial cell BTO:0003123 Y Y PubMed:21277871 PENTACON inducible:tumor cells conditioned media AAP, DGA 4/21/2014 3 3300009058 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity PTGES proteins, scarcely expressed in the microsomal fraction, were strongly induced by IL-1beta in vascular smooth muscle cells isolated from aorta (mRNA and protein, time course study) aortic smooth muscle cell BTO:0004577 Y Y PubMed:17403097 PENTACON inducible:IL-1beta AAP, DGA 4/21/2014 3 3300009059 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGES expression (mRNA) was induced by 7alpha-hydroxy-DHEA (1, 10, and 100 nM) after 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7alpha-hydroxy-DHEA AAP, DGA 4/21/2014 3 3300009060 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGES expression (mRNA and protein) was induced by TNF-alpha (10 ng/mL) after 4 and 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:TNF-alpha AAP, DGA 4/21/2014 3 3300009061 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGES expression (mRNA) was induced by 7alpha-hydroxy-DHEA (1, 10, and 100 nM) + TNF-alpha (10 ng/mL) after 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7alpha-hydroxy-DHEA + TNF-alpha AAP, DGA 4/21/2014 3 3300009062 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGES expression (mRNA) was induced by 7beta-hydroxy-DHEA (1, 10, and 100 nM) after 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7beta-hydroxy-DHEA AAP, DGA 4/21/2014 3 3300009063 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGES expression (mRNA) was induced by 7beta-hydroxy-DHEA (1, 10, and 100 nM) + TNF-alpha (10 ng/mL) after 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7beta-hydroxy-DHEA + TNF-alpha AAP, DGA 4/21/2014 3 3300009064 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGES expression (mRNA) was induced by 7beta-hydroxy-EpiA (1, 10, and 100 nM) after 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7beta-hydroxy-EpiA AAP, DGA 4/21/2014 3 3300009065 Faith O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity PTGES mRNA was upregulated in HUVEC after 4 hr bradykinin (10 nM) exposure HUVEC cell BTO:0001949 Y Y PubMed:11208485 PENTACON inducible:bradykinin; in the paper, the authors use inducible PGE-S to refer to the gene. BLASTing the primers used to amplify PGE-S identified PTGES AAP, DGA 4/21/2014 3 3300009066 Faith Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity PTGES2 was expressed constitutively (mRNA and protein) in microvascular endothelial cells released from human foreskin (up-regulation as a function of time was studied) microvascular endothelial cell BTO:0003123 Y Y PubMed:21277871 PENTACON AAP 4/21/2014 3 3300009067 Faith Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity PTGES2 proteins were expressed in the microsomal fraction in resting vascular smooth muscle cells isolated from aorta aortic smooth muscle cell BTO:0004577 Y Y PubMed:17403097 PENTACON AAP 4/21/2014 3 3300009068 Faith Q15185 10728 PTGES3 Homo sapiens 9606 Comment/tissue specificity PTGES3 was expressed constitutively (mRNA and protein) in microvascular endothelial cells released from human foreskin (up-regulation as a function of time was studied) microvascular endothelial cell BTO:0003123 Y Y PubMed:21277871 PENTACON AAP, ASD 4/21/2014 3 3300009069 Faith Q15185 10728 PTGES3 Homo sapiens 9606 Comment/tissue specificity PTGES3 proteins were expressed in the cytosolic fraction in resting vascular smooth muscle cells isolated from aorta aortic smooth muscle cell BTO:0004577 Y Y PubMed:17403097 PENTACON AAP, ASD 4/21/2014 3 3300009070 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-1;Isoform 1 heart BTO:0000562 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009071 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-1;Isoform 1 heart UBERON:0000948 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009072 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-1;Isoform 1 placenta BTO:0001078 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009073 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-1;Isoform 1 placenta UBERON:0001987 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009074 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-2;Isoform 2;FP(S) heart BTO:0000562 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009075 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-2;Isoform 2;FP(S) heart UBERON:0000948 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009076 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-2;Isoform 2;FP(S) placenta BTO:0001078 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009077 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-2;Isoform 2;FP(S) placenta UBERON:0001987 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009078 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-2;Isoform 2;FP(S) skeletal muscle BTO:0001103 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009079 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Isoform: P43088-2;Isoform 2;FP(S) skeletal muscle tissue UBERON:0001134 Y Y PubMed:14984197 PENTACON AAP, ASD 4/21/2014 3 3300009080 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity mRNA was detected by RNA blot hybridization of mRNA extracted from HAEC. aortic endothelial cell BTO:0003245 Y Y PubMed:8185632 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009081 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity 24 h incubation with IL-1alpha (1 ng/mL) induced expression of PTGIS in HAEC. mRNA was detected by RNA blot hybridization. aortic endothelial cell BTO:0003245 Y Y PubMed:8185632 PENTACON inducible:IL-1alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009082 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity 24 h incubation with IL-1beta (1 ng/mL) induced expression of PTGIS in HAEC. mRNA was detected by RNA blot hybridization. aortic endothelial cell BTO:0003245 Y Y PubMed:8185632 PENTACON inducible:IL-1beta AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009083 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity 24 h incubation with IL-6 (2.5 ng/mL) induced expression of PTGIS in HAEC. mRNA was detected by RNA blot hybridization. aortic endothelial cell BTO:0003245 Y Y PubMed:8185632 PENTACON inducible:IL-6 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009084 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in small intestine small intestine BTO:0000651 Y Y PubMed:8185632 PENTACON low but significant mRNA levels AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009085 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in small intestine small intestine UBERON:0002108 Y Y PubMed:8185632 PENTACON low but significant mRNA levels AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009086 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in kidney kidney BTO:0000671 Y Y PubMed:8185632 PENTACON low but significant mRNA levels AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009087 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in kidney kidney UBERON:0002113 Y Y PubMed:8185632 PENTACON low but significant mRNA levels AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009088 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in liver liver BTO:0000759 Y Y PubMed:8185632 PENTACON low but significant mRNA levels AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009089 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in liver liver UBERON:0002107 Y Y PubMed:8185632 PENTACON low but significant mRNA levels AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009090 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in brain brain BTO:0000142 Y Y PubMed:8185632 PENTACON low but significant mRNA levels AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009091 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in brain brain UBERON:0000955 Y Y PubMed:8185632 PENTACON low but significant mRNA levels AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009092 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in umbilical vein umbilical vein BTO:0001509 Y Y PubMed:8034007 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009093 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity poly(A)+ mRNA was detected in umbilical vein umbilical vein UBERON:0002066 Y Y PubMed:8034007 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009094 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity PTGIS mRNA is up-regulated by high shear stimulation (defined as 25 dyn/cm^2 in PubMed:10694510). Up-regulation is time-dependent. HUVEC cell BTO:0001949 Y Y PubMed:10694510 PENTACON inducible: high shear stress AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009095 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity PTGIS protein was expressed constitutively in vascular smooth muscle cells isolated from aorta aortic smooth muscle cell BTO:0004577 Y Y PubMed:17403097 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009096 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity CTXA2 (1 ug/ml for 20 h) treatment resulted in the up-regulation of PTGIS (protein). HUVEC cell BTO:0001949 Y Y PubMed:11483590 PENTACON inducible:CTXA2 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009097 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity IL-1beta (1 ng/ml for 20 h) treatment resulted in the up-regulation of PTGIS (protein). HUVEC cell BTO:0001949 Y Y PubMed:11483590 PENTACON inducible:IL-1beta AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009098 Faith P18054 239 ALOX12 Homo sapiens 9606 Comment/tissue specificity ALOX12 mRNA was detected in umbilical smooth muscle cells vascular smooth muscle cell BTO:0004578 smooth muscle cell of the umbilical artery CL:0002594 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M 4/21/2014 3 3300009099 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Atherosclerotic lesions contained Cox-1 protein (70 kd and 50 kd bands). The 50 kd band was more pronounced in athersclerotic lesions than normal artery tissue. artery BTO:0000573 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; constitutive; in plaque AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009100 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Atherosclerotic lesions contained Cox-1 protein (70 kd and 50 kd bands). The 50 kd band was more pronounced in athersclerotic lesions than normal artery tissue. artery UBERON:0001637 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; constitutive; in plaque AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009101 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Atherosclerotic lesions contained Cox-1 protein (70 kd and 50 kd bands). The 50 kd band was more pronounced in athersclerotic lesions than normal artery tissue. artery BTO:0000573 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; constitutive AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009102 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Atherosclerotic lesions contained Cox-1 protein (70 kd and 50 kd bands). The 50 kd band was more pronounced in athersclerotic lesions than normal artery tissue. artery UBERON:0001637 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396; constitutive AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009103 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity The endothelium of plaque microvessels showed prominent Cox-1 and Cox-2 protein immunostaining microvascular endothelium BTO:0003122 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009104 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity The endothelium of plaque microvessels showed prominent Cox-1 and Cox-2 protein immunostaining microvascular endothelium UBERON:0008339 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009105 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain prostate gland BTO:0001129 Y Y PubMed:8365485 PENTACON pool 5 adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009106 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain prostate gland UBERON:0002367 Y Y PubMed:8365485 PENTACON pool 5 adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009107 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain uterus BTO:0001424 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009108 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain uterus UBERON:0000995 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009109 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain small intestine BTO:0000651 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009110 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain small intestine UBERON:0002108 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009111 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain mammary gland BTO:0000817 Y Y PubMed:8365485 PENTACON pool 2 non-lactating females AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009112 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain mammary gland UBERON:0001911 Y Y PubMed:8365485 PENTACON pool 2 non-lactating females AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009113 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain stomach BTO:0001307 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009114 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain stomach UBERON:0000945 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009115 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain lung BTO:0000763 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009116 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain lung UBERON:0002048 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009117 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain thymus BTO:0001374 Y Y PubMed:8365485 PENTACON 3 year old male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009118 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain thymus UBERON:0002370 Y Y PubMed:8365485 PENTACON 3 year old male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009119 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain liver BTO:0000759 Y Y PubMed:8365485 PENTACON adult female;adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009120 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain liver UBERON:0002107 Y Y PubMed:8365485 PENTACON adult female;adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009121 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain kidney BTO:0000671 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009122 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain kidney UBERON:0002113 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009123 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain testis BTO:0001363 Y Y PubMed:8365485 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009124 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain testis UBERON:0000473 Y Y PubMed:8365485 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009125 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain pancreas BTO:0000988 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009126 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain pancreas UBERON:0001264 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009127 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain brain BTO:0000142 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009128 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain brain UBERON:0000955 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009129 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 protein expression was induced by 2 h (2, 4, 8, 24 h measured) treatement of HUVEC with VEGF (10 ng/ml) HUVEC cell BTO:0001949 Y Y PubMed:9627078 PENTACON inducible: VEGF AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009130 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA is up-regulated by high shear stimulation (defined as 25 dyn/cm^2 in PubMed:10694510; shear stress loading in PubMed:9848885 was 24 dyne/cm^2). Up-regulation is time-dependent. HUVEC cell BTO:0001949 Y Y PubMed:9848885 PubMed:10694510 PENTACON inducible: high shear stress AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009131 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in HUVEC (protein in PubMed:11483590) HUVEC cell BTO:0001949 Y Y PubMed:1380156 PubMed:7568157 PubMed:11208485 PubMed:9627078 PubMed:9647328 PubMed:11483590 PENTACON sometimes, it is stated that a low level is constitutively expressed AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009132 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in monocytes monocyte BTO:0000876 Y Y PubMed:1380156 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009133 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity alveolar macrophage BTO:0000802 Y Y ECO:0000006 PubMed:8282809 PENTACON constitutive AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009134 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity macrophage cell line BTO:0002278 U937(CD59+) cell CLO:0009466 Y Y ECO:0000006 PubMed:7695610 PENTACON constitutive AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009135 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity aortic smooth muscle cell BTO:0004577 Y Y ECO:0000006 PubMed:17403097 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009136 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Treatment of THP-1 cells with TPA (16 nM in DMSO) for 24 h caused an increase in PGH synthase-1 mRNA and protein (time course study) THP-1 cell BTO:0001370 THP-1 cell CLO:0009348 Y Y PubMed:9547543 PENTACON inducible: phorbol ester TPA AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009137 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Treatment of THP-1 cells with phorbol 12-myristate 13-acetate (2 ng/mL) caused an increase in PGH synthase protein (time course study) THP-1 cell BTO:0001370 THP-1 cell CLO:0009348 Y Y PubMed:1742485 PENTACON inducible: phorbol 12-myristate 13-acetate AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009138 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Normal arterial tissue contained Cox-1 protein artery BTO:0000573 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009139 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Normal arterial tissue contained Cox-1 protein artery UBERON:0001637 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009140 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in tunica mediae of umbilical cord artery umbilical artery BTO:0000841 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009141 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in tunica mediae of umbilical cord artery umbilical artery UBERON:0001310 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009142 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in tunica mediae of umbilical cord vein umbilical vein BTO:0001509 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009143 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity PTGS1 mRNA was detected in tunica mediae of umbilical cord vein umbilical vein UBERON:0002066 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009144 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity The endothelium of plaque microvessels showed prominent Cox-1 and Cox-2 protein immunostaining microvascular endothelium BTO:0003122 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009145 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity The endothelium of plaque microvessels showed prominent Cox-1 and Cox-2 protein immunostaining microvascular endothelium UBERON:0008339 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009146 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein was abundant in atheromatous lesions, as compared to normal arterial tissue. 70 and 50 kd bands were detected. artery BTO:0000573 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009147 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein was abundant in atheromatous lesions, as compared to normal arterial tissue. 70 and 50 kd bands were detected. artery UBERON:0001637 atherosclerosis DOID: 1936 Atherosclerosis SNOMEDCT:195251000 Y Y PubMed:10514410 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009148 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein was detected in infiltrating mononuclear cells and endothelial cells of blood vessels synovial tissues of patients with RA. It appeared to be localized to the perinuclear region and endoplasmic reticulum. mononuclear cell BTO:0000878 rheumatoid arthritis DOID: 7148 Rheumatoid arthritis SNOMEDCT:69896004 Y Y PubMed:8132748 PENTACON From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009149 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein was detected in infiltrating mononuclear cells and endothelial cells of blood vessels synovial tissues of patients with RA. It appeared to be localized to the perinuclear region and endoplasmic reticulum. vascular endothelial cell BTO:0001854 rheumatoid arthritis DOID: 7148 Rheumatoid arthritis SNOMEDCT:69896004 Y Y PubMed:8132748 PENTACON From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009150 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in tunica mediae of umbilical cord artery umbilical artery BTO:0000841 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009151 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in tunica mediae of umbilical cord artery umbilical artery UBERON:0001310 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009152 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in tunica mediae of umbilical cord vein umbilical vein BTO:0001509 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009153 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in tunica mediae of umbilical cord vein umbilical vein UBERON:0002066 Y Y PubMed:9647328 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009154 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Co-incubation of HUVECs with platelets induced PTGS2 (protein) in a dose- and time- dependent manner. HUVEC cell BTO:0001949 Y Y PubMed:11483590 PENTACON inducible:platelets with cell-cell contact AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009155 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Incubation of HUVECs next to platelets (no cell-cell contact) for 20 h induced PTGS2 (protein) in a dose- and time- dependent manner. HUVEC cell BTO:0001949 Y Y PubMed:11483590 PENTACON inducible:platelets without cell-cell contact AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009156 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity When HUVECs were incubated with increasing concentrations of the TXA2 analog, CTXA2 (0.01–1 μg/ml), the expression of PTGS2 dose-dependently increased. HUVEC cell BTO:0001949 Y Y PubMed:11483590 PENTACON inducible:CTXA2 (carboxylic TXA2) AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009157 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA and protein was detected in HUVEC HUVEC cell BTO:0001949 Y Y PubMed:1380156 PubMed:8526850 PubMed:7568157 PubMed:9647328 PENTACON low level constitutively expressed AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009158 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 RNA expression was induced in HUVEC treated with PMA (20 ng/ml) and cycloheximide (10 ug/ml) for 4 h HUVEC cell BTO:0001949 Y Y PubMed:1380156 PENTACON inducible: phorbol 12-myristate 13-acetate and cycloheximide AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009159 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in monocytes monocyte BTO:0000876 Y Y PubMed:1380156 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009160 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA is up-regulated by high shear stimulation (defined as 25 dyn/cm^2 in PubMed:10694510). Up-regulation is time-dependent. HUVEC cell BTO:0001949 Y Y PubMed:10694510 PENTACON inducible: high shear stress AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009161 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of PTGS2 mRNA was induced in ECV304 cells treated with IL-1alpha (10 ng/ml). Induction is time-dependent endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:IL-1alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009162 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of PTGS2 mRNA was induced in ECV304 cells treated with PMA (10 ng/ml) for 4 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:phorbol 12-myristate 13-acetate (PMA) AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009163 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity HUVEC cell BTO:0001949 Y Y ECO:0000006 PubMed:8526850 PENTACON inducible:phorbol myristate acetate (PMA) AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009164 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of PTGS2 mRNA was induced in ECV304 cells treated with FBS (10 %) for 4 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:fetal bovine serum AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009165 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of PTGS2 mRNA was induced in ECV304 cells treated with IL-1beta (10 ng/ml) for 24 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:IL-1beta AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009166 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 expression was induced in HUVEC treated with IL-1beta [(mRNA) 5 ng/ml for 3 h in PubMed:12881220; (mRNA) 1 ng/ml for 24 h in PubMed:7568157; (protein) 1 ng/ml for 20 h in PubMed:11483590] HUVEC cell BTO:0001949 Y Y PubMed:12881220 PubMed:7568157 PubMed:11483590 PENTACON inducible:IL-1beta AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009167 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA steady state expression was stimulated in ECV304 cells treated with cycloheximide (5 ug/ml) for 2 h or 6 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:cycloheximide AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009168 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was stimulated in ECV304 cells treated with pactamycin (1 ug/ml) for 3 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:pactamycin AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009169 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was stimulated in ECV304 cells treated with puromycin (100 ug/ml) for 3 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:puromycin AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009170 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was stimulated in ECV304 cells treated with cycloheximide (10 ug/ml) and IL-1alpha (10 ng/ml) for 3 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:cycloheximide and IL-1alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009171 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was stimulated in ECV304 cells treated with pactamycin (1 ug/ml) and IL-1alpha (10 ng/ml) for 3 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:pactamycin and IL-1alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009172 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was stimulated in ECV304 cells treated with puromycin (100 ug/ml) and IL-1alpha (10 ng/ml) for 3 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:puromycin and IL-1alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009173 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of PTGS2 mRNA was induced in ECV304 cells treated with FBS (10 %) + IL-1alpha (10 ng/ml) for 4 h endothelial cell line BTO:0001519 ECV304 cell CLO:0002881 Y Y PubMed:8163473 PENTACON inducible:fetal bovine serum and IL-1alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009174 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of PTGS2 mRNA was induced in HUVEC treated with IL-1alpha (10 ng/ml in PubMed:8163473 and 25 units/ml in PubMed:8526850). Induction is time-dependent HUVEC cell BTO:0001949 Y Y PubMed:8163473 PubMed:8526850 PENTACON inducible:IL-1alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009175 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA expression was induced in a human endothelial cell line derived from a patient with angiosarcoma after 2 h treatment with TNFalpha (10 ng/ml) and glucose (5.5 mM and 30 mM). Protein expression was induced, measured at 24 h exposure. endothelial cell line BTO:0001519 Y Y PubMed:21040737 PENTACON inducible: TNF-alpha and high glucose AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009176 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA expression in HUVECs was significantly increased by the medium conditioned by H9c2 cells cultured under hypoxic conditions for 1 h and 3 h. Protein expression increased for 3, 6 and 12 h exposure. HUVEC cell BTO:0001949 Y Y PubMed:12881220 PENTACON inducible: hypoxic myocyte-conditioned medium conditioned with rat myocytes AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009177 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA expression was induced in HUVEC treated with VEGF (20 ng/ml) for 3 h HUVEC cell BTO:0001949 Y Y PubMed:12881220 PENTACON inducible: VEGF AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009178 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was upregulated in HUVEC after 4 hr bradykinin (10 nM) exposure HUVEC cell BTO:0001949 Y Y PubMed:11208485 PENTACON inducible:bradykinin AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009179 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity 24 h exposure to LPS (10 ug/ml) increased PTGS2 mRNA and protein expression in alveolar macrophages alveolar macrophage BTO:0000802 Y Y PubMed:8282809 PubMed:7528741 PENTACON inducible: LPS AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009180 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Macrophages exposed to LPS for 6 hours showed enhanced PTGS2 mRNA expression 2 to 8 fold in a dose-dependent fashion (1, 10, 25, 50 100 ng/ml). At 50 ng/ml upregulation was observed as early as 1 h exposure. macrophage cell line BTO:0002278 U937(CD59+) cell CLO:0009466 Y Y PubMed:7695610 PENTACON inducible: LPS AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009181 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Macrophages primed with IFN-gamma (10 U/ml of human recombinant IFN-gamma) for 24 h then stimulated with TNF-alpha (100 U/ml) for 6 h showed moderate accumulation of PTGS2 mRNA. macrophage cell line BTO:0002278 U937(CD59+) cell CLO:0009466 Y Y PubMed:7695610 PENTACON inducible: IFN-gamma primed + TNF-alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009182 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Macrophages primed with IFN-gamma (10 U/ml of human recombinant IFN-gamma) for 24 h then stimulated with IFN-gamma (100 U/ml) for 6 h showed moderate accumulation of PTGS2 mRNA. macrophage cell line BTO:0002278 U937(CD59+) cell CLO:0009466 Y Y PubMed:7695610 PENTACON inducible: IFN-gamma primed + IFN-gamma AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009183 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Macrophages primed with IFN-gamma (10 U/ml of human recombinant IFN-gamma) for 24 h then stimulated with LPS (100 ng/ml) for 6 h showed a 207% increase in the expression of PTGS2 mRNA. macrophage cell line BTO:0002278 U937(CD59+) cell CLO:0009466 Y Y PubMed:7695610 PENTACON inducible: IFN-gamma primed + LPS AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009184 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Macrophages co-stimulated with IFN-gamma (100 U/ml) and TNF-alpha (100 U/ml) for 24 h displayed increased accumulation of PTGS2 mRNA. macrophage cell line BTO:0002278 U937(CD59+) cell CLO:0009466 Y Y PubMed:7695610 PENTACON inducible: IFN-gamma and TNF-alpha co-stimulation AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009185 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Macrophages co-stimulated with IFN-gamma (100 U/ml) and LPS (100 ng/ml) for 24 h displayed increased accumulation of PTGS2 mRNA. macrophage cell line BTO:0002278 U937(CD59+) cell CLO:0009466 Y Y PubMed:7695610 PENTACON inducible: IFN-gamma and LPS co-stimulation AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009186 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity IL-1beta up-regulated COX-2 expression in terms of mRNA and protein in microvascular endothelial cells released from human foreskin (up-regulation as a function of time was studied) microvascular endothelial cell BTO:0003123 Y Y PubMed:21277871 PENTACON inducible:IL-1beta AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009187 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Tumor cells conditioned media induced PTGS2 mRNA and protein levels in a time-dependent manner microvascular endothelial cell BTO:0003123 Y Y PubMed:21277871 PENTACON inducible:tumor cells conditioned media AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009188 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 protein and mRNA was induced by IL-1beta in vascular smooth muscle cells isolated from aorta (time course study) aortic smooth muscle cell BTO:0004577 Y Y PubMed:17403097 PENTACON inducible:IL-1beta AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009189 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGS2 expression (mRNA) was induced by 7alpha-hydroxy-DHEA (10 nM) after 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7alpha-hydroxy-DHEA AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009190 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGS2 expression (mRNA and protein) was induced by TNF-alpha (10 ng/mL) after 4 and 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:TNF-alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009191 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGS2 expression (mRNA) was induced by 7alpha-hydroxy-DHEA (1, 10, and 100 nM) + TNF-alpha (10 ng/mL) after 4 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7alpha-hydroxy-DHEA + TNF-alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009192 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGS2 expression (mRNA) was induced by 7beta-hydroxy-DHEA (100 nM) after 4 and 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7beta-hydroxy-DHEA AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009193 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGS2 expression (mRNA) was induced by 7beta-hydroxy-DHEA (1 and 10 nM) + TNF-alpha (10 ng/mL) after 4 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7beta-hydroxy-DHEA + TNF-alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009194 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In PBMC isolated from healthy male donors, PTGS2 expression (mRNA) was induced by 7beta-hydroxy-EpiA (1 nM) + TNF-alpha (10 ng/mL) after 4 and 24 h exposure peripheral blood mononuclear cell BTO:0001025 Y Y PubMed:18555503 PENTACON inducible:7beta-hydroxy-EpiA + TNF-alpha AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009195 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain prostate gland BTO:0001129 Y Y PubMed:8365485 PENTACON pool 5 adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009196 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain prostate gland UBERON:0002367 Y Y PubMed:8365485 PENTACON pool 5 adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009197 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain uterus BTO:0001424 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009198 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain uterus UBERON:0000995 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009199 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain small intestine BTO:0000651 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009200 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain small intestine UBERON:0002108 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009201 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain mammary gland BTO:0000817 Y Y PubMed:8365485 PENTACON pool 2 non-lactating females AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009202 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain mammary gland UBERON:0001911 Y Y PubMed:8365485 PENTACON pool 2 non-lactating females AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009203 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain stomach BTO:0001307 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009204 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain stomach UBERON:0000945 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009205 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain lung BTO:0000763 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009206 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain lung UBERON:0002048 Y Y PubMed:8365485 PENTACON adult female AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009207 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain thymus BTO:0001374 Y Y PubMed:8365485 PENTACON 3 year old male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009208 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain thymus UBERON:0002370 Y Y PubMed:8365485 PENTACON 3 year old male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009209 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain liver BTO:0000759 Y Y PubMed:8365485 PENTACON adult female;adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009210 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain liver UBERON:0002107 Y Y PubMed:8365485 PENTACON adult female;adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009211 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain kidney BTO:0000671 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009212 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain kidney UBERON:0002113 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009213 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain testis BTO:0001363 Y Y PubMed:8365485 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009214 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain testis UBERON:0000473 Y Y PubMed:8365485 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009215 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain pancreas BTO:0000988 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009216 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain pancreas UBERON:0001264 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009217 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain brain BTO:0000142 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009218 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity PTGS2 mRNA was detected in prostate, uterus, small intestine, mammary gland, stomach, lung, thymus, liver, kidney, testis, pancreas, and brain brain UBERON:0000955 Y Y PubMed:8365485 PENTACON adult male AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009219 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta HUVEC cell BTO:0001949 Y Y PubMed:8034687 PubMed:9838218 PENTACON down regulated when stimulated with endoperoxide analog U46619 AAP, DGA, ASD 4/21/2014 3 3300009220 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta HEL-92.1.7 cell BTO:0003320 HEL 92.1.7 cell CLO:0003682 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009221 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta aortic smooth muscle cell BTO:0004577 immortal smooth muscle cell line cell CLO:0000078 Y Y ECO:0000006 PubMed:9838218 PENTACON from review:PubMed:20059330; from review:PubMed:19095631; from review:PubMed:15369681 AAP, DGA, ASD 4/21/2014 3 3300009222 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta aortic smooth muscle cell BTO:0004577 fetus BTO:0000449 immortal smooth muscle cell line cell CLO:0000078 Y Y ECO:0000006 PubMed:9838218 PENTACON from review:PubMed:20059330; from review:PubMed:19095631; from review:PubMed:15369681 AAP, DGA, ASD 4/21/2014 3 3300009223 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta uterus BTO:0001424 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009224 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta uterus UBERON:0000995 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009225 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta brain BTO:0000142 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009226 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta brain UBERON:0000955 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009227 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta brain BTO:0000142 fetus BTO:0000449 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009228 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta brain UBERON:0000955 fetus BTO:0000449 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009229 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta thymus BTO:0001374 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009230 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta thymus UBERON:0002370 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009231 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta small intestine BTO:0000651 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009232 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta small intestine UBERON:0002108 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009233 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta liver BTO:0000759 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009234 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-2;Isoform 2;Beta liver UBERON:0002107 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009235 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha HEL-92.1.7 cell BTO:0003320 HEL 92.1.7 cell CLO:0003682 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009236 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha aortic smooth muscle cell BTO:0004577 immortal smooth muscle cell line cell CLO:0000078 Y Y ECO:0000006 PubMed:9838218 PENTACON from review:PubMed:20059330; from review:PubMed:19095631; from review:PubMed:15369681 AAP, DGA, ASD 4/21/2014 3 3300009237 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha aortic smooth muscle cell BTO:0004577 fetus BTO:0000449 immortal smooth muscle cell line cell CLO:0000078 Y Y ECO:0000006 PubMed:9838218 PENTACON from review:PubMed:20059330; from review:PubMed:19095631; from review:PubMed:15369681 AAP, DGA, ASD 4/21/2014 3 3300009238 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha uterus BTO:0001424 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009239 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha uterus UBERON:0000995 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009240 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha HUVEC cell BTO:0001949 Y Y PubMed:9838218 PENTACON Does not agree with 8034687 AAP, DGA, ASD 4/21/2014 3 3300009241 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha brain BTO:0000142 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009242 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha brain UBERON:0000955 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009243 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha brain BTO:0000142 fetus BTO:0000449 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009244 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha brain UBERON:0000955 fetus BTO:0000449 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009245 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha thymus BTO:0001374 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009246 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha thymus UBERON:0002370 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009247 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha small intestine BTO:0000651 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009248 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha small intestine UBERON:0002108 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009249 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha liver BTO:0000759 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009250 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity Isoform: P21731-3;Isoform 1;Alpha liver UBERON:0002107 Y Y PubMed:9838218 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009251 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity TBXA2R protein was detected in HUVECs HUVEC cell BTO:0001949 Y Y PubMed:11483590 PENTACON AAP, DGA, ASD 4/21/2014 3 3300009252 Faith P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity TBXAS1 mRNA is up-regulated by high shear stimulation (defined as 25 dyn/cm^2 in PubMed:10694510). Up-regulation is time-dependent. HUVEC cell BTO:0001949 Y Y PubMed:10694510 PENTACON inducible: high shear stress AAP, DGA, ASD 4/21/2014 3 3300009253 Faith P24557 6916 TBXAS1 Homo sapiens 9606 Comment/tissue specificity TBXAS1 mRNA expression was induced in a human endothelial cell line derived from a patient with angiosarcoma by treatment with TNFalpha (10 ng/ml) and high glucose (30 mM) after 2 h. endothelial cell line BTO:0001519 Y Y PubMed:21040737 PENTACON inducible: TNF-alpha and high glucose AAP, DGA, ASD 4/21/2014 3 3300009254 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Prostaglandins, endogenously formed via the COX-2 (PTGS2) pathway stimulate the expression of functionally active thrombomodulin in human coronary artery smooth muscle cells. Because thrombomodulin is an important inhibitor of blood coagulation, these findings provide a novel platelet-independent mechanism to explain the prothrombotic effects of COX-2 inhibitors. coronary artery smooth muscle cell BTO:0005101 smooth muscle cell of the coronary artery CL:0002592 atherosclerosis DOID:1936 Y Y ECO:0000006 PubMed:15591227 PENTACON From review: PubMed:20059330; FC: No DOID term. No evidence in article for venous thrombosis or myocardial infarction (the adverse cardiovascular events from Fig 2). There may be evidence in a cited article. May require follow up with Tilo/Katie. (JR: I think that what the figure is saying is that thrombosis can lead to venous thrombosis or myocardial infarction, and that upregulation of thrombomodulin by COX2 is decreasing the likelihood of thrombosis, so COX2 is decreasing the likelihood of these outcomes and playing a protective role, consistent with what Tilo said above.) AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009255 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF Henles loop BTO:0004608 hypertension DOID:10763 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009258 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF thick ascending limb of loop of Henle UBERON:0001291 hypertension DOID:10763 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009259 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF macula densa BTO:0003940 hypertension DOID:10763 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009260 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF macula densa UBERON:0002335 hypertension DOID:10763 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009261 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1–derived platelet thromboxane (Txa2) contributes to cardiac fibrosis parenchyma BTO:0001539 cardiac muscle cell CL:0000746 heart disease DOID:114 Y Y ECO:0000033 Pubmed:16395396 PENTACON COX1 produces TXA2 which has a contributing effect to cardiac fibrosis AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009262 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1–derived platelet thromboxane (Txa2) contributes to cardiac fibrosis cardiac muscle tissue UBERON:0001133 cardiac muscle cell CL:0000746 heart disease DOID:114 Y Y ECO:0000033 Pubmed:16395396 PENTACON COX1 produces TXA2 which has a contributing effect to cardiac fibrosis AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009263 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 mRNA was expressed in both normal and atherosclerotic sections but appeared to be induced in atherosclerotic tissue artery wall BTO:0002009 atherosclerosis DOID:1936 Atherosclerosis of artery SNOMEDCT:441574008 Y Y ECO:0000006 Pubmed:10952950 PENTACON From review: Pubmed:16395396; inducible AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009264 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 mRNA was expressed in both normal and atherosclerotic sections but appeared to be induced in atherosclerotic tissue artery wall UBERON:0000415 atherosclerosis DOID:1936 Atherosclerosis of artery SNOMEDCT:441574008 Y Y ECO:0000006 Pubmed:10952950 PENTACON From review: Pubmed:16395396; inducible AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009265 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/Involvement in disease COX-2 mRNA expression was not detected in 5 normal arterial sections that were obtained postmortem from young individuals who had no gross or microscopic evidence of atherosclerosis. However, all 10 samples analyzed from patients with atherosclerosis showed COX-2 mRNA expression atherosclerosis DOID:1936 Y Y ECO:0000006 Pubmed:10952950 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009266 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/Involvement in disease COX-2 mRNA expression was not detected in 5 normal arterial sections that were obtained postmortem from young individuals who had no gross or microscopic evidence of atherosclerosis. However, all 10 samples analyzed from patients with atherosclerosis showed COX-2 mRNA expression Atherosclerosis of artery SNOMEDCT:441574008 Y Y ECO:0000006 Pubmed:10952950 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009267 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/Involvement in disease Low to undetectable levels of COX2 are present in normal mucosa samples however a COX2 transcript is apparent in 12 of 14 colorectal carcinomas colon mucinous adenocarcinoma DOID:3029 Y Y ECO:0000006 Pubmed:7926468 PENTACON From review: PMID: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009268 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/Involvement in disease Low to undetectable levels of COX2 are present in normal mucosa samples however a COX2 transcript is apparent in 12 of 14 colorectal carcinomas colon mucinous adenocarcinoma DOID:3029 Y Y ECO:0000033 PMID: 20168319 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009269 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF Henles loop BTO:0004608 congestive heart failure DOID:6000 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009270 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF thick ascending limb of loop of Henle UBERON:0001291 congestive heart failure DOID:6000 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009271 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF macula densa BTO:0003940 congestive heart failure DOID:6000 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009272 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF macula densa UBERON:0002335 congestive heart failure DOID:6000 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009273 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity During the trial, the rofecoxib group showed increased blood pressure and higher incidence of congestive heart failure, pulmonary edema, and cardiac failure positive regulation of blood pressure GO:0045777 congestive heart failure DOID:6000 rofecoxib CHEBI:8887 Y Y ECO:0000006 Pubmed:15713943 PENTACON From review: Pubmed:18834304 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009274 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF Henles loop BTO:0004608 diabetes mellitus DOID:9351 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009275 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF thick ascending limb of loop of Henle UBERON:0001291 diabetes mellitus DOID:9351 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009276 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF macula densa BTO:0003940 diabetes mellitus DOID:9351 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009277 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity a minimal to marked COX-2 expression was observed in the macula densa and TAL of several subjects with a clinical history of diabetes, hypertension, or CHF macula densa UBERON:0002335 diabetes mellitus DOID:9351 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009278 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Celecoxib produced similar inhibitory effects on this index of monocyte COX-2 activity monocyte BTO:0000876 monocyte CL:0000576 Y Y ECO:0000006 Pubmed:9874808 PENTACON From review: Pubmed:17003913;From review: Pubmed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009279 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 activity in platelets causes platelet aggregation, vasoconstriction, and vascular proliferation platelet aggregation GO:0070527 blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000033 Pubmed:15470192 PENTACON From review: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009280 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 activity in platelets causes platelet aggregation, vasoconstriction, and vascular proliferation vasoconstriction GO:0042310 blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000033 Pubmed:15470192 PENTACON From review: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009281 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 and -2 were expressed at equal levels in kidney cortex, but COX-1 was more abundant than COX-2 in outer and inner medulla renal cortex BTO:0001166 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009282 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 and -2 were expressed at equal levels in kidney cortex, but COX-1 was more abundant than COX-2 in outer and inner medulla cortex of kidney UBERON:0001225 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009283 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-1 and -2 were expressed at equal levels in kidney cortex, but COX-1 was more abundant than COX-2 in outer and inner medulla renal cortex BTO:0001166 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009284 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-1 and -2 were expressed at equal levels in kidney cortex, but COX-1 was more abundant than COX-2 in outer and inner medulla cortex of kidney UBERON:0001225 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009285 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 and -2 were expressed at equal levels in kidney cortex, but COX-1 was more abundant than COX-2 in outer and inner medulla renal medulla BTO:0001167 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009286 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 and -2 were expressed at equal levels in kidney cortex, but COX-1 was more abundant than COX-2 in outer and inner medulla renal medulla UBERON:0000362 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009287 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-1 and -2 were expressed at equal levels in kidney cortex, but COX-1 was more abundant than COX-2 in outer and inner medulla renal medulla BTO:0001167 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009288 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-1 and -2 were expressed at equal levels in kidney cortex, but COX-1 was more abundant than COX-2 in outer and inner medulla renal medulla UBERON:0000362 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009289 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Expression of COX-1 was increased in monocytes ex vivo, most markedly in cells isolated from blood drawn 30 minutes after LPS injection monocyte BTO:0000876 monocyte CL:0000576 Y Y ECO:0000006 Pubmed:10811855 PENTACON From review: Pubmed:19095631; From review: Pubmed:21508345; inducible by LPS AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009290 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity extracts from cultured human umbilical vein endothelial cells challenged with 20 nM phorbol myristate acetate (PMA) showed an increase in COX-2 immunoreactivity related both to the increase in enzyme activity and the variations observed by Western blot analysis. Under these conditions, analysis of the same cell lysates with another immunometric assay specific for COX-1 revealed insignificant variation of this enzyme. HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 phorbol 13-acetate 12-myristate CHEBI:37537 Y Y ECO:0000006 Pubmed:7857975 PENTACON From review: PubMed:16395396; inducible by PMA AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009291 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity extracts from cultured human umbilical vein endothelial cells challenged with 20 nM phorbol myristate acetate (PMA) showed an increase in COX-2 immunoreactivity related both to the increase in enzyme activity and the variations observed by Western blot analysis. Under these conditions, analysis of the same cell lysates with another immunometric assay specific for COX-1 revealed insignificant variation of this enzyme. HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y ECO:0000006 Pubmed:7857975 PENTACON From review: PubMed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009292 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In situ detection of COX-2 mRNA in the endothelium of a human umbilical artery umbilical artery endothelium BTO:0000857 Y Y ECO:0000006 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009293 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In situ detection of COX-2 mRNA in the endothelium of a human umbilical artery umbilical artery endothelium UBERON:0007778 Y Y ECO:0000006 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009294 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity After 24 h of incubation in serum-free medium, the unstimulated HASMCs produced small amount of COX-2 mRNA. However, for HASMCs treated with 100 ng/ml of LPS, the amount of COX-2 mRNA first increased to a maximum after 2 h of treatment, then decreased gradually. This increase was markedly inhibited by 24 h preincubation with 10 µM Sal B aortic smooth muscle cell BTO:0004577 aortic smooth muscle cell CL:0002539 lipopolysaccharide CHEBI:16412 Y Y ECO:0000006 Pubmed:16440326 PENTACON From review: Pubmed:17003913; inducible by LPS AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009303 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity After exposure to cholesterol-deficient medium with or without LDL for 24 hours, LDL decreased COX-2 message in a dose-dependent manner. RT-PCR analysis determined that LDL had no effect on the expression of COX-1 and PGIS. HUVEC cell BTO:0001949 Y Y ECO:0000006 Pubmed:12067908 PENTACON From review: Pubmed:18834304 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009304 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity After exposure to cholesterol-deficient medium with or without LDL for 24 hours, LDL decreased COX-2 message in a dose-dependent manner. RT-PCR analysis determined that LDL had no effect on the expression of COX-1 and PGIS. HUVEC cell BTO:0001949 Y Y ECO:0000006 Pubmed:12067908 PENTACON From review: Pubmed:18834304 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009305 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Co-incubation with platelets for 20 h induced COX-2 in a dose-dependent manner. IL-1β (1 ng/ml) also induced COX-2. By comparison, COX-1 was detectable in untreated cells, and its expression did not change with platelet addition or IL-1β treatment HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y ECO:0000006 Pubmed:11483590 PENTACON From review: Pubmed:21508345; inducible by IL-beta and coincubation with platelets AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009310 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Co-incubation with platelets for 20 h induced COX-2 in a dose-dependent manner. IL-1β (1 ng/ml) also induced COX-2. By comparison, COX-1 was detectable in untreated cells, and its expression did not change with platelet addition or IL-1β treatment HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y ECO:0000006 Pubmed:11483590 PENTACON From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009311 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in platelets produces TxA2 which promotes platelet activation and aggregation UKNOWN GO:1901731 blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009312 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in platelets produces TxA2 which promotes platelet activation and aggregation UKNOWN GO:1901731 vasculature UBERON:0002049 platelet CL:0000233 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009313 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in platelets produces TxA2 which promotes platelet activation and aggregation positive regulation of platelet activation GO:0010572 blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009314 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in platelets produces TxA2 which promotes platelet activation and aggregation positive regulation of platelet activation GO:0010572 vasculature UBERON:0002049 platelet CL:0000233 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009315 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases oxidant stress and activates protein C, inhibiting the coagulation cascade negative regulation of blood coagulation GO:0030195 vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009316 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases oxidant stress and activates protein C, inhibiting the coagulation cascade negative regulation of blood coagulation GO:0030195 blood vessel endothelium UBERON:0004638 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009317 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases oxidant stress and activates protein C, inhibiting the coagulation cascade negative regulation of blood coagulation GO:0030195 vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009318 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases oxidant stress and activates protein C, inhibiting the coagulation cascade negative regulation of blood coagulation GO:0030195 blood vessel smooth muscle UBERON:0004237 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009319 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of vasoconstriction GO:0045906 vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009320 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of vasoconstriction GO:0045906 blood vessel endothelium UBERON:0004638 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009321 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet activation GO:0010544 vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009322 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet activation GO:0010544 blood vessel endothelium UBERON:0004638 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009323 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet aggregation GO:0090331 vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009324 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet aggregation GO:0090331 blood vessel endothelium UBERON:0004638 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009325 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of vasoconstriction GO:0045906 vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009326 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of vasoconstriction GO:0045906 blood vessel smooth muscle UBERON:0004237 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009327 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet activation GO:0010544 vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009328 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet activation GO:0010544 blood vessel smooth muscle UBERON:0004237 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009329 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet aggregation GO:0090331 vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009330 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-1 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet aggregation GO:0090331 blood vessel smooth muscle UBERON:0004237 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009331 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 mRNA was expressed in both normal and atherosclerotic sections but appeared to be induced in atherosclerotic tissue artery wall BTO:0002009 Y Y ECO:0000006 Pubmed:10952950 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009332 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX-1 mRNA was expressed in both normal and atherosclerotic sections but appeared to be induced in atherosclerotic tissue artery wall UBERON:0000415 Y Y ECO:0000006 Pubmed:10952950 PENTACON From review: Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009333 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in induced by shear stress in cultured HUVECs while Cox-1 levels remain unchanged HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y ECO:0000006 Pubmed:8816815 PENTACON From review: PubMed:16395396; inducible by shear stress AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009334 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Cox-2 in induced by shear stress in cultured HUVECs while Cox-1 levels remain unchanged HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y ECO:0000006 Pubmed:8816815 PENTACON From review: PubMed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009335 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases oxidant stress and activates protein C, inhibiting the coagulation cascade negative regulation of blood coagulation GO:0030195 vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009336 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases oxidant stress and activates protein C, inhibiting the coagulation cascade negative regulation of blood coagulation GO:0030195 blood vessel endothelium UBERON:0004638 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009337 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases oxidant stress and activates protein C, inhibiting the coagulation cascade negative regulation of blood coagulation GO:0030195 vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009338 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases oxidant stress and activates protein C, inhibiting the coagulation cascade negative regulation of blood coagulation GO:0030195 blood vessel smooth muscle UBERON:0004237 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009339 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of vasoconstriction GO:0045906 vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009340 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of vasoconstriction GO:0045906 blood vessel endothelium UBERON:0004638 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009341 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet activation GO:0010544 vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009342 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet activation GO:0010544 blood vessel endothelium UBERON:0004638 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009343 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet aggregation GO:0090331 vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009344 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet aggregation GO:0090331 blood vessel endothelium UBERON:0004638 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009345 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of vasoconstriction GO:0045906 vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009346 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of vasoconstriction GO:0045906 blood vessel smooth muscle UBERON:0004237 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009347 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet activation GO:0010544 vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009348 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet activation GO:0010544 blood vessel smooth muscle UBERON:0004237 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009349 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet aggregation GO:0090331 vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009350 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Cox-2 in the endothelium and smooth muscles cells produces PGI2 which decreases vascular tone and inhibits platelet activation and aggregation negative regulation of platelet aggregation GO:0090331 blood vessel smooth muscle UBERON:0004237 vascular associated smooth muscle cell CL:0000359 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009351 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-2 mRNA abundance was significantly higher in cortex and medulla from kidneys with arterial stenosis compared with control kidneys renal cortex BTO:0001166 Stricture of artery SNOMEDCT:68109007 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009352 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-2 mRNA abundance was significantly higher in cortex and medulla from kidneys with arterial stenosis compared with control kidneys cortex of kidney UBERON:0001225 Stricture of artery SNOMEDCT:68109007 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009353 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-2 mRNA abundance was significantly higher in cortex and medulla from kidneys with arterial stenosis compared with control kidneys renal cortex BTO:0001166 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009354 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-2 mRNA abundance was significantly higher in cortex and medulla from kidneys with arterial stenosis compared with control kidneys cortex of kidney UBERON:0001225 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009355 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-2 protein expression is induced in human mesangial cells by increasing percentage of collagen type I on collagen coated plates. mesangial cell BTO:0000853 mesangial cell CL:0000650 Y Y ECO:0000006 PubMed:21209362 PENTACON inducible:extracellular matrix composition/collagen type I AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009356 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-2 was readily detected ex vivo in neutrophils at both 90 and 180 minutes after injection neutrophil BTO:0000130 neutrophil CL:0000775 Y Y ECO:0000006 Pubmed:10811855 PENTACON From review: Pubmed:19095631; From review: Pubmed:21508345; inducible by LPS AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009357 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-2–dependent PGI2 was shown to afford protection against oxidant injury to cardiomyocytes in vivo. COX-2–dependent PGI2 formation appears to contribute to the atheroprotection afforded by estrogen and mediated via its ER-α receptor in vivo. COX-2 inhibition elevates blood pressure and augments the pressor response to dietary sodium. inhibition of COX-2 modulates vascular remodeling induced by hemodynamic stress. suppression of COX-2–dependent PGI2 formation, can both augment the response to thrombotic and hypertensive stimuli and initiate and accelerate atherogenesis. positive regulation of prostaglandin secretion GO:0032308 parenchyma BTO:0001539 cardiac muscle cell CL:0000746 Y Y ECO:0000033 Pubmed:16395396 PENTACON COX2 produces PGI2 which has a cardioprotective effect AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009358 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX-2–dependent PGI2 was shown to afford protection against oxidant injury to cardiomyocytes in vivo. COX-2–dependent PGI2 formation appears to contribute to the atheroprotection afforded by estrogen and mediated via its ER-α receptor in vivo. COX-2 inhibition elevates blood pressure and augments the pressor response to dietary sodium. inhibition of COX-2 modulates vascular remodeling induced by hemodynamic stress. suppression of COX-2–dependent PGI2 formation, can both augment the response to thrombotic and hypertensive stimuli and initiate and accelerate atherogenesis. positive regulation of prostaglandin secretion GO:0032308 cardiac muscle tissue UBERON:0001133 cardiac muscle cell CL:0000746 Y Y ECO:0000033 Pubmed:16395396 PENTACON COX2 produces PGI2 which has a cardioprotective effect AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009359 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX1 in the renal cortex produces TxA2 and PGF2alpha leading to increased vascular tone and blood pressure positive regulation of blood pressure GO:0045777 renal cortex BTO:0001166 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009360 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX1 in the renal cortex produces TxA2 and PGF2alpha leading to increased vascular tone and blood pressure positive regulation of blood pressure GO:0045777 cortex of kidney UBERON:0001225 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009361 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX1 in the renal cortex produces TxA2 and PGF2alpha leading to increased vascular tone and blood pressure vasoconstriction GO:0042310 renal cortex BTO:0001166 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009362 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX1 in the renal cortex produces TxA2 and PGF2alpha leading to increased vascular tone and blood pressure vasoconstriction GO:0042310 cortex of kidney UBERON:0001225 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009363 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX1 is present in all paired mucosa and carcinoma samples colorectal mucosa BTO:0002435 Y Y ECO:0000006 Pubmed:7926468 PENTACON From review: PMID: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009364 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX1 is present in all paired mucosa and carcinoma samples colorectal mucosa UBERON:0013067 Y Y ECO:0000006 Pubmed:7926468 PENTACON From review: PMID: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009365 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX1 is present in all paired mucosa and carcinoma samples colorectal mucosa BTO:0002435 Y Y ECO:0000033 PMID: 20168319 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009366 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity COX1 is present in all paired mucosa and carcinoma samples colorectal mucosa UBERON:0013067 Y Y ECO:0000033 PMID: 20168319 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009367 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 expression in HUVECs is induced by exposure to platelet microparticles HUVEC cell BTO:0001949 Y Y ECO:0000006 Pubmed:9151784 PENTACON From review: Pubmed:18834304 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009368 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal cortex produces PGI2 resulting in increased renin production and ultimately increased blood pressure and sodium retention positive regulation of blood pressure GO:0045777 renal cortex BTO:0001166 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009369 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal cortex produces PGI2 resulting in increased renin production and ultimately increased blood pressure and sodium retention positive regulation of blood pressure GO:0045777 cortex of kidney UBERON:0001225 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009370 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal cortex produces PGI2 resulting in increased renin production and ultimately increased blood pressure and sodium retention renin activity GO:0004195 renal cortex BTO:0001166 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009371 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal cortex produces PGI2 resulting in increased renin production and ultimately increased blood pressure and sodium retention renin activity GO:0004195 cortex of kidney UBERON:0001225 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009372 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal cortex produces PGI2 resulting in increased renin production and ultimately increased blood pressure and sodium retention renal system process involved in regulation of systemic arterial blood pressure GO:0003071 renal cortex BTO:0001166 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009373 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal cortex produces PGI2 resulting in increased renin production and ultimately increased blood pressure and sodium retention renal system process involved in regulation of systemic arterial blood pressure GO:0003071 cortex of kidney UBERON:0001225 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009374 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal cortex produces PGI2 resulting in increased renin production and ultimately increased blood pressure and sodium retention negative regulation of renal sodium excretion GO:0035814 renal cortex BTO:0001166 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009375 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal cortex produces PGI2 resulting in increased renin production and ultimately increased blood pressure and sodium retention negative regulation of renal sodium excretion GO:0035814 cortex of kidney UBERON:0001225 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009376 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention vasodilation GO:0042311 renal medulla BTO:0001167 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009377 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention vasodilation GO:0042311 renal medulla UBERON:0000362 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009378 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention positive regulation of natriuresis GO:0003079 renal medulla BTO:0001167 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009379 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention positive regulation of natriuresis GO:0003079 renal medulla UBERON:0000362 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009380 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention positive regulation of diuresis GO:0003103 renal medulla BTO:0001167 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009381 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention positive regulation of diuresis GO:0003103 renal medulla UBERON:0000362 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009382 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention negative regulation of blood pressure GO:0045776 renal medulla BTO:0001167 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009383 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention negative regulation of blood pressure GO:0045776 renal medulla UBERON:0000362 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009384 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention positive regulation of renal sodium excretion GO:0035815 renal medulla BTO:0001167 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009385 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity COX2 in the renal medulla produces PGE2 and PGI2 resulting in decreased vascular tone, increased MBF, natriuresis, diuresis and ultimately decreased blood pressure and sodium retention positive regulation of renal sodium excretion GO:0035815 renal medulla UBERON:0000362 Y Y ECO:0000033 Pubmed:16395396 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009386 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of COX-2 immunoreactive protein in adult kidney could be localized to endothelial and smooth muscle cells of arteries (interlobar artery), arterioles and veins and intraglomerularly in podocytes. These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. arterial endothelial cell BTO:0004758 interlobulary artery endothelial cell CL:1001216 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889; endothelial cell of artery in kidney AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009406 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of COX-2 immunoreactive protein in adult kidney could be localized to endothelial and smooth muscle cells of arteries (interlobar artery), arterioles and veins and intraglomerularly in podocytes. These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. podocyte BTO:0002295 glomerular visceral epithelial cell CL:0000653 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009407 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of COX-2 immunoreactive protein in adult kidney could be localized to endothelial and smooth muscle cells of arteries (interlobar artery), arterioles and veins and intraglomerularly in podocytes. These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. vascular endothelial cell BTO:0001854 endothelial cell of arteriole CL:1000412 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889;endothelial cell of arteriole in kidney AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009408 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of COX-2 immunoreactive protein in adult kidney could be localized to endothelial and smooth muscle cells of arteries (interlobar artery), arterioles and veins and intraglomerularly in podocytes. These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. vascular smooth muscle cell BTO:0004578 kidney artery smooth muscle cell CL:1001064 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009409 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of COX-2 immunoreactive protein in adult kidney could be localized to endothelial and smooth muscle cells of arteries (interlobar artery), arterioles and veins and intraglomerularly in podocytes. These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. vascular smooth muscle cell BTO:0004578 kidney venous system smooth muscle cell CL:1001068 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009410 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Expression of COX-2 immunoreactive protein in adult kidney could be localized to endothelial and smooth muscle cells of arteries (interlobar artery), arterioles and veins and intraglomerularly in podocytes. These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. venous endothelial cell BTO:0004759 vein endothelial cell CL:0002543 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009411 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity HASMCs expressed COX-1 mRNA and the amount was not affected by treatment with 100 ng/ml of LPS alone or by prior treatment for 24 h with 10 µM Sal B aortic smooth muscle cell BTO:0004577 aortic smooth muscle cell CL:0002539 Y Y ECO:0000006 Pubmed:16440326 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009412 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Ibuprofen, but not celecoxib, significantly inhibited TxA2-dependent platelet aggregation UKNOWN GO:1901731 blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000006 Pubmed:9874808 PENTACON From review: Pubmed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009413 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity IL-1 induced Cox2 expression, which was elevated modestly in the sPLA2-IID transfected cells compared to control cells, was further increased in cells co-expressinf sPLA2-IID and glypican HEK-293 cell BTO:0000007 Y Y ECO:0000006 Pubmed:11106649 PENTACON From review: Pubmed:22155285; induced by IL-1 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009414 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistochemistry of bone marrow sections showed that megakaryocytes express COX-1 (Fig. ​(Fig.1),1), which is consistent with the current notion that platelets express only COX-1. Quite unexpectedly, megakaryocytes stained positively also for COX-2 (Fig. ​(Fig.1),1), indicating that both COX isoforms are present in human megakaryocytes. megakaryocyte BTO:0000843 megakaryocyte CL:0000556 Y Y ECO:0000006 Pubmed:12032335 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009415 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistochemistry of bone marrow sections showed that megakaryocytes express COX-1 (Fig. ​(Fig.1),1), which is consistent with the current notion that platelets express only COX-1. Quite unexpectedly, megakaryocytes stained positively also for COX-2 (Fig. ​(Fig.1),1), indicating that both COX isoforms are present in human megakaryocytes. bone marrow UBERON:0002371 megakaryocyte CL:0000556 Y Y ECO:0000006 Pubmed:12032335 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009416 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Immunohistochemistry of bone marrow sections showed that megakaryocytes express COX-1 (Fig. ​(Fig.1),1), which is consistent with the current notion that platelets express only COX-1. Quite unexpectedly, megakaryocytes stained positively also for COX-2 (Fig. ​(Fig.1),1), indicating that both COX isoforms are present in human megakaryocytes. megakaryocyte BTO:0000843 megakaryocyte CL:0000556 Y Y ECO:0000006 Pubmed:12032335 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009417 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Immunohistochemistry of bone marrow sections showed that megakaryocytes express COX-1 (Fig. ​(Fig.1),1), which is consistent with the current notion that platelets express only COX-1. Quite unexpectedly, megakaryocytes stained positively also for COX-2 (Fig. ​(Fig.1),1), indicating that both COX isoforms are present in human megakaryocytes. bone marrow UBERON:0002371 megakaryocyte CL:0000556 Y Y ECO:0000006 Pubmed:12032335 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009418 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. cortical collecting duct BTO:0002643 kidney collecting duct cell CL:1001225 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009419 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. cortical collecting duct UBERON:0004203 kidney collecting duct cell CL:1001225 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009420 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. medullary collecting duct cell BTO:0004535 kidney collecting duct cell CL:1001225 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009421 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. renal cortex BTO:0001166 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889;The more specific ""renal cortex interstitium"" not available in BRENDA. AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009422 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. renal cortex interstitium UBERON:0005270 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889;The more specific ""renal cortex interstitium"" not available in BRENDA. AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009423 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. renal medulla BTO:0001167 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889;The more specific ""renal medulla interstitium"" not available in BRENDA. AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009424 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. renal medulla interstitium UBERON:0005211 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889;The more specific ""renal medulla interstitium"" not available in BRENDA. AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009425 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. vascular endothelial cell BTO:0001854 kidney afferent arteriole endothelial cell CL:1001096 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009426 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. vascular smooth muscle cell BTO:0004578 kidney artery smooth muscle cell CL:1001064 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009427 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. vascular smooth muscle cell BTO:0004578 kidney venous system smooth muscle cell CL:1001068 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009428 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistology of adult kidney showed expression of COX-1 in collecting duct cells (increasing from cortex to renal medulla), cortical and medullary interstitial cells (including tissue macrophages), endothelial cells, and smooth muscle cells of pre- and postglomerular vessels (including the vasa recta). These data were confirmed by in situ mRNA analysis using digoxigenin-labeled riboprobes. vasa recta UBERON:0004726 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009429 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Immunoprecipitation of COX-2 was not altered in monocytes monocyte BTO:0000876 monocyte CL:0000576 Y Y ECO:0000006 Pubmed:10811855 PENTACON From review: Pubmed:19095631; From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009430 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In adult kidney, COX-1 immunoreactivity was associated with endothelial cells of arteries, with mesangial cells at the glomerular hilum and with cortical interstitial cells (Figure 2, c, e, and g). COX-1 immunoreactivity was detected in collecting duct principal cells in cortex and medulla collecting duct BTO:0000761 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009431 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In adult kidney, COX-1 immunoreactivity was associated with endothelial cells of arteries, with mesangial cells at the glomerular hilum and with cortical interstitial cells (Figure 2, c, e, and g). COX-1 immunoreactivity was detected in collecting duct principal cells in cortex and medulla collecting duct of renal tubule UBERON:0001232 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009432 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In adult kidney, COX-1 immunoreactivity was associated with endothelial cells of arteries, with mesangial cells at the glomerular hilum and with cortical interstitial cells (Figure 2, c, e, and g). COX-1 immunoreactivity was detected in collecting duct principal cells in cortex and medulla mesangial cell BTO:0000853 glomerular mesangial cell CL:1000742 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009433 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In adult kidney, COX-1 immunoreactivity was associated with endothelial cells of arteries, with mesangial cells at the glomerular hilum and with cortical interstitial cells (Figure 2, c, e, and g). COX-1 immunoreactivity was detected in collecting duct principal cells in cortex and medulla hilum of kidney UBERON:0008716 glomerular mesangial cell CL:1000742 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009434 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In adult kidney, COX-2 immunoreactivity was associated with preglomerular, glomerular, and postglomerular vessels (Figure 2, a, b, d, f, and j, k). Preglomerular vessels of all calibers from arteries to arterioles were labeled in the smooth muscle cell layer (Figure 2, b, d, and k; Figures 4A and 5B). In glomeruli, labeling was observed in parietal epithelial cells (Figure 2b) and in few intraglomerular cells, probably podocytes (Figure 4A) (8). In the postglomerular vasculature, labeling was associated with outer medullary vasa recta, as seen in the compound picture of a longitudinal section and in cross sections of outer medulla renal glomerulus BTO:0000530 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009435 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In adult kidney, COX-2 immunoreactivity was associated with preglomerular, glomerular, and postglomerular vessels (Figure 2, a, b, d, f, and j, k). Preglomerular vessels of all calibers from arteries to arterioles were labeled in the smooth muscle cell layer (Figure 2, b, d, and k; Figures 4A and 5B). In glomeruli, labeling was observed in parietal epithelial cells (Figure 2b) and in few intraglomerular cells, probably podocytes (Figure 4A) (8). In the postglomerular vasculature, labeling was associated with outer medullary vasa recta, as seen in the compound picture of a longitudinal section and in cross sections of outer medulla renal glomerulus UBERON:0000074 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009436 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In control kidneys, minimal to mild COX-2 expression was observed in the glomerular podocytes, in small blood vessels (smooth muscle cells and endothelial cells) and in a small number of interstitial cells within the tip of the papilla. No COX-2 protein or mRNA was observed in the macula densa or thick ascending limb of the loop of Henle (TAL). renal artery BTO:0001165 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009437 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In control kidneys, minimal to mild COX-2 expression was observed in the glomerular podocytes, in small blood vessels (smooth muscle cells and endothelial cells) and in a small number of interstitial cells within the tip of the papilla. No COX-2 protein or mRNA was observed in the macula densa or thick ascending limb of the loop of Henle (TAL). kidney blood vessel UBERON:0003517 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009438 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In control kidneys, minimal to mild COX-2 expression was observed in the glomerular podocytes, in small blood vessels (smooth muscle cells and endothelial cells) and in a small number of interstitial cells within the tip of the papilla. No COX-2 protein or mRNA was observed in the macula densa or thick ascending limb of the loop of Henle (TAL). renal glomerulus BTO:0000530 glomerular visceral epithelial cell CL:0000653 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009439 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In control kidneys, minimal to mild COX-2 expression was observed in the glomerular podocytes, in small blood vessels (smooth muscle cells and endothelial cells) and in a small number of interstitial cells within the tip of the papilla. No COX-2 protein or mRNA was observed in the macula densa or thick ascending limb of the loop of Henle (TAL). renal glomerulus UBERON:0000074 glomerular visceral epithelial cell CL:0000653 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009440 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In control kidneys, minimal to mild COX-2 expression was observed in the glomerular podocytes, in small blood vessels (smooth muscle cells and endothelial cells) and in a small number of interstitial cells within the tip of the papilla. No COX-2 protein or mRNA was observed in the macula densa or thick ascending limb of the loop of Henle (TAL). renal papilla BTO:0003925 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009441 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In control kidneys, minimal to mild COX-2 expression was observed in the glomerular podocytes, in small blood vessels (smooth muscle cells and endothelial cells) and in a small number of interstitial cells within the tip of the papilla. No COX-2 protein or mRNA was observed in the macula densa or thick ascending limb of the loop of Henle (TAL). renal papilla UBERON:0001228 Y Y ECO:0000006 Pubmed:11499548 PENTACON From review: Pubmed:17361113; From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009442 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In cultured human endothelial cells cyclooxygenase-2 is up-regulated by steady laminar shear stress (LSS) HUVEC cell BTO:0001949 endothelial cell of umbilical vein CL:0002618 Y Y ECO:0000006 PubMed:8816815 PENTACON From review: PubMed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009443 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Interstitial cells also have faint COX-1 positivity. Immunoreactive protein was also detected in endothelial cells and smooth muscles cells of arteries, arterioles, and veins. arterial endothelial cell BTO:0004758 fetus BTO:0000449 endothelial cell of artery CL:1000413 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009444 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Interstitial cells also have faint COX-1 positivity. Immunoreactive protein was also detected in endothelial cells and smooth muscles cells of arteries, arterioles, and veins. cortical collecting duct BTO:0002643 fetus BTO:0000449 kidney collecting duct cell CL:1001225 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009445 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Interstitial cells also have faint COX-1 positivity. Immunoreactive protein was also detected in endothelial cells and smooth muscles cells of arteries, arterioles, and veins. cortical collecting duct UBERON:0004203 fetus BTO:0000449 kidney collecting duct cell CL:1001225 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009446 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Interstitial cells also have faint COX-1 positivity. Immunoreactive protein was also detected in endothelial cells and smooth muscles cells of arteries, arterioles, and veins. medullary collecting duct cell BTO:0004535 fetus BTO:0000449 kidney collecting duct cell CL:1001225 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009447 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Interstitial cells also have faint COX-1 positivity. Immunoreactive protein was also detected in endothelial cells and smooth muscles cells of arteries, arterioles, and veins. podocyte BTO:0002295 fetus BTO:0000449 glomerular visceral epithelial cell CL:0000653 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009448 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Interstitial cells also have faint COX-1 positivity. Immunoreactive protein was also detected in endothelial cells and smooth muscles cells of arteries, arterioles, and veins. vascular endothelial cell BTO:0001854 fetus BTO:0000449 endothelial cell of arteriole CL:1000412 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009449 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Interstitial cells also have faint COX-1 positivity. Immunoreactive protein was also detected in endothelial cells and smooth muscles cells of arteries, arterioles, and veins. vascular smooth muscle cell BTO:0004578 fetus BTO:0000449 kidney artery smooth muscle cell CL:1001064 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009450 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Interstitial cells also have faint COX-1 positivity. Immunoreactive protein was also detected in endothelial cells and smooth muscles cells of arteries, arterioles, and veins. vascular smooth muscle cell BTO:0004578 fetus BTO:0000449 kidney venous system smooth muscle cell CL:1001068 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009451 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-1 was primarily expressed in podocytes and collecting duct cells. Expression levels of COX-1 in both cell types increased markedly from subcapsular to juxtamedullary cortex. Interstitial cells also have faint COX-1 positivity. Immunoreactive protein was also detected in endothelial cells and smooth muscles cells of arteries, arterioles, and veins. venous endothelial cell BTO:0004759 fetus BTO:0000449 vein endothelial cell CL:0002543 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009452 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-2 was found primarily in endothelial and smooth muscle cells of arteries and veins. Glomerular expression was detectable in juxtamedullary glomeruli. arterial endothelial cell BTO:0004758 fetus BTO:0000449 endothelial cell of artery CL:1000413 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009453 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-2 was found primarily in endothelial and smooth muscle cells of arteries and veins. Glomerular expression was detectable in juxtamedullary glomeruli. renal glomerulus BTO:0000530 fetus BTO:0000449 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889;juxtamedullary glomeruli AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009454 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-2 was found primarily in endothelial and smooth muscle cells of arteries and veins. Glomerular expression was detectable in juxtamedullary glomeruli. renal glomerulus UBERON:0000074 fetus BTO:0000449 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889;juxtamedullary glomeruli AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009455 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-2 was found primarily in endothelial and smooth muscle cells of arteries and veins. Glomerular expression was detectable in juxtamedullary glomeruli. vascular smooth muscle cell BTO:0004578 fetus BTO:0000449 kidney artery smooth muscle cell CL:1001064 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009456 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-2 was found primarily in endothelial and smooth muscle cells of arteries and veins. Glomerular expression was detectable in juxtamedullary glomeruli. vascular smooth muscle cell BTO:0004578 fetus BTO:0000449 kidney venous system smooth muscle cell CL:1001068 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009457 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In fetal kidney, COX-2 was found primarily in endothelial and smooth muscle cells of arteries and veins. Glomerular expression was detectable in juxtamedullary glomeruli. venous endothelial cell BTO:0004759 fetus BTO:0000449 vein endothelial cell CL:0002543 Y Y ECO:0000006 PubMed:9140046 PENTACON From primary source: PubMed:12093889 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009458 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In two human fetal kidneys (gestational weeks 29 and 30), COX-2 immunoreactivity was associated with the parietal epithelial cells of Bowman's capsule and with endothelium and vascular smooth muscle glomerular epithelium BTO:0001515 fetus BTO:0000449 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009459 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In two human fetal kidneys (gestational weeks 29 and 30), COX-2 immunoreactivity was associated with the parietal epithelial cells of Bowman's capsule and with endothelium and vascular smooth muscle glomerular parietal epithelium UBERON:0005750 fetus BTO:0000449 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009460 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Incubation of the whole blood from subjects receiving COX-2 inhibitor nimesulide with LPS ex vivo resulted in a marked suppression of LPS-induced PGE2 generation blood BTO:0000089 nimesulide CHEBI:44445 Y Y ECO:0000006 PubMed:9808683 PENTACON From review: PubMed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009461 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Incubation of the whole blood from subjects receiving COX-2 inhibitor nimesulide with LPS ex vivo resulted in a marked suppression of LPS-induced PGE2 generation blood UBERON:0000178 nimesulide CHEBI:44445 Y Y ECO:0000006 PubMed:9808683 PENTACON From review: PubMed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009462 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells central nervous system BTO:0000227 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009463 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells central nervous system UBERON:0001017 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009464 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells chondrocyte BTO:0000249 chondrocyte CL:0000138 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by inflammatory and mitogenic stimuli AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009465 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells fetal membrane BTO:0000473 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by hormones AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009466 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells fetal membrane UBERON:0005630 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by hormones AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009467 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells fibroblast BTO:0000452 fibroblast CL:0000057 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by inflammatory and mitogenic stimuli AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009468 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells kidney BTO:0000671 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009469 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells kidney UBERON:0002113 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009470 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells macrophage BTO:0000801 macrophage CL:0000235 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by inflammatory and mitogenic stimuli AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009471 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells monocyte BTO:0000876 monocyte CL:0000576 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by inflammatory and mitogenic stimuli AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009472 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells ovary BTO:0000975 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by hormones AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009473 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells female gonad UBERON:0000992 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by hormones AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009474 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells synovial cell BTO:0003652 synovial cell CL:0000214 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by inflammatory and mitogenic stimuli AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009475 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells testis BTO:0001363 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009476 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells testis UBERON:0000473 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009477 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells tracheal epithelium BTO:0001389 epithelial cell CL:0000066 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009478 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells epithelium of trachea UBERON:0001901 epithelial cell CL:0000066 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009479 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Induced by inflammatory and mitogenic stimuli in monocytes/macrophages, synoviocytes, chondrocytes, and fibroblasts; induced by laminar shear stress and platelet microparticles in vascular endothelial cells; induced by hormones in the ovaries and fetal membranes; constitutive in the CNS, kidney, testes, tracheal epithelial cells vascular endothelial cell BTO:0001854 blood vessel endothelial cell CL:0000071 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631; inducible by laminar shear stress and platelet microparticles AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009480 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity inhibition of baseline and furosemide stimulated renin release by a specific COX-2 inhibitor in healthy volunteers with normal salt intake regulation of renin secretion into blood stream GO:1900133 kidney BTO:0000671 celecoxib CHEBI:41423 Y Y ECO:0000006 Pubmed:16221219 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009481 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity inhibition of baseline and furosemide stimulated renin release by a specific COX-2 inhibitor in healthy volunteers with normal salt intake regulation of renin secretion into blood stream GO:1900133 kidney UBERON:0002113 celecoxib CHEBI:41423 Y Y ECO:0000006 Pubmed:16221219 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009482 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity inhibition of baseline and furosemide stimulated renin release by a specific COX-2 inhibitor in healthy volunteers with normal salt intake regulation of aldosterone secretion GO:2000858 kidney BTO:0000671 celecoxib CHEBI:41423 Y Y ECO:0000006 Pubmed:16221219 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009483 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity inhibition of baseline and furosemide stimulated renin release by a specific COX-2 inhibitor in healthy volunteers with normal salt intake regulation of aldosterone secretion GO:2000858 kidney UBERON:0002113 celecoxib CHEBI:41423 Y Y ECO:0000006 Pubmed:16221219 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009484 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Inhibition of Cox1 activity in platelets and Cox2 activity in monocytes in response to various NSAIDs blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000006 Pubmed:18992652 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009485 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Inhibition of Cox1 activity in platelets and Cox2 activity in monocytes in response to various NSAIDs monocyte BTO:0000876 monocyte CL:0000576 Y Y ECO:0000006 Pubmed:18992652 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009486 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Inhibition of Cox1 and Cox2 is associated with a transient but significant decline in urinary sodium excretion. The glomerular filtration rate (GFR) was decreased by indomethacin (Cox1 inhibition) but was not changed significantly by MK-966 (Cox2 inhibition) treatment. Thromboxane biosynthesis by platelets was inhibited by indomethacin only. blood platelet BTO:0000132 platelet CL:0000233 indometacin CHEBI:49662 Y Y ECO:0000006 Pubmed:10215647 PENTACON From review: Pubmed:17003913;From review: Pubmed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009487 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Inhibition of Cox1 and Cox2 is associated with a transient but significant decline in urinary sodium excretion. The glomerular filtration rate (GFR) was decreased by indomethacin (Cox1 inhibition) but was not changed significantly by MK-966 (Cox2 inhibition) treatment. Thromboxane biosynthesis by platelets was inhibited by indomethacin only. positive regulation of renal sodium excretion GO:0035815 kidney BTO:0000671 indometacin CHEBI:49662 Y Y ECO:0000006 Pubmed:10215647 PENTACON From review: Pubmed:17003913;From review: Pubmed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009488 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Inhibition of Cox1 and Cox2 is associated with a transient but significant decline in urinary sodium excretion. The glomerular filtration rate (GFR) was decreased by indomethacin (Cox1 inhibition) but was not changed significantly by MK-966 (Cox2 inhibition) treatment. Thromboxane biosynthesis by platelets was inhibited by indomethacin only. positive regulation of renal sodium excretion GO:0035815 kidney UBERON:0002113 indometacin CHEBI:49662 Y Y ECO:0000006 Pubmed:10215647 PENTACON From review: Pubmed:17003913;From review: Pubmed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009489 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Inhibition of Cox1 and Cox2 is associated with a transient but significant decline in urinary sodium excretion. The glomerular filtration rate (GFR) was decreased by indomethacin (Cox1 inhibition) but was not changed significantly by MK-966 (Cox2 inhibition) treatment. Thromboxane biosynthesis by platelets was inhibited by indomethacin only. positive regulation of renal sodium excretion GO:0035815 kidney BTO:0000671 indometacin CHEBI:49662 Y Y ECO:0000006 Pubmed:10215647 PENTACON From review: Pubmed:17003913;From review: Pubmed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009490 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Inhibition of Cox1 and Cox2 is associated with a transient but significant decline in urinary sodium excretion. The glomerular filtration rate (GFR) was decreased by indomethacin (Cox1 inhibition) but was not changed significantly by MK-966 (Cox2 inhibition) treatment. Thromboxane biosynthesis by platelets was inhibited by indomethacin only. positive regulation of renal sodium excretion GO:0035815 kidney UBERON:0002113 indometacin CHEBI:49662 Y Y ECO:0000006 Pubmed:10215647 PENTACON From review: Pubmed:17003913;From review: Pubmed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009491 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Inhibition of Cox1 and Cox2 is associated with a transient but significant decline in urinary sodium excretion. The glomerular filtration rate (GFR) was decreased by indomethacin (Cox1 inhibition) but was not changed significantly by MK-966 (Cox2 inhibition) treatment. Thromboxane biosynthesis by platelets was inhibited by indomethacin only. positive regulation of renal sodium excretion GO:0035815 kidney BTO:0000671 rofecoxib CHEBI:8887 Y Y ECO:0000006 Pubmed:10215647 PENTACON From review: Pubmed:17003913;From review: Pubmed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009492 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Inhibition of Cox1 and Cox2 is associated with a transient but significant decline in urinary sodium excretion. The glomerular filtration rate (GFR) was decreased by indomethacin (Cox1 inhibition) but was not changed significantly by MK-966 (Cox2 inhibition) treatment. Thromboxane biosynthesis by platelets was inhibited by indomethacin only. positive regulation of renal sodium excretion GO:0035815 kidney UBERON:0002113 rofecoxib CHEBI:8887 Y Y ECO:0000006 Pubmed:10215647 PENTACON From review: Pubmed:17003913;From review: Pubmed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009493 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Interleukin-18 enhances COX-2 enzyme activity in human mesangial cells. mesangial cell BTO:0000853 mesangial cell CL:0000650 Y Y ECO:0000006 PubMed:22433003 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009494 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Low to undetectable levels of COX2 are present in normal mucosa samples however a COX2 transcript is apparent in 12 of 14 colorectal carcinomas colonic mucosa BTO:0000271 Y Y ECO:0000006 Pubmed:7926468 PENTACON From review: PMID: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009495 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Low to undetectable levels of COX2 are present in normal mucosa samples however a COX2 transcript is apparent in 12 of 14 colorectal carcinomas colonic mucosa UBERON:0000317 Y Y ECO:0000006 Pubmed:7926468 PENTACON From review: PMID: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009496 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Most tissues, but particularly platelets, stomach, and kidney blood platelet BTO:0000132 platelet CL:0000233 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009497 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Most tissues, but particularly platelets, stomach, and kidney kidney BTO:0000671 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009498 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Most tissues, but particularly platelets, stomach, and kidney kidney UBERON:0002113 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009499 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Most tissues, but particularly platelets, stomach, and kidney stomach BTO:0001307 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009500 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Most tissues, but particularly platelets, stomach, and kidney stomach UBERON:0000945 Y Y ECO:0000033 Pubmed:11157642 PENTACON From review: Pubmed:19095631 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009501 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/Involvement in disease PGF2alpha increased matrix metalloproteinase 1 (MMP-1) secretion by cultured human uterine cervical fibroblast cells. (This evidence is related to PTGS2 through PubMed:18703136, which showed that PGF2alpha upregulated COX-2 expression and led to more PGF2alpha production). uterine cervix UBERON:0000002 fibroblast BTO:0000452 Fibrosis SNOMEDCT:112674009 Y Y ECO:0000006 PubMed:12087084 PENTACON From primary source: PubMed:19376970; From review: PubMed:20059330;Evidence for Heart - fibroblasts Review Fig. 2; Evidence for fibrosis in conjunction with PubMed:18703136 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009502 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Prostaglandin I2 had previously been shown to be the predominant cyclooxygenase product in endothelium, inhibiting platelet aggregation, causing vasodilatation, and preventing the proliferation of vascular smooth-muscle cells in vitro. However, it was assumed that prostaglandin I2 was derived mainly from COX-1, the only cyclooxygenase species expressed constitutively in endothelial cells. This assumption later proved incorrect, since studies in mice and humans showed that COX-2 was the dominant source vasodilation GO:0042311 endothelial cell BTO:0001176 endothelial cell CL:0000115 Y Y ECO:0000033 Pubmed:15470192 PENTACON From review: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009503 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Prostaglandin I2 had previously been shown to be the predominant cyclooxygenase product in endothelium, inhibiting platelet aggregation, causing vasodilatation, and preventing the proliferation of vascular smooth-muscle cells in vitro. However, it was assumed that prostaglandin I2 was derived mainly from COX-1, the only cyclooxygenase species expressed constitutively in endothelial cells. This assumption later proved incorrect, since studies in mice and humans showed that COX-2 was the dominant source negative regulation of platelet aggregation GO:0090331 endothelial cell BTO:0001176 endothelial cell CL:0000115 Y Y ECO:0000033 Pubmed:15470192 PENTACON From review: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009504 Rose Q96P68 27199 OXGR1 Homo sapiens 9606 Comment/function Receptor for alpha-ketoglutarate. Seems to act exclusively through a G(q)-mediated pathway (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP, ASD 9/18/2013 100 3300009505 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Serum TXB2 was markedly suppressed in whole blood from subjects receiving aspirin but not nimesulide blood BTO:0000089 acetylsalicylic acid CHEBI:15365 Y Y ECO:0000006 PubMed:9808683 PENTACON From review: PubMed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009506 Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Serum TXB2 was markedly suppressed in whole blood from subjects receiving aspirin but not nimesulide blood UBERON:0000178 acetylsalicylic acid CHEBI:15365 Y Y ECO:0000006 PubMed:9808683 PENTACON From review: PubMed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009507 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Sphingosine 1-phosphate treatment for 2 h induced COX-2 protein levels in human primary mesangial cells in a concentration dependent manner. mesangial cell BTO:0000853 mesangial cell CL:0000650 Y Y ECO:0000006 PubMed:24064301 PENTACON inducible:sphingosine 1-phosphate;COX-1 found in rat mesangial cells AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009508 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity The accelerated thrombotic response to pharmacological perturbation of PGI2 produced by PTGS2 in vascular smooth muscle is explicable by its actions on the coagulation system (induction of thrombomodulin negatively regulating thrombosis). coronary artery smooth muscle cell BTO:0005101 smooth muscle cell of the coronary artery CL:0002592 Thrombosis of blood vessel SNOMEDCT:439129009 Y Y ECO:0000033 PubMed:20059330 PENTACON FC: Tilo said that the negative regulation of thrombosis has a protective effect against adverse cardiovascular events.<--JR: I believe this is consistent with the figure, see comment below FC: No DOID term. AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009509 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity The PHS2 message levels in cells stimulated with IL-1, PMA, or LPS showed significant increases, relative to control cells, after a 4-h incubation. Cells stimulated with TNF required 12 h of incubation before PHS I1 message induction was observed HUVEC cell BTO:0001949 lipopolysaccharide CHEBI:16412 Y Y ECO:0000006 Pubmed:8473346 PENTACON Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009510 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity The PHS2 message levels in cells stimulated with IL-1, PMA, or LPS showed significant increases, relative to control cells, after a 4-h incubation. Cells stimulated with TNF required 12 h of incubation before PHS I1 message induction was observed HUVEC cell BTO:0001949 interleukins CHEBI:52998 Y Y ECO:0000006 Pubmed:8473346 PENTACON Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009511 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity The PHS2 message levels in cells stimulated with IL-1, PMA, or LPS showed significant increases, relative to control cells, after a 4-h incubation. Cells stimulated with TNF required 12 h of incubation before PHS I1 message induction was observed HUVEC cell BTO:0001949 phorbol 13-acetate 12-myristate CHEBI:37537 Y Y ECO:0000006 Pubmed:8473346 PENTACON Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009512 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Vascular expression of both COX isoforms was examined by Western blot tests of proteins isolated from human renal artery renal artery BTO:0001165 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009513 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Vascular expression of both COX isoforms was examined by Western blot tests of proteins isolated from human renal artery renal artery UBERON:0001184 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009514 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Vascular expression of both COX isoforms was examined by Western blot tests of proteins isolated from human renal artery renal artery BTO:0001165 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009515 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Vascular expression of both COX isoforms was examined by Western blot tests of proteins isolated from human renal artery renal artery UBERON:0001184 Y Y ECO:0000006 Pubmed:15100359 PENTACON From review: Pubmed:17003913 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009516 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity VEGF and bFGF up-regulated COX-1 and COX-2 expression at 4 hours in HMECs HMEpC cell BTO:0002178 luminal epithelial cell of mammary gland CL:0002326 Y Y ECO:0000006 Pubmed:12791666 PENTACON From review: 20168319 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009517 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity VEGF and bFGF up-regulated COX-1 and COX-2 expression at 4 hours in HMECs HMEpC cell BTO:0002178 luminal epithelial cell of mammary gland CL:0002326 Y Y ECO:0000006 Pubmed:12791666 PENTACON From review: 20168319; inducible by VEGF and bFGF AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009518 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity We isolated a full length PHS I1 cDNA by using the PHSII890 insert as a probe to screen a Xgtll library from human umbilical vein endothelial cells HUVEC cell BTO:0001949 Y Y ECO:0000006 Pubmed:8473346 PENTACON Pubmed:16395396 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009520 Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Western blot analysis showed that static HUVECs expressed COX-1, PGIS, TXS, PGFS, L-PGDS, cPGES, and mPGES-2 but not mPGES-1 and H-PGDS. A low expression of COX-2 was detected. In HUVECs subjected to steady LSS COX-2 was significantly induced HUVEC cell BTO:0001949 Y Y ECO:0000006 Pubmed:19122175 PENTACON From review: Pubmed:21508345 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009521 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Western blot analysis showed that static HUVECs expressed COX-1, PGIS, TXS, PGFS, L-PGDS, cPGES, and mPGES-2 but not mPGES-1 and H-PGDS. A low expression of COX-2 was detected. In HUVECs subjected to steady LSS COX-2 was significantly induced HUVEC cell BTO:0001949 Y Y ECO:0000006 Pubmed:19122175 PENTACON From review: Pubmed:21508345; induced by laminar shear stress AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009522 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Western blot analysis showed that static HUVECs expressed COX-1, PGIS, TXS, PGFS, L-PGDS, cPGES, and mPGES-2 but not mPGES-1 and H-PGDS. A low expression of COX-2 was detected. In HUVECs subjected to steady LSS COX-2 was significantly induced HUVEC cell BTO:0001949 Y Y ECO:0000006 Pubmed:19122175 PENTACON From review: Pubmed:21508345; AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009523 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity This study shows that COX-2 inhibitors have the potential to cause renal impairment in patients who rely on prostaglandins to counterbalance endogenous vasoconstrictors and maintain renal function kidney BTO:0000671 kidney failure DOID:1074 Renal failure SNOMEDCT:198524000 Y Y ECO:0000006 PubMed:11448662 PENTACON From review: PubMed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009524 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity This study shows that COX-2 inhibitors have the potential to cause renal impairment in patients who rely on prostaglandins to counterbalance endogenous vasoconstrictors and maintain renal function kidney UBERON:0002113 kidney failure DOID:1074 Renal failure SNOMEDCT:198524000 Y Y ECO:0000006 PubMed:11448662 PENTACON From review: PubMed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009525 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Studies of renal COX physiology have established that inhibition of COX-2 plays the major role in the blood pressure increase observed in patients on NSAIDS negative regulation of blood pressure GO:0045776 kidney BTO:0000671 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009526 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Studies of renal COX physiology have established that inhibition of COX-2 plays the major role in the blood pressure increase observed in patients on NSAIDS negative regulation of blood pressure GO:0045776 kidney UBERON:0002113 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009527 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Polymorphisms in COX-2, PGI synthase, and the IP have variously been associated with hypertension and adverse cardiovascular outcome after angioplasty positive regulation of blood pressure GO:0045777 vasculature BTO:0003718 Angioplasty of blood vessel SNOMEDCT:418285008 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009528 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Polymorphisms in COX-2, PGI synthase, and the IP have variously been associated with hypertension and adverse cardiovascular outcome after angioplasty positive regulation of blood pressure GO:0045777 vasculature UBERON:0002049 Angioplasty of blood vessel SNOMEDCT:418285008 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009529 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Polymorphisms in COX-2, PGI synthase, and the IP have variously been associated with hypertension and adverse cardiovascular outcome after angioplasty positive regulation of blood pressure GO:0045777 vasculature BTO:0003718 Angioplasty of blood vessel SNOMEDCT:418285008 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009530 Faith Q16647 5740 PTGIS Homo sapiens 9606 Comment/tissue specificity Polymorphisms in COX-2, PGI synthase, and the IP have variously been associated with hypertension and adverse cardiovascular outcome after angioplasty positive regulation of blood pressure GO:0045777 vasculature UBERON:0002049 Angioplasty of blood vessel SNOMEDCT:418285008 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009531 Faith P43119 5739 PTGIR Homo sapiens 9606 Comment/tissue specificity Polymorphisms in COX-2, PGI synthase, and the IP have variously been associated with hypertension and adverse cardiovascular outcome after angioplasty positive regulation of blood pressure GO:0045777 vasculature BTO:0003718 Angioplasty of blood vessel SNOMEDCT:418285008 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, ASD 4/21/2014 3 3300009532 Faith P43119 5739 PTGIR Homo sapiens 9606 Comment/tissue specificity Polymorphisms in COX-2, PGI synthase, and the IP have variously been associated with hypertension and adverse cardiovascular outcome after angioplasty positive regulation of blood pressure GO:0045777 vasculature UBERON:0002049 Angioplasty of blood vessel SNOMEDCT:418285008 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, ASD 4/21/2014 3 3300009533 Faith P43119 5739 PTGIR Homo sapiens 9606 Comment/tissue specificity Prostacyclin receptor variant (R212C) is defective in adenylyl cyclase activation in both patient blood and in an in vitro COS-1 overexpression system. This promotes increased platelet aggregation, a hallmark of atherothrombosis. Our analysis of patients in 3 separate white cohorts reveals that this dysfunctional receptor is not likely an initiating factor in cardiovascular disease but that it accelerates the course of disease in those patients with the greatest risk factors. activation of adenylate cyclase activity GO:0007190 blood BTO:0000089 Y Y ECO:0000006 PubMed:18323528 PENTACON From review: PubMed:20059330 AAP, ASD 4/21/2014 3 3300009534 Faith P43119 5739 PTGIR Homo sapiens 9606 Comment/tissue specificity Prostacyclin receptor variant (R212C) is defective in adenylyl cyclase activation in both patient blood and in an in vitro COS-1 overexpression system. This promotes increased platelet aggregation, a hallmark of atherothrombosis. Our analysis of patients in 3 separate white cohorts reveals that this dysfunctional receptor is not likely an initiating factor in cardiovascular disease but that it accelerates the course of disease in those patients with the greatest risk factors. activation of adenylate cyclase activity GO:0007190 blood UBERON:0000178 Y Y ECO:0000006 PubMed:18323528 PENTACON From review: PubMed:20059330 AAP, ASD 4/21/2014 3 3300009535 Faith P43119 5739 PTGIR Homo sapiens 9606 Comment/tissue specificity Prostacyclin receptor variant (R212C) is defective in adenylyl cyclase activation in both patient blood and in an in vitro COS-1 overexpression system. This promotes increased platelet aggregation, a hallmark of atherothrombosis. Our analysis of patients in 3 separate white cohorts reveals that this dysfunctional receptor is not likely an initiating factor in cardiovascular disease but that it accelerates the course of disease in those patients with the greatest risk factors. negative regulation of platelet aggregation GO:0090331 blood BTO:0000089 Y Y ECO:0000006 PubMed:18323528 PENTACON From review: PubMed:20059330 AAP, ASD 4/21/2014 3 3300009536 Faith P43119 5739 PTGIR Homo sapiens 9606 Comment/tissue specificity Prostacyclin receptor variant (R212C) is defective in adenylyl cyclase activation in both patient blood and in an in vitro COS-1 overexpression system. This promotes increased platelet aggregation, a hallmark of atherothrombosis. Our analysis of patients in 3 separate white cohorts reveals that this dysfunctional receptor is not likely an initiating factor in cardiovascular disease but that it accelerates the course of disease in those patients with the greatest risk factors. negative regulation of platelet aggregation GO:0090331 blood UBERON:0000178 Y Y ECO:0000006 PubMed:18323528 PENTACON From review: PubMed:20059330 AAP, ASD 4/21/2014 3 3300009537 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/Involvement in disease In a meta-analysis of published and unpublished data from randomised trials, allocation to a selective COX-2 inhibitor (in placebo comparison) was associated with a 42% relative increase in the incidence of serious vascular events, with no significant heterogeneity among the different selective COX-2 inhibitors. This was chiefly attributable to an increased risk of mycardial infarction. myocardial infarction DOID:5844 cyclooxygenase 2 inhibitor CHEBI:50629 Y Y ECO:0000006 PubMed:16740558 PENTACON From review: PubMed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009538 Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/Involvement in disease In a meta-analysis of published and unpublished data from randomised trials, allocation to a selective COX-2 inhibitor (in placebo comparison) was associated with a 42% relative increase in the incidence of serious vascular events, with no significant heterogeneity among the different selective COX-2 inhibitors. This was chiefly attributable to an increased risk of mycardial infarction. Myocardial infarction SNOMEDCT:22298006 cyclooxygenase 2 inhibitor CHEBI:50629 Y Y ECO:0000006 PubMed:16740558 PENTACON From review: PubMed:20059330 AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009539 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistochemistry of bone marrow sections showed that megakaryocytes express COX-1 (Fig. ​(Fig.1),1), which is consistent with the current notion that platelets express only COX-1. Quite unexpectedly, megakaryocytes stained positively also for COX-2 (Fig. ​(Fig.1),1), indicating that both COX isoforms are present in human megakaryocytes. megakaryocyte BTO:0000843 megakaryocyte CL:0000556 Y Y ECO:0000033 Pubmed:19095631 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009540 Jenn/Faith P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity Immunohistochemistry of bone marrow sections showed that megakaryocytes express COX-1 (Fig. ​(Fig.1),1), which is consistent with the current notion that platelets express only COX-1. Quite unexpectedly, megakaryocytes stained positively also for COX-2 (Fig. ​(Fig.1),1), indicating that both COX isoforms are present in human megakaryocytes. bone marrow UBERON:0002371 megakaryocyte CL:0000556 Y Y ECO:0000033 Pubmed:19095631 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009541 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Immunohistochemistry of bone marrow sections showed that megakaryocytes express COX-1 (Fig. ​(Fig.1),1), which is consistent with the current notion that platelets express only COX-1. Quite unexpectedly, megakaryocytes stained positively also for COX-2 (Fig. ​(Fig.1),1), indicating that both COX isoforms are present in human megakaryocytes. megakaryocyte BTO:0000843 megakaryocyte CL:0000556 Y Y ECO:0000033 Pubmed:19095631 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009542 Jenn/Faith P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Immunohistochemistry of bone marrow sections showed that megakaryocytes express COX-1 (Fig. ​(Fig.1),1), which is consistent with the current notion that platelets express only COX-1. Quite unexpectedly, megakaryocytes stained positively also for COX-2 (Fig. ​(Fig.1),1), indicating that both COX isoforms are present in human megakaryocytes. bone marrow UBERON:0002371 megakaryocyte CL:0000556 Y Y ECO:0000033 Pubmed:19095631 PENTACON AAP, DGA, AAP-M, ASD 4/21/2014 3 3300009543 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 EC 1.1.1.- Y Y EC number UniProtKB AAP, ASD 9/3/2014 155 3300033521 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/function Converts progesterone to its inactive form, 20-alpha-dihydroxyprogesterone (20-alpha-OHP). In the liver and intestine, may have a role in the transport of bile. May have a role in monitoring the intrahepatic bile acid concentration. Has a low bile-binding ability. May play a role in myelin formation. Y Y ECO:0000269 PubMed:11013348 PubMed:8573067 UniProtKB AAP, ASD 9/3/2014 155 3300033522 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/subcellular location Cytoplasm cytoplasm GO:0005737 SL-0086 Y Y UniProtKB AAP, ASD 9/3/2014 155 3300033523 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. liver BTO:0000759 Y Y ECO:0000269 PubMed:11013348 UniProtKB AAP, ASD 9/3/2014 155 3300033524 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. testis BTO:0001363 Y Y ECO:0000269 PubMed:11013348 UniProtKB AAP, ASD 9/3/2014 155 3300033525 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. testis UBERON:0000473 Y Y ECO:0000269 PubMed:11013348 UniProtKB AAP, ASD 9/3/2014 155 3300033526 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. brain BTO:0000142 Y Y ECO:0000269 PubMed:11013348 UniProtKB AAP, ASD 9/3/2014 155 3300033527 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. brain UBERON:0000955 Y Y ECO:0000269 PubMed:11013348 UniProtKB AAP, ASD 9/3/2014 155 3300033528 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. uterus BTO:0001424 Y Y ECO:0000269 PubMed:11013348 UniProtKB AAP, ASD 9/3/2014 155 3300033529 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. uterus UBERON:0000995 Y Y ECO:0000269 PubMed:11013348 UniProtKB AAP, ASD 9/3/2014 155 3300033530 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. keratinocyte cell line BTO:0000375 HaCaT cell BTO:0000552 Y Y ECO:0000269 PubMed:11013348 UniProtKB AAP, ASD 9/3/2014 155 3300033531 curatus Q92887 1244 ABCC2 Homo sapiens 9606 Comment/function Mediates hepatobiliary excretion of numerous organic anions. May function as a cellular cisplatin transporter. Y Y UniProtKB AAP, AAP-M, ASD 9/3/2014 146 3300033532 curatus Q92887 1244 ABCC2 Homo sapiens 9606 Comment/subcellular location Apical cell membrane;Multi-pass membrane protein apical plasma membrane GO:0016324 SL-0015 Y Y UniProtKB AAP, AAP-M, ASD 9/3/2014 146 3300033533 curatus Q92887 1244 ABCC2 Homo sapiens 9606 Comment/tissue specificity Expressed by polarized cells in liver, kidney and intestine. The highest expression is found in liver. liver BTO:0000759 Y Y UniProtKB AAP, AAP-M, ASD 9/3/2014 146 3300033534 curatus Q92887 1244 ABCC2 Homo sapiens 9606 Comment/tissue specificity Expressed by polarized cells in liver, kidney and intestine. The highest expression is found in liver. kidney BTO:0000671 Y Y UniProtKB AAP, AAP-M, ASD 9/3/2014 146 3300033535 curatus Q92887 1244 ABCC2 Homo sapiens 9606 Comment/tissue specificity Expressed by polarized cells in liver, kidney and intestine. The highest expression is found in liver. kidney UBERON:0002113 Y Y UniProtKB AAP, AAP-M, ASD 9/3/2014 146 3300033536 curatus Q92887 1244 ABCC2 Homo sapiens 9606 Comment/tissue specificity Expressed by polarized cells in liver, kidney and intestine. The highest expression is found in liver. intestine BTO:0000648 Y Y UniProtKB AAP, AAP-M, ASD 9/3/2014 146 3300033537 curatus Q92887 1244 ABCC2 Homo sapiens 9606 Comment/tissue specificity Expressed by polarized cells in liver, kidney and intestine. The highest expression is found in liver. intestine UBERON:0000160 Y Y UniProtKB AAP, AAP-M, ASD 9/3/2014 146 3300033538 curatus Q92887 1244 ABCC2 Homo sapiens 9606 Comment/Involvement in disease Dubin-Johnson syndrome (DJS): Autosomal recessive disorder characterized by conjugated hyperbilirubinemia, an increase in the urinary excretion of coproporphyrin isomer I, deposition of melanin-like pigment in hepatocytes, and prolonged retention of sulfobromophthalein, but otherwise normal liver function. MIM:237500 Dubin-Johnson syndrome DOID:12308 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:10053008 PubMed:10464142 PubMed:11266082 PubMed:11477083 PubMed:25336012 PubMed:9425227 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, AAP-M, ASD 9/3/2014 146 3300033539 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 EC 1.3.1.48 Y Y EC number UniProtKB AAP, ASD 9/3/2014 105 3300033540 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/function Functions as 15-oxo-prostaglandin 13-reductase and acts on 15-keto-PGE1, 15-keto-PGE2, 15-keto-PGE1-alpha and 15-keto-PGE2-alpha with highest activity towards 15-keto-PGE2. Overexpression represses transcriptional activity of PPARG and inhibits adipocyte differentiation (By similarity). Y Y ECO:0000269 ECO:0000250 : PubMed:19000823 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 9/3/2014 105 3300033541 curatus O15438 8714 ABCC3 Homo sapiens 9606 Comment/function May act as an inducible transporter in the biliary and intestinal excretion of organic anions. Acts as an alternative route for the export of bile acids and glucuronides from cholestatic hepatocytes (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP, DGA, AAP-M, ASD 9/3/2014 139 3300033544 curatus O15438 8714 ABCC3 Homo sapiens 9606 Comment/subcellular location Membrane;Multi-pass membrane protein membrane GO:0016020 SL-0162 Y Y UniProtKB AAP, DGA, AAP-M, ASD 9/3/2014 139 3300033545 curatus O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. liver BTO:0000759 Y Y UniProtKB AAP, DGA, AAP-M, ASD 9/3/2014 139 3300033546 curatus O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. colon BTO:0000269 Y Y UniProtKB AAP, DGA, AAP-M, ASD 9/3/2014 139 3300033547 curatus O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. colon UBERON:0001155 Y Y UniProtKB AAP, DGA, AAP-M, ASD 9/3/2014 139 3300033548 curatus O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. testis BTO:0001363 Y Y UniProtKB AAP, DGA, AAP-M, ASD 9/3/2014 139 3300033549 curatus O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. testis UBERON:0000473 Y Y UniProtKB AAP, DGA, AAP-M, ASD 9/3/2014 139 3300033550 curatus O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. brain BTO:0000142 Y Y UniProtKB AAP, DGA, AAP-M, ASD 9/3/2014 139 3300033551 curatus O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. brain UBERON:0000955 Y Y UniProtKB AAP, DGA, AAP-M, ASD 9/3/2014 139 3300033552 curatus O95255 368 ABCC6 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney and liver. Very low expression in other tissues. kidney BTO:0000671 Y Y UniProtKB AAP, DGA, ASD 9/3/2014 156 3300033556 curatus O95255 368 ABCC6 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney and liver. Very low expression in other tissues. liver BTO:0000759 Y Y UniProtKB AAP, DGA, ASD 9/3/2014 156 3300033557 curatus O95255 368 ABCC6 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney and liver. Very low expression in other tissues. liver UBERON:0002107 Y Y UniProtKB AAP, DGA, ASD 9/3/2014 156 3300033558 curatus O95255 368 ABCC6 Homo sapiens 9606 Comment/Involvement in disease Pseudoxanthoma elasticum (PXE): A multisystem disorder characterized by accumulation of mineralized and fragmented elastic fibers in the skin, vascular walls, and Burch membrane in the eye. Clinically, patients exhibit characteristic lesions of the posterior segment of the eye including peau d'orange, angioid streaks, and choroidal neovascularizations, of the skin including soft, ivory colored papules in a reticular pattern that predominantly affect the neck and large flexor surfaces, and of the cardiovascular system with peripheral and coronary arterial occlusive disease as well as gastrointestinal bleedings. MIM:264800 pseudoxanthoma elasticum DOID:2738 The disease is caused by mutations affecting the gene represented in this entry. Homozygous or compound heterozygous ABCC6 mutations have been found in the overwhelming majority of cases. Individuals carrying heterozygous mutations express limited manifestations of the pseudoxanthoma elasticum phenotype. Y Y ECO:0000269 PubMed:10811882 PubMed:10835642 PubMed:10954200 PubMed:11427982 PubMed:11536079 PubMed:11702217 PubMed:15086542 PubMed:15098239 PubMed:15459974 PubMed:16086317 PubMed:17617515 PubMed:19339160 PubMed:20034067 PubMed:25615550 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 9/3/2014 156 3300033559 curatus O95255 368 ABCC6 Homo sapiens 9606 Comment/Involvement in disease Arterial calcification of infancy, generalized, 2 (GACI2): A severe autosomal recessive disorder characterized by calcification of the internal elastic lamina of muscular arteries and stenosis due to myointimal proliferation. The disorder is often fatal within the first 6 months of life because of myocardial ischemia resulting in refractory heart failure. MIM:614473 arterial calcification of infancy DOID:0050644 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:22209248 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, DGA, ASD 9/3/2014 156 3300033560 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/function ATP-dependent transporter probably involved in cellular detoxification through lipophilic anion extrusion. Y Y ECO:0000269 PubMed:12527806 PubMed:15256465 UniProtKB AAP, ASD 9/3/2014 94 3300033562 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB AAP, ASD 9/3/2014 94 3300033563 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. spleen BTO:0001281 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 9/3/2014 94 3300033564 curatus Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/function Participates in physiological processes involving bile acids, conjugated steroids and cyclic nucleotides. Enhances the cellular extrusion of cAMP and cGMP. Stimulates the ATP-dependent uptake of a range of physiological and synthetic lipophilic anions, including the glutathione S-conjugates leukotriene C4 and dinitrophenyl S-glutathione, steroid sulfates such as dehydroepiandrosterone 3-sulfate (DHEAS) and estrone 3-sulfate, glucuronides such as estradiol 17-beta-D-glucuronide (E(2)17betaG), the monoanionic bile acids glycocholate and taurocholate, and methotrexate. Probably functions to secrete earwax. Y Y ECO:0000269 PubMed:12764137 PubMed:15537867 PubMed:16444273 UniProtKB AAP, DGA, AAP-M 9/3/2014 104 3300033566 curatus Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/subcellular location Membrane;Multi-pass membrane protein membrane GO:0016020 SL-0162 Y Y UniProtKB AAP, DGA, AAP-M 9/3/2014 104 3300033567 curatus Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. testis BTO:0001363 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB AAP, DGA, AAP-M 9/3/2014 104 3300033573 curatus Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. testis UBERON:0000473 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB AAP, DGA, AAP-M 9/3/2014 104 3300033574 curatus Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. brain BTO:0000142 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB AAP, DGA, AAP-M 9/3/2014 104 3300033575 curatus Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. brain UBERON:0000955 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB AAP, DGA, AAP-M 9/3/2014 104 3300033576 curatus Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. placenta BTO:0001078 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB AAP, DGA, AAP-M 9/3/2014 104 3300033577 curatus Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB AAP, DGA, AAP-M 9/3/2014 104 3300033578 curatus P52895 1646 AKR1C2 Homo sapiens 9606 EC 1.-.-.- Y Y EC number UniProtKB AAP, ASD 9/3/2014 148 3300033580 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/function Works in concert with the 5-alpha/5-beta-steroid reductases to convert steroid hormones into the 3-alpha/5-alpha and 3-alpha/5-beta-tetrahydrosteroids. Catalyzes the inactivation of the most potent androgen 5-alpha-dihydrotestosterone (5-alpha-DHT) to 5-alpha-androstane-3-alpha,17-beta-diol (3-alpha-diol). Has a high bile-binding ability. Y Y ECO:0000269 PubMed:8573067 PubMed:15929998 PubMed:17034817 PubMed:17442338 UniProtKB AAP, ASD 9/3/2014 148 3300033581 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/subcellular location Cytoplasm cytoplasm GO:0005737 SL-0086 Y Y UniProtKB AAP, ASD 9/3/2014 148 3300033582 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity Expressed in fetal testes. Expressed in fetal and adult adrenal glands. testis BTO:0001363 fetus BTO:0000449 Y Y ECO:0000269 PubMed:21802064 UniProtKB AAP, ASD 9/3/2014 148 3300033583 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/Involvement in disease 46,XY sex reversal 8 (SRXY8): A disorder of sex development. Affected individuals have a 46,XY karyotype but present as phenotypically normal females. MIM:614279 46 XY gonadal dysgenesis DOID:14448 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:21802064 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 9/3/2014 148 3300033584 curatus Q15067 51 ACOX1 Homo sapiens 9606 EC 1.3.3.6 Y Y EC number UniProtKB AAP, ASD 9/3/2014 152 3300033585 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/function Catalyzes the desaturation of acyl-CoAs to 2-trans-enoyl-CoAs. Isoform 1 shows highest activity against medium-chain fatty acyl-CoAs and activity decreases with increasing chain length. Isoform 2 is active against a much broader range of substrates and shows activity towards very long-chain acyl-CoAs. Isoform 2 is twice as active as isoform 1 against 16-hydroxy-palmitoyl-CoA and is 25% more active against 1,16-hexadecanodioyl-CoA. Y Y ECO:0000269 PubMed:17603022 PubMed:17458872 UniProtKB AAP, ASD 9/3/2014 152 3300033586 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/pathway Lipid metabolism; peroxisomal fatty acid beta-oxidation. lipid metabolic process GO:0006629 UPA00436 Y Y UniProtKB IDA in GO AAP, ASD 9/3/2014 152 3300033588 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/pathway Lipid metabolism; peroxisomal fatty acid beta-oxidation. fatty acid beta-oxidation using acyl-CoA oxidase GO:0033540 UPA00661 Y Y UniProtKB TAS in GO AAP, ASD 9/3/2014 152 3300033589 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. heart BTO:0000562 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB AAP, ASD 9/3/2014 152 3300033591 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. lung BTO:0000763 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 9/3/2014 152 3300033592 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. muscle BTO:0000887 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 9/3/2014 152 3300033594 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. musculature UBERON:0001015 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 9/3/2014 152 3300033595 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. white adipose tissue BTO:0001456 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 9/3/2014 152 3300033596 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. white adipose tissue UBERON:0001347 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 9/3/2014 152 3300033597 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. testis BTO:0001363 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 9/3/2014 152 3300033598 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. testis UBERON:0000473 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 9/3/2014 152 3300033599 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/Involvement in disease Adrenoleukodystrophy, pseudoneonatal (Pseudo-NALD): A peroxisomal single-enzyme disorder of fatty acid beta-oxidation, resulting in clinical manifestations that remind neonatal adrenoleukodystrophy. Clinical features include mental retardation, leukodystrophy, seizures, mild hepatomegaly, hearing deficit. Pseudo-NALD is characterized by increased plasma levels of very-long chain fatty acids, due to decreased or absent peroxisome acyl-CoA oxidase activity. Peroxisomes are intact and functioning. MIM:264470 peroxisomal acyl-CoA oxidase deficiency DOID:0050797 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:11815777 PubMed:17458872 PubMed:8040306 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 9/3/2014 152 3300033600 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 EC 3.1.1.5 Y Y EC number UniProtKB AAP 9/3/2014 110 3300033602 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/function Calcium-independent phospholipase A2, which catalyzes the hydrolysis of the sn-2 position of glycerophospholipids, PtdSer and to a lower extent PtdCho. Cleaves membrane phospholipids. Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 UniProtKB AAP 9/3/2014 110 3300033603 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. parenchyma UBERON:0000353 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033607 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033608 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033609 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. placenta BTO:0001078 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033610 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033611 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. brain BTO:0000142 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033612 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033613 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. liver BTO:0000759 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033614 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033615 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033616 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033617 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. kidney BTO:0000671 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033618 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033619 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. heart BTO:0000562 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033620 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. heart UBERON:0000948 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB AAP 9/3/2014 110 3300033621 curatus P13584 1580 CYP4B1 Homo sapiens 9606 EC 1.14.14.1 Y Y EC number UniProtKB AAP, ASD 9/3/2014 140 3300033623 curatus P13584 1580 CYP4B1 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Y Y UniProtKB AAP, ASD 9/3/2014 140 3300033624 curatus P13584 1580 CYP4B1 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Peripheral membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y UniProtKB TAS in GO AAP, ASD 9/3/2014 140 3300033625 curatus P13584 1580 CYP4B1 Homo sapiens 9606 Comment/tissue specificity Detected in the liver and lung (at protein level). lung UBERON:0002048 Y Y ECO:0000269 PubMed:12695542 UniProtKB AAP, ASD 9/3/2014 140 3300033627 curatus Q9UNU6 1582 CYP8B1 Homo sapiens 9606 EC 1.14.13.95 Y Y EC number UniProtKB AAP 9/3/2014 116 3300033629 curatus Q9UNU6 1582 CYP8B1 Homo sapiens 9606 Comment/function Involved in bile acid synthesis and is responsible for the conversion of 7 alpha-hydroxy-4-cholesten-3-one into 7 alpha, 12 alpha-dihydroxy-4-cholesten-3-one. Responsible for the balance between formation of cholic acid and chenodeoxycholic acid. Has a rather broad substrate specificity including a number of 7-alpha-hydroxylated C27 steroids. Y Y ECO:0000250 UniProtKB:O02766 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP 9/3/2014 116 3300033630 curatus Q9UNU6 1582 CYP8B1 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Single-pass membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y UniProtKB AAP 9/3/2014 116 3300033631 curatus Q9UNU6 1582 CYP8B1 Homo sapiens 9606 Comment/tissue specificity Liver. liver BTO:0000759 Y Y UniProtKB AAP 9/3/2014 116 3300033633 curatus Q9UNU6 1582 CYP8B1 Homo sapiens 9606 Comment/tissue specificity Liver. liver UBERON:0002107 Y Y UniProtKB AAP 9/3/2014 116 3300033634 curatus Q9H4B8 64180 DPEP3 Homo sapiens 9606 EC 3.4.13.19 Y Y EC number UniProtKB AAP 9/3/2014 96 3300033635 curatus Q9H4B8 64180 DPEP3 Homo sapiens 9606 Comment/function Probable metalloprotease which hydrolyzes cystinyl-bis-glycine. May be involved in meiosis (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP 9/3/2014 96 3300033636 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 EC 1.14.14.1 Y Y EC number UniProtKB AAP 9/3/2014 121 3300033639 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 Comment/function Catalyzes leukotriene B4 omega-hydroxylation and arachidonic acid omega-hydroxylation but with an activity much lower than that of CYP4F2. Catalyzes the hydroxylation of the antihistamine ebastine. Y Y UniProtKB AAP 9/3/2014 121 3300033640 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, liver, colon and heart. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:11162607 PubMed:11162645 UniProtKB AAP 9/3/2014 121 3300033643 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, liver, colon and heart. liver BTO:0000759 Y Y ECO:0000269 PubMed:11162607 PubMed:11162645 UniProtKB AAP 9/3/2014 121 3300033644 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, liver, colon and heart. liver UBERON:0002107 Y Y ECO:0000269 PubMed:11162607 PubMed:11162645 UniProtKB AAP 9/3/2014 121 3300033645 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, liver, colon and heart. colon BTO:0000269 Y Y ECO:0000269 PubMed:11162607 PubMed:11162645 UniProtKB AAP 9/3/2014 121 3300033646 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, liver, colon and heart. colon UBERON:0001155 Y Y ECO:0000269 PubMed:11162607 PubMed:11162645 UniProtKB AAP 9/3/2014 121 3300033647 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, liver, colon and heart. heart BTO:0000562 Y Y ECO:0000269 PubMed:11162607 PubMed:11162645 UniProtKB AAP 9/3/2014 121 3300033648 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, liver, colon and heart. heart UBERON:0000948 Y Y ECO:0000269 PubMed:11162607 PubMed:11162645 UniProtKB AAP 9/3/2014 121 3300033649 curatus P14550 10327 AKR1A1 Homo sapiens 9606 EC 1.1.1.2 Y Y EC number UniProtKB AAP, ASD 7/9/2014 155 3300033651 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/function Catalyzes the NADPH-dependent reduction of a variety of aromatic and aliphatic aldehydes to their corresponding alcohols. Catalyzes the reduction of mevaldate to mevalonic acid and of glyceraldehyde to glycerol. Has broad substrate specificity. In vitro substrates include succinic semialdehyde, 4-nitrobenzaldehyde, 1,2-naphthoquinone, methylglyoxal, and D-glucuronic acid. Plays a role in the activation of procarcinogens, such as polycyclic aromatic hydrocarbon trans-dihydrodiols, and in the metabolism of various xenobiotics and drugs, including the anthracyclines doxorubicin (DOX) and daunorubicin (DAUN). Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 PubMed:18276838 UniProtKB AAP, ASD 7/9/2014 155 3300033652 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. liver BTO:0000759 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033654 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033655 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. stomach BTO:0001307 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033656 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. stomach UBERON:0000945 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033657 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. brain BTO:0000142 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033658 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033659 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. lung BTO:0000763 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033660 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. lung UBERON:0002048 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033661 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. placenta BTO:0001078 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033662 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033663 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033664 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 7/9/2014 155 3300033665 curatus Q8NCG7 221955 DAGLB Homo sapiens 9606 EC 3.1.1.- Y Y EC number UniProtKB AAP, ASD 9/3/2014 94 3300033666 curatus Q8NCG7 221955 DAGLB Homo sapiens 9606 Comment/function Catalyzes the hydrolysis of diacylglycerol (DAG) to 2-arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses. Y Y ECO:0000269 PubMed:14610053 UniProtKB AAP, ASD 9/3/2014 94 3300033667 curatus Q8NCG7 221955 DAGLB Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB AAP, ASD 9/3/2014 94 3300033668 curatus Q9Y4D2 747 DAGLA Homo sapiens 9606 EC 3.1.1.- Y Y EC number UniProtKB AAP, ASD 9/3/2014 103 3300033670 curatus Q9Y4D2 747 DAGLA Homo sapiens 9606 Comment/function Catalyzes the hydrolysis of diacylglycerol (DAG) to 2-arachidonoyl-glycerol (2-AG), the most abundant endocannabinoid in tissues. Required for axonal growth during development and for retrograde synaptic signaling at mature synapses. Y Y ECO:0000269 PubMed:14610053 UniProtKB AAP, ASD 9/3/2014 103 3300033671 curatus Q9Y4D2 747 DAGLA Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB AAP, ASD 9/3/2014 103 3300033672 curatus Q9Y4D2 747 DAGLA Homo sapiens 9606 Comment/tissue specificity Highly expressed in brain and pancreas. brain UBERON:0000955 Y Y ECO:0000269 PubMed:14610053 PubMed:16051747 UniProtKB AAP, ASD 9/3/2014 103 3300033673 curatus Q9Y4D2 747 DAGLA Homo sapiens 9606 Comment/tissue specificity Highly expressed in brain and pancreas. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:14610053 PubMed:16051747 UniProtKB AAP, ASD 9/3/2014 103 3300033674 curatus Q9Y4D2 747 DAGLA Homo sapiens 9606 Comment/tissue specificity Highly expressed in brain and pancreas. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:14610053 PubMed:16051747 UniProtKB AAP, ASD 9/3/2014 103 3300033675 curatus Q9Y4D2 747 DAGLA Homo sapiens 9606 Comment/Involvement in disease Spinocerebellar ataxia 20 (SCA20): Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA20 is an autosomal dominant, adult-onset form characterized by dysarthria due to spasmodic dysphonia followed by slowly progressive ataxia. MIM:608687 spinocerebellar ataxia DOID:1441 The disease may be caused by mutations affecting the gene represented in this entry. A copy number variation consisting of a 260-kb duplication at chromosome 11q12.2-12.3 is responsible for SCA20. The critical gene within the duplicated segment may be DAGLA. Y Y ECO:0000269 PubMed:18801880 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 9/3/2014 103 3300033676 curatus Q99685 11343 MGLL Homo sapiens 9606 EC 3.1.1.23 Y Y EC number UniProtKB AAP, ASD 9/3/2014 129 3300033678 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/pathway Glycerolipid metabolism; triacylglycerol degradation. triglyceride catabolic process GO:0019433 UPA00256 Y Y UniProtKB AAP, ASD 9/3/2014 129 3300033682 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. adipose tissue UBERON:0001013 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033683 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. lung BTO:0000763 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033684 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. lung UBERON:0002048 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033685 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. liver BTO:0000759 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033686 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. liver UBERON:0002107 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033687 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. kidney BTO:0000671 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033688 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033689 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. brain BTO:0000142 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033690 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. brain UBERON:0000955 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033691 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. heart BTO:0000562 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033692 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. heart UBERON:0000948 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 9/3/2014 129 3300033693 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB AAP, ASD 9/3/2014 126 3300033697 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. brain BTO:0000142 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 9/3/2014 126 3300033698 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. kidney BTO:0000671 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 9/3/2014 126 3300033699 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 9/3/2014 126 3300033700 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. placenta BTO:0001078 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 9/3/2014 126 3300033701 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 9/3/2014 126 3300033702 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 9/3/2014 126 3300033703 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 9/3/2014 126 3300033704 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 EC 3.4.11.- Y Y EC number UniProtKB AAP 7/9/2014 103 3300033706 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/function Aminopeptidases catalyze the hydrolysis of amino acid residues from the N-terminus of peptide or protein substrates. Able to cleave angiotensin III to generate angiotensin IV, a bioactive peptide of the renin-angiotensin pathway. Not able to cleave angiotensin I and angiotensin II. May play a role in the proteolytic processing of bioactive peptides in tissues such as testis and heart. Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033707 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. brain UBERON:0000955 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033709 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. placenta BTO:0001078 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033710 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033711 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. liver BTO:0000759 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033712 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. liver UBERON:0002107 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033713 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. testis BTO:0001363 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033714 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. testis UBERON:0000473 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033715 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. heart BTO:0000562 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033716 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. heart UBERON:0000948 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033717 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. lung BTO:0000763 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033718 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. lung UBERON:0002048 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033719 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. kidney BTO:0000671 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033720 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 7/9/2014 103 3300033721 curatus Q9H4A4 6051 RNPEP Homo sapiens 9606 EC 3.4.11.6 Y Y EC number UniProtKB AAP 9/3/2014 128 3300033723 curatus Q9H4A4 6051 RNPEP Homo sapiens 9606 Comment/function Exopeptidase which selectively removes arginine and/or lysine residues from the N-terminus of several peptide substrates including Arg(0)-Leu-enkephalin, Arg(0)-Met-enkephalin and Arg(-1)-Lys(0)-somatostatin-14. Can hydrolyze leukotriene A4 (LTA-4) into leukotriene B4 (LTB-4) (By similarity). Y Y ECO:0000250 UniProtKB UPDATE ver_2 Changes in: EVID AAP 9/3/2014 128 3300033724 curatus Q9H4A4 6051 RNPEP Homo sapiens 9606 Comment/subcellular location Secreted extracellular region GO:0005576 SL-0243 Y Y UniProtKB AAP 9/3/2014 128 3300033725 curatus Q9HAU8 57140 RNPEPL1 Homo sapiens 9606 EC 3.4.11.- Y Y EC number UniProtKB AAP 5/14/2014 122 3300033726 curatus Q9HAU8 57140 RNPEPL1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Expressed at relatively higher levels in heart and skeletal muscle. heart UBERON:0000948 Y Y ECO:0000269 PubMed:11017071 UniProtKB AAP 5/14/2014 122 3300033727 curatus Q9HAU8 57140 RNPEPL1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Expressed at relatively higher levels in heart and skeletal muscle. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:11017071 UniProtKB AAP 5/14/2014 122 3300033728 curatus Q9HAU8 57140 RNPEPL1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Expressed at relatively higher levels in heart and skeletal muscle. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:11017071 UniProtKB AAP 5/14/2014 122 3300033729 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/function May mediate the release of newly synthesized prostaglandins from cells, the transepithelial transport of prostaglandins, and the clearance of prostaglandins from the circulation. Transports PGD2, as well as PGE1, PGE2 and PGF2A. Y Y UniProtKB AAP, ASD 9/3/2014 119 3300033731 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/subcellular location Cell membrane;Multi-pass membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB AAP, ASD 9/3/2014 119 3300033732 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Significant expression observed in ling, kidney, spleen, and heart. lung BTO:0000763 Y Y ECO:0000269 PubMed:22331663 UniProtKB AAP, ASD 9/3/2014 119 3300033733 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Significant expression observed in ling, kidney, spleen, and heart. kidney BTO:0000671 Y Y ECO:0000269 PubMed:22331663 UniProtKB AAP, ASD 9/3/2014 119 3300033734 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Significant expression observed in ling, kidney, spleen, and heart. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:22331663 UniProtKB AAP, ASD 9/3/2014 119 3300033735 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Significant expression observed in ling, kidney, spleen, and heart. spleen BTO:0001281 Y Y ECO:0000269 PubMed:22331663 UniProtKB AAP, ASD 9/3/2014 119 3300033736 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Significant expression observed in ling, kidney, spleen, and heart. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:22331663 UniProtKB AAP, ASD 9/3/2014 119 3300033737 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Significant expression observed in ling, kidney, spleen, and heart. heart BTO:0000562 Y Y ECO:0000269 PubMed:22331663 UniProtKB AAP, ASD 9/3/2014 119 3300033738 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Significant expression observed in ling, kidney, spleen, and heart. heart UBERON:0000948 Y Y ECO:0000269 PubMed:22331663 UniProtKB AAP, ASD 9/3/2014 119 3300033739 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/Involvement in disease Hypertrophic osteoarthropathy, primary, autosomal recessive, 2 (PHOAR2): A disease characterized by digital clubbing, periostosis, acroosteolysis, painful joint enlargement, and variable features of pachydermia that include thickened facial skin and a thickened scalp. Other developmental anomalies include delayed closure of the cranial sutures and congenital heart disease. MIM:614441 primary hypertrophic osteoarthropathy DOID:14283 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:22197487 PubMed:22331663 PubMed:22553128 PubMed:22696055 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID AAP, ASD 9/3/2014 119 3300033740 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> heart BTO:0000562 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} AAP, ASD 12/7/2011 1111 3300033942 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #2,3,8# prostate gland (#8# in primary prostate stromal cells, co-localization with RODH like 3alpha/17beta-HSD, EC 1.1.1.239 <27>; #3# epithelial cells, but not the stromal cells or endothelial cells <36>) <10,16,27,28,36> prostate gland BTO:0001129 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} AAP, ASD 12/7/2011 1111 3300033943 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #2,3,8# prostate gland (#8# in primary prostate stromal cells, co-localization with RODH like 3alpha/17beta-HSD, EC 1.1.1.239 <27>; #3# epithelial cells, but not the stromal cells or endothelial cells <36>) <10,16,27,28,36> prostate gland UBERON:0002367 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} AAP, ASD 12/7/2011 1111 3300033944 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #2,3,8# prostate gland (#8# in primary prostate stromal cells, co-localization with RODH like 3alpha/17beta-HSD, EC 1.1.1.239 <27>; #3# epithelial cells, but not the stromal cells or endothelial cells <36>) <10,16,27,28,36> prostate gland BTO:0001129 1.1.1.213 Y Y Pubmed:16179381 BRENDA <27> Bauman, D.R.; Steckelbroeck, S.; Williams, M.V.; Peehl, D.M.; Penning, T.M.: Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease. Mol. Endocrinol. (2006) 20, 444-458. {Pubmed:16179381} AAP, ASD 12/7/2011 1111 3300033945 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #2,3,8# prostate gland (#8# in primary prostate stromal cells, co-localization with RODH like 3alpha/17beta-HSD, EC 1.1.1.239 <27>; #3# epithelial cells, but not the stromal cells or endothelial cells <36>) <10,16,27,28,36> prostate gland UBERON:0002367 1.1.1.213 Y Y ECO:0000033 Pubmed:16179381 BRENDA <27> Bauman, D.R.; Steckelbroeck, S.; Williams, M.V.; Peehl, D.M.; Penning, T.M.: Identification of the major oxidative 3alpha-hydroxysteroid dehydrogenase in human prostate that converts 5alpha-androstane-3alpha,17beta-diol to 5alpha-dihydrotestosterone: a potential therapeutic target for androgen-dependent disease. Mol. Endocrinol. (2006) 20, 444-458. {Pubmed:16179381} AAP, ASD 12/7/2011 1111 3300033946 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #8# adipose tissue (#8# the enzyme expression is positively correlated to adiposity in woman <16>) <16> adipose tissue BTO:0001487 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} AAP, ASD 12/7/2011 1111 3300033948 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #8# adipose tissue (#8# the enzyme expression is positively correlated to adiposity in woman <16>) <16> adipose tissue UBERON:0001013 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} AAP, ASD 12/7/2011 1111 3300033949 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #8# astrocyte (#8# high expression and activity in astrocytes of glaucomatous optic nerve head <16>) <16> astrocyte BTO:0000099 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} AAP, ASD 12/7/2011 1111 3300033951 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity #15,19# non-small cell lung cancer cell <42> non-small cell lung cancer cell BTO:0002058 1.3.1.20 Y Y ECO:0000006 Pubmed:17266043 BRENDA <42> Wang, H.W.; Lin, C.P.; Chiu, J.H.; Chow, K.C.; Kuo, K.T.; Lin, C.S.; Wang, L.S.: Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin. Int. J. Cancer (2007) 120, 2019-2027. {Pubmed:17266043} AAP, ASD 12/7/2011 1111 3300033953 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/Involvement in disease #15,19# non-small cell lung cancer cell <42> lung cancer DOID:1324 1.3.1.20 Y Y ECO:0000006 Pubmed:17266043 BRENDA <42> Wang, H.W.; Lin, C.P.; Chiu, J.H.; Chow, K.C.; Kuo, K.T.; Lin, C.S.; Wang, L.S.: Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin. Int. J. Cancer (2007) 120, 2019-2027. {Pubmed:17266043} AAP, ASD 12/7/2011 1111 3300033954 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity #4,45# fibroblast <62,71> fibroblast BTO:0000452 1.3.3.6 Y Y ECO:0000006 Pubmed:18536048 BRENDA <62> Carrozzo, R.; Bellini, C.; Lucioli, S.; Deodato, F.; Cassandrini, D.; Cassanello, M.; Caruso, U.; Rizzo, C.; Rizza, T.; Napolitano, M.L.; Wanders, R.J.; Jakobs, C.; Bruno, C.; Santorelli, F.M.; Dionisi-Vici, C.; Bonioli, E.: Peroxisomal acyl-CoA-oxidase deficiency: two new cases. Am. J. Med. Genet. A (2008) 146A, 1676-1681. {Pubmed:18536048} AAP, ASD 12/7/2011 1111 3300033955 curatus/Jenn P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4,6,15# cerebrospinal fluid (#4# richest source of the enzyme <14>; #15# qualitative and quantitative fluctuations of prostaglandin D synthase isoforms from cerebrospinal fluid reflect both major and subtle brain pathophysiology <38>; #4,6# identification of several enzyme isoforms <55>) <14,18,38,55> cerebrospinal fluid BTO:0000237 5.3.99.2 Y Y ECO:0000006 Pubmed:16410653 BRENDA <38> Harrington, M.G.; Fonteh, A.N.; Biringer, R.G.; AF, R.H.; Cowan, R.P.: Prostaglandin D synthase isoforms from cerebrospinal fluid vary with brain pathology. Dis. Markers (2006) 22, 281-289. {Pubmed:} AAP, DGA 12/7/2011 1111 3300034035 curatus/Jenn P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4,6,15# cerebrospinal fluid (#4# richest source of the enzyme <14>; #15# qualitative and quantitative fluctuations of prostaglandin D synthase isoforms from cerebrospinal fluid reflect both major and subtle brain pathophysiology <38>; #4,6# identification of several enzyme isoforms <55>) <14,18,38,55> cerebrospinal fluid UBERON:0001359 5.3.99.2 Y Y ECO:0000006 Pubmed:16410653 BRENDA <38> Harrington, M.G.; Fonteh, A.N.; Biringer, R.G.; AF, R.H.; Cowan, R.P.: Prostaglandin D synthase isoforms from cerebrospinal fluid vary with brain pathology. Dis. Markers (2006) 22, 281-289. {Pubmed:} AAP, DGA 12/7/2011 1111 3300034036 curatus/Jenn P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4,6,15# cerebrospinal fluid (#4# richest source of the enzyme <14>; #15# qualitative and quantitative fluctuations of prostaglandin D synthase isoforms from cerebrospinal fluid reflect both major and subtle brain pathophysiology <38>; #4,6# identification of several enzyme isoforms <55>) <14,18,38,55> hydranencephaly DOID:4626 5.3.99.2 Y Y ECO:0000006 Pubmed:16410653 BRENDA <38> Harrington, M.G.; Fonteh, A.N.; Biringer, R.G.; AF, R.H.; Cowan, R.P.: Prostaglandin D synthase isoforms from cerebrospinal fluid vary with brain pathology. Dis. Markers (2006) 22, 281-289. {Pubmed:}; PENTACON Notes: All isoforms of PTGDS were absent from the CSF in hydranencephaly and one or more invariant forms were lost in schizencephaly, Arnold-Chiari malformation, myelomeningocele, Dandy-Walker syndrome, Wilson’s disease, Leigh’s disease and moyamoya disease with Down’s syndrome. AAP, DGA 12/7/2011 1111 3300034037 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# cytotrophoblast (#2# extravillous cytotrophoblast is strongly posistive for enzyme protein in the basal plate <33>) <33> cytotrophoblast BTO:0000322 5.3.99.3 Y Y ECO:0000006 Pubmed:17403423 BRENDA <33> Fujikura, T.; Mukai, M.: Prostaglandin E2 synthase in syncytiotrophoblastic vesicles found in the placental intervillous space. Am. J. Obstet. Gynecol. (2007) 196, 361-361. {Pubmed:} AAP, DGA 12/7/2011 1111 3300034038 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# cytotrophoblast (#2# extravillous cytotrophoblast is strongly posistive for enzyme protein in the basal plate <33>) <33> cytotrophoblast UBERON:0000319 5.3.99.3 Y Y ECO:0000006 Pubmed:17403423 BRENDA <33> Fujikura, T.; Mukai, M.: Prostaglandin E2 synthase in syncytiotrophoblastic vesicles found in the placental intervillous space. Am. J. Obstet. Gynecol. (2007) 196, 361-361. {Pubmed:} AAP, DGA 12/7/2011 1111 3300034039 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# syncytiotrophoblast (#2# enzyme protein is prominent in vesicles separating from syncytiotrophoblast into the intervillous space <33>) <33> syncytiotrophoblast BTO:0001335 5.3.99.3 Y Y ECO:0000006 Pubmed:17403423 BRENDA <33> Fujikura, T.; Mukai, M.: Prostaglandin E2 synthase in syncytiotrophoblastic vesicles found in the placental intervillous space. Am. J. Obstet. Gynecol. (2007) 196, 361-361. {Pubmed:} AAP, DGA 12/7/2011 1111 3300034040 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# syncytiotrophoblast (#2# enzyme protein is prominent in vesicles separating from syncytiotrophoblast into the intervillous space <33>) <33> syncytiotrophoblast UBERON:0000371 5.3.99.3 Y Y ECO:0000006 Pubmed:17403423 BRENDA <33> Fujikura, T.; Mukai, M.: Prostaglandin E2 synthase in syncytiotrophoblastic vesicles found in the placental intervillous space. Am. J. Obstet. Gynecol. (2007) 196, 361-361. {Pubmed:} AAP, DGA 12/7/2011 1111 3300034041 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2,7# placenta (#2# immunolocalized in extravillous trophoblasts and macrophages, in early gestation also in cytotrophoblasts and syncytiotrophoblasts <26>; #2# immunolocalized to the fibroblasts and macrophages in villous stroma, also in apoptotic early gestational syncytiotrophoblasts <26>; #7# application of glucocorticoids to mother or fetus significantly stimulate enzyme isoform mPGES1 in placenta. Enzyme is localized to placental trophoblast cells <39>) <26,33,39> placenta BTO:0001078 5.3.99.3 Y Y ECO:0000006 Pubmed:17403423 BRENDA <33> Fujikura, T.; Mukai, M.: Prostaglandin E2 synthase in syncytiotrophoblastic vesicles found in the placental intervillous space. Am. J. Obstet. Gynecol. (2007) 196, 361-361. {Pubmed:} AAP, DGA 12/7/2011 1111 3300034042 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2,7# placenta (#2# immunolocalized in extravillous trophoblasts and macrophages, in early gestation also in cytotrophoblasts and syncytiotrophoblasts <26>; #2# immunolocalized to the fibroblasts and macrophages in villous stroma, also in apoptotic early gestational syncytiotrophoblasts <26>; #7# application of glucocorticoids to mother or fetus significantly stimulate enzyme isoform mPGES1 in placenta. Enzyme is localized to placental trophoblast cells <39>) <26,33,39> placenta UBERON:0001987 5.3.99.3 Y Y ECO:0000006 Pubmed:17403423 BRENDA <33> Fujikura, T.; Mukai, M.: Prostaglandin E2 synthase in syncytiotrophoblastic vesicles found in the placental intervillous space. Am. J. Obstet. Gynecol. (2007) 196, 361-361. {Pubmed:} AAP, DGA 12/7/2011 1111 3300034043 curatus P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #4# HLE B-3 cell (#4# lens epithelial cell line <39>) <39> HLE-B3 cell BTO:0002221 1.1.1.21 Y Y ECO:0000006 Pubmed:12490536 BRENDA <39> Ramana, K.V.; Friedrich, B.; Bhatnagar, A.; Srivastava, S.K.: Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells. FASEB J. (2003) 17, 315-317. {Pubmed:12490536} AAP, DGA, ASD 12/7/2011 1111 3300034044 curatus P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #4# HLE B-3 cell (#4# lens epithelial cell line <39>) <39> lens epithelial cell line BTO:0001874 1.1.1.21 Y Y ECO:0000006 Pubmed:12490536 BRENDA <39> Ramana, K.V.; Friedrich, B.; Bhatnagar, A.; Srivastava, S.K.: Aldose reductase mediates cytotoxic signals of hyperglycemia and TNF-alpha in human lens epithelial cells. FASEB J. (2003) 17, 315-317. {Pubmed:12490536} AAP, DGA, ASD 12/7/2011 1111 3300034045 curatus P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #4,5# endothelial cell (#4# umbilical vein endothelial cell <41>) <41,110,139> endothelial cell BTO:0001176 1.1.1.21 Y Y ECO:0000006 Pubmed:15251463 BRENDA <41> Ramana, K.V.; Bhatnagar, A.; Srivastava, S.K.: Aldose reductase regulates TNF-alpha-induced cell signaling and apoptosis in vascular endothelial cells. FEBS Lett. (2004) 570, 189-194. {Pubmed:15251463} AAP, DGA, ASD 12/7/2011 1111 3300034046 curatus P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #4,5# endothelial cell (#4# umbilical vein endothelial cell <41>) <41,110,139> HUVEC cell BTO:0001949 1.1.1.21 Y Y ECO:0000006 Pubmed:15251463 BRENDA <41> Ramana, K.V.; Bhatnagar, A.; Srivastava, S.K.: Aldose reductase regulates TNF-alpha-induced cell signaling and apoptosis in vascular endothelial cells. FEBS Lett. (2004) 570, 189-194. {Pubmed:15251463} AAP, DGA, ASD 12/7/2011 1111 3300034047 curatus P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #4,5# endothelial cell (#4# umbilical vein endothelial cell <41>) <41,110,139> umbilical vein endothelium UBERON:0007777 1.1.1.21 Y Y ECO:0000006 Pubmed:15251463 BRENDA <41> Ramana, K.V.; Bhatnagar, A.; Srivastava, S.K.: Aldose reductase regulates TNF-alpha-induced cell signaling and apoptosis in vascular endothelial cells. FEBS Lett. (2004) 570, 189-194. {Pubmed:15251463} AAP, DGA, ASD 12/7/2011 1111 3300034048 curatus/Jenn P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #6# non-small-cell lung cancer cell (#6# enzyme expression analysis, 59 different samples <47>) <47> non-small cell lung adenocarcinoma cell line BTO:0004078 lung adenocarcinoma DOID:3910 1.1.1.184 Y Y ECO:0000006 Pubmed:16103446 BRENDA <47> Takenaka, K.; Ogawa, E.; Oyanagi, H.; Wada, H.; Tanaka, F.: Carbonyl reductase expression and its clinical significance in non-small-cell lung cancer. Cancer Epidemiol. Biomarkers Prev. (2005) 14, 1972-1975. {Pubmed:16103446} AAP, ASD 12/7/2011 1111 3300034049 curatus/Jenn P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #6# non-small-cell lung cancer cell (#6# enzyme expression analysis, 59 different samples <47>) <47> lung UBERON:0002048 lung adenocarcinoma DOID:3910 1.1.1.184 Y Y ECO:0000006 Pubmed:16103446 BRENDA <47> Takenaka, K.; Ogawa, E.; Oyanagi, H.; Wada, H.; Tanaka, F.: Carbonyl reductase expression and its clinical significance in non-small-cell lung cancer. Cancer Epidemiol. Biomarkers Prev. (2005) 14, 1972-1975. {Pubmed:16103446} AAP, ASD 12/7/2011 1111 3300034050 curatus/Jenn Q8TBF2 127281 FAM213B Homo sapiens 9606 Comment/tissue specificity #1,2,12# kidney (#1# low activity <41>; #2# proximal tubule, the enzyme is associated with the cyclooxygenase-I, COX-I <34>; #1# AKR1B3 <47>) <25,31,34,41,47> kidney BTO:0000671 kidney tubule cell CL:1000507 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP 12/7/2011 1111 3300034052 curatus/Jenn Q8TBF2 127281 FAM213B Homo sapiens 9606 Comment/tissue specificity #1,2,12# kidney (#1# low activity <41>; #2# proximal tubule, the enzyme is associated with the cyclooxygenase-I, COX-I <34>; #1# AKR1B3 <47>) <25,31,34,41,47> kidney UBERON:0002113 kidney tubule cell CL:1000507 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP 12/7/2011 1111 3300034053 curatus/Jenn Q8TBF2 127281 FAM213B Homo sapiens 9606 Comment/tissue specificity #1,2,12# kidney (#1# low activity <41>; #2# proximal tubule, the enzyme is associated with the cyclooxygenase-I, COX-I <34>; #1# AKR1B3 <47>) <25,31,34,41,47> renal proximal tubule BTO:0001498 kidney tubule cell CL:1000507 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP 12/7/2011 1111 3300034054 curatus/Jenn Q8TBF2 127281 FAM213B Homo sapiens 9606 Comment/tissue specificity #1,2,12# kidney (#1# low activity <41>; #2# proximal tubule, the enzyme is associated with the cyclooxygenase-I, COX-I <34>; #1# AKR1B3 <47>) <25,31,34,41,47> proximal tubule UBERON:0004134 kidney tubule cell CL:1000507 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP 12/7/2011 1111 3300034055 curatus/Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,12# more (#3# immunocytochemical localization study <26>; #2# enzyme tissue localization analysis <34>; #12# isozyme expression levels and tissue distribution, overview <31>; #1# low activity in deferent duct and epididymidis <41>) <26,31,34,41> renal proximal tubule BTO:0001498 kidney tubule cell CL:1000507 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034056 curatus/Jenn P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,12# more (#3# immunocytochemical localization study <26>; #2# enzyme tissue localization analysis <34>; #12# isozyme expression levels and tissue distribution, overview <31>; #1# low activity in deferent duct and epididymidis <41>) <26,31,34,41> proximal tubule UBERON:0004134 kidney tubule cell CL:1000507 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034057 curatus/Jenn Q8TBF2 127281 FAM213B Homo sapiens 9606 Comment/tissue specificity #2# renal cell carcinoma (#2# the enzyme is associated with the cyclooxygenase-II, COX-II <34>) <34> renal cell carcinoma cell BTO:0000037 renal cell carcinoma DOID:4450 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP 12/7/2011 1111 3300034058 curatus/Jenn Q8TBF2 127281 FAM213B Homo sapiens 9606 Comment/tissue specificity #2# renal cell carcinoma (#2# the enzyme is associated with the cyclooxygenase-II, COX-II <34>) <34> lung UBERON:0002048 renal cell carcinoma DOID:4450 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP 12/7/2011 1111 3300034059 curatus/Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity #2# renal cell carcinoma (#2# the enzyme is associated with the cyclooxygenase-II, COX-II <34>) <34> renal cell carcinoma cell BTO:0000037 renal cell carcinoma DOID:4450 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034060 curatus/Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity #2# renal cell carcinoma (#2# the enzyme is associated with the cyclooxygenase-II, COX-II <34>) <34> renal tubule UBERON:0009773 renal cell carcinoma DOID:4450 1.1.1.188 Y Y ECO:0000006 Pubmed:16157291 BRENDA <34> Sakurai, M.; Oishi, K.; Watanabe, K.: Localization of cyclooxygenases-1 and -2, and prostaglandin F synthase in human kidney and renal cell carcinoma. Biochem. Biophys. Res. Commun. (2005) 338, 82-86. {Pubmed:16157291} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034061 curatus/Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity #3# SK-N-AS cell (#3# human neuroblastoma cell <55>) <55> SK-N-AS cell BTO:0002827 neuroblastoma DOID:769 1.14.99.1 Y Y ECO:0000006 Pubmed:16185670 BRENDA <55> Zhang, D.; Wood, C.E.: Neuronal prostaglandin endoperoxide synthase 2 responses to oxygen and glucose deprivation are mediated by mitogen-activated protein kinase ERK1/2. Brain Res. (2005) 1060, 100-107. {Pubmed:16185670}; PENTACON Notes: Oxygen and glucose deprivation AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034062 curatus/Jenn P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #4,26# A-549 cell (#4# lung adenocarcinoma cell line <64>; #26# type II alveolar epithelial cell line, AR expression analysis <57>) <57,64> A-549 cell BTO:0000018 bronchiolo-alveolar adenocarcinoma DOID:4926 homocysteine CHEBI:17230 1.1.1.21 Y Y ECO:0000006 Pubmed:16225842 BRENDA <57> Jiang, H.; Wang, X.F.; Fang, L.; Tang, C.; Zhu, Y.; Wang, X.: Upregulation of aldose reductase by homocysteine in type II alveolar epithelial cells. Biochem. Biophys. Res. Commun. (2005) 337, 1084-1091. {Pubmed:16225842}; PENTACON Notes: Expression induced by Homocysteine AAP, DGA, ASD 12/7/2011 1111 3300034063 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,11,13,16,17,18,19,20,21# more (#2# DU4475 cell, highest protein expression <24>; #5,13,18# endometrium, located in epithelial, glandular and stromal cells <19>; #16# endometrium, mainly in luminal and glandular epithelium, higher levels of PGES-1 mRNA occur during pregnancy on days 10-11 when compared with days 12-17, intermediate levels of PGES-1 protein are observed on days 10-13, afterwards, PGES-1 mRNA and protein expression decrease, followed by an increase from days 18-19 or 22-23 of pregnancy, highest mRNA and protein levels are reached on days 24-25 <20>; #2# Hs 578T cell <24>; #2# in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer <25>; #17# protein expression occurs in luminal epithelial and stromal cells around the implanting blastocyst on day 5 of pregnancy, with the progression of implantation to day 6, the protein is mainly expressed in the cells of the primary decidual zone <22>; #11# seminal vesicular gland <27>; #2# ZR-75-1 cell <24>; #1# distribution of mPEGS-2, overview <29>; #3# the enzyme expression is altered in rats with nephrogenic and central diabetes insipidus, expression overview <28>; #19,20# tissue distribution of isozme expression, overview <31>; #21# tissue distribution of isozyme expression, overview <31>; #2# tissue-specific expression analysis <32>; #1# no microsomal enzyme immunostaining or mRNA in thecal cell or oocyte <43>; #2# MPGES-1 is not detected in LNCaP cells <81>) <19,20,22,24,25,27,28,29,31,32,43,81> mammary epithelial cell line BTO:0002768 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170}; PENTACON Notes: DU4475 cell line AAP, DGA 12/7/2011 1111 3300034068 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,11,13,16,17,18,19,20,21# more (#2# DU4475 cell, highest protein expression <24>; #5,13,18# endometrium, located in epithelial, glandular and stromal cells <19>; #16# endometrium, mainly in luminal and glandular epithelium, higher levels of PGES-1 mRNA occur during pregnancy on days 10-11 when compared with days 12-17, intermediate levels of PGES-1 protein are observed on days 10-13, afterwards, PGES-1 mRNA and protein expression decrease, followed by an increase from days 18-19 or 22-23 of pregnancy, highest mRNA and protein levels are reached on days 24-25 <20>; #2# Hs 578T cell <24>; #2# in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer <25>; #17# protein expression occurs in luminal epithelial and stromal cells around the implanting blastocyst on day 5 of pregnancy, with the progression of implantation to day 6, the protein is mainly expressed in the cells of the primary decidual zone <22>; #11# seminal vesicular gland <27>; #2# ZR-75-1 cell <24>; #1# distribution of mPEGS-2, overview <29>; #3# the enzyme expression is altered in rats with nephrogenic and central diabetes insipidus, expression overview <28>; #19,20# tissue distribution of isozme expression, overview <31>; #21# tissue distribution of isozyme expression, overview <31>; #2# tissue-specific expression analysis <32>; #1# no microsomal enzyme immunostaining or mRNA in thecal cell or oocyte <43>; #2# MPGES-1 is not detected in LNCaP cells <81>) <19,20,22,24,25,27,28,29,31,32,43,81> Hs-578T cell BTO:0003885 breast carcinoma DOID:3459 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170} AAP, DGA 12/7/2011 1111 3300034069 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity Hs-578T cell Hs-578T cell BTO:0003885 breast carcinoma DOID:3459 Y Y ECO:0000006 Pubmed:16353170 PENTACON Added by PENTACON AAP, DGA, AAP-M, ASD 0 3300034070 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,11,13,16,17,18,19,20,21# more (#2# DU4475 cell, highest protein expression <24>; #5,13,18# endometrium, located in epithelial, glandular and stromal cells <19>; #16# endometrium, mainly in luminal and glandular epithelium, higher levels of PGES-1 mRNA occur during pregnancy on days 10-11 when compared with days 12-17, intermediate levels of PGES-1 protein are observed on days 10-13, afterwards, PGES-1 mRNA and protein expression decrease, followed by an increase from days 18-19 or 22-23 of pregnancy, highest mRNA and protein levels are reached on days 24-25 <20>; #2# Hs 578T cell <24>; #2# in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer <25>; #17# protein expression occurs in luminal epithelial and stromal cells around the implanting blastocyst on day 5 of pregnancy, with the progression of implantation to day 6, the protein is mainly expressed in the cells of the primary decidual zone <22>; #11# seminal vesicular gland <27>; #2# ZR-75-1 cell <24>; #1# distribution of mPEGS-2, overview <29>; #3# the enzyme expression is altered in rats with nephrogenic and central diabetes insipidus, expression overview <28>; #19,20# tissue distribution of isozme expression, overview <31>; #21# tissue distribution of isozyme expression, overview <31>; #2# tissue-specific expression analysis <32>; #1# no microsomal enzyme immunostaining or mRNA in thecal cell or oocyte <43>; #2# MPGES-1 is not detected in LNCaP cells <81>) <19,20,22,24,25,27,28,29,31,32,43,81> ZR-75-1 cell BTO:0003136 ductal carcinoma DOID:3007 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170} AAP, DGA 12/7/2011 1111 3300034071 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# MCF-7 cell <24,58> MCF-7 cell BTO:0000093 breast adenocarcinoma DOID:3458 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170} AAP, DGA 12/7/2011 1111 3300034072 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# breast (#2# in normal breast the enzyme is seen in myoepithelial cells and in stromal fibroblasts and vascular smooth muscle, in breast disease, the enzyme is observed in epithelial cells adjacent to cancer, in scattered foci of fibrocystic disease, in ductal carcinoma in situ and in invasive cancers, in addition to myoepithelial cells <24>) <24> breast BTO:0000149 myoepithelial cell CL:0000185 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170}; PENTACON Notes: Expression of mPGES-1 was restricted to myoepithelial cells in normal lobules and in cancers. Expression in epithelial cells was seen in in situ breast cancers and in infiltrating carcinomas but not in normal ducts. AAP, DGA 12/7/2011 1111 3300034073 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# breast (#2# in normal breast the enzyme is seen in myoepithelial cells and in stromal fibroblasts and vascular smooth muscle, in breast disease, the enzyme is observed in epithelial cells adjacent to cancer, in scattered foci of fibrocystic disease, in ductal carcinoma in situ and in invasive cancers, in addition to myoepithelial cells <24>) <24> breast UBERON:0000310 myoepithelial cell CL:0000185 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170}; PENTACON Notes: Expression of mPGES-1 was restricted to myoepithelial cells in normal lobules and in cancers. Expression in epithelial cells was seen in in situ breast cancers and in infiltrating carcinomas but not in normal ducts. AAP, DGA 12/7/2011 1111 3300034074 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# breast (#2# in normal breast the enzyme is seen in myoepithelial cells and in stromal fibroblasts and vascular smooth muscle, in breast disease, the enzyme is observed in epithelial cells adjacent to cancer, in scattered foci of fibrocystic disease, in ductal carcinoma in situ and in invasive cancers, in addition to myoepithelial cells <24>) <24> breast BTO:0000149 epithelial cell CL:0000066 ductal carcinoma DOID:3007 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170}; PENTACON Notes: Expression of mPGES-1 was restricted to myoepithelial cells in normal lobules and in cancers. Expression in epithelial cells was seen in in situ breast cancers and in infiltrating carcinomas but not in normal ducts. AAP, DGA 12/7/2011 1111 3300034075 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# breast (#2# in normal breast the enzyme is seen in myoepithelial cells and in stromal fibroblasts and vascular smooth muscle, in breast disease, the enzyme is observed in epithelial cells adjacent to cancer, in scattered foci of fibrocystic disease, in ductal carcinoma in situ and in invasive cancers, in addition to myoepithelial cells <24>) <24> breast UBERON:0000310 epithelial cell CL:0000066 ductal carcinoma DOID:3007 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170}; PENTACON Notes: Expression of mPGES-1 was restricted to myoepithelial cells in normal lobules and in cancers. Expression in epithelial cells was seen in in situ breast cancers and in infiltrating carcinomas but not in normal ducts. AAP, DGA 12/7/2011 1111 3300034076 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# breast (#2# in normal breast the enzyme is seen in myoepithelial cells and in stromal fibroblasts and vascular smooth muscle, in breast disease, the enzyme is observed in epithelial cells adjacent to cancer, in scattered foci of fibrocystic disease, in ductal carcinoma in situ and in invasive cancers, in addition to myoepithelial cells <24>) <24> breast BTO:0000149 vascular associated smooth muscle cell CL:0000359 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170}; PENTACON Notes: Expression of mPGES-1 was restricted to myoepithelial cells in normal lobules and in cancers. Expression in epithelial cells was seen in in situ breast cancers and in infiltrating carcinomas but not in normal ducts. AAP, DGA 12/7/2011 1111 3300034077 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# breast (#2# in normal breast the enzyme is seen in myoepithelial cells and in stromal fibroblasts and vascular smooth muscle, in breast disease, the enzyme is observed in epithelial cells adjacent to cancer, in scattered foci of fibrocystic disease, in ductal carcinoma in situ and in invasive cancers, in addition to myoepithelial cells <24>) <24> breast UBERON:0000310 vascular associated smooth muscle cell CL:0000359 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170}; PENTACON Notes: Expression of mPGES-1 was restricted to myoepithelial cells in normal lobules and in cancers. Expression in epithelial cells was seen in in situ breast cancers and in infiltrating carcinomas but not in normal ducts. AAP, DGA 12/7/2011 1111 3300034078 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity In the endothelial cells of medium and small-sized blood vessels within the tumour, upregulation of COX-2 endothelial cell CL:0000115 ductal carcinoma DOID:3007 Y Y ECO:0000006 Pubmed:16353170 PENTACON Added by PENTACON; PENTACON Notes: In the endothelial cells of medium and small-sized blood vessels within the tumour, upregulation of COX-2. AAP, DGA, AAP-M, ASD 0 3300034079 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# MDA-MB-231 cell <24,58> MDA-MB-231 cell BTO:0000815 adenocarcinoma DOID:299 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170} AAP, DGA 12/7/2011 1111 3300034081 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity #2# MDA-MB-231 cell <24,58> MDA-MB-231 cell BTO:0000815 adenocarcinoma DOID:299 Y Y ECO:0000006 Pubmed:16353170 PENTACON Added by PENTACON AAP, DGA, AAP-M, ASD 0 3300034082 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# MCF-10A cell <24> MCF-10A cell BTO:0001939 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170} AAP, DGA 12/7/2011 1111 3300034083 Jenn P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity #2# MCF-10A cell <24> MCF-10A cell BTO:0001939 Y Y ECO:0000006 Pubmed:16353170 PENTACON Added by PENTACON AAP, DGA, AAP-M, ASD 0 3300034084 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# T-47D cell <24,58> T-47D cell BTO:0001248 breast carcinoma DOID:3459 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170} AAP, DGA 12/7/2011 1111 3300034085 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# SK-BR-3 cell (#2# lowest protein expression <24>) <24> SK-BR-3 cell BTO:0002419 adenocarcinoma DOID:299 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170} AAP, DGA 12/7/2011 1111 3300034086 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #2# MDA-MB-468 cell (#2# lowest protein expression <24>) <24> MDA-MB-468 cell BTO:0001570 adenocarcinoma DOID:299 5.3.99.3 Y Y ECO:0000006 Pubmed:16353170 BRENDA <24> Mehrotra, S.; Morimiya, A.; Agarwal, B.; Konger, R.; Badve, S.: Microsomal prostaglandin E(2) synthase-1 in breast cancer: a potential target for therapy. J. Pathol. (2006) 208, 356-363. {Pubmed:16353170} AAP, DGA 12/7/2011 1111 3300034088 curatus/Jenn P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,6,7,8,10,11,25,29,30# liver (#2# moderate expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #11# major form of soluble NADPH-dependent all-trans-retinal dehydrogenase in liver <58>; #25# black and white donors, show similar CBR1 mRNA and protein levels. CBR1 1096G-A polymorphism is common in samples from white donors <78>; #25# CBR1 is prominently expressed in the liver <76>; #29# low expression of CBR3 <76>) <9,11,15,24,29,33,38,39,40,48,54,58,61,74,76,78> liver BTO:0000759 1.1.1.184 Y Y ECO:0000006 Pubmed:16382174 BRENDA <48> Slupe, A.; Williams, B.; Larson, C.; Lee, L.M.; Primbs, T.; Bruesch, A.J.; Bjorklund, C.; Warner, D.L.; Peloquin, J.; Shadle, S.E.; Gambliel, H.A.; Cusack, B.J.; Olson, R.D.; Charlier, H.A.: Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductase. Cardiovasc. Toxicol. (2005) 5, 365-376. {Pubmed:16382174}; PENTACON Notes: liver CBR1 cDNA expressed in a recombinant system AAP, ASD 12/7/2011 1111 3300034090 curatus/Jenn P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,6,7,8,10,11,25,29,30# liver (#2# moderate expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #11# major form of soluble NADPH-dependent all-trans-retinal dehydrogenase in liver <58>; #25# black and white donors, show similar CBR1 mRNA and protein levels. CBR1 1096G-A polymorphism is common in samples from white donors <78>; #25# CBR1 is prominently expressed in the liver <76>; #29# low expression of CBR3 <76>) <9,11,15,24,29,33,38,39,40,48,54,58,61,74,76,78> liver UBERON:0002107 1.1.1.184 Y Y ECO:0000006 Pubmed:16382174 BRENDA <48> Slupe, A.; Williams, B.; Larson, C.; Lee, L.M.; Primbs, T.; Bruesch, A.J.; Bjorklund, C.; Warner, D.L.; Peloquin, J.; Shadle, S.E.; Gambliel, H.A.; Cusack, B.J.; Olson, R.D.; Charlier, H.A.: Reduction of 13-deoxydoxorubicin and daunorubicinol anthraquinones by human carbonyl reductase. Cardiovasc. Toxicol. (2005) 5, 365-376. {Pubmed:16382174}; PENTACON Notes: liver CBR1 cDNA expressed in a recombinant system AAP, ASD 12/7/2011 1111 3300034091 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,11,13,16,17,18,19,20,21# more (#2# DU4475 cell, highest protein expression <24>; #5,13,18# endometrium, located in epithelial, glandular and stromal cells <19>; #16# endometrium, mainly in luminal and glandular epithelium, higher levels of PGES-1 mRNA occur during pregnancy on days 10-11 when compared with days 12-17, intermediate levels of PGES-1 protein are observed on days 10-13, afterwards, PGES-1 mRNA and protein expression decrease, followed by an increase from days 18-19 or 22-23 of pregnancy, highest mRNA and protein levels are reached on days 24-25 <20>; #2# Hs 578T cell <24>; #2# in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer <25>; #17# protein expression occurs in luminal epithelial and stromal cells around the implanting blastocyst on day 5 of pregnancy, with the progression of implantation to day 6, the protein is mainly expressed in the cells of the primary decidual zone <22>; #11# seminal vesicular gland <27>; #2# ZR-75-1 cell <24>; #1# distribution of mPEGS-2, overview <29>; #3# the enzyme expression is altered in rats with nephrogenic and central diabetes insipidus, expression overview <28>; #19,20# tissue distribution of isozme expression, overview <31>; #21# tissue distribution of isozyme expression, overview <31>; #2# tissue-specific expression analysis <32>; #1# no microsomal enzyme immunostaining or mRNA in thecal cell or oocyte <43>; #2# MPGES-1 is not detected in LNCaP cells <81>) <19,20,22,24,25,27,28,29,31,32,43,81> synovial tissue BTO:0001338 fibroblast CL:0000057 rheumatoid arthritis DOID:7148 5.3.99.3 in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer Y Y ECO:0000033 Pubmed:16399384 BRENDA <25> Pettersson, P.L.; Thoren, S.; Jakobsson, P.J.: Human microsomal prostaglandin E synthase 1: a member of the MAPEG protein superfamily. Methods Enzymol. (2005) 401, 147-161. {Pubmed:16399384} AAP, DGA 12/7/2011 1111 3300034092 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,11,13,16,17,18,19,20,21# more (#2# DU4475 cell, highest protein expression <24>; #5,13,18# endometrium, located in epithelial, glandular and stromal cells <19>; #16# endometrium, mainly in luminal and glandular epithelium, higher levels of PGES-1 mRNA occur during pregnancy on days 10-11 when compared with days 12-17, intermediate levels of PGES-1 protein are observed on days 10-13, afterwards, PGES-1 mRNA and protein expression decrease, followed by an increase from days 18-19 or 22-23 of pregnancy, highest mRNA and protein levels are reached on days 24-25 <20>; #2# Hs 578T cell <24>; #2# in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer <25>; #17# protein expression occurs in luminal epithelial and stromal cells around the implanting blastocyst on day 5 of pregnancy, with the progression of implantation to day 6, the protein is mainly expressed in the cells of the primary decidual zone <22>; #11# seminal vesicular gland <27>; #2# ZR-75-1 cell <24>; #1# distribution of mPEGS-2, overview <29>; #3# the enzyme expression is altered in rats with nephrogenic and central diabetes insipidus, expression overview <28>; #19,20# tissue distribution of isozme expression, overview <31>; #21# tissue distribution of isozyme expression, overview <31>; #2# tissue-specific expression analysis <32>; #1# no microsomal enzyme immunostaining or mRNA in thecal cell or oocyte <43>; #2# MPGES-1 is not detected in LNCaP cells <81>) <19,20,22,24,25,27,28,29,31,32,43,81> layer of synovial tissue UBERON:0007616 fibroblast CL:0000057 rheumatoid arthritis DOID:7148 5.3.99.3 in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer Y Y ECO:0000033 Pubmed:16399384 BRENDA <25> Pettersson, P.L.; Thoren, S.; Jakobsson, P.J.: Human microsomal prostaglandin E synthase 1: a member of the MAPEG protein superfamily. Methods Enzymol. (2005) 401, 147-161. {Pubmed:16399384} AAP, DGA 12/7/2011 1111 3300034093 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,11,13,16,17,18,19,20,21# more (#2# DU4475 cell, highest protein expression <24>; #5,13,18# endometrium, located in epithelial, glandular and stromal cells <19>; #16# endometrium, mainly in luminal and glandular epithelium, higher levels of PGES-1 mRNA occur during pregnancy on days 10-11 when compared with days 12-17, intermediate levels of PGES-1 protein are observed on days 10-13, afterwards, PGES-1 mRNA and protein expression decrease, followed by an increase from days 18-19 or 22-23 of pregnancy, highest mRNA and protein levels are reached on days 24-25 <20>; #2# Hs 578T cell <24>; #2# in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer <25>; #17# protein expression occurs in luminal epithelial and stromal cells around the implanting blastocyst on day 5 of pregnancy, with the progression of implantation to day 6, the protein is mainly expressed in the cells of the primary decidual zone <22>; #11# seminal vesicular gland <27>; #2# ZR-75-1 cell <24>; #1# distribution of mPEGS-2, overview <29>; #3# the enzyme expression is altered in rats with nephrogenic and central diabetes insipidus, expression overview <28>; #19,20# tissue distribution of isozme expression, overview <31>; #21# tissue distribution of isozyme expression, overview <31>; #2# tissue-specific expression analysis <32>; #1# no microsomal enzyme immunostaining or mRNA in thecal cell or oocyte <43>; #2# MPGES-1 is not detected in LNCaP cells <81>) <19,20,22,24,25,27,28,29,31,32,43,81> synovial tissue BTO:0001338 macrophage CL:0000235 rheumatoid arthritis DOID:7148 5.3.99.3 in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer Y Y ECO:0000033 Pubmed:16399384 BRENDA <25> Pettersson, P.L.; Thoren, S.; Jakobsson, P.J.: Human microsomal prostaglandin E synthase 1: a member of the MAPEG protein superfamily. Methods Enzymol. (2005) 401, 147-161. {Pubmed:16399384} AAP, DGA 12/7/2011 1111 3300034094 curatus/Jenn O14684 9536 PTGES Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,11,13,16,17,18,19,20,21# more (#2# DU4475 cell, highest protein expression <24>; #5,13,18# endometrium, located in epithelial, glandular and stromal cells <19>; #16# endometrium, mainly in luminal and glandular epithelium, higher levels of PGES-1 mRNA occur during pregnancy on days 10-11 when compared with days 12-17, intermediate levels of PGES-1 protein are observed on days 10-13, afterwards, PGES-1 mRNA and protein expression decrease, followed by an increase from days 18-19 or 22-23 of pregnancy, highest mRNA and protein levels are reached on days 24-25 <20>; #2# Hs 578T cell <24>; #2# in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer <25>; #17# protein expression occurs in luminal epithelial and stromal cells around the implanting blastocyst on day 5 of pregnancy, with the progression of implantation to day 6, the protein is mainly expressed in the cells of the primary decidual zone <22>; #11# seminal vesicular gland <27>; #2# ZR-75-1 cell <24>; #1# distribution of mPEGS-2, overview <29>; #3# the enzyme expression is altered in rats with nephrogenic and central diabetes insipidus, expression overview <28>; #19,20# tissue distribution of isozme expression, overview <31>; #21# tissue distribution of isozyme expression, overview <31>; #2# tissue-specific expression analysis <32>; #1# no microsomal enzyme immunostaining or mRNA in thecal cell or oocyte <43>; #2# MPGES-1 is not detected in LNCaP cells <81>) <19,20,22,24,25,27,28,29,31,32,43,81> layer of synovial tissue UBERON:0007616 macrophage CL:0000235 rheumatoid arthritis DOID:7148 5.3.99.3 in patients with rheumatoid arthritis, the protein is overexpressed in synovial tissue, particularly by macrophages and fibroblasts in the synovial lining layer Y Y ECO:0000033 Pubmed:16399384 BRENDA <25> Pettersson, P.L.; Thoren, S.; Jakobsson, P.J.: Human microsomal prostaglandin E synthase 1: a member of the MAPEG protein superfamily. Methods Enzymol. (2005) 401, 147-161. {Pubmed:16399384} AAP, DGA 12/7/2011 1111 3300034095 curatus/Jenn P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4# astrocyte (#4# lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive astrocytes in the chronic multiple sclerosis <43>) <43> astrocyte BTO:0000099 astrocyte CL:0000127 multiple sclerosis DOID:2377 5.3.99.2 Y Y ECO:0000006 Pubmed:16409554 BRENDA <43> Kagitani-Shimono, K.; Mohri, I.; Oda, H.; Ozono, K.; Suzuki, K.; Urade, Y.; Taniike, M.: Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis. Neuropathol. Appl. Neurobiol. (2006) 32, 64-73. {Pubmed:16409554} (c); PENTACON Notes: the expression of L-PGDS was upregulated in the OLs and astrocytes under stress. The majority of L-PGDS-positive cells in the shadow plaques were OLs; however, about 85% of L-PGDS-positive cells were astrocytes in chronic plaques. AAP, DGA 12/7/2011 1111 3300034098 curatus/Jenn P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4# astrocyte (#4# lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive astrocytes in the chronic multiple sclerosis <43>) <43> brain white matter UBERON:0003544 astrocyte CL:0000127 multiple sclerosis DOID:2377 5.3.99.2 Y Y ECO:0000006 Pubmed:16409554 BRENDA <43> Kagitani-Shimono, K.; Mohri, I.; Oda, H.; Ozono, K.; Suzuki, K.; Urade, Y.; Taniike, M.: Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis. Neuropathol. Appl. Neurobiol. (2006) 32, 64-73. {Pubmed:16409554} (c); PENTACON Notes: the expression of L-PGDS was upregulated in the OLs and astrocytes under stress. The majority of L-PGDS-positive cells in the shadow plaques were OLs; however, about 85% of L-PGDS-positive cells were astrocytes in chronic plaques. AAP, DGA 12/7/2011 1111 3300034099 curatus/Jenn P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4# oligodendrocyte (#4# lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes in the chronic multiple sclerosis <43>) <43> oligodendrocyte BTO:0000962 oligodendrocyte CL:0000128 multiple sclerosis DOID:2377 5.3.99.2 Y Y ECO:0000006 Pubmed:16409554 BRENDA <43> Kagitani-Shimono, K.; Mohri, I.; Oda, H.; Ozono, K.; Suzuki, K.; Urade, Y.; Taniike, M.: Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis. Neuropathol. Appl. Neurobiol. (2006) 32, 64-73. {Pubmed:16409554} (c); PENTACON Notes: the expression of L-PGDS was upregulated in the OLs and astrocytes under stress. The majority of L-PGDS-positive cells in the shadow plaques were OLs; however, about 85% of L-PGDS-positive cells were astrocytes in chronic plaques. AAP, DGA 12/7/2011 1111 3300034101 curatus/Jenn P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4# oligodendrocyte (#4# lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes in the chronic multiple sclerosis <43>) <43> brain white matter UBERON:0003544 oligodendrocyte CL:0000128 multiple sclerosis DOID:2377 5.3.99.2 Y Y ECO:0000006 Pubmed:16409554 BRENDA <43> Kagitani-Shimono, K.; Mohri, I.; Oda, H.; Ozono, K.; Suzuki, K.; Urade, Y.; Taniike, M.: Lipocalin-type prostaglandin D synthase (beta-trace) is upregulated in the alphaB-crystallin-positive oligodendrocytes and astrocytes in the chronic multiple sclerosis. Neuropathol. Appl. Neurobiol. (2006) 32, 64-73. {Pubmed:16409554} (c); PENTACON Notes: the expression of L-PGDS was upregulated in the OLs and astrocytes under stress. The majority of L-PGDS-positive cells in the shadow plaques were OLs; however, about 85% of L-PGDS-positive cells were astrocytes in chronic plaques. AAP, DGA 12/7/2011 1111 3300034102 curatus/Jenn P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,12,14,15# lung (#1# low activity <41>; #5# contractile interstitial cells <8>; #5# two different active sites <9,12,13,17>; #2,5# lung-type isozyme <22,29,32>; #5# PGH2 9-,11-endoperoxide reductase activity lung-type isozyme <29>; #1# PGFS-I, lung-type isozyme <33>) <1,5,6,8,9,10,12,13,15,17,21,22,24,25,29,31,32,33,35,41,47> lung BTO:0000763 1.1.1.188 Y Y ECO:0000006 Pubmed:16475787 BRENDA <35> Komoto, J.; Yamada, T.; Watanabe, K.; Woodward, D.F.; Takusagawa, F.: Prostaglandin F2alpha formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost. Biochemistry (2006) 45, 1987-1996. {Pubmed:16475787}; PENTACON Notes: liver cDNA expressed in recombinant system AAP, ASD 12/7/2011 1111 3300034105 curatus/Jenn P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,12,14,15# lung (#1# low activity <41>; #5# contractile interstitial cells <8>; #5# two different active sites <9,12,13,17>; #2,5# lung-type isozyme <22,29,32>; #5# PGH2 9-,11-endoperoxide reductase activity lung-type isozyme <29>; #1# PGFS-I, lung-type isozyme <33>) <1,5,6,8,9,10,12,13,15,17,21,22,24,25,29,31,32,33,35,41,47> lung UBERON:0002048 1.1.1.188 Y Y ECO:0000006 Pubmed:16475787 BRENDA <35> Komoto, J.; Yamada, T.; Watanabe, K.; Woodward, D.F.; Takusagawa, F.: Prostaglandin F2alpha formation from prostaglandin H2 by prostaglandin F synthase (PGFS): crystal structure of PGFS containing bimatoprost. Biochemistry (2006) 45, 1987-1996. {Pubmed:16475787}; PENTACON Notes: liver cDNA expressed in recombinant system AAP, ASD 12/7/2011 1111 3300034106 curatus Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity #2,5,7,13,16,18,22# myometrium (#5# expressed to a lesser extent <19>; #16# intermediate abundance of the protein <20>; #2# isoform mPGES-1 localizes mostly in myometrial and vascular smooth muscle cells of pregnant women. Isoform cPGES is diffusely located throughout the myometrium. Expression of COX-2 and isoform mPGES-1 mRNA with term labour, whereas cPGES expression does not change. Interleukin 1beta stimulates release of prostaglandin E2 by myometrical smooth muscle cells and increases COX-2 and mPGES-1 mRNA and protein expression <48>; #22# isoform mPGES-2 protein is largely in stromal cells surrounding smooth vascular muscle. Expression of mPGES-2 mRNA increases with term labour and preterm labour <48>; #7# myometrial smooth muscle cell <39>) <19,20,39,48> myometrium BTO:0000907 5.3.99.3 Y Y ECO:0000006 Pubmed:17105783 BRENDA <48> Astle, S.; Newton, R.; Thornton, S.; Vatish, M.; Slater, D.M.: Expression and regulation of prostaglandin E synthase isoforms in human myometrium with labour. Mol. Hum. Reprod. (2007) 13, 69-75. {Pubmed:17105783} AAP 12/7/2011 1111 3300034109 curatus Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity #2,5,7,13,16,18,22# myometrium (#5# expressed to a lesser extent <19>; #16# intermediate abundance of the protein <20>; #2# isoform mPGES-1 localizes mostly in myometrial and vascular smooth muscle cells of pregnant women. Isoform cPGES is diffusely located throughout the myometrium. Expression of COX-2 and isoform mPGES-1 mRNA with term labour, whereas cPGES expression does not change. Interleukin 1beta stimulates release of prostaglandin E2 by myometrical smooth muscle cells and increases COX-2 and mPGES-1 mRNA and protein expression <48>; #22# isoform mPGES-2 protein is largely in stromal cells surrounding smooth vascular muscle. Expression of mPGES-2 mRNA increases with term labour and preterm labour <48>; #7# myometrial smooth muscle cell <39>) <19,20,39,48> myometrium UBERON:0001296 5.3.99.3 Y Y ECO:0000006 Pubmed:17105783 BRENDA <48> Astle, S.; Newton, R.; Thornton, S.; Vatish, M.; Slater, D.M.: Expression and regulation of prostaglandin E synthase isoforms in human myometrium with labour. Mol. Hum. Reprod. (2007) 13, 69-75. {Pubmed:17105783} AAP 12/7/2011 1111 3300034110 curatus Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/tissue specificity #2,22# vascular smooth muscle cell (#22# cells express both microsomal isoforms mPGES-1 and mPGES-2 and cytosolic isoform cPGES <46>; #2# cells express both microsomal isoforms mPGES-1 and mPGES-2 and cytosolic isoform cPGES. Isoform mPGES-1 contributes most to total activity and is induced by interleukin IL-1beta, which in turn reduces the ability of cells to produce prostaglandin I2 <46>) <46> vascular smooth muscle cell BTO:0004578 5.3.99.3 Y Y ECO:0000006 Pubmed:17403097 BRENDA <46> Camacho, M.; Gerboles, E.; Escudero, J.R.; Anton, R.; Garcia-Moll, X.; Vila, L.: Microsomal prostaglandin E synthase-1, which is not coupled to a particular cyclooxygenase isoenzyme, is essential for prostaglandin E(2) biosynthesis in vascular smooth muscle cells. J. Thromb. Haemost. (2007) 5, 1411-1419. {Pubmed:17403097} AAP 12/7/2011 1111 3300034112 curatus O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity #27# pancreas <65> pancreas BTO:0000988 1.1.1.184 Y Y Pubmed:18493841 BRENDA <65> Miura, T.; Nishinaka, T.; Terada, T.: Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol. Cell. Biochem. (2008) 315, 113-121. {Pubmed:18493841} AAP, ASD 12/7/2011 1111 3300034114 curatus O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity #27# pancreas <65> pancreas UBERON:0001264 1.1.1.184 Y Y Pubmed:18493841 BRENDA <65> Miura, T.; Nishinaka, T.; Terada, T.: Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol. Cell. Biochem. (2008) 315, 113-121. {Pubmed:18493841} AAP, ASD 12/7/2011 1111 3300034115 curatus O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity #27# prostate (#27# lower expression in prostate and testis than in ovary <65>) <65> lung UBERON:0002048 1.1.1.184 Y Y ECO:0000006 Pubmed:18493841 PENTACON <65> Miura, T.; Nishinaka, T.; Terada, T.: Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol. Cell. Biochem. (2008) 315, 113-121. {Pubmed:18493841} AAP, ASD 12/7/2011 1111 3300034116 curatus O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity #7,10,27,33# ovary (#27# lower expression in prostate and testis than in ovary <65>) <1,65,73> ovary BTO:0000975 1.1.1.184 Y Y Pubmed:18493841 BRENDA <65> Miura, T.; Nishinaka, T.; Terada, T.: Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol. Cell. Biochem. (2008) 315, 113-121. {Pubmed:18493841} AAP, ASD 12/7/2011 1111 3300034120 curatus O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity #7,10,27,33# ovary (#27# lower expression in prostate and testis than in ovary <65>) <1,65,73> female gonad UBERON:0000992 1.1.1.184 Y Y Pubmed:18493841 BRENDA <65> Miura, T.; Nishinaka, T.; Terada, T.: Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol. Cell. Biochem. (2008) 315, 113-121. {Pubmed:18493841} AAP, ASD 12/7/2011 1111 3300034121 curatus O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity #7,10,27,33# ovary (#27# lower expression in prostate and testis than in ovary <65>) <1,65,73> lung BTO:0000763 1.1.1.184 Y Y ECO:0000006 Pubmed:18493841 PENTACON <65> Miura, T.; Nishinaka, T.; Terada, T.: Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol. Cell. Biochem. (2008) 315, 113-121. {Pubmed:18493841} AAP, ASD 12/7/2011 1111 3300034122 curatus O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity #8,27# intestine <38,65> intestine BTO:0000648 1.1.1.184 Y Y Pubmed:18493841 BRENDA <65> Miura, T.; Nishinaka, T.; Terada, T.: Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol. Cell. Biochem. (2008) 315, 113-121. {Pubmed:18493841} AAP, ASD 12/7/2011 1111 3300034123 curatus O75828 874 CBR3 Homo sapiens 9606 Comment/tissue specificity #8,27# intestine <38,65> intestine UBERON:0000160 1.1.1.184 Y Y Pubmed:18493841 BRENDA <65> Miura, T.; Nishinaka, T.; Terada, T.: Different functions between human monomeric carbonyl reductase 3 and carbonyl reductase 1. Mol. Cell. Biochem. (2008) 315, 113-121. {Pubmed:18493841} AAP, ASD 12/7/2011 1111 3300034124 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,6,7,8,10,11,25,29,30# liver (#2# moderate expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #11# major form of soluble NADPH-dependent all-trans-retinal dehydrogenase in liver <58>; #25# black and white donors, show similar CBR1 mRNA and protein levels. CBR1 1096G-A polymorphism is common in samples from white donors <78>; #25# CBR1 is prominently expressed in the liver <76>; #29# low expression of CBR3 <76>) <9,11,15,24,29,33,38,39,40,48,54,58,61,74,76,78> liver BTO:0000759 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034125 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,6,7,8,10,11,25,29,30# liver (#2# moderate expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #11# major form of soluble NADPH-dependent all-trans-retinal dehydrogenase in liver <58>; #25# black and white donors, show similar CBR1 mRNA and protein levels. CBR1 1096G-A polymorphism is common in samples from white donors <78>; #25# CBR1 is prominently expressed in the liver <76>; #29# low expression of CBR3 <76>) <9,11,15,24,29,33,38,39,40,48,54,58,61,74,76,78> liver UBERON:0002107 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034126 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #2,6,8,10,25,29,32,33,34# kidney (#8# high expression level <38>; #2# strong expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #32# high expression of CHCR1 at both the mRNA and protein levels <73>; #33# high expression of CHCR2 at both the mRNA and protein levels <73>; #29# low expression of CBR3 <76>) <28,38,39,40,73,76> kidney BTO:0000671 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034128 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #2,6,8,10,25,29,32,33,34# kidney (#8# high expression level <38>; #2# strong expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #32# high expression of CHCR1 at both the mRNA and protein levels <73>; #33# high expression of CHCR2 at both the mRNA and protein levels <73>; #29# low expression of CBR3 <76>) <28,38,39,40,73,76> kidney UBERON:0002113 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034129 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #25,29# stomach (#29# low expression of CBR3 <76>) <76> small intestine BTO:0000651 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034132 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #25,29# stomach (#29# low expression of CBR3 <76>) <76> small intestine UBERON:0002108 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034133 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #25,29# colon (#29# low expression of CBR3 <76>) <76> colon BTO:0000269 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034134 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #25,29# colon (#29# low expression of CBR3 <76>) <76> colon UBERON:0001155 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034135 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #3,5,6,8,25,29,34# lung (#8# ciliated cells, nonciliated bronchiolar cells, Type II alveolar pneumocytes, epithelial cells of the ducts of the bronchial gland <8>; #29# low expression of CBR3 <76>) <3,6,8,10,12,30,54,73,76> lung BTO:0000763 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034136 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #3,5,6,8,25,29,34# lung (#8# ciliated cells, nonciliated bronchiolar cells, Type II alveolar pneumocytes, epithelial cells of the ducts of the bronchial gland <8>; #29# low expression of CBR3 <76>) <3,6,8,10,12,30,54,73,76> lung UBERON:0002048 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034137 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #8,10,25,29# heart (#8# high expression level <38>; #29# low expression of CBR3 <76>) <19,38,42,43,49,63,68,76> heart BTO:0000562 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA low expression level; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034138 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #8,10,25,29# heart (#8# high expression level <38>; #29# low expression of CBR3 <76>) <19,38,42,43,49,63,68,76> heart UBERON:0000948 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA low expression; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} AAP, ASD 12/7/2011 1111 3300034139 curatus/Jodi P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity #15# breast (#15# normal breast expresses very high levels of AKR1C3 relative to other tissues <45>) <45> breast BTO:0000149 1.1.1.188 Y Y ECO:0000033 Pubmed:19010312 BRENDA <45> Byrns, M.; Penning, T.: Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chem. Biol. Interact. (2009) 178, 221-227. {Pubmed:19010312} AAP, ASD 12/7/2011 1111 3300034141 curatus/Jodi P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity #15# breast (#15# normal breast expresses very high levels of AKR1C3 relative to other tissues <45>) <45> breast UBERON:0000310 1.1.1.188 Y Y ECO:0000033 Pubmed:19010312 BRENDA <45> Byrns, M.; Penning, T.: Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chem. Biol. Interact. (2009) 178, 221-227. {Pubmed:19010312} AAP, ASD 12/7/2011 1111 3300034142 curatus/Jodi P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity #15# breast cancer cell (#15# 18fold increase in the median AKR1C3 mRNA levels in breast cancer patients as compared to those without disease <45>) <45> breast cancer cell BTO:0000150 breast cancer DOID:1612 1.1.1.188 Y Y ECO:0000033 Pubmed:19010312 BRENDA <45> Byrns, M.; Penning, T.: Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chem. Biol. Interact. (2009) 178, 221-227. {Pubmed:19010312} AAP, ASD 12/7/2011 1111 3300034144 curatus/Jodi P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity #15# breast cancer cell (#15# 18fold increase in the median AKR1C3 mRNA levels in breast cancer patients as compared to those without disease <45>) <45> breast UBERON:0000310 breast cancer DOID:1612 1.1.1.188 Y Y ECO:0000033 Pubmed:19010312 BRENDA <45> Byrns, M.; Penning, T.: Type 5 17beta-hydroxysteroid dehydrogenase/prostaglandin F synthase (AKR1C3): Role in breast cancer and inhibition by non-steroidal anti-inflammatory drug analogs. Chem. Biol. Interact. (2009) 178, 221-227. {Pubmed:19010312} AAP, ASD 12/7/2011 1111 3300034145 curatus P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #2,5,11# placenta (#5# expression levels in uninucleated trophoblasts of the placentome of pregnant cows, especially chorionic plate and apical tertiary villi, overview <37>; #2# the prostaglandin synthase expression profile favours production of PGD2, PGE2 and PGF2, with high levels of prostaglandin transporters and catabolic prostaglandin dehydrogenase suggesting rapid prostaglandin turnover <51>) <37,47,51> placenta BTO:0001078 1.1.1.188 Y Y ECO:0000033 Pubmed:19010934 BRENDA <47> Kabututu, Z.; Manin, M.; Pointud, J.C.; Maruyama, T.; Nagata, N.; Lambert, S.; Lefrancois-Martinez, A.M.; Martinez, A.; Urade, Y.: Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7. J. Biochem. (2009) 145, 161-168. {Pubmed:19010934} AAP, DGA, ASD 12/7/2011 1111 3300034147 curatus P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #2,5,11# placenta (#5# expression levels in uninucleated trophoblasts of the placentome of pregnant cows, especially chorionic plate and apical tertiary villi, overview <37>; #2# the prostaglandin synthase expression profile favours production of PGD2, PGE2 and PGF2, with high levels of prostaglandin transporters and catabolic prostaglandin dehydrogenase suggesting rapid prostaglandin turnover <51>) <37,47,51> placenta UBERON:0001987 1.1.1.188 Y Y ECO:0000033 Pubmed:19010934 BRENDA <47> Kabututu, Z.; Manin, M.; Pointud, J.C.; Maruyama, T.; Nagata, N.; Lambert, S.; Lefrancois-Martinez, A.M.; Martinez, A.; Urade, Y.: Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7. J. Biochem. (2009) 145, 161-168. {Pubmed:19010934} AAP, DGA, ASD 12/7/2011 1111 3300034148 curatus P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,12,14,15# lung (#1# low activity <41>; #5# contractile interstitial cells <8>; #5# two different active sites <9,12,13,17>; #2,5# lung-type isozyme <22,29,32>; #5# PGH2 9-,11-endoperoxide reductase activity lung-type isozyme <29>; #1# PGFS-I, lung-type isozyme <33>) <1,5,6,8,9,10,12,13,15,17,21,22,24,25,29,31,32,33,35,41,47> lung BTO:0000763 1.1.1.188 Y Y Pubmed:19010934 BRENDA <47> Kabututu, Z.; Manin, M.; Pointud, J.C.; Maruyama, T.; Nagata, N.; Lambert, S.; Lefrancois-Martinez, A.M.; Martinez, A.; Urade, Y.: Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7. J. Biochem. (2009) 145, 161-168. {Pubmed:19010934} AAP, ASD 12/7/2011 1111 3300034149 curatus P42330 8644 AKR1C3 Homo sapiens 9606 Comment/tissue specificity #1,2,3,5,12,14,15# lung (#1# low activity <41>; #5# contractile interstitial cells <8>; #5# two different active sites <9,12,13,17>; #2,5# lung-type isozyme <22,29,32>; #5# PGH2 9-,11-endoperoxide reductase activity lung-type isozyme <29>; #1# PGFS-I, lung-type isozyme <33>) <1,5,6,8,9,10,12,13,15,17,21,22,24,25,29,31,32,33,35,41,47> lung UBERON:0002048 1.1.1.188 Y Y Pubmed:19010934 BRENDA <47> Kabututu, Z.; Manin, M.; Pointud, J.C.; Maruyama, T.; Nagata, N.; Lambert, S.; Lefrancois-Martinez, A.M.; Martinez, A.; Urade, Y.: Prostaglandin F2alpha synthase activities of aldo-keto reductase 1B1, 1B3 and 1B7. J. Biochem. (2009) 145, 161-168. {Pubmed:19010934} AAP, ASD 12/7/2011 1111 3300034150 curatus/Jodi P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #4# testis <2,5> testis BTO:0001363 1.1.1.21 Y Y ECO:0000006 Pubmed:1901806 BRENDA <2> Tanimoto, T.; Ohta, M.; Tanaka, A.; Ikemoto, I.; Machida, T.: Purification and characterization of human testis aldose and aldehyde reductase. Int. J. Biochem. (1991) 23, 421-428. {Pubmed:1901806} AAP, DGA, ASD 12/7/2011 1111 3300034151 curatus/Jodi P15121 231 AKR1B1 Homo sapiens 9606 Comment/tissue specificity #4# testis <2,5> testis UBERON:0000473 1.1.1.21 Y Y ECO:0000006 Pubmed:1901806 BRENDA <2> Tanimoto, T.; Ohta, M.; Tanaka, A.; Ikemoto, I.; Machida, T.: Purification and characterization of human testis aldose and aldehyde reductase. Int. J. Biochem. (1991) 23, 421-428. {Pubmed:1901806} AAP, DGA, ASD 12/7/2011 1111 3300034152 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,6,7,8,10,11,25,29,30# liver (#2# moderate expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #11# major form of soluble NADPH-dependent all-trans-retinal dehydrogenase in liver <58>; #25# black and white donors, show similar CBR1 mRNA and protein levels. CBR1 1096G-A polymorphism is common in samples from white donors <78>; #25# CBR1 is prominently expressed in the liver <76>; #29# low expression of CBR3 <76>) <9,11,15,24,29,33,38,39,40,48,54,58,61,74,76,78> liver BTO:0000759 1.1.1.184 Y Y ECO:0000006 Pubmed:19022938 BRENDA <78> Gonzalez-Covarrubias, V.; Zhang, J.; Kalabus, J.L.; Relling, M.V.; Blanco, J.G.: Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donors. Drug Metab. Dispos. (2009) 37, 400-407. {Pubmed:19022938} AAP, ASD 12/7/2011 1111 3300034153 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,6,7,8,10,11,25,29,30# liver (#2# moderate expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #11# major form of soluble NADPH-dependent all-trans-retinal dehydrogenase in liver <58>; #25# black and white donors, show similar CBR1 mRNA and protein levels. CBR1 1096G-A polymorphism is common in samples from white donors <78>; #25# CBR1 is prominently expressed in the liver <76>; #29# low expression of CBR3 <76>) <9,11,15,24,29,33,38,39,40,48,54,58,61,74,76,78> liver UBERON:0002107 1.1.1.184 Y Y ECO:0000006 Pubmed:19022938 BRENDA <78> Gonzalez-Covarrubias, V.; Zhang, J.; Kalabus, J.L.; Relling, M.V.; Blanco, J.G.: Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donors. Drug Metab. Dispos. (2009) 37, 400-407. {Pubmed:19022938} AAP, ASD 12/7/2011 1111 3300034154 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #25# lymphoblastoid cell line (#25# GM10853, GM10845, GM10857, GM10858, GM10860, GM17240, GM16654, GM16688, and GM16689 <78>) <78> lymphoblastoid cell line BTO:0000773 1.1.1.184 Y Y ECO:0000006 Pubmed:19022938 BRENDA <78> Gonzalez-Covarrubias, V.; Zhang, J.; Kalabus, J.L.; Relling, M.V.; Blanco, J.G.: Pharmacogenetics of human carbonyl reductase 1 (CBR1) in livers from black and white donors. Drug Metab. Dispos. (2009) 37, 400-407. {Pubmed:19022938} AAP, ASD 12/7/2011 1111 3300034156 curatus/Jodi P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4# cartilage <58> cartilage BTO:0000206 5.3.99.2 Y Y ECO:0000006 Pubmed:19094210 BRENDA <58> Zayed, N.; Li, X.; Chabane, N.; Benderdour, M.; Martel-Pelletier, J.; Pelletier, J.P.; Duval, N.; Fahmi, H.: Increased expression of lipocalin-type prostaglandin D2 synthase in osteoarthritic cartilage. Arthritis Res. Ther. (2008) 10, R146. {Pubmed:19094210} AAP, DGA 12/7/2011 1111 3300034158 curatus/Jodi P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4# cartilage <58> cartilage tissue UBERON:0002418 5.3.99.2 Y Y ECO:0000006 Pubmed:19094210 BRENDA <58> Zayed, N.; Li, X.; Chabane, N.; Benderdour, M.; Martel-Pelletier, J.; Pelletier, J.P.; Duval, N.; Fahmi, H.: Increased expression of lipocalin-type prostaglandin D2 synthase in osteoarthritic cartilage. Arthritis Res. Ther. (2008) 10, R146. {Pubmed:19094210} AAP, DGA 12/7/2011 1111 3300034159 Jodi P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4# cartilage <58> cartilage BTO:0000206 osteoarthritis DOID:8398 Y Y ECO:0000006 Pubmed:19094210 PENTACON Added by PENTACON; PENTACON Notes: levels of PTGDS 3-fold higher in cartilage from patients with osteoarthritis AAP, DGA 0 3300034160 Jodi P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4# cartilage <58> cartilage tissue UBERON:0002418 osteoarthritis DOID:8398 Y Y ECO:0000006 Pubmed:19094210 PENTACON Added by PENTACON; PENTACON Notes: levels of PTGDS 3-fold higher in cartilage from patients with osteoarthritis AAP, DGA 0 3300034161 curatus P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #3,4,5,12,13# brain (#5# cellular localization of the enzyme changes postnatally. The enzyme is distributed in most neurons of the brain of 1-2 week old rats, whereas it is localized in the oligodendrocytes of adult animals <5>; #5# prostaglandin-H2 D-isomerase is produced in the membrane system surrounding the brain and is secreted into the cerebrospinal fluid to become beta-trace <9>; #4,5# glutathione-independent enzyme <24>; #3# enzyme mRNA is up-regulated in mouse model of globoid cell leukodystrophy or Krabbe's disease, of Tay-Sachs disease, Sandhoff disease, GM1 gangliosidosis and Niemann-Pick type C1 disease,. Oligodendrocytes of all these mouse models show strong immunoreactivity for enzyme, but not astrocytes or microglia <52>; #3# ischemic region, contralateral cortex <85>) <1,3,5,8,9,11,21,24,26,27,40,52,65,76,84,85> brain BTO:0000142 5.3.99.2 Y Y ECO:0000033 Pubmed:19131342 BRENDA metabolite production in brain assumed to be due to PTGDS, direct evidence in mouse; <65> Irikura, D.; Aritake, K.; Nagata, N.; Maruyama, T.; Shimamoto, S.; Urade, Y.: Biochemical, functional and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin d synthase. J. Biol. Chem. (2009) 284, 7623-7630. {Pubmed:19131342}; PENTACON Notes: data is for non-human experiments AAP, DGA 12/7/2011 1111 3300034162 curatus P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #3,4,5,12,13# brain (#5# cellular localization of the enzyme changes postnatally. The enzyme is distributed in most neurons of the brain of 1-2 week old rats, whereas it is localized in the oligodendrocytes of adult animals <5>; #5# prostaglandin-H2 D-isomerase is produced in the membrane system surrounding the brain and is secreted into the cerebrospinal fluid to become beta-trace <9>; #4,5# glutathione-independent enzyme <24>; #3# enzyme mRNA is up-regulated in mouse model of globoid cell leukodystrophy or Krabbe's disease, of Tay-Sachs disease, Sandhoff disease, GM1 gangliosidosis and Niemann-Pick type C1 disease,. Oligodendrocytes of all these mouse models show strong immunoreactivity for enzyme, but not astrocytes or microglia <52>; #3# ischemic region, contralateral cortex <85>) <1,3,5,8,9,11,21,24,26,27,40,52,65,76,84,85> brain UBERON:0000955 5.3.99.2 Y Y ECO:0000033 Pubmed:19131342 BRENDA metabolite production in brain assumed to be due to PTGDS, direct evidence in mouse;<65> Irikura, D.; Aritake, K.; Nagata, N.; Maruyama, T.; Shimamoto, S.; Urade, Y.: Biochemical, functional and pharmacological characterization of AT-56, an orally active and selective inhibitor of lipocalin-type prostaglandin d synthase. J. Biol. Chem. (2009) 284, 7623-7630. {Pubmed:19131342}; PENTACON Notes: data is for non-human experiments AAP, DGA 12/7/2011 1111 3300034163 Jodi P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity cerebrospinal fluid (CSF) cerebrospinal fluid BTO:0000237 Y Y ECO:0000006 Pubmed:19131342 PENTACON Added by PENTACON AAP, DGA 0 3300034164 Jodi P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity cerebrospinal fluid (CSF) cerebrospinal fluid UBERON:0001359 Y Y ECO:0000006 Pubmed:19131342 PENTACON Added by PENTACON AAP, DGA 0 3300034165 Chandra P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Central nervous system central nervous system BTO:0000227 5.3.99.2 Y Y ECO:0000033 Pubmed:9010921 BRENDA AAP, DGA 12/7/2011 1111 3300034168 Chandra P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity Central nervous system central nervous system UBERON:0001017 5.3.99.2 Y Y ECO:0000033 Pubmed:9010921 BRENDA AAP, DGA 12/7/2011 1111 3300034169 curatus/Chandra O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity #4# megakaryoblast (#4# precursor cells of platelets, CMK cells, Dami cells. The activity is undetectable in platelets and appears during differentiation of megakaryoblasts to megakaryocytes <22>) <22> megakaryotic cell line BTO:0000844 megakaryocytic leukemia DOID:8761 5.3.99.2 Y Y ECO:0000006 Pubmed:9353279 BRENDA <22> Mahmud, I.; Ueda, N.; Yamaguchi, H.; Yamashita, R.; Yamamoto, S.; Kanaoka, Y.; Urade, Y.; Hayaishi, O.: Prostaglandin D synthase in human megakaryoblastic cells. J. Biol. Chem. (1997) 272, 28263-28266. {Pubmed:9353279} (c) AAP, ASD 12/7/2011 1111 3300034171 curatus O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity #4# megakaryoblast (#4# precursor cells of platelets, CMK cells, Dami cells. The activity is undetectable in platelets and appears during differentiation of megakaryoblasts to megakaryocytes <22>) <22> CMK cell BTO:0000978 megakaryocytic leukemia DOID:8761 5.3.99.2 precursor cells of platelets, CMK cells, Dami cells. The activity is undetectable in platelets and appears during differentiation of megakaryoblasts to megakaryocytes Y Y ECO:0000006 Pubmed:9353279 BRENDA <22> Mahmud, I.; Ueda, N.; Yamaguchi, H.; Yamashita, R.; Yamamoto, S.; Kanaoka, Y.; Urade, Y.; Hayaishi, O.: Prostaglandin D synthase in human megakaryoblastic cells. J. Biol. Chem. (1997) 272, 28263-28266. {Pubmed:9353279} (c) AAP, ASD 12/7/2011 1111 3300034172 curatus/Chandra O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity #4# megakaryotic cell line (#4# CMK86, CMK, CMK11-5 and Dami cells. Expression level is highest in CMK86 cells and is less in CMK cells, CMK11-5 cells and Dami cells in that order <13>) <13> megakaryotic cell line BTO:0000844 megakaryocytic leukemia DOID:8761 5.3.99.2 megakaryotic cell line Y Y ECO:0000006 Pubmed:9425264 BRENDA <13> Suzuki, T.; Watanabe, K.; Kanaoka, Y.; Sato, T.; Hayaishi, O.: Induction of hematopoietic prostaglandin D synthase in human megakaryocytic cells by phorbol ester. Biochem. Biophys. Res. Commun. (1997) 241, 288-293. {Pubmed:9425264} (c) AAP, ASD 12/7/2011 1111 3300034173 curatus/Chandra O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity #4# megakaryotic cell line (#4# CMK86, CMK, CMK11-5 and Dami cells. Expression level is highest in CMK86 cells and is less in CMK cells, CMK11-5 cells and Dami cells in that order <13>) <13> CMK-86 cell BTO:0004960 megakaryocytic leukemia DOID:8761 5.3.99.2 CMK86, CMK, CMK11-5 and Dami cells. Expression level is highest in CMK86 cells and is less in CMK cells, CMK11-5 cells and Dami cells in that order Y Y ECO:0000006 Pubmed:9425264 BRENDA <13> Suzuki, T.; Watanabe, K.; Kanaoka, Y.; Sato, T.; Hayaishi, O.: Induction of hematopoietic prostaglandin D synthase in human megakaryocytic cells by phorbol ester. Biochem. Biophys. Res. Commun. (1997) 241, 288-293. {Pubmed:9425264} (c) AAP, ASD 12/7/2011 1111 3300034174 curatus/Chandra O60760 27306 HPGDS Homo sapiens 9606 Comment/tissue specificity #4# megakaryotic cell line (#4# CMK86, CMK, CMK11-5 and Dami cells. Expression level is highest in CMK86 cells and is less in CMK cells, CMK11-5 cells and Dami cells in that order <13>) <13> CMK cell BTO:0000978 megakaryocytic leukemia DOID:8761 5.3.99.2 CMK86, CMK, CMK11-5 and Dami cells. Expression level is highest in CMK86 cells and is less in CMK cells, CMK11-5 cells and Dami cells in that order Y Y ECO:0000006 Pubmed:9425264 BRENDA <13> Suzuki, T.; Watanabe, K.; Kanaoka, Y.; Sato, T.; Hayaishi, O.: Induction of hematopoietic prostaglandin D synthase in human megakaryocytic cells by phorbol ester. Biochem. Biophys. Res. Commun. (1997) 241, 288-293. {Pubmed:9425264} (c) AAP, ASD 12/7/2011 1111 3300034175 curatus P23219 5742 PTGS1 Homo sapiens 9606 Comment/tissue specificity #3# platelet (#3# isozyme 1 <37>) <37,56> blood platelet BTO:0000132 1.14.99.1 Y Y ECO:0000033 Pubmed:9444611 BRENDA <37> Patrignani, P.; Panara, M.R.; Sciulli, M.G.; Santini, G.; Renda, G.; Patrono, C.: Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Physiol. Pharmacol. (1997) 48, 623-631. {Pubmed:9444611} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034176 curatus P35354 5743 PTGS2 Homo sapiens 9606 Comment/tissue specificity #3# monocyte (#3# isozyme 2 <37>) <37> monocyte BTO:0000876 1.14.99.1 Y Y ECO:0000006 Pubmed:9444611 BRENDA <37> Patrignani, P.; Panara, M.R.; Sciulli, M.G.; Santini, G.; Renda, G.; Patrono, C.: Differential inhibition of human prostaglandin endoperoxide synthase-1 and -2 by nonsteroidal anti-inflammatory drugs. J. Physiol. Pharmacol. (1997) 48, 623-631. {Pubmed:9444611} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034179 curatus/Chandra P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4,6# seminal plasma <6,7,37,68> seminal plasma BTO:0001232 5.3.99.2 seminal plasma Y Y ECO:0000006 Pubmed:9475419 BRENDA <6> Tokugawa, Y.; Kunishige, I.; Kubota, Y.; Shimoya, K.; Nobunaga, T.; Kimura, T.; Saji, F.; Murata, Y.; Eguchi, N.; Oda, H.; Urade, Y.; Hayaishi, O.: Lipocalin-type prostaglandin D synthase in human male reproductive organs and seminal plasma. Biol. Reprod. (1998) 58, 600-607. {Pubmed:9475419} (c) AAP, DGA 12/7/2011 1111 3300034182 curatus/Chandra P41222 5730 PTGDS Homo sapiens 9606 Comment/tissue specificity #4,6# seminal plasma <6,7,37,68> seminal fluid UBERON:0006530 5.3.99.2 seminal plasma Y Y ECO:0000006 Pubmed:9475419 BRENDA <6> Tokugawa, Y.; Kunishige, I.; Kubota, Y.; Shimoya, K.; Nobunaga, T.; Kimura, T.; Saji, F.; Murata, Y.; Eguchi, N.; Oda, H.; Urade, Y.; Hayaishi, O.: Lipocalin-type prostaglandin D synthase in human male reproductive organs and seminal plasma. Biol. Reprod. (1998) 58, 600-607. {Pubmed:9475419} (c) AAP, DGA 12/7/2011 1111 3300034183 curatus O00154 11332 ACOT7 Homo sapiens 9606 Comment/tissue specificity #3,7,9,10,11,12,13,22,25,27,35,41,48,50,61# brain (#7# expression of isozyme CTE-I, not MTE-I <84>; #9# brain-specific enzyme, several isoforms <86>; #50# central and peripheric nervous system, brain-specific isozyme <91>; #7# major isozyme brain acyl-CoA hydrolase, enzyme expression level during pre- and post-natal brain development <93>; #48# major isozyme is CTE-I, poor expression of MTE-I, expression of PTE-Ia, no expression of PTE-Ib <90>; #7# expression in a neuron-specific manner. The level of the major 43000 Da isoform is low until embryonic day 12.5, elevates to a peak 7 days after birth. Thereafter, it declines somewhat and reaches a steady-state level in adulthood <93>; #7# localized exclusively in neurons <99>; #7# Acot7 is expressed mainly in brain and testis of male mice. In female mice, mRNA expression of Acot7 isoforms is highest in brain, lung, kidney, heart and ovary <105>; #7# PPT1 is localized in the presynaptic compartment <111>; #61# PPT1 is localized in the presynaptic compartment and is most likely associated with the synaptosomes and synaptic vesicles. PPT1 deficiency causes an abnormally low level of synaptic vesicle proteins in the soluble fractions of the postmortem brain tissues from an infantile neuronal ceroid lipofuscinosis patient <111>) <11,14,23,45,47,50,51,52,53,57,84,86,89,90,91,92,93,96,99,102,105,111> brain BTO:0000142 3.1.2.2 Y Y ECO:0000006 Pubmed:10578051 BRENDA <52> Yamada, J.; Kurata, A.; Hirata, M.; Taniguchi, T.; Takama, H.; Furihata, T.; Shiratori, K.; Iida, N.; Takagi-Sakuma, M.; Watanabe, T.; Kurosaki, K.; Endo, T.; Suga, T.: Purification, molecular cloning, and genomic organization of human brain long-chain acyl-CoA hydrolase. J. Biochem. (1999) 126, 1013-1019. {Pubmed:10578051} AAP, ASD 12/7/2011 1111 3300034184 curatus O00154 11332 ACOT7 Homo sapiens 9606 Comment/tissue specificity #3,7,9,10,11,12,13,22,25,27,35,41,48,50,61# brain (#7# expression of isozyme CTE-I, not MTE-I <84>; #9# brain-specific enzyme, several isoforms <86>; #50# central and peripheric nervous system, brain-specific isozyme <91>; #7# major isozyme brain acyl-CoA hydrolase, enzyme expression level during pre- and post-natal brain development <93>; #48# major isozyme is CTE-I, poor expression of MTE-I, expression of PTE-Ia, no expression of PTE-Ib <90>; #7# expression in a neuron-specific manner. The level of the major 43000 Da isoform is low until embryonic day 12.5, elevates to a peak 7 days after birth. Thereafter, it declines somewhat and reaches a steady-state level in adulthood <93>; #7# localized exclusively in neurons <99>; #7# Acot7 is expressed mainly in brain and testis of male mice. In female mice, mRNA expression of Acot7 isoforms is highest in brain, lung, kidney, heart and ovary <105>; #7# PPT1 is localized in the presynaptic compartment <111>; #61# PPT1 is localized in the presynaptic compartment and is most likely associated with the synaptosomes and synaptic vesicles. PPT1 deficiency causes an abnormally low level of synaptic vesicle proteins in the soluble fractions of the postmortem brain tissues from an infantile neuronal ceroid lipofuscinosis patient <111>) <11,14,23,45,47,50,51,52,53,57,84,86,89,90,91,92,93,96,99,102,105,111> brain UBERON:0000955 3.1.2.2 Y Y ECO:0000006 Pubmed:10578051 BRENDA <52> Yamada, J.; Kurata, A.; Hirata, M.; Taniguchi, T.; Takama, H.; Furihata, T.; Shiratori, K.; Iida, N.; Takagi-Sakuma, M.; Watanabe, T.; Kurosaki, K.; Endo, T.; Suga, T.: Purification, molecular cloning, and genomic organization of human brain long-chain acyl-CoA hydrolase. J. Biochem. (1999) 126, 1013-1019. {Pubmed:10578051} AAP, ASD 12/7/2011 1111 3300034185 curatus O15120 10555 AGPAT2 Homo sapiens 9606 Comment/tissue specificity #4,28# adipocyte (#28# isozyme AGPAT2 <40>) <38,40> adipocyte BTO:0000443 2.3.1.51 Y Y ECO:0000006 Pubmed:16495223 BRENDA <40> Gale, S.E.; Frolov, A.; Han, X.; Bickel, P.E.; Cao, L.; Bowcock, A.; Schaffer, J.E.; Ory, D.S.: A regulatory role for 1-acylglycerol-3-phosphate-O-acyltransferase 2 in adipocyte differentiation. J. Biol. Chem. (2006) 281, 11082-11089. {Pubmed:16495223} AAP 12/7/2011 1111 3300034189 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity #2,16# epithelium (#2# airway <100>; #2# isozyme 15-hLO-2 <72>; #2# of the tracheobronchial tree, 15-LOX-1 <120>) <72,92,100,104,120> prostate gland BTO:0001129 epithelium BTO:0000416 1.13.11.33 Y Y ECO:0000006 Pubmed:17164141 BRENDA <92> Tang, D.G.; Bhatia, B.; Tang, S.; Schneider-Broussard, R.: 15-Lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size). Prostaglandins Other Lipid Mediat. (2007) 82, 135-146. {Pubmed:17164141} AAP 12/7/2011 1111 3300034194 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity #2,16# prostate (#2# 15-lipoxygenase 2, 15-LOX2, is down-regulated in prostate cancers compared with normal and benign prostate tissues <28>; #16# epithelial cells, 15-LOX2 has multiple alternatively spliced isoforms and is a negative cell-cycle regulator in normal prostate epithelial cells, 15-LOX2 is positively regulated by Sp1 and negatively regulated by Sp3, overview <92>; #2# epithelium, isozyme 15-hLO-2 <78>; #2# 15-LOX-2 <120>) <28,29,62,78,92,104,120> prostate epithelium UBERON:0000428 1.13.11.33 Y Y ECO:0000006 Pubmed:17164141 BRENDA <92> Tang, D.G.; Bhatia, B.; Tang, S.; Schneider-Broussard, R.: 15-Lipoxygenase 2 (15-LOX2) is a functional tumor suppressor that regulates human prostate epithelial cell differentiation, senescence, and growth (size). Prostaglandins Other Lipid Mediat. (2007) 82, 135-146. {Pubmed:17164141} AAP 12/7/2011 1111 3300034195 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #29,34,43,45# hepatoma cell <61,80,83> hepatoma cell line BTO:0000578 6.2.1.3 Y Y ECO:0000006 Pubmed:17934335 BRENDA <80> Sung, Y.K.; Park, M.K.; Hong, S.H.; Hwang, S.Y.; Kwack, M.H.; Kim, J.C.; Kim, M.K.: Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. (2007) 39, 477-482. {Pubmed:17934335} AAP, AAP-M, ASD 12/7/2011 1111 3300034196 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #29,34,43,45# hepatoma cell <61,80,83> hepatoma cell line BTO:0000578 6.2.1.3 Y Y ECO:0000006 Pubmed:18003621 BRENDA <83> Yao, H.; Ye, J.: Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J. Biol. Chem. (2007) 283, 849-854. {Pubmed:18003621} AAP, AAP-M, ASD 12/7/2011 1111 3300034197 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #29,43# Hep-G2 cell <68,80> Hep-G2 cell BTO:0000599 6.2.1.3 Y Y Pubmed:17934335 BRENDA <80> Sung, Y.K.; Park, M.K.; Hong, S.H.; Hwang, S.Y.; Kwack, M.H.; Kim, J.C.; Kim, M.K.: Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. (2007) 39, 477-482. {Pubmed:17934335} AAP, AAP-M, ASD 12/7/2011 1111 3300034198 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #4,29,43,45# Huh-7 cell <77,83> HuH-7 cell BTO:0001950 6.2.1.3 Y Y ECO:0000006 Pubmed:18003621 BRENDA <83> Yao, H.; Ye, J.: Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J. Biol. Chem. (2007) 283, 849-854. {Pubmed:18003621} AAP, AAP-M, ASD 12/7/2011 1111 3300034199 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #43# Hep-3B cell <80> HEP-3B cell BTO:0000972 6.2.1.3 Y Y Pubmed:17934335 BRENDA <80> Sung, Y.K.; Park, M.K.; Hong, S.H.; Hwang, S.Y.; Kwack, M.H.; Kim, J.C.; Kim, M.K.: Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. (2007) 39, 477-482. {Pubmed:17934335} AAP, AAP-M, ASD 12/7/2011 1111 3300034200 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #43# SNU-423 cell <80> SNU-423 cell BTO:0003187 6.2.1.3 Y Y ECO:0000006 Pubmed:17934335 BRENDA <80> Sung, Y.K.; Park, M.K.; Hong, S.H.; Hwang, S.Y.; Kwack, M.H.; Kim, J.C.; Kim, M.K.: Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. (2007) 39, 477-482. {Pubmed:17934335} AAP, AAP-M, ASD 12/7/2011 1111 3300034201 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #43# SNU-354 cell <80> SNU-354 cell BTO:0003190 6.2.1.3 Y Y ECO:0000006 Pubmed:17934335 BRENDA <80> Sung, Y.K.; Park, M.K.; Hong, S.H.; Hwang, S.Y.; Kwack, M.H.; Kim, J.C.; Kim, M.K.: Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. (2007) 39, 477-482. {Pubmed:17934335} AAP, AAP-M, ASD 12/7/2011 1111 3300034202 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #43# SNU-368 cell <80> SNU-368 cell BTO:0003169 6.2.1.3 Y Y ECO:0000006 Pubmed:17934335 BRENDA <80> Sung, Y.K.; Park, M.K.; Hong, S.H.; Hwang, S.Y.; Kwack, M.H.; Kim, J.C.; Kim, M.K.: Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. (2007) 39, 477-482. {Pubmed:17934335} AAP, AAP-M, ASD 12/7/2011 1111 3300034203 curatus O75715 2880 GPX5 Homo sapiens 9606 Comment/tissue specificity #5,6,7,10,15,19,46# epididymis (#5,6,7,10,15# GPX5 <76>; #46# Gpx-5 <82>) <76,82,85> epididymis BTO:0000408 1.11.1.9 Y Y ECO:0000033 Pubmed:18498225 BRENDA <82> Toppo, S.; Vanin, S.; Bosello, V.; Tosatto, S.C.: Evolutionary and structural insights into the multifaceted glutathione peroxidase (Gpx) superfamily. Antioxid. Redox Signal. (2008) 10, 1501-1514. {Pubmed:18498225} AAP, ASD 12/7/2011 1111 3300034205 curatus O75715 2880 GPX5 Homo sapiens 9606 Comment/tissue specificity #5,6,7,10,15,19,46# epididymis (#5,6,7,10,15# GPX5 <76>; #46# Gpx-5 <82>) <76,82,85> epididymis UBERON:0001301 1.11.1.9 Y Y ECO:0000006 Pubmed:18498225 BRENDA <82> Toppo, S.; Vanin, S.; Bosello, V.; Tosatto, S.C.: Evolutionary and structural insights into the multifaceted glutathione peroxidase (Gpx) superfamily. Antioxid. Redox Signal. (2008) 10, 1501-1514. {Pubmed:18498225} AAP, ASD 12/7/2011 1111 3300034206 curatus O95573 2181 ACSL3 Homo sapiens 9606 Comment/tissue specificity #29,34,43,45# hepatoma cell <61,80,83> hepatoma cell line BTO:0000578 6.2.1.3 Y Y ECO:0000006 Pubmed:18003621 BRENDA <83> Yao, H.; Ye, J.: Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J. Biol. Chem. (2007) 283, 849-854. {Pubmed:18003621} AAP, AAP-M, ASD 12/7/2011 1111 3300034208 curatus O95573 2181 ACSL3 Homo sapiens 9606 Comment/tissue specificity #4,29,43,45# Huh-7 cell <77,83> HuH-7 cell BTO:0001950 6.2.1.3 Y Y ECO:0000006 Pubmed:18003621 BRENDA <83> Yao, H.; Ye, J.: Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J. Biol. Chem. (2007) 283, 849-854. {Pubmed:18003621} AAP, AAP-M, ASD 12/7/2011 1111 3300034209 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity #1,2,3,4,5,6,8,9,13# plasma (#3# at least 6 plasma isozymes <59>) <3,4,5,6,7,10,12,13,14,15,16,17,18,20,21,22,23,24,25,26,27,28,30,31,32,33,34,35,36,37,38,39,40,41,53,55,57,58,59,61,62,63,64,67,68> blood plasma BTO:0000131 2.3.1.43 Y Y ECO:0000033 Pubmed:15249036 BRENDA <61> Lane, S.B.; Tchedre, K.T.; Nair, M.P.; Thigpen, A.E.; Lacko, A.G.: Characterization of lecithin:cholesterol acyltransferase expressed in a human lung cell line. Protein Expr. Purif. (2004) 36, 157-164. {Pubmed:15249036} AAP, DGA 12/7/2011 1111 3300034210 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity #2,3,11,13# liver (#3,11# enzyme expression <93,94>; #3# secretion from to plasma <59>; #3# expression of LCAT <92>) <59,61,83,92,93,94> liver BTO:0000759 2.3.1.43 Y Y ECO:0000006 Pubmed:15249036 BRENDA <61> Lane, S.B.; Tchedre, K.T.; Nair, M.P.; Thigpen, A.E.; Lacko, A.G.: Characterization of lecithin:cholesterol acyltransferase expressed in a human lung cell line. Protein Expr. Purif. (2004) 36, 157-164. {Pubmed:15249036} AAP, DGA 12/7/2011 1111 3300034211 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity #2,3,11,13# liver (#3,11# enzyme expression <93,94>; #3# secretion from to plasma <59>; #3# expression of LCAT <92>) <59,61,83,92,93,94> liver UBERON:0002107 2.3.1.43 Y Y ECO:0000006 Pubmed:15249036 BRENDA <61> Lane, S.B.; Tchedre, K.T.; Nair, M.P.; Thigpen, A.E.; Lacko, A.G.: Characterization of lecithin:cholesterol acyltransferase expressed in a human lung cell line. Protein Expr. Purif. (2004) 36, 157-164. {Pubmed:15249036} AAP, DGA 12/7/2011 1111 3300034212 curatus P05177 1544 CYP1A2 Homo sapiens 9606 Comment/tissue specificity #2,3,4,5,7,28,40,54,61,62,63,64,71,72,73# liver (#7# CYP4A6 <14>; #5# hepatic mixed-function oxidase <20>) <2,3,4,14,17,20,29,31,35,39,40,51,60,61,63,65,70> liver BTO:0000759 1.14.14.1 Y Y ECO:0000006 Pubmed:18845175 BRENDA <60> Leoni, C.; Buratti, F.M.; Testai, E.: The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol. Appl. Pharmacol. (2008) 233, 343-352. {Pubmed:18845175} AAP, DGA, ASD 12/7/2011 1111 3300034213 curatus P05177 1544 CYP1A2 Homo sapiens 9606 Comment/tissue specificity #2,3,4,5,7,28,40,54,61,62,63,64,71,72,73# liver (#7# CYP4A6 <14>; #5# hepatic mixed-function oxidase <20>) <2,3,4,14,17,20,29,31,35,39,40,51,60,61,63,65,70> liver UBERON:0002107 1.14.14.1 Y Y ECO:0000006 Pubmed:18845175 BRENDA <60> Leoni, C.; Buratti, F.M.; Testai, E.: The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol. Appl. Pharmacol. (2008) 233, 343-352. {Pubmed:18845175} AAP, DGA, ASD 12/7/2011 1111 3300034214 curatus P05177 1544 CYP1A2 Homo sapiens 9606 Comment/tissue specificity #3,4,57,58,62,74,75# hepatocyte <44,48,55> hepatocyte BTO:0000575 1.14.14.1 Y Y ECO:0000006 Pubmed:19041297 BRENDA <48> Pekthong, D.; Blanchard, N.; Abadie, C.; Bonet, A.; Heyd, B.; Mantion, G.; Berthelot, A.; Richert, L.; Martin, H.: Effects of Andrographis paniculata extract and Andrographolide on hepatic cytochrome P450 mRNA expression and monooxygenase activities after in vivo administration to rats and in vitro in rat and human hepatocyte cultures. Chem. Biol. Interact. (2009) 179, 247-255. {Pubmed:19041297} AAP, DGA, ASD 12/7/2011 1111 3300034215 curatus P07203 2876 GPX1 Homo sapiens 9606 Comment/tissue specificity #44# adrenal gland (#44# GPx1 is highly expressed in adrenal glands <88>) <88> adrenal gland BTO:0000047 1.11.1.9 Y Y ECO:0000006 Pubmed:17937619 BRENDA <88> Schmutzler, C.; Mentrup, B.; Schomburg, L.; Hoang-Vu, C.; Herzog, V.; Koehrle, J.: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. (2007) 388, 1053-1059. {Pubmed:17937619} AAP, DGA, ASD 12/7/2011 1111 3300034217 curatus P07203 2876 GPX1 Homo sapiens 9606 Comment/tissue specificity #44# adrenal gland (#44# GPx1 is highly expressed in adrenal glands <88>) <88> adrenal gland UBERON:0002369 1.11.1.9 Y Y ECO:0000006 Pubmed:17937619 BRENDA <88> Schmutzler, C.; Mentrup, B.; Schomburg, L.; Hoang-Vu, C.; Herzog, V.; Koehrle, J.: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. (2007) 388, 1053-1059. {Pubmed:17937619} AAP, DGA, ASD 12/7/2011 1111 3300034218 curatus P07203 2876 GPX1 Homo sapiens 9606 Comment/tissue specificity #44# adrenal gland (#44# GPx1 is highly expressed in adrenal glands <88>) <88> leukocyte BTO:0000751 1.11.1.9 Y Y ECO:0000006 Pubmed:17937619 PENTACON <88> Schmutzler, C.; Mentrup, B.; Schomburg, L.; Hoang-Vu, C.; Herzog, V.; Koehrle, J.: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. (2007) 388, 1053-1059. {Pubmed:17937619} AAP, DGA, ASD 12/7/2011 1111 3300034219 curatus P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity #1,2,3,4,5# liver <1,2,3,4,6,7> liver BTO:0000759 1.14.13.67 Y Y ECO:0000006 Pubmed:19353999 BRENDA <7> Wanwimolruk, S.; Wong, K.; Wanwimolruk, P.: Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metab. Drug Interact. (2009) 24, 17-35. {Pubmed:19353999} AAP, DGA, ASD 12/7/2011 1111 3300034220 curatus P08684 1576 CYP3A4 Homo sapiens 9606 Comment/tissue specificity #1,2,3,4,5# liver <1,2,3,4,6,7> liver UBERON:0002107 1.14.13.67 Y Y ECO:0000006 Pubmed:19353999 BRENDA <7> Wanwimolruk, S.; Wong, K.; Wanwimolruk, P.: Variable inhibitory effect of different brands of commercial herbal supplements on human cytochrome P-450 CYP3A4. Drug Metab. Drug Interact. (2009) 24, 17-35. {Pubmed:19353999} AAP, DGA, ASD 12/7/2011 1111 3300034221 curatus P09917 240 ALOX5 Homo sapiens 9606 Comment/tissue specificity #1,2,3,4,5,6,7,14,16# leukocyte (#14# peritoneal <63>; #3,4,6,7# polymorphonuclear <9,15,19,27,31,40,67,74,78>; #1,4# peritoneal polymorphonuclear <17,30>; #3# polymorphonuclear leukocyte <58>; #3# from healthy individuals, quantitative expression analysis <76>) <2,5,6,7,9,11,12,15,16,17,19,20,23,27,30,31,38,40,43,47,56,58,63,67,74,76,78,81,91,109> leukocyte BTO:0000751 1.13.11.34 Y Y ECO:0000033 Pubmed:17576065 BRENDA <81> Radmark, O.; Werz, O.; Steinhilber, D.; Samuelsson, B.: 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. (2007) 32, 332-341. {Pubmed:17576065} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034224 curatus P09917 240 ALOX5 Homo sapiens 9606 Comment/tissue specificity #3,16# HL-60 cell (#3# the 5-lipoxygenase core promoter is unmethylated, expression of 5-lipoxygenase protein upon differentiation <91>) <81,91,101> HL-60 cell BTO:0000738 1.13.11.34 Y Y ECO:0000033 Pubmed:17576065 BRENDA <81> Radmark, O.; Werz, O.; Steinhilber, D.; Samuelsson, B.: 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. (2007) 32, 332-341. {Pubmed:17576065} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034225 curatus P09917 240 ALOX5 Homo sapiens 9606 Comment/tissue specificity #3,16# prostate cancer cell (#3# constitutive production of 5-hydroxyeicosatetraenoic acid <32>; #3# high enzyme expression level <65>) <32,65,81> prostate cancer cell line BTO:0001033 1.13.11.34 Y Y ECO:0000033 Pubmed:17576065 BRENDA <81> Radmark, O.; Werz, O.; Steinhilber, D.; Samuelsson, B.: 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. (2007) 32, 332-341. {Pubmed:17576065} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034226 curatus P09917 240 ALOX5 Homo sapiens 9606 Comment/tissue specificity #3,16# carcinoma cell (#3# of diverse tissues, e.g. colon, lung breast, prostate, pancreas, bone, brain, and mesothelial cancer cells <65>) <65,81> carcinoma cell BTO:0000176 1.13.11.34 Y Y ECO:0000033 Pubmed:17576065 BRENDA <81> Radmark, O.; Werz, O.; Steinhilber, D.; Samuelsson, B.: 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. (2007) 32, 332-341. {Pubmed:17576065} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034227 curatus P09917 240 ALOX5 Homo sapiens 9606 Comment/tissue specificity #3,16# Mono-Mac-6 cell (#3# highest expression <101>; #16# a monocytic cell line <81>) <81,91,100,101> Mono-Mac-6 cell BTO:0002333 1.13.11.34 Y Y ECO:0000033 Pubmed:17576065 BRENDA <81> Radmark, O.; Werz, O.; Steinhilber, D.; Samuelsson, B.: 5-Lipoxygenase: regulation of expression and enzyme activity. Trends Biochem. Sci. (2007) 32, 332-341. {Pubmed:17576065} AAP, DGA, AAP-M, ASD 12/7/2011 1111 3300034228 curatus P09960 4048 LTA4H Homo sapiens 9606 Comment/tissue specificity #14# granulocyte <54> granulocyte BTO:0000539 3.3.2.6 Y Y ECO:0000006 Pubmed:16282974 BRENDA <54> Helgadottir, A.; Manolescu, A.; Helgason, A.; Thorleifsson, G.; Thorsteinsdottir, U.; Gudbjartsson, D.F.; Gretarsdottir, S.; Magnusson, K.P.; Gudmundsson, G.; Hicks, A.; Jonsson, T.; Grant, S.F.; Sainz, J.; OBrien, S.J.; Sveinbjornsdottir, S.; Valdimarsson, E.M.; Matthiasson, S.E.; Levey, A.I.; Abramson, J.L.; Reilly, M.P.; Vaccarino, V.; Wolfe, M.L.; Gudnason, V.; Quyyumi, A.A.; Topol, E.J.; Rader, D.J.; Thorgeirsson, G.; Gulcher, J.R.; Hakonarson, H.; Kong, A.; Stefansson, K.: A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nat. Genet. (2006) 38, 68-74. {Pubmed:16282974} AAP, ASD 12/7/2011 1111 3300034231 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/tissue specificity #16# urinary bladder cancer cell <68> urinary bladder cancer cell BTO:0000362 1.1.1.141 Y Y ECO:0000006 Pubmed:18632593 BRENDA <68> Celis, J.E.; Gromov, P.; Cabezon, T.; Moreira, J.M.; Friis, E.; Jirstroem, K.; Llombart-Bosch, A.; Timmermans-Wielenga, V.; Rank, F.; Gromova, I.: 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. Mol. Cell. Proteomics (2008) 7, 1795-1809. {Pubmed:18632593} AAP, ASD 12/7/2011 1111 3300034236 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/tissue specificity #16# keratinocyte (#16# in hair follicle, 15-hydroxyprostaglandin dehydrogenase is expressed mainly in keratinocytes and melanocytes <55>) <55> keratinocyte BTO:0000667 1.1.1.141 Y Y ECO:0000006 Pubmed:18328086 BRENDA <55> Michelet, J.F.; Colombe, L.; Gautier, B.; Gaillard, O.; Benech, F.; Pereira, R.; Boulle, C.; Dalko-Csiba, M.; Rozot, R.; Neuwels, M.; Bernard, B.A.: Expression of NAD(+) dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle. Exp. Dermatol. (2008) 17, 821-828. {Pubmed:18328086} AAP, ASD 12/7/2011 1111 3300034237 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/tissue specificity #16# hair follicle (#16# 15-hydroxyprostaglandin dehydrogenase is expressed mainly in keratinocytes and melanocytes <55>) <55> hair follicle BTO:0000554 1.1.1.141 Y Y ECO:0000006 Pubmed:18328086 BRENDA <55> Michelet, J.F.; Colombe, L.; Gautier, B.; Gaillard, O.; Benech, F.; Pereira, R.; Boulle, C.; Dalko-Csiba, M.; Rozot, R.; Neuwels, M.; Bernard, B.A.: Expression of NAD(+) dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle. Exp. Dermatol. (2008) 17, 821-828. {Pubmed:18328086} AAP, ASD 12/7/2011 1111 3300034239 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/tissue specificity #16# hair follicle (#16# 15-hydroxyprostaglandin dehydrogenase is expressed mainly in keratinocytes and melanocytes <55>) <55> hair follicle UBERON:0002073 1.1.1.141 Y Y ECO:0000006 Pubmed:18328086 BRENDA <55> Michelet, J.F.; Colombe, L.; Gautier, B.; Gaillard, O.; Benech, F.; Pereira, R.; Boulle, C.; Dalko-Csiba, M.; Rozot, R.; Neuwels, M.; Bernard, B.A.: Expression of NAD(+) dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle. Exp. Dermatol. (2008) 17, 821-828. {Pubmed:18328086} AAP, ASD 12/7/2011 1111 3300034240 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/tissue specificity #16# melanocyte (#16# in hair follicle, 15-hydroxyprostaglandin dehydrogenase is expressed mainly in keratinocytes and melanocytes <55>) <55> melanocyte BTO:0000847 1.1.1.141 Y Y ECO:0000006 Pubmed:18328086 BRENDA <55> Michelet, J.F.; Colombe, L.; Gautier, B.; Gaillard, O.; Benech, F.; Pereira, R.; Boulle, C.; Dalko-Csiba, M.; Rozot, R.; Neuwels, M.; Bernard, B.A.: Expression of NAD(+) dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle. Exp. Dermatol. (2008) 17, 821-828. {Pubmed:18328086} AAP, ASD 12/7/2011 1111 3300034242 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/tissue specificity #16# invasive breast apocrine carcinoma cell (#16# invasiveapocrine carcinoma cells correspond to a distinct molecular subtype of breast carcinomas characterized by the expression of 15-prostaglandin dehydrogenase alone or in combination with a novel form of acyl-CoA synthetase medium-chain family member 1, 15-prostaglandin dehydrogenase is not expressed by other breast cancer types <68>) <68> invasive breast apocrine carcinoma cell BTO:0004633 1.1.1.141 Y Y ECO:0000006 Pubmed:18632593 BRENDA <68> Celis, J.E.; Gromov, P.; Cabezon, T.; Moreira, J.M.; Friis, E.; Jirstroem, K.; Llombart-Bosch, A.; Timmermans-Wielenga, V.; Rank, F.; Gromova, I.: 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. Mol. Cell. Proteomics (2008) 7, 1795-1809. {Pubmed:18632593} AAP, ASD 12/7/2011 1111 3300034244 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/tissue specificity #4,16# breast cancer cell (#4# expression of the enzyme and the estrogen receptor is correlated <43>) <43,68> breast cancer cell BTO:0000150 1.1.1.141 Y Y ECO:0000006 Pubmed:18632593 BRENDA <68> Celis, J.E.; Gromov, P.; Cabezon, T.; Moreira, J.M.; Friis, E.; Jirstroem, K.; Llombart-Bosch, A.; Timmermans-Wielenga, V.; Rank, F.; Gromova, I.: 15-prostaglandin dehydrogenase expression alone or in combination with ACSM1 defines a subgroup of the apocrine molecular subtype of breast carcinoma. Mol. Cell. Proteomics (2008) 7, 1795-1809. {Pubmed:18632593} AAP, ASD 12/7/2011 1111 3300034246 curatus P18054 239 ALOX12 Homo sapiens 9606 Comment/tissue specificity #1,2,10,15,16# blood platelet (#2,15# isozyme 12-hLO <59,62>) <40,44,53,54,55,59,62,73,76,78,79,90,92> blood platelet BTO:0000132 1.13.11.31 Y Y ECO:0000006 Pubmed:18547056 BRENDA <59> Jacquot, C.; Wecksler, A.T.; McGinley, C.M.; Segraves, E.N.; Holman, T.R.; van der Donk, W.A.: Isotope sensitive branching and kinetic isotope effects in the reaction of deuterated arachidonic acids with human 12- and 15-lipoxygenases. Biochemistry (2008) 47, 7295-7303. {Pubmed:18547056} AAP, DGA, AAP-M 12/7/2011 1111 3300034247 curatus P18283 2877 GPX2 Homo sapiens 9606 Comment/tissue specificity #45# gastrointestinal tract (#45# GPx-2 <82>) <82> gastrointestinal tract BTO:0000511 1.11.1.9 Y Y ECO:0000033 Pubmed:18498225 BRENDA <82> Toppo, S.; Vanin, S.; Bosello, V.; Tosatto, S.C.: Evolutionary and structural insights into the multifaceted glutathione peroxidase (Gpx) superfamily. Antioxid. Redox Signal. (2008) 10, 1501-1514. {Pubmed:18498225} AAP, ASD 12/7/2011 1111 3300034249 curatus P18283 2877 GPX2 Homo sapiens 9606 Comment/tissue specificity #45# gastrointestinal tract (#45# GPx-2 <82>) <82> digestive tract UBERON:0001555 1.11.1.9 Y Y ECO:0000033 Pubmed:18498225 BRENDA <82> Toppo, S.; Vanin, S.; Bosello, V.; Tosatto, S.C.: Evolutionary and structural insights into the multifaceted glutathione peroxidase (Gpx) superfamily. Antioxid. Redox Signal. (2008) 10, 1501-1514. {Pubmed:18498225} AAP, ASD 12/7/2011 1111 3300034250 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #39# lymph <149> lymph BTO:0000855 2.3.2.2 Y Y Pubmed:18357469 BRENDA <149> Heisterkamp, N.; Groffen, J.; Warburton, D.; Sneddon, T.P.: The human gamma-glutamyltransferase gene family. Hum. Genet. (2008) 123, 321-332. {Pubmed:18357469} (review) AAP, DGA, ASD 12/7/2011 1111 3300034253 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #39# lymph <149> lymph UBERON:0002391 2.3.2.2 Y Y Pubmed:18357469 BRENDA <149> Heisterkamp, N.; Groffen, J.; Warburton, D.; Sneddon, T.P.: The human gamma-glutamyltransferase gene family. Hum. Genet. (2008) 123, 321-332. {Pubmed:18357469} (review) AAP, DGA, ASD 12/7/2011 1111 3300034254 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #39# prostate <149> prostate gland UBERON:0002367 2.3.2.2 Y Y Pubmed:18357469 BRENDA <149> Heisterkamp, N.; Groffen, J.; Warburton, D.; Sneddon, T.P.: The human gamma-glutamyltransferase gene family. Hum. Genet. (2008) 123, 321-332. {Pubmed:18357469} (review); Edited by PENTACON AAP, DGA, ASD 12/7/2011 1111 3300034255 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #4,7,10,36,39# mammary gland (#10# lactating, milk-membranes <14>; #4,36# mammary cell products formed by exocytosis: mammary tumour virus <26>) <14,18,26,149> mammary gland BTO:0000817 2.3.2.2 Y Y Pubmed:18357469 BRENDA <149> Heisterkamp, N.; Groffen, J.; Warburton, D.; Sneddon, T.P.: The human gamma-glutamyltransferase gene family. Hum. Genet. (2008) 123, 321-332. {Pubmed:18357469} (review) AAP, DGA, ASD 12/7/2011 1111 3300034256 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #4,7,10,36,39# mammary gland (#10# lactating, milk-membranes <14>; #4,36# mammary cell products formed by exocytosis: mammary tumour virus <26>) <14,18,26,149> mammary gland UBERON:0001911 2.3.2.2 Y Y Pubmed:18357469 BRENDA <149> Heisterkamp, N.; Groffen, J.; Warburton, D.; Sneddon, T.P.: The human gamma-glutamyltransferase gene family. Hum. Genet. (2008) 123, 321-332. {Pubmed:18357469} (review) AAP, DGA, ASD 12/7/2011 1111 3300034257 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #6,39# blood (#6# serum <10,13,36,37,38,53>; #6# leakage of enzyme by proteolysis from liver to blood serum <13>; #6# 6 isoforms, serum of patients with cellular hepatic carcinoma <60>; #6# dyslipidemic patients exhibiting metabolic syndrome are characterized by elevated GGT activity which is associated with perturbed metabolism of thiol compounds <114>; #6# elevated GGT is significantly associated with increased cancer risk in men <119>; #6# from individuals with no alcohol-related problems (NARP), individuals presenting alcohol abuse (AA) or individuals with alcohol dependence (AD). The highest gamma-glutamyltransferase values are seen in the AD group <109>; #6# in a general population of children, overweight and abdominal fat distribution are associated with increased GGT. GGT activity is higher in boys than in girls as puberty starts <130>; #6# the mean values of the gamma-glutamyltransferase in chronic dialysis patients and renal transplant recipients with hepatitis C virus infection are 3 or 4times above the reference limit and a greater frequency of patients evolve with values persistently elevated <170>) <10,13,36,37,38,53,60,109,114,119,130,149,170> blood BTO:0000089 2.3.2.2 Y Y Pubmed:18357469 BRENDA <149> Heisterkamp, N.; Groffen, J.; Warburton, D.; Sneddon, T.P.: The human gamma-glutamyltransferase gene family. Hum. Genet. (2008) 123, 321-332. {Pubmed:18357469} (review) AAP, DGA, ASD 12/7/2011 1111 3300034258 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #6,39# blood (#6# serum <10,13,36,37,38,53>; #6# leakage of enzyme by proteolysis from liver to blood serum <13>; #6# 6 isoforms, serum of patients with cellular hepatic carcinoma <60>; #6# dyslipidemic patients exhibiting metabolic syndrome are characterized by elevated GGT activity which is associated with perturbed metabolism of thiol compounds <114>; #6# elevated GGT is significantly associated with increased cancer risk in men <119>; #6# from individuals with no alcohol-related problems (NARP), individuals presenting alcohol abuse (AA) or individuals with alcohol dependence (AD). The highest gamma-glutamyltransferase values are seen in the AD group <109>; #6# in a general population of children, overweight and abdominal fat distribution are associated with increased GGT. GGT activity is higher in boys than in girls as puberty starts <130>; #6# the mean values of the gamma-glutamyltransferase in chronic dialysis patients and renal transplant recipients with hepatitis C virus infection are 3 or 4times above the reference limit and a greater frequency of patients evolve with values persistently elevated <170>) <10,13,36,37,38,53,60,109,114,119,130,149,170> blood UBERON:0000178 2.3.2.2 Y Y Pubmed:18357469 BRENDA <149> Heisterkamp, N.; Groffen, J.; Warburton, D.; Sneddon, T.P.: The human gamma-glutamyltransferase gene family. Hum. Genet. (2008) 123, 321-332. {Pubmed:18357469} (review) AAP, DGA, ASD 12/7/2011 1111 3300034259 curatus/Chandra P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #2,4,6,7,8,10,12,15,25# kidney (#12# cortex <30>; #12# brush border of convoluted tubules <30>; #6,7# luminal membrane of proximal tubules <36>) <2,3,9,15,16,20,22,29,30,31,32,33,34,35,36,40,41,42,53,68,75,79,80,85,87,127,174,175> kidney BTO:0000671 2.3.2.2 Y Y direct evidence Pubmed:4442 BRENDA <41> Miller, S.P.; Awasthi, Y.C.; Srivastava, S.K.: Studies of human kidney gamma-glutamyl transpeptidase. Purification and structural, kinetic and immunological properties. J. Biol. Chem. (1976) 251, 2271-2278. {Pubmed:4442} AAP, DGA, ASD 12/7/2011 1111 3300034260 curatus/Chandra P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #2,4,6,7,8,10,12,15,25# kidney (#12# cortex <30>; #12# brush border of convoluted tubules <30>; #6,7# luminal membrane of proximal tubules <36>) <2,3,9,15,16,20,22,29,30,31,32,33,34,35,36,40,41,42,53,68,75,79,80,85,87,127,174,175> kidney UBERON:0002113 2.3.2.2 Y Y direct evidence Pubmed:4442 BRENDA <41> Miller, S.P.; Awasthi, Y.C.; Srivastava, S.K.: Studies of human kidney gamma-glutamyl transpeptidase. Purification and structural, kinetic and immunological properties. J. Biol. Chem. (1976) 251, 2271-2278. {Pubmed:4442} AAP, DGA, ASD 12/7/2011 1111 3300034261 Chandra P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity liver BTO:0000759 2.3.2.2 Y Y direct evidence Pubmed:4442 BRENDA <41> Miller, S.P.; Awasthi, Y.C.; Srivastava, S.K.: Studies of human kidney gamma-glutamyl transpeptidase. Purification and structural, kinetic and immunological properties. J. Biol. Chem. (1976) 251, 2271-2278. {Pubmed:4442} AAP, DGA, ASD 12/7/2011 1111 3300034262 Chandra P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity liver UBERON:0002107 2.3.2.2 Y Y direct evidence Pubmed:4442 BRENDA <41> Miller, S.P.; Awasthi, Y.C.; Srivastava, S.K.: Studies of human kidney gamma-glutamyl transpeptidase. Purification and structural, kinetic and immunological properties. J. Biol. Chem. (1976) 251, 2271-2278. {Pubmed:4442} AAP, DGA, ASD 12/7/2011 1111 3300034263 curatus/Chandra P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #6# bile <10,46,53> bile BTO:0000121 2.3.2.2 Y Y ECO:0000006 Pubmed:18198 BRENDA <46> Indirani, N.; Hill, P.G.: Partial purification and some properties of gamma-glutamyl transpeptidase from human bile. Biochim. Biophys. Acta (1977) 483, 57-62. {Pubmed:18198}; PENTACON Notes: Purified from bile - not recominant AAP, DGA, ASD 12/7/2011 1111 3300034264 curatus/Chandra P19440 2678 GGT1 Homo sapiens 9606 Comment/tissue specificity #6# bile <10,46,53> bile UBERON:0001970 2.3.2.2 Y Y ECO:0000006 Pubmed:18198 BRENDA <46> Indirani, N.; Hill, P.G.: Partial purification and some properties of gamma-glutamyl transpeptidase from human bile. Biochim. Biophys. Acta (1977) 483, 57-62. {Pubmed:18198}; PENTACON Notes: Purified from bile - not recominant AAP, DGA, ASD 12/7/2011 1111 3300034265 curatus P20813 1555 CYP2B6 Homo sapiens 9606 Comment/tissue specificity #2,3,4,5,7,28,40,54,61,62,63,64,71,72,73# liver (#7# CYP4A6 <14>; #5# hepatic mixed-function oxidase <20>) <2,3,4,14,17,20,29,31,35,39,40,51,60,61,63,65,70> liver BTO:0000759 1.14.14.1 Y Y ECO:0000006 Pubmed:18845175 BRENDA <60> Leoni, C.; Buratti, F.M.; Testai, E.: The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol. Appl. Pharmacol. (2008) 233, 343-352. {Pubmed:18845175} AAP, ASD 12/7/2011 1111 3300034266 curatus P20813 1555 CYP2B6 Homo sapiens 9606 Comment/tissue specificity #2,3,4,5,7,28,40,54,61,62,63,64,71,72,73# liver (#7# CYP4A6 <14>; #5# hepatic mixed-function oxidase <20>) <2,3,4,14,17,20,29,31,35,39,40,51,60,61,63,65,70> liver UBERON:0002107 1.14.14.1 Y Y ECO:0000006 Pubmed:18845175 BRENDA <60> Leoni, C.; Buratti, F.M.; Testai, E.: The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol. Appl. Pharmacol. (2008) 233, 343-352. {Pubmed:18845175} AAP, ASD 12/7/2011 1111 3300034267 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #41# thyroid gland <88> thyroid gland BTO:0001379 1.11.1.9 Y Y ECO:0000006 Pubmed:17937619 BRENDA <88> Schmutzler, C.; Mentrup, B.; Schomburg, L.; Hoang-Vu, C.; Herzog, V.; Koehrle, J.: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. (2007) 388, 1053-1059. {Pubmed:17937619} AAP, DGA, ASD 12/7/2011 1111 3300034268 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #41# thyroid gland <88> thyroid gland UBERON:0002046 1.11.1.9 Y Y ECO:0000006 Pubmed:17937619 BRENDA <88> Schmutzler, C.; Mentrup, B.; Schomburg, L.; Hoang-Vu, C.; Herzog, V.; Koehrle, J.: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. (2007) 388, 1053-1059. {Pubmed:17937619} AAP, DGA, ASD 12/7/2011 1111 3300034269 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #41# HUVEC cell (#41# GPx-3 is detected at very low levels under basal conditions <122>) <122> HUVEC cell BTO:0001949 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal CHEBI:75142 1.11.1.9 Y Y ECO:0000006 Pubmed:19766714 BRENDA <122> Westphal, K.; Stangl, V.; Faehling, M.; Dreger, H.; Weller, A.; Baumann, G.; Stangl, K.; Meiners, S.: Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells. Free Radic. Biol. Med. (2009) 47, 1652-1660. {Pubmed:19766714}; Expression in HUVEC cells is induced by MG-132 treatment, Edited by PENTACON AAP, DGA, ASD 12/7/2011 1111 3300034271 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #41# thyroid carcinoma cell <88> thyroid carcinoma DOID:3963 1.11.1.9 Y Y ECO:0000006 Pubmed:17937619 BRENDA <88> Schmutzler, C.; Mentrup, B.; Schomburg, L.; Hoang-Vu, C.; Herzog, V.; Koehrle, J.: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. (2007) 388, 1053-1059. {Pubmed:17937619} AAP, DGA, ASD 12/7/2011 1111 3300034273 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #41# aortic smooth muscle cell (#41# GPx-3 is detected at very low levels under basal conditions <122>) <122> aortic smooth muscle cell BTO:0004577 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal CHEBI:75142 1.11.1.9 Y Y ECO:0000006 Pubmed:19766714 BRENDA <122> Westphal, K.; Stangl, V.; Faehling, M.; Dreger, H.; Weller, A.; Baumann, G.; Stangl, K.; Meiners, S.: Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells. Free Radic. Biol. Med. (2009) 47, 1652-1660. {Pubmed:19766714}, Expression is induced by MG-132 treatment, Edited by PENTACON AAP, DGA, ASD 12/7/2011 1111 3300034274 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #41# thyrocyte (#41# GPx3 is exclusively expressed in thyrocytes <88>) <88> thyroid follicular lumen UBERON:0012246 1.11.1.9 Y Y ECO:0000006 Pubmed:17937619 BRENDA <88> Schmutzler, C.; Mentrup, B.; Schomburg, L.; Hoang-Vu, C.; Herzog, V.; Koehrle, J.: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. (2007) 388, 1053-1059. {Pubmed:17937619} AAP, DGA, ASD 12/7/2011 1111 3300034276 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #41# HAEC cell (#41# GPx-3 is detected at very low levels under basal conditions <122>) <122> aortic endothelial cell BTO:0003245 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal CHEBI:75142 1.11.1.9 Y Y ECO:0000006 Pubmed:19766714 BRENDA <122> Westphal, K.; Stangl, V.; Faehling, M.; Dreger, H.; Weller, A.; Baumann, G.; Stangl, K.; Meiners, S.: Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells. Free Radic. Biol. Med. (2009) 47, 1652-1660. {Pubmed:19766714}; Expression is induced by MG-132 treatment, Edited by PENTACON AAP, DGA, ASD 12/7/2011 1111 3300034277 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #6,41# plasma (#41# GPx-3 <82>; #41# GPx-3 is secreted into the plasma <122>) <82,103,122> blood plasma BTO:0000131 1.11.1.9 Y Y ECO:0000033 Pubmed:19766714 BRENDA <122> Westphal, K.; Stangl, V.; Faehling, M.; Dreger, H.; Weller, A.; Baumann, G.; Stangl, K.; Meiners, S.: Human-specific induction of glutathione peroxidase-3 by proteasome inhibition in cardiovascular cells. Free Radic. Biol. Med. (2009) 47, 1652-1660. {Pubmed:19766714}; Edited by PENTACON AAP, DGA, ASD 12/7/2011 1111 3300034279 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #6,8,41# prostate gland (#8# expression is observed in the membranes of vacuoles contained in prostate secretions as well as in the endothelium of arterioles and venules <104>) <92,104,118> prostate gland BTO:0001129 1.11.1.9 Y Y ECO:0000006 Pubmed:17804715 BRENDA <92> Yu, Y.P.; Yu, G.; Tseng, G.; Cieply, K.; Nelson, J.; Defrances, M.; Zarnegar, R.; Michalopoulos, G.; Luo, J.H.: Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res. (2007) 67, 8043-8050. {Pubmed:17804715} AAP, DGA, ASD 12/7/2011 1111 3300034280 curatus P22352 2878 GPX3 Homo sapiens 9606 Comment/tissue specificity #6,8,41# prostate gland (#8# expression is observed in the membranes of vacuoles contained in prostate secretions as well as in the endothelium of arterioles and venules <104>) <92,104,118> prostate gland UBERON:0002367 1.11.1.9 Y Y ECO:0000006 Pubmed:17804715 BRENDA <92> Yu, Y.P.; Yu, G.; Tseng, G.; Cieply, K.; Nelson, J.; Defrances, M.; Zarnegar, R.; Michalopoulos, G.; Luo, J.H.: Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis. Cancer Res. (2007) 67, 8043-8050. {Pubmed:17804715} AAP, DGA, ASD 12/7/2011 1111 3300034281 curatus P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity #29,34,43,45# hepatoma cell <61,80,83> hepatoma cell line BTO:0000578 6.2.1.3 Y Y ECO:0000006 Pubmed:18003621 BRENDA <83> Yao, H.; Ye, J.: Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J. Biol. Chem. (2007) 283, 849-854. {Pubmed:18003621} AAP, AAP-M, ASD 12/7/2011 1111 3300034282 curatus P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity #29,43# Hep-G2 cell <68,80> Hep-G2 cell BTO:0000599 6.2.1.3 Y Y ECO:0000006 Pubmed:16705061 BRENDA <68> Parkes, H.A.; Preston, E.; Wilks, D.; Ballesteros, M.; Carpenter, L.; Wood, L.; Kraegen, E.W.; Furler, S.M.; Cooney, G.J.: Overexpression of acyl-CoA synthetase-1 increases lipid deposition in hepatic (HepG2) cells and rodent liver in vivo. Am. J. Physiol. Endocrinol. Metab. (2006) 291, E737-E744. {Pubmed:16705061} AAP, AAP-M, ASD 12/7/2011 1111 3300034283 curatus P33121 2180 ACSL1 Homo sapiens 9606 Comment/tissue specificity #4,29,43,45# Huh-7 cell <77,83> HuH-7 cell BTO:0001950 6.2.1.3 Y Y ECO:0000006 Pubmed:18003621 BRENDA <83> Yao, H.; Ye, J.: Long chain acyl-CoA synthetase 3-mediated phosphatidylcholine synthesis is required for assembly of very low density lipoproteins in human hepatoma Huh7 cells. J. Biol. Chem. (2007) 283, 849-854. {Pubmed:18003621} AAP, AAP-M, ASD 12/7/2011 1111 3300034284 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #1,3,5,6,7,11,22,29,42,43,50,52# liver (#5,6,7,11,29# high activity <1>; #1# embryonic liver <70>; #6# exceptionally high concentration in the liver <103>; #42# diabetes reduces the amount of sEH protein in the liver and insulin restored the level of protein <131>; #52# laboratory rats have by far the lowest levels of hepatic sEH among the mammals studied <128>; #42# sEH protein and expression levels during treatment with different dietary oils, overview <124>) <1,2,3,4,5,6,7,8,10,11,12,13,19,20,22,24,25,37,41,46,49,50,53,54,56,60,61,63,65,66,70,84,95,101,103,110,124,127,128,131,132,133,139,142,145> liver BTO:0000759 3.3.2.10 Y Y ECO:0000033 Pubmed:20425256 BRENDA <128> Wang, Y.X.; Ulu, A.; Zhang, L.N.; Hammock, B.: Soluble epoxide hydrolase in atherosclerosis. Curr. Atheroscler. Rep. (2010) 12, 174-183. {Pubmed:20425256} AAP, DGA, ASD 12/7/2011 1111 3300034285 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #1,3,5,6,7,11,22,29,42,43,50,52# liver (#5,6,7,11,29# high activity <1>; #1# embryonic liver <70>; #6# exceptionally high concentration in the liver <103>; #42# diabetes reduces the amount of sEH protein in the liver and insulin restored the level of protein <131>; #52# laboratory rats have by far the lowest levels of hepatic sEH among the mammals studied <128>; #42# sEH protein and expression levels during treatment with different dietary oils, overview <124>) <1,2,3,4,5,6,7,8,10,11,12,13,19,20,22,24,25,37,41,46,49,50,53,54,56,60,61,63,65,66,70,84,95,101,103,110,124,127,128,131,132,133,139,142,145> liver UBERON:0002107 3.3.2.10 Y Y ECO:0000033 Pubmed:20425256 BRENDA <128> Wang, Y.X.; Ulu, A.; Zhang, L.N.; Hammock, B.: Soluble epoxide hydrolase in atherosclerosis. Curr. Atheroscler. Rep. (2010) 12, 174-183. {Pubmed:20425256} AAP, DGA, ASD 12/7/2011 1111 3300034286 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #1,3,5,6,7,11,22,29,42,43,50,52# liver (#5,6,7,11,29# high activity <1>; #1# embryonic liver <70>; #6# exceptionally high concentration in the liver <103>; #42# diabetes reduces the amount of sEH protein in the liver and insulin restored the level of protein <131>; #52# laboratory rats have by far the lowest levels of hepatic sEH among the mammals studied <128>; #42# sEH protein and expression levels during treatment with different dietary oils, overview <124>) <1,2,3,4,5,6,7,8,10,11,12,13,19,20,22,24,25,37,41,46,49,50,53,54,56,60,61,63,65,66,70,84,95,101,103,110,124,127,128,131,132,133,139,142,145> liver BTO:0000759 3.3.2.10 Y Y ECO:0000006 Pubmed:20359531 BRENDA <132> Tsai, H.J.; Hwang, S.H.; Morisseau, C.; Yang, J.; Jones, P.D.; Kasagami, T.; Kim, I.H.; Hammock, B.D.: Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs. Eur. J. Pharm. Sci. (2010) 40, 222-238. {Pubmed:20359531} AAP, DGA, ASD 12/7/2011 1111 3300034287 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #1,3,5,6,7,11,22,29,42,43,50,52# liver (#5,6,7,11,29# high activity <1>; #1# embryonic liver <70>; #6# exceptionally high concentration in the liver <103>; #42# diabetes reduces the amount of sEH protein in the liver and insulin restored the level of protein <131>; #52# laboratory rats have by far the lowest levels of hepatic sEH among the mammals studied <128>; #42# sEH protein and expression levels during treatment with different dietary oils, overview <124>) <1,2,3,4,5,6,7,8,10,11,12,13,19,20,22,24,25,37,41,46,49,50,53,54,56,60,61,63,65,66,70,84,95,101,103,110,124,127,128,131,132,133,139,142,145> liver UBERON:0002107 3.3.2.10 Y Y ECO:0000006 Pubmed:20359531 BRENDA <132> Tsai, H.J.; Hwang, S.H.; Morisseau, C.; Yang, J.; Jones, P.D.; Kasagami, T.; Kim, I.H.; Hammock, B.D.: Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs. Eur. J. Pharm. Sci. (2010) 40, 222-238. {Pubmed:20359531} AAP, DGA, ASD 12/7/2011 1111 3300034288 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #1,3,5,6,7,11,22,29,42,43,50,52# liver (#5,6,7,11,29# high activity <1>; #1# embryonic liver <70>; #6# exceptionally high concentration in the liver <103>; #42# diabetes reduces the amount of sEH protein in the liver and insulin restored the level of protein <131>; #52# laboratory rats have by far the lowest levels of hepatic sEH among the mammals studied <128>; #42# sEH protein and expression levels during treatment with different dietary oils, overview <124>) <1,2,3,4,5,6,7,8,10,11,12,13,19,20,22,24,25,37,41,46,49,50,53,54,56,60,61,63,65,66,70,84,95,101,103,110,124,127,128,131,132,133,139,142,145> liver BTO:0000759 3.3.2.10 Y Y Pubmed:19746975 BRENDA <139> Eldrup, A.B.; Soleymanzadeh, F.; Taylor, S.J.; Muegge, I.; Farrow, N.A.; Joseph, D.; McKellop, K.; Man, C.C.; Kukulka, A.; De Lombaert, S.: Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J. Med. Chem. (2009) 52, 5880-5895. {Pubmed:19746975} AAP, DGA, ASD 12/7/2011 1111 3300034291 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #1,3,5,6,7,11,22,29,42,43,50,52# liver (#5,6,7,11,29# high activity <1>; #1# embryonic liver <70>; #6# exceptionally high concentration in the liver <103>; #42# diabetes reduces the amount of sEH protein in the liver and insulin restored the level of protein <131>; #52# laboratory rats have by far the lowest levels of hepatic sEH among the mammals studied <128>; #42# sEH protein and expression levels during treatment with different dietary oils, overview <124>) <1,2,3,4,5,6,7,8,10,11,12,13,19,20,22,24,25,37,41,46,49,50,53,54,56,60,61,63,65,66,70,84,95,101,103,110,124,127,128,131,132,133,139,142,145> liver UBERON:0002107 3.3.2.10 Y Y Pubmed:19746975 BRENDA <139> Eldrup, A.B.; Soleymanzadeh, F.; Taylor, S.J.; Muegge, I.; Farrow, N.A.; Joseph, D.; McKellop, K.; Man, C.C.; Kukulka, A.; De Lombaert, S.: Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J. Med. Chem. (2009) 52, 5880-5895. {Pubmed:19746975} AAP, DGA, ASD 12/7/2011 1111 3300034292 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #3,5,6,7,42,50# brain (#6# distribution of enzyme mainly in the neuronal cell bodies, oligodendrocytes and scattered astrocytes. High expression of enzyme in ependymal cells of choroid plexus <78>; #7# expression of soluble epoxide hydrolase is significantly lower in stroke-prone than in stroke-resitant rats. Identification of 3 polymorphisms that significantly influence promoter transcriptional activity in vitro <77>; #50# in vascular smooth muscle and endothelial cell layers, in white matter <133>; #42# in vascular smooth muscle and endothelial cell layersm in white matter. sEH in rodent brain is neither vascular nor glial, but rather neuronal. In brain parenchymal tissue, sEH is markedly expressed in neuronal cell bodies and processes, particularly within the cerebral cortex and striatum <133>; #42# sEH distribution, immunohistochemical analysis, overview. sEH immunoreactivity is almost exclusively located in astrocytes throughout the brain, except in the central amygdala, where neurons are also positive for sEH <146>; #42# wide expression of sEH in cortical and hippocampal astrocytes and also in a few specific neuron types in the cortex, cerebellum, and medulla, immunohistochemical analysis, overview <125>) <13,39,52,63,75,77,78,84,100,125,133,136,145,146> brain BTO:0000142 3.3.2.10 Y Y ECO:0000033 Pubmed:19779591 BRENDA <133> Iliff, J.J.; Alkayed, N.J.: Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent. Future Neurol. (2009) 4, 179-199. {Pubmed:19779591} AAP, DGA, ASD 12/7/2011 1111 3300034296 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #3,5,6,7,42,50# brain (#6# distribution of enzyme mainly in the neuronal cell bodies, oligodendrocytes and scattered astrocytes. High expression of enzyme in ependymal cells of choroid plexus <78>; #7# expression of soluble epoxide hydrolase is significantly lower in stroke-prone than in stroke-resitant rats. Identification of 3 polymorphisms that significantly influence promoter transcriptional activity in vitro <77>; #50# in vascular smooth muscle and endothelial cell layers, in white matter <133>; #42# in vascular smooth muscle and endothelial cell layersm in white matter. sEH in rodent brain is neither vascular nor glial, but rather neuronal. In brain parenchymal tissue, sEH is markedly expressed in neuronal cell bodies and processes, particularly within the cerebral cortex and striatum <133>; #42# sEH distribution, immunohistochemical analysis, overview. sEH immunoreactivity is almost exclusively located in astrocytes throughout the brain, except in the central amygdala, where neurons are also positive for sEH <146>; #42# wide expression of sEH in cortical and hippocampal astrocytes and also in a few specific neuron types in the cortex, cerebellum, and medulla, immunohistochemical analysis, overview <125>) <13,39,52,63,75,77,78,84,100,125,133,136,145,146> brain UBERON:0000955 3.3.2.10 Y Y ECO:0000033 Pubmed:19779591 BRENDA <133> Iliff, J.J.; Alkayed, N.J.: Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent. Future Neurol. (2009) 4, 179-199. {Pubmed:19779591} AAP, DGA, ASD 12/7/2011 1111 3300034297 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #4,5,6,7,11,29,42,50,52# kidney (#6,7,42# cortex <63>; #5,6,7,11,29# high activity <1>; #6# diseased and healthy, primarily vascular localization, low enzyme levels in the surrounding tubules <38>; #7# the activity for epoxyeicosatrienoic acids is elevated 5 to 54fold in renal cortical S9 fraction from the spontaneously hypertensive rats compared to normotensive Wistar-Kyoto rats <49>; #6# exceptionally high concentration in the kidney <103>; #42# distribution in proximal tubules but not in the glomerulus or other regions, immunohistochemic analysis <131>) <1,37,38,41,49,63,84,89,103,110,113,127,128,129,131,133,142,145> kidney BTO:0000671 3.3.2.10 Y Y ECO:0000033 Pubmed:20425256 BRENDA <128> Wang, Y.X.; Ulu, A.; Zhang, L.N.; Hammock, B.: Soluble epoxide hydrolase in atherosclerosis. Curr. Atheroscler. Rep. (2010) 12, 174-183. {Pubmed:20425256} AAP, DGA, ASD 12/7/2011 1111 3300034299 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #4,5,6,7,11,29,42,50,52# kidney (#6,7,42# cortex <63>; #5,6,7,11,29# high activity <1>; #6# diseased and healthy, primarily vascular localization, low enzyme levels in the surrounding tubules <38>; #7# the activity for epoxyeicosatrienoic acids is elevated 5 to 54fold in renal cortical S9 fraction from the spontaneously hypertensive rats compared to normotensive Wistar-Kyoto rats <49>; #6# exceptionally high concentration in the kidney <103>; #42# distribution in proximal tubules but not in the glomerulus or other regions, immunohistochemic analysis <131>) <1,37,38,41,49,63,84,89,103,110,113,127,128,129,131,133,142,145> kidney UBERON:0002113 3.3.2.10 Y Y ECO:0000033 Pubmed:20425256 BRENDA <128> Wang, Y.X.; Ulu, A.; Zhang, L.N.; Hammock, B.: Soluble epoxide hydrolase in atherosclerosis. Curr. Atheroscler. Rep. (2010) 12, 174-183. {Pubmed:20425256} AAP, DGA, ASD 12/7/2011 1111 3300034300 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #4,5,6,7,42,50# heart <63,74,84,90,102,107,111,127,129,135,136,141,142,145> heart BTO:0000562 3.3.2.10 Y Y ECO:0000033 Pubmed:19891972 BRENDA <141> Deng, Y.; Theken, K.N.; Lee, C.R.: Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J. Mol. Cell. Cardiol. (2010) 48, 331-341. {Pubmed:19891972} AAP, DGA, ASD 12/7/2011 1111 3300034303 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #4,5,6,7,42,50# heart <63,74,84,90,102,107,111,127,129,135,136,141,142,145> heart UBERON:0000948 3.3.2.10 Y Y ECO:0000033 Pubmed:19891972 BRENDA <141> Deng, Y.; Theken, K.N.; Lee, C.R.: Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J. Mol. Cell. Cardiol. (2010) 48, 331-341. {Pubmed:19891972} AAP, DGA, ASD 12/7/2011 1111 3300034304 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #5,42,50# cardiomyocyte <107,111,141> cardiac muscle cell CL:0000746 3.3.2.10 Y Y ECO:0000033 Pubmed:19891972 BRENDA <141> Deng, Y.; Theken, K.N.; Lee, C.R.: Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J. Mol. Cell. Cardiol. (2010) 48, 331-341. {Pubmed:19891972} AAP, DGA, ASD 12/7/2011 1111 3300034305 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #5,6,42,50# myocardium <83,102,140,141> myocardium BTO:0000901 3.3.2.10 Y Y ECO:0000033 Pubmed:19891972 BRENDA <141> Deng, Y.; Theken, K.N.; Lee, C.R.: Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J. Mol. Cell. Cardiol. (2010) 48, 331-341. {Pubmed:19891972} AAP, DGA, ASD 12/7/2011 1111 3300034306 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #5,6,42,50# myocardium <83,102,140,141> myocardium UBERON:0002349 3.3.2.10 Y Y ECO:0000033 Pubmed:19891972 BRENDA <141> Deng, Y.; Theken, K.N.; Lee, C.R.: Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J. Mol. Cell. Cardiol. (2010) 48, 331-341. {Pubmed:19891972} AAP, DGA, ASD 12/7/2011 1111 3300034307 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #5,6,7,42,50# lung (#6# exclusively cytosolic <57>; #42# immunohistochemical analysis showing the expression of the sEH in lungs from wild-type mice kept under normoxic conditions or after exposure to 21 days hypoxia, overview <126>; #50# sEH is expressed in the wall of pulmonary arteries, however, sEH expression is absent in samples from patients with pulmonary hypertension <126>) <57,63,84,93,97,126,134,145> lung BTO:0000763 3.3.2.10 Y Y ECO:0000006 Pubmed:19679679 BRENDA <126> Keserue, B.; Barbosa-Sicard, E.; Schermuly, R.T.; Tanaka, H.; Hammock, B.D.; Weissmann, N.; Fisslthaler, B.; Fleming, I.: Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition. Cardiovasc. Res. (2010) 85, 232-240. {Pubmed:19679679} AAP, DGA, ASD 12/7/2011 1111 3300034308 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #5,6,7,42,50# lung (#6# exclusively cytosolic <57>; #42# immunohistochemical analysis showing the expression of the sEH in lungs from wild-type mice kept under normoxic conditions or after exposure to 21 days hypoxia, overview <126>; #50# sEH is expressed in the wall of pulmonary arteries, however, sEH expression is absent in samples from patients with pulmonary hypertension <126>) <57,63,84,93,97,126,134,145> lung UBERON:0002048 3.3.2.10 Y Y ECO:0000006 Pubmed:19679679 BRENDA <126> Keserue, B.; Barbosa-Sicard, E.; Schermuly, R.T.; Tanaka, H.; Hammock, B.D.; Weissmann, N.; Fisslthaler, B.; Fleming, I.: Hypoxia-induced pulmonary hypertension: comparison of soluble epoxide hydrolase deletion vs. inhibition. Cardiovasc. Res. (2010) 85, 232-240. {Pubmed:19679679} AAP, DGA, ASD 12/7/2011 1111 3300034309 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #50# hepatoma cell <117> hepatoma cell line BTO:0000578 3.3.2.10 Y Y ECO:0000006 Pubmed:19952412 BRENDA <117> Oguro, A.; Sakamoto, K.; Suzuki, S.; Imaoka, S.: Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth. Biol. Pharm. Bull. (2009) 32, 1962-1967. {Pubmed:19952412} AAP, DGA, ASD 12/7/2011 1111 3300034313 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #50# HEK-293 cell <134,137> HEK-293 cell BTO:0000007 3.3.2.10 Y Y Pubmed:19704161 BRENDA <134> Barbosa-Sicard, E.; Froemel, T.; Keserue, B.; Brandes, R.P.; Morisseau, C.; Hammock, B.D.; Braun, T.; Krueger, M.; Fleming, I.: Inhibition of the soluble epoxide hydrolase by tyrosine nitration. J. Biol. Chem. (2009) 284, 28156-28163. {Pubmed:19704161} AAP, DGA, ASD 12/7/2011 1111 3300034314 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #50# HEK-293 cell <134,137> HEK-293 cell BTO:0000007 3.3.2.10 Y Y ECO:0000006 Pubmed:19645482 BRENDA <137> Shen, H.; Ding, F.; Wang, S.; Deng, Q.; Zhang, X.; Chen, Y.; Zhou, G.; Xu, S.; Chen, H.; Tong, X.; Tong, V.; Mitra, K.; Kumar, S.; Tsai, C.; Stevenson, A.; Pai, L.; Alonso-Galicia, M.; Chen, X.; Soisson, S.; Roy, S.; Zhang, B.; Tata, J.; Berger, J.; Colle: Discovery of a highly potent, selective, and bioavailable soluble epoxide hydrolase inhibitor with excellent ex vivo target engagement. J. Med. Chem. (2009) 52, 5009-5012. {Pubmed:} AAP, DGA, ASD 12/7/2011 1111 3300034315 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #50# Hep-G2 cell <139> Hep-G2 cell BTO:0000599 3.3.2.10 Y Y ECO:0000006 Pubmed:19746975 BRENDA <139> Eldrup, A.B.; Soleymanzadeh, F.; Taylor, S.J.; Muegge, I.; Farrow, N.A.; Joseph, D.; McKellop, K.; Man, C.C.; Kukulka, A.; De Lombaert, S.: Structure-based optimization of arylamides as inhibitors of soluble epoxide hydrolase. J. Med. Chem. (2009) 52, 5880-5895. {Pubmed:19746975} AAP, DGA, ASD 12/7/2011 1111 3300034316 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #50# glia (#50# restricted primarily to oligodendrocytes in the white matter <133>) <133> glia BTO:0000524 3.3.2.10 Y Y ECO:0000033 Pubmed:19779591 BRENDA <133> Iliff, J.J.; Alkayed, N.J.: Soluble epoxide hydrolase inhibition: targeting multiple mechanisms of ischemic brain injury with a single agent. Future Neurol. (2009) 4, 179-199. {Pubmed:19779591} AAP, DGA, ASD 12/7/2011 1111 3300034317 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #50# LNCaP cell <143> LNCaP cell BTO:0001321 3.3.2.10 Y Y ECO:0000006 Pubmed:20339956 BRENDA <143> Xie, W.; Tang, X.; Lu, Q.; Ames, R.S.; Ratcliffe, S.J.; Li, H.: Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology. Mol. Biotechnol. (2010) 45, 207-217. {Pubmed:20339956} AAP, DGA, ASD 12/7/2011 1111 3300034320 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #6,42,50# blood vessel (#6# cytosolic localization <57>; #6# exclusively cytosolic <57>) <57,128,136> blood vessel BTO:0001102 3.3.2.10 Y Y ECO:0000033 Pubmed:20425256 BRENDA <128> Wang, Y.X.; Ulu, A.; Zhang, L.N.; Hammock, B.: Soluble epoxide hydrolase in atherosclerosis. Curr. Atheroscler. Rep. (2010) 12, 174-183. {Pubmed:20425256} AAP, DGA, ASD 12/7/2011 1111 3300034321 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #6,42,50# blood vessel (#6# cytosolic localization <57>; #6# exclusively cytosolic <57>) <57,128,136> blood vessel UBERON:0001981 3.3.2.10 Y Y ECO:0000033 Pubmed:20425256 BRENDA <128> Wang, Y.X.; Ulu, A.; Zhang, L.N.; Hammock, B.: Soluble epoxide hydrolase in atherosclerosis. Curr. Atheroscler. Rep. (2010) 12, 174-183. {Pubmed:20425256} AAP, DGA, ASD 12/7/2011 1111 3300034322 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #6,50# Hep-3B cell <117,131> HEP-3B cell BTO:0000972 3.3.2.10 Y Y ECO:0000006 Pubmed:19952412 BRENDA <117> Oguro, A.; Sakamoto, K.; Suzuki, S.; Imaoka, S.: Contribution of hydrolase and phosphatase domains in soluble epoxide hydrolase to vascular endothelial growth factor expression and cell growth. Biol. Pharm. Bull. (2009) 32, 1962-1967. {Pubmed:19952412} AAP, DGA, ASD 12/7/2011 1111 3300034323 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #6,50# HUVEC cell (#6# treatment with angiotensin II results in increased expression of soluble epoxide hydrolase at both the mRNA and protein level <82>) <82,134> HUVEC cell BTO:0001949 3.3.2.10 Y Y Pubmed:19704161 BRENDA <134> Barbosa-Sicard, E.; Froemel, T.; Keserue, B.; Brandes, R.P.; Morisseau, C.; Hammock, B.D.; Braun, T.; Krueger, M.; Fleming, I.: Inhibition of the soluble epoxide hydrolase by tyrosine nitration. J. Biol. Chem. (2009) 284, 28156-28163. {Pubmed:19704161} AAP, DGA, ASD 12/7/2011 1111 3300034324 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #9,42,50# endothelial cell (#42# from lung <134>; #9# of aorta, treatment with angiotensin II results in increased expression of soluble epoxide hydrolase at both the mRNA and protein level <82>) <82,134,141,143> endothelial cell BTO:0001176 3.3.2.10 Y Y Pubmed:19704161 BRENDA <134> Barbosa-Sicard, E.; Froemel, T.; Keserue, B.; Brandes, R.P.; Morisseau, C.; Hammock, B.D.; Braun, T.; Krueger, M.; Fleming, I.: Inhibition of the soluble epoxide hydrolase by tyrosine nitration. J. Biol. Chem. (2009) 284, 28156-28163. {Pubmed:19704161} AAP, DGA, ASD 12/7/2011 1111 3300034325 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #9,42,50# endothelial cell (#42# from lung <134>; #9# of aorta, treatment with angiotensin II results in increased expression of soluble epoxide hydrolase at both the mRNA and protein level <82>) <82,134,141,143> endothelial cell BTO:0001176 3.3.2.10 Y Y ECO:0000033 Pubmed:19891972 BRENDA <141> Deng, Y.; Theken, K.N.; Lee, C.R.: Cytochrome P450 epoxygenases, soluble epoxide hydrolase, and the regulation of cardiovascular inflammation. J. Mol. Cell. Cardiol. (2010) 48, 331-341. {Pubmed:19891972} AAP, DGA, ASD 12/7/2011 1111 3300034326 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #9,42,50# endothelial cell (#42# from lung <134>; #9# of aorta, treatment with angiotensin II results in increased expression of soluble epoxide hydrolase at both the mRNA and protein level <82>) <82,134,141,143> lung BTO:0000763 3.3.2.10 Y Y ECO:0000033 Pubmed:20339956 BRENDA <143> Xie, W.; Tang, X.; Lu, Q.; Ames, R.S.; Ratcliffe, S.J.; Li, H.: Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology. Mol. Biotechnol. (2010) 45, 207-217. {Pubmed:20339956} AAP, DGA, ASD 12/7/2011 1111 3300034327 curatus P35610 6646 SOAT1 Homo sapiens 9606 Comment/tissue specificity #6,23# monocyte (#23# serotonin upregiulates ACAT-1 expression in human monocyte-macrophages <51>) <23,40,51,92> monocyte BTO:0000876 2.3.1.26 Y Y ECO:0000006 Pubmed:16157345 BRENDA <51> Suguro, T.; Watanabe, T.; Kanome, T.; Kodate, S.; Hirano, T.; Miyazaki, A.; Adachi, M.: Serotonin acts as an up-regulator of acyl-coenzyme A:cholesterol acyltransferase-1 in human monocyte-macrophages. Atherosclerosis (2006) 186, 275-281. {Pubmed:16157345} AAP, ASD 12/7/2011 1111 3300034328 curatus P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity #1,7,9,10,31,34,35,36,37,45,46,48,64,65# liver (#65# strong expression <107>; #7# isozyme CTE-I expression, low amount of isozyme MTE-I <84>; #10# of rats treated with 3-thia fatty acids, i.e. tetradecylthioacetic acid and 3-dithiacarboxylic acid <72>; #48# major isozyme is CTE-I, only weak expression of PTE-Ia, expression of PTE-Ib, no expression of MTE-I <90>; #48# Acot1 mRNA levels are increased by 90fold in liver by treatment with Wy-14,643. Acot1 mRNA is also increased by 15fold in the liver of hepatocyte nuclear factor 4a (HNF4alpha) knockout animals. Acot1 is under regulation by an interplay between HNF4alpha and PPARalpha <109>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #7# weak expression of Acot7 in male mice <105>) <1,3,4,5,6,7,10,11,12,14,17,20,21,24,27,28,30,31,34,38,39,42,44,45,46,47,48,49,50,55,56,58,60,70,72,78,81,82,84,89,90,105,107,109> liver BTO:0000759 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034338 curatus P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity #1,7,9,10,31,34,35,36,37,45,46,48,64,65# liver (#65# strong expression <107>; #7# isozyme CTE-I expression, low amount of isozyme MTE-I <84>; #10# of rats treated with 3-thia fatty acids, i.e. tetradecylthioacetic acid and 3-dithiacarboxylic acid <72>; #48# major isozyme is CTE-I, only weak expression of PTE-Ia, expression of PTE-Ib, no expression of MTE-I <90>; #48# Acot1 mRNA levels are increased by 90fold in liver by treatment with Wy-14,643. Acot1 mRNA is also increased by 15fold in the liver of hepatocyte nuclear factor 4a (HNF4alpha) knockout animals. Acot1 is under regulation by an interplay between HNF4alpha and PPARalpha <109>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #7# weak expression of Acot7 in male mice <105>) <1,3,4,5,6,7,10,11,12,14,17,20,21,24,27,28,30,31,34,38,39,42,44,45,46,47,48,49,50,55,56,58,60,70,72,78,81,82,84,89,90,105,107,109> liver UBERON:0002107 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034339 curatus P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity #1,7,9,10,31,34,35,36,37,45,46,48,64,65# liver (#65# strong expression <107>; #7# isozyme CTE-I expression, low amount of isozyme MTE-I <84>; #10# of rats treated with 3-thia fatty acids, i.e. tetradecylthioacetic acid and 3-dithiacarboxylic acid <72>; #48# major isozyme is CTE-I, only weak expression of PTE-Ia, expression of PTE-Ib, no expression of MTE-I <90>; #48# Acot1 mRNA levels are increased by 90fold in liver by treatment with Wy-14,643. Acot1 mRNA is also increased by 15fold in the liver of hepatocyte nuclear factor 4a (HNF4alpha) knockout animals. Acot1 is under regulation by an interplay between HNF4alpha and PPARalpha <109>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #7# weak expression of Acot7 in male mice <105>) <1,3,4,5,6,7,10,11,12,14,17,20,21,24,27,28,30,31,34,38,39,42,44,45,46,47,48,49,50,55,56,58,60,70,72,78,81,82,84,89,90,105,107,109> kidney UBERON:0002113 3.1.2.2 Y Y ECO:0000006 Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034340 curatus P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity #7,10,12,13,34,45,48,62,64,65# heart (#65# strong expression <107>; #7# expression of isozyme CTE-I and MTE-I <84>; #48# strong expression of MTE-I, expression of CTE-I and PTE-Ia, no expression of PTE-Ib <90>; #10# differential regulation of distinct ACSl isoforms at the transcriptional level <97>; #7# moderate expression in male mice. In female mice, mRNA expression of Acot7 isoforms is highest in brain, lung, kidney, heart and ovary <105>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #62# treatment with a PPARalpha agonist (peroxisome proliferator-activated receptor alpha agonist) increases MTE-1 mRNA, protein expression, and activity and the rate of palmitate export from isolated cardiac mitochondria, suggesting that MTE-I functions to regulate the concentration of long-chain fatty acyl-CoA in the mitochondrial matrix through the generation and export of free fatty acid anions. Thus, upregulation of MTE-I activity may prevent the accumulation of long-chain fatty acyl-CoA in the mitochondrial matrix when the heart is exposed to high levels of fatty acids <108>) <14,37,41,47,49,50,66,81,84,89,90,97,105,107,108> heart BTO:0000562 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034341 curatus P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity #7,10,12,13,34,45,48,62,64,65# heart (#65# strong expression <107>; #7# expression of isozyme CTE-I and MTE-I <84>; #48# strong expression of MTE-I, expression of CTE-I and PTE-Ia, no expression of PTE-Ib <90>; #10# differential regulation of distinct ACSl isoforms at the transcriptional level <97>; #7# moderate expression in male mice. In female mice, mRNA expression of Acot7 isoforms is highest in brain, lung, kidney, heart and ovary <105>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #62# treatment with a PPARalpha agonist (peroxisome proliferator-activated receptor alpha agonist) increases MTE-1 mRNA, protein expression, and activity and the rate of palmitate export from isolated cardiac mitochondria, suggesting that MTE-I functions to regulate the concentration of long-chain fatty acyl-CoA in the mitochondrial matrix through the generation and export of free fatty acid anions. Thus, upregulation of MTE-I activity may prevent the accumulation of long-chain fatty acyl-CoA in the mitochondrial matrix when the heart is exposed to high levels of fatty acids <108>) <14,37,41,47,49,50,66,81,84,89,90,97,105,107,108> heart UBERON:0000948 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034342 curatus P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity #7,10,12,13,34,45,48,62,64,65# heart (#65# strong expression <107>; #7# expression of isozyme CTE-I and MTE-I <84>; #48# strong expression of MTE-I, expression of CTE-I and PTE-Ia, no expression of PTE-Ib <90>; #10# differential regulation of distinct ACSl isoforms at the transcriptional level <97>; #7# moderate expression in male mice. In female mice, mRNA expression of Acot7 isoforms is highest in brain, lung, kidney, heart and ovary <105>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #62# treatment with a PPARalpha agonist (peroxisome proliferator-activated receptor alpha agonist) increases MTE-1 mRNA, protein expression, and activity and the rate of palmitate export from isolated cardiac mitochondria, suggesting that MTE-I functions to regulate the concentration of long-chain fatty acyl-CoA in the mitochondrial matrix through the generation and export of free fatty acid anions. Thus, upregulation of MTE-I activity may prevent the accumulation of long-chain fatty acyl-CoA in the mitochondrial matrix when the heart is exposed to high levels of fatty acids <108>) <14,37,41,47,49,50,66,81,84,89,90,97,105,107,108> kidney BTO:0000671 3.1.2.2 Y Y ECO:0000006 Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034343 curatus P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity #7,45,48,64,65# muscle (#65# strong expression <107>; #7# low expression of isozyme MTE-I <84>; #48# strong expression of MTE-I, only weak expression of CTE-I, expression of PTE-Ia, no expression of PTE-Ib <90>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #7# weak expression of Acot7 in male mice <105>) <81,84,90,105,107> muscle BTO:0000887 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034344 curatus P49753 10965 ACOT2 Homo sapiens 9606 Comment/tissue specificity #7,45,48,64,65# muscle (#65# strong expression <107>; #7# low expression of isozyme MTE-I <84>; #48# strong expression of MTE-I, only weak expression of CTE-I, expression of PTE-Ia, no expression of PTE-Ib <90>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #7# weak expression of Acot7 in male mice <105>) <81,84,90,105,107> musculature UBERON:0001015 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034345 curatus P59796 257202 GPX6 Homo sapiens 9606 Comment/tissue specificity #47# olfactory epithelium (#47# GPx-6 <82>) <82> olfactory epithelium BTO:0000108 1.11.1.9 Y Y ECO:0000033 Pubmed:18498225 BRENDA <82> Toppo, S.; Vanin, S.; Bosello, V.; Tosatto, S.C.: Evolutionary and structural insights into the multifaceted glutathione peroxidase (Gpx) superfamily. Antioxid. Redox Signal. (2008) 10, 1501-1514. {Pubmed:18498225} AAP, ASD 12/7/2011 1111 3300034347 curatus P59796 257202 GPX6 Homo sapiens 9606 Comment/tissue specificity #47# olfactory epithelium (#47# GPx-6 <82>) <82> olfactory epithelium UBERON:0001997 1.11.1.9 Y Y ECO:0000033 Pubmed:18498225 BRENDA <82> Toppo, S.; Vanin, S.; Bosello, V.; Tosatto, S.C.: Evolutionary and structural insights into the multifaceted glutathione peroxidase (Gpx) superfamily. Antioxid. Redox Signal. (2008) 10, 1501-1514. {Pubmed:18498225} AAP, ASD 12/7/2011 1111 3300034348 curatus Q05469 3991 LIPE Homo sapiens 9606 Comment/tissue specificity #1,2,3,10,11# adipocyte (#1# adipocytes retrovirally engineered from murine embryonic fibroblasts <51>; #2# dydrogesterone and norethisterone regulate expression of hormone-sensitive lipase in human subcutaneous abdominal adipocytes <48>; #11# women with polycystic ovary syndrome or obesity have significantly decreased expression of hormone-sensitive lipase. Knock down of hormone-sensitive lipase by RNAi reduces basal and catecholamine-induced lipolysis. Treatment of mesenchymal stem cells with a selective inhibitor of hormone-sensitive lipase during and/or after differentiation in adipocytes reduces basal lipolysis by 50% <44>) <34,36,44,47,48,51> adipocyte BTO:0000443 3.1.1.79 Y Y ECO:0000006 Pubmed:17327373 BRENDA <44> Ryden, M.; Jocken, J.; van Harmelen, V.; Dicker, A.; Hoffstedt, J.; Wiren, M.; Blomqvist, L.; Mairal, A.; Langin, D.; Blaak, E.; Arner, P.: Comparative studies of the role of hormone-sensitive lipase and adipose triglyceride lipase in human fat cell lipolysis. Am. J. Physiol. Endocrinol. Metab. (2007) 292, E1847-E1855. {Pubmed:17327373} AAP, DGA, ASD 12/7/2011 1111 3300034350 curatus Q05469 3991 LIPE Homo sapiens 9606 Comment/tissue specificity #2,3,11# skeletal muscle (#2# enzyme activity increases early in exercise and remains elevated for the duration of the exercise <33>; #3# expressed at a higher level in oxidative fibres than in glycolytic fibres. The two physiological stimuli adrenaline and contraction increase enzyme activity in muscle, and the effects are partially additive. Adrenaline acts via beta-adrenergic activation of cAMP-dependent protein kinase, while the effect of contractions is mediated by protein kinase C, at least partly via the extracellular signal-regulated kinase pathway. Endurance training diminishes the sensitivity of muscle hormone-sensitive lipase to adrenaline but increases the contraction-mediated activation <41>; #2# in the skeletal muscle at rest there is a high constitutive level of hormone-sensitive lipase activity, which is not a function of biopsy freezing. The combination of low adrenaline and Ca2+ levels and resting levels of insulin appears to dictate the levels of activity of hormone-sensitive lipase at rest. During the onset of low and moderate aerobic exercise enzyme activity is activated by contractions, in the apparent absence of increases in circulating adrenaline. However, adrenaline may contribute to the early activation of the enzyme during intense aerobic exercise. The contraction-induced activation appears to be related to the increase in protein kinase C and extracellular signal regulated kinase activity associated with Ca2+ and/or other unknown activators. As low- and moderate-intensity exercise continues beyond a few min, activation by adrenaline through the cAMP cascade and protein kinase A also appears to occur. With prolonged moderate-intensity exercise beyond 1–2 h and sustained high-intensity exercise, HSL activity decreases despite continuing increases in adrenaline, possibly as a result of increasing accumulation of free AMP, activation of AMP-activated kinase and phosphorylation of inhibitory sites on the hormone-sensitive lipase. Intramuscular factors dominate the control of hormone-sensitive lipase activity, with hormonal factors playing a smaller role <42>; #2# muscle hormone-sensitive lipase mRNA (80%) and protein content (50%) are higher in women than in men. Total activity increases during exercise (47%) but does not differ between sexes. Accordingly, hormone-sensitive lipase specific activity (HSL activity per HSL protein content) increased during exercise (62%) and is higher in men than in women <43>) <6,8,12,33,39,41,42,43,55,60> skeletal muscle BTO:0001103 3.1.1.79 Y Y ECO:0000033 Pubmed:18492774 BRENDA <55> Fernandez, C.; Hansson, O.; Nevsten, P.; Holm, C.; Klint, C.: Hormone-sensitive lipase is necessary for normal mobilization of lipids during submaximal exercise. Am. J. Physiol. Endocrinol. Metab. (2008) 295, E179-E186. {Pubmed:18492774} AAP, DGA, ASD 12/7/2011 1111 3300034352 curatus Q05469 3991 LIPE Homo sapiens 9606 Comment/tissue specificity #2,3,11# skeletal muscle (#2# enzyme activity increases early in exercise and remains elevated for the duration of the exercise <33>; #3# expressed at a higher level in oxidative fibres than in glycolytic fibres. The two physiological stimuli adrenaline and contraction increase enzyme activity in muscle, and the effects are partially additive. Adrenaline acts via beta-adrenergic activation of cAMP-dependent protein kinase, while the effect of contractions is mediated by protein kinase C, at least partly via the extracellular signal-regulated kinase pathway. Endurance training diminishes the sensitivity of muscle hormone-sensitive lipase to adrenaline but increases the contraction-mediated activation <41>; #2# in the skeletal muscle at rest there is a high constitutive level of hormone-sensitive lipase activity, which is not a function of biopsy freezing. The combination of low adrenaline and Ca2+ levels and resting levels of insulin appears to dictate the levels of activity of hormone-sensitive lipase at rest. During the onset of low and moderate aerobic exercise enzyme activity is activated by contractions, in the apparent absence of increases in circulating adrenaline. However, adrenaline may contribute to the early activation of the enzyme during intense aerobic exercise. The contraction-induced activation appears to be related to the increase in protein kinase C and extracellular signal regulated kinase activity associated with Ca2+ and/or other unknown activators. As low- and moderate-intensity exercise continues beyond a few min, activation by adrenaline through the cAMP cascade and protein kinase A also appears to occur. With prolonged moderate-intensity exercise beyond 1–2 h and sustained high-intensity exercise, HSL activity decreases despite continuing increases in adrenaline, possibly as a result of increasing accumulation of free AMP, activation of AMP-activated kinase and phosphorylation of inhibitory sites on the hormone-sensitive lipase. Intramuscular factors dominate the control of hormone-sensitive lipase activity, with hormonal factors playing a smaller role <42>; #2# muscle hormone-sensitive lipase mRNA (80%) and protein content (50%) are higher in women than in men. Total activity increases during exercise (47%) but does not differ between sexes. Accordingly, hormone-sensitive lipase specific activity (HSL activity per HSL protein content) increased during exercise (62%) and is higher in men than in women <43>) <6,8,12,33,39,41,42,43,55,60> skeletal muscle tissue UBERON:0001134 3.1.1.79 Y Y ECO:0000033 Pubmed:18492774 BRENDA <55> Fernandez, C.; Hansson, O.; Nevsten, P.; Holm, C.; Klint, C.: Hormone-sensitive lipase is necessary for normal mobilization of lipids during submaximal exercise. Am. J. Physiol. Endocrinol. Metab. (2008) 295, E179-E186. {Pubmed:18492774} AAP, DGA, ASD 12/7/2011 1111 3300034353 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #1,2,3,4,11# lung <2,3,9,13,19,23,25,30,37> lung BTO:0000763 4.4.1.20 Y Y ECO:0000006 Pubmed:12895593 BRENDA <37> Lam, B.K.: Leukotriene C4 synthase. Prostaglandins Leukot. Essent. Fatty Acids (2003) 69, 111-116. {Pubmed:} AAP, DGA, ASD 12/7/2011 1111 3300034354 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #1,2,3,4,11# lung <2,3,9,13,19,23,25,30,37> lung UBERON:0002048 4.4.1.20 Y Y ECO:0000006 Pubmed:12895593 BRENDA <37> Lam, B.K.: Leukotriene C4 synthase. Prostaglandins Leukot. Essent. Fatty Acids (2003) 69, 111-116. {Pubmed:} AAP, DGA, ASD 12/7/2011 1111 3300034355 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #11# more (#11# nasal biopsies <55>) <55> lamina propria BTO:0002330 4.4.1.20 Y Y ECO:0000006 Pubmed:19364335 BRENDA <55> Westergren, V.S.; Wilson, S.J.; Penrose, J.F.; Howarth, P.H.; Sampson, A.P.: Nasal mucosal expression of the leukotriene and prostanoid pathways in seasonal and perennial allergic rhinitis. Clin. Exp. Allergy (2009) 39, 820-828. {Pubmed:19364335} AAP, DGA, ASD 12/7/2011 1111 3300034356 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #11# polymorphonuclear leukocyte <32> polymorphonuclear leukocyte BTO:0001026 4.4.1.20 Y Y ECO:0000006 Pubmed:12765316 BRENDA <32> Zaitsu, M.; Hamasaki, Y.; Matsuo, M.; Ichimaru, T.; Fujita, I.; Ishii, E.: Leukotriene synthesis is increased by transcriptional up-regulation of 5-lipoxygenase, leukotriene A4 hydrolase, and leukotriene C4 synthase in asthmatic children. J. Asthma (2003) 40, 147-154. {Pubmed:12765316} AAP, DGA, ASD 12/7/2011 1111 3300034357 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #11# leukocyte <34> leukocyte BTO:0000751 4.4.1.20 Y Y ECO:0000006 Pubmed:15648658 BRENDA <34> Mansour, M.; Tornhamre, S.: Inhibition of 5-lipoxygenase and leukotriene C4 synthase in human blood cells by thymoquinone. J. Enzyme Inhib. Med. Chem. (2004) 19, 431-436. {Pubmed:15648658} AAP, DGA, ASD 12/7/2011 1111 3300034358 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #11# macrophage (#11# co-localization for 5-lipoxygenase activating protein, LTC4 synthase, cyclooxygenase-1 and prostaglandin D2 synthase in nasal biopsies. 10-43% of LTC4 synthase-positive cells being macrophages in perennial and seasonal allergic rhinitis biopsies. In the rhinitic biopsies, LTC4 synthase is detectable in 6-76% of macrophages <55>) <55> macrophage BTO:0000801 4.4.1.20 Y Y ECO:0000006 Pubmed:19364335 BRENDA <55> Westergren, V.S.; Wilson, S.J.; Penrose, J.F.; Howarth, P.H.; Sampson, A.P.: Nasal mucosal expression of the leukotriene and prostanoid pathways in seasonal and perennial allergic rhinitis. Clin. Exp. Allergy (2009) 39, 820-828. {Pubmed:19364335} AAP, DGA, ASD 12/7/2011 1111 3300034363 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #11# RBL-2H3 cell <36> RBL-2H3 cell BTO:0000833 4.4.1.20 Y Y ECO:0000006 Pubmed:15084748 BRENDA <36> Mandal, A.K.; Skoch, J.; Bacskai, B.J.; Hyman, B.T.; Christmas, P.; Miller, D.; Yamin, T.t.D.; Xu, S.; Wisniewski, D.; Evans, J.F.; Soberman, R.J.: The membrane organization of leukotriene synthesis. Proc. Natl. Acad. Sci. USA (2004) 101, 6587-6592. {Pubmed:15084748} AAP, DGA, ASD 12/7/2011 1111 3300034365 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #11# bronchial epithelial cell line <44> bronchial epithelial cell line BTO:0002022 4.4.1.20 Y Y ECO:0000006 Pubmed:17517102 BRENDA <44> Jame, A.J.; Lackie, P.M.; Cazaly, A.M.; Sayers, I.; Penrose, J.F.; Holgate, S.T.; Sampson, A.P.: Human bronchial epithelial cells express an active and inducible biosynthetic pathway for leukotrienes B4 and C4. Clin. Exp. Allergy (2007) 37, 880-892. {Pubmed:17517102} AAP, DGA, ASD 12/7/2011 1111 3300034366 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #11# bronchial epithelial cell <44> bronchial epithelial cell BTO:0002922 4.4.1.20 Y Y ECO:0000006 Pubmed:17517102 BRENDA <44> Jame, A.J.; Lackie, P.M.; Cazaly, A.M.; Sayers, I.; Penrose, J.F.; Holgate, S.T.; Sampson, A.P.: Human bronchial epithelial cells express an active and inducible biosynthetic pathway for leukotrienes B4 and C4. Clin. Exp. Allergy (2007) 37, 880-892. {Pubmed:17517102} AAP, DGA, ASD 12/7/2011 1111 3300034367 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #2,3,11# mast cell (#2# Kirsten sarcoma-transfected mast cell <14>; #3# derived from cord blood, expression of two C4 leukotriene synthase isoenzymes <5>; #2# bone-marrow-derived <25>; #11# co-localization for 5-lipoxygenase activating protein, LTC4 synthase, cyclooxygenase-1 and prostaglandin D2 synthase in nasal biopsies, 22-26% of LTC4 synthase-positive cells being mast cells in perennial and seasonal allergic rhinitis biopsies. In the rhinitic biopsies, LTC4 synthase is detectable in 10-38% of mast cells, but it does not localize to mast cells in the normal biopsies <55>) <2,3,5,14,25,55> mast cell BTO:0000830 4.4.1.20 Y Y ECO:0000006 Pubmed:19364335 BRENDA <55> Westergren, V.S.; Wilson, S.J.; Penrose, J.F.; Howarth, P.H.; Sampson, A.P.: Nasal mucosal expression of the leukotriene and prostanoid pathways in seasonal and perennial allergic rhinitis. Clin. Exp. Allergy (2009) 39, 820-828. {Pubmed:19364335} AAP, DGA, ASD 12/7/2011 1111 3300034368 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #2,3,11# mast cell (#2# Kirsten sarcoma-transfected mast cell <14>; #3# derived from cord blood, expression of two C4 leukotriene synthase isoenzymes <5>; #2# bone-marrow-derived <25>; #11# co-localization for 5-lipoxygenase activating protein, LTC4 synthase, cyclooxygenase-1 and prostaglandin D2 synthase in nasal biopsies, 22-26% of LTC4 synthase-positive cells being mast cells in perennial and seasonal allergic rhinitis biopsies. In the rhinitic biopsies, LTC4 synthase is detectable in 10-38% of mast cells, but it does not localize to mast cells in the normal biopsies <55>) <2,3,5,14,25,55> lamina propria UBERON:0000030 4.4.1.20 Y Y ECO:0000006 Pubmed:19364335 BRENDA <55> Westergren, V.S.; Wilson, S.J.; Penrose, J.F.; Howarth, P.H.; Sampson, A.P.: Nasal mucosal expression of the leukotriene and prostanoid pathways in seasonal and perennial allergic rhinitis. Clin. Exp. Allergy (2009) 39, 820-828. {Pubmed:19364335} AAP, DGA, ASD 12/7/2011 1111 3300034369 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #3,10,11# monocyte <9,39,40> immortal monocyte cell line cell CLO:0000106 4.4.1.20 Y Y ECO:0000006 Pubmed:16980379 BRENDA <39> Serio, K.J.; Luo, C.; Luo, L.; Mao, J.T.: TNF-alpha downregulates the leukotriene C4 synthase gene in mononuclear phagocytes. Am. J. Physiol. (2007) 292, L215-L222. {Pubmed:16980379} AAP, DGA, ASD 12/7/2011 1111 3300034370 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #3,11# eosinophil (#11# co-localization for 5-lipoxygenase activating protein, LTC4 synthase, cyclooxygenase-1 and prostaglandin D2 synthase in nasal biopsies, 10% of LTC4 synthase-positive cells being eosinophils in perennial and seasonal allergic rhinitis biopsies. In the rhinitic biopsies, LTC4 synthase is detectable in 19% of eosinophils <55>) <2,3,5,55> eosinophil BTO:0000399 4.4.1.20 Y Y ECO:0000006 Pubmed:19364335 BRENDA <55> Westergren, V.S.; Wilson, S.J.; Penrose, J.F.; Howarth, P.H.; Sampson, A.P.: Nasal mucosal expression of the leukotriene and prostanoid pathways in seasonal and perennial allergic rhinitis. Clin. Exp. Allergy (2009) 39, 820-828. {Pubmed:19364335} AAP, DGA, ASD 12/7/2011 1111 3300034373 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #3,11# THP-1 cell (#3# monocytic leukemia cell line <3,9,14>) <3,9,14,37,39,57> THP-1 cell BTO:0001370 4.4.1.20 Y Y ECO:0000006 Pubmed:12895593 BRENDA <37> Lam, B.K.: Leukotriene C4 synthase. Prostaglandins Leukot. Essent. Fatty Acids (2003) 69, 111-116. {Pubmed:} AAP, DGA, ASD 12/7/2011 1111 3300034375 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #3,11# THP-1 cell (#3# monocytic leukemia cell line <3,9,14>) <3,9,14,37,39,57> THP-1 cell BTO:0001370 4.4.1.20 Y Y ECO:0000006 Pubmed:16980379 BRENDA <39> Serio, K.J.; Luo, C.; Luo, L.; Mao, J.T.: TNF-alpha downregulates the leukotriene C4 synthase gene in mononuclear phagocytes. Am. J. Physiol. (2007) 292, L215-L222. {Pubmed:16980379} AAP, DGA, ASD 12/7/2011 1111 3300034376 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #3,11# THP-1 cell (#3# monocytic leukemia cell line <3,9,14>) <3,9,14,37,39,57> THP-1 cell BTO:0001370 4.4.1.20 Y Y ECO:0000006 Pubmed:19767084 BRENDA <57> Steinke, J.W.; Culp, J.A.; Kropf, E.; Borish, L.: Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated with aspirin desensitization. J. Allergy Clin. Immunol. (2009) 124, 724-730. {Pubmed:19767084} AAP, DGA, ASD 12/7/2011 1111 3300034377 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #3,11# KG-1 cell <3,20,37> KG-1 cell BTO:0000670 4.4.1.20 Y Y ECO:0000006 Pubmed:12895593 BRENDA <37> Lam, B.K.: Leukotriene C4 synthase. Prostaglandins Leukot. Essent. Fatty Acids (2003) 69, 111-116. {Pubmed:} AAP, DGA, ASD 12/7/2011 1111 3300034378 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10# lung (#10# very low expression level <15>) <15> lung BTO:0000763 2.3.1.75 Y Y Pubmed:16106050 BRENDA <15> Yen, C.L.; Brown, C.H.; Monetti, M.; Farese, R.V.: A human skin multifunctional O-acyltransferase that catalyzes the synthesis of acylglycerols, waxes, and retinyl esters. J. Lipid Res. (2005) 46, 2388-2397. {Pubmed:16106050} AAP 12/7/2011 1111 3300034380 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10# lung (#10# very low expression level <15>) <15> lung UBERON:0002048 2.3.1.75 Y Y Pubmed:16106050 BRENDA <15> Yen, C.L.; Brown, C.H.; Monetti, M.; Farese, R.V.: A human skin multifunctional O-acyltransferase that catalyzes the synthesis of acylglycerols, waxes, and retinyl esters. J. Lipid Res. (2005) 46, 2388-2397. {Pubmed:16106050} AAP 12/7/2011 1111 3300034381 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10# testis (#10# very low expression level <15>) <15> testis BTO:0001363 2.3.1.75 Y Y Pubmed:16106050 BRENDA <15> Yen, C.L.; Brown, C.H.; Monetti, M.; Farese, R.V.: A human skin multifunctional O-acyltransferase that catalyzes the synthesis of acylglycerols, waxes, and retinyl esters. J. Lipid Res. (2005) 46, 2388-2397. {Pubmed:16106050} AAP 12/7/2011 1111 3300034383 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10# testis (#10# very low expression level <15>) <15> testis UBERON:0000473 2.3.1.75 Y Y Pubmed:16106050 BRENDA <15> Yen, C.L.; Brown, C.H.; Monetti, M.; Farese, R.V.: A human skin multifunctional O-acyltransferase that catalyzes the synthesis of acylglycerols, waxes, and retinyl esters. J. Lipid Res. (2005) 46, 2388-2397. {Pubmed:16106050} AAP 12/7/2011 1111 3300034384 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10,13,14# skin (#10# predominantly <15>; #2# high expression level <15>; #10,13,14# predominant expression <13>; #14# predominant expression of AWAT1 <13>; #10# predominant expression of AWAT2 <13>) <8,13,15> skin BTO:0001253 2.3.1.75 Y Y ECO:0000006 Pubmed:15220349 BRENDA <8> Cheng, J.B.; Russell, D.W.: Mammalian wax biosynthesis. II. Expression cloning of wax synthase cDNAs encoding a member of the acyltransferase enzyme family. J. Biol. Chem. (2004) 279, 37798-37807. {Pubmed:15220349} AAP 12/7/2011 1111 3300034386 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10,13,14# skin (#10# predominantly <15>; #2# high expression level <15>; #10,13,14# predominant expression <13>; #14# predominant expression of AWAT1 <13>; #10# predominant expression of AWAT2 <13>) <8,13,15> skin of body UBERON:0002097 2.3.1.75 Y Y ECO:0000006 Pubmed:15220349 BRENDA <8> Cheng, J.B.; Russell, D.W.: Mammalian wax biosynthesis. II. Expression cloning of wax synthase cDNAs encoding a member of the acyltransferase enzyme family. J. Biol. Chem. (2004) 279, 37798-37807. {Pubmed:15220349} AAP 12/7/2011 1111 3300034387 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10,13,14# skin (#10# predominantly <15>; #2# high expression level <15>; #10,13,14# predominant expression <13>; #14# predominant expression of AWAT1 <13>; #10# predominant expression of AWAT2 <13>) <8,13,15> skin BTO:0001253 2.3.1.75 Y Y ECO:0000006 Pubmed:15671038 BRENDA <13> Turkish, A.R.; Henneberry, A.L.; Cromley, D.; Padamsee, M.; Oelkers, P.; Bazzi, H.; Christiano, A.M.; Billheimer, J.T.; Sturley, S.L.: Identification of two novel human acyl-CoA wax alcohol acyltransferases: members of the diacylglycerol acyltransferase 2 (DGAT2) gene superfamily. J. Biol. Chem. (2005) 280, 14755-14764. {Pubmed:15671038} AAP 12/7/2011 1111 3300034388 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10,13,14# skin (#10# predominantly <15>; #2# high expression level <15>; #10,13,14# predominant expression <13>; #14# predominant expression of AWAT1 <13>; #10# predominant expression of AWAT2 <13>) <8,13,15> skin of body UBERON:0002097 2.3.1.75 Y Y ECO:0000006 Pubmed:15671038 BRENDA <13> Turkish, A.R.; Henneberry, A.L.; Cromley, D.; Padamsee, M.; Oelkers, P.; Bazzi, H.; Christiano, A.M.; Billheimer, J.T.; Sturley, S.L.: Identification of two novel human acyl-CoA wax alcohol acyltransferases: members of the diacylglycerol acyltransferase 2 (DGAT2) gene superfamily. J. Biol. Chem. (2005) 280, 14755-14764. {Pubmed:15671038} AAP 12/7/2011 1111 3300034389 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10,13,14# skin (#10# predominantly <15>; #2# high expression level <15>; #10,13,14# predominant expression <13>; #14# predominant expression of AWAT1 <13>; #10# predominant expression of AWAT2 <13>) <8,13,15> skin BTO:0001253 2.3.1.75 Y Y Pubmed:16106050 BRENDA <15> Yen, C.L.; Brown, C.H.; Monetti, M.; Farese, R.V.: A human skin multifunctional O-acyltransferase that catalyzes the synthesis of acylglycerols, waxes, and retinyl esters. J. Lipid Res. (2005) 46, 2388-2397. {Pubmed:16106050} AAP 12/7/2011 1111 3300034390 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10,13,14# skin (#10# predominantly <15>; #2# high expression level <15>; #10,13,14# predominant expression <13>; #14# predominant expression of AWAT1 <13>; #10# predominant expression of AWAT2 <13>) <8,13,15> skin of body UBERON:0002097 2.3.1.75 Y Y Pubmed:16106050 BRENDA <15> Yen, C.L.; Brown, C.H.; Monetti, M.; Farese, R.V.: A human skin multifunctional O-acyltransferase that catalyzes the synthesis of acylglycerols, waxes, and retinyl esters. J. Lipid Res. (2005) 46, 2388-2397. {Pubmed:16106050} AAP 12/7/2011 1111 3300034391 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10,13,14# skin (#10# predominantly <15>; #2# high expression level <15>; #10,13,14# predominant expression <13>; #14# predominant expression of AWAT1 <13>; #10# predominant expression of AWAT2 <13>) <8,13,15> skin BTO:0001253 2.3.1.75 Y Y ECO:0000006 Pubmed:15671038 BRENDA <13> Turkish, A.R.; Henneberry, A.L.; Cromley, D.; Padamsee, M.; Oelkers, P.; Bazzi, H.; Christiano, A.M.; Billheimer, J.T.; Sturley, S.L.: Identification of two novel human acyl-CoA wax alcohol acyltransferases: members of the diacylglycerol acyltransferase 2 (DGAT2) gene superfamily. J. Biol. Chem. (2005) 280, 14755-14764. {Pubmed:15671038} AAP 12/7/2011 1111 3300034393 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #1,6,7,9,10,22# heart (#22# northern blot analysis <57>; #9# myocardium <16>) <9,13,16,17,19,21,46,57> heart BTO:0000562 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034394 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #1,6,7,9,10,22# heart (#22# northern blot analysis <57>; #9# myocardium <16>) <9,13,16,17,19,21,46,57> heart UBERON:0000948 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034395 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #22# thymus (#22# highly expressed, detected by Northern blot analysis <57>) <57> thymus BTO:0001374 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034397 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #22# thymus (#22# highly expressed, detected by Northern blot analysis <57>) <57> thymus UBERON:0002370 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034398 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #22# thymus (#22# highly expressed, detected by Northern blot analysis <57>) <57> thymus BTO:0001374 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034399 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #22# adipocyte (#22# by retrieving LPCAT3 expression pattern from Genevestigator <57>) <57> adipocyte BTO:0000443 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034400 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #22,26# HEK-293 cell <64,65> HEK-293 cell BTO:0000007 2.3.1.23 Y Y ECO:0000006 Pubmed:19351971 BRENDA <64> Jain, S.; Zhang, X.; Khandelwal, P.J.; Saunders, A.J.; Cummings, B.S.; Oelkers, P.: Characterization of human lysophospholipid acyltransferase 3. J. Lipid Res. (2009) 50, 1563-1570. {Pubmed:19351971} AAP 12/7/2011 1111 3300034402 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #22,26# neutrophil <61,68> neutrophil BTO:0000130 2.3.1.23 Y Y ECO:0000006 Pubmed:18772128 BRENDA <61> Gijon, M.A.; Riekhof, W.R.; Zarini, S.; Murphy, R.C.; Voelker, D.R.: Lysophospholipid acyltransferases and arachidonate recycling in human neutrophils. J. Biol. Chem. (2008) 283, 30235-30245. {Pubmed:18772128} AAP 12/7/2011 1111 3300034403 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #4,5,6,10,17,18,22,26# lung (#4# adenoma <28>; #17# LPCAT is predominantly expressed in the lung <55>; #18# LPCAT is predominantly expressed in the lung, LPCAT expression in the developing and adult lung, overview <55>; #17# LPCAT1 is predominantly expressed in the lung, in particular in alveolar type II cells, but occurs also in other tissues <53>; #22# highly expressed, detected by Northern blot analysis <57>) <5,6,12,14,22,28,46,50,53,55,57,58,65,68> lung BTO:0000763 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034404 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #4,5,6,10,17,18,22,26# lung (#4# adenoma <28>; #17# LPCAT is predominantly expressed in the lung <55>; #18# LPCAT is predominantly expressed in the lung, LPCAT expression in the developing and adult lung, overview <55>; #17# LPCAT1 is predominantly expressed in the lung, in particular in alveolar type II cells, but occurs also in other tissues <53>; #22# highly expressed, detected by Northern blot analysis <57>) <5,6,12,14,22,28,46,50,53,55,57,58,65,68> lung UBERON:0002048 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034405 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #5,6,22# pancreas (#6# very low activity <46>; #22# northern blot analysis <57>; #5# determined by RT-PCR analysis <56>) <46,56,57> pancreas BTO:0000988 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034407 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #5,6,22# pancreas (#6# very low activity <46>; #22# northern blot analysis <57>; #5# determined by RT-PCR analysis <56>) <46,56,57> pancreas UBERON:0001264 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034408 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #6,22,23,25,27# testis (#22# northern blot analysis <57>) <46,57,62,69> testis BTO:0001363 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034413 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #6,22,23,25,27# testis (#22# northern blot analysis <57>) <46,57,62,69> testis UBERON:0000473 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} AAP 12/7/2011 1111 3300034414 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #6,22,23,25,27# testis (#22# northern blot analysis <57>) <46,57,62,69> testis BTO:0001363 2.3.1.23 Y Y ECO:0000006 Pubmed:18718904 BRENDA <62> Shindou, H.; Shimizu, T.: Acyl-CoA:lysophospholipid acyltransferases. J. Biol. Chem. (2009) 284, 1-5. {Pubmed:18718904} AAP 12/7/2011 1111 3300034415 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #6,22,23,25,27# testis (#22# northern blot analysis <57>) <46,57,62,69> testis UBERON:0000473 2.3.1.23 Y Y ECO:0000006 Pubmed:18718904 BRENDA <62> Shindou, H.; Shimizu, T.: Acyl-CoA:lysophospholipid acyltransferases. J. Biol. Chem. (2009) 284, 1-5. {Pubmed:18718904} AAP 12/7/2011 1111 3300034416 curatus Q7L5N7 54947 LPCAT2 Homo sapiens 9606 Comment/tissue specificity #2,10# HUVEC cell (#2# activity is enhanced in H2O2-treated cells <25>; #10# H2O2-stimulated <25>) <25> HUVEC cell BTO:0001949 2.3.1.67 Y Y ECO:0000006 Pubmed:17268064 BRENDA <25> Tosaki, T.; Sakamoto, H.; Kitahara, J.; Imai, H.; Nakagawa, Y.: Enhancement of acetyl-CoA: 1-O-alkyl-2-lyso-sn-glycero-3-phosphocholine acetyltransferase activity by hydrogen peroxide. Biol. Pharm. Bull. (2007) 30, 272-278. {Pubmed:17268064} AAP 12/7/2011 1111 3300034418 curatus Q86TX2 641371 ACOT1 Homo sapiens 9606 Comment/tissue specificity #1,7,9,10,31,34,35,36,37,45,46,48,64,65# liver (#65# strong expression <107>; #7# isozyme CTE-I expression, low amount of isozyme MTE-I <84>; #10# of rats treated with 3-thia fatty acids, i.e. tetradecylthioacetic acid and 3-dithiacarboxylic acid <72>; #48# major isozyme is CTE-I, only weak expression of PTE-Ia, expression of PTE-Ib, no expression of MTE-I <90>; #48# Acot1 mRNA levels are increased by 90fold in liver by treatment with Wy-14,643. Acot1 mRNA is also increased by 15fold in the liver of hepatocyte nuclear factor 4a (HNF4alpha) knockout animals. Acot1 is under regulation by an interplay between HNF4alpha and PPARalpha <109>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #7# weak expression of Acot7 in male mice <105>) <1,3,4,5,6,7,10,11,12,14,17,20,21,24,27,28,30,31,34,38,39,42,44,45,46,47,48,49,50,55,56,58,60,70,72,78,81,82,84,89,90,105,107,109> liver BTO:0000759 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034420 curatus Q86TX2 641371 ACOT1 Homo sapiens 9606 Comment/tissue specificity #1,7,9,10,31,34,35,36,37,45,46,48,64,65# liver (#65# strong expression <107>; #7# isozyme CTE-I expression, low amount of isozyme MTE-I <84>; #10# of rats treated with 3-thia fatty acids, i.e. tetradecylthioacetic acid and 3-dithiacarboxylic acid <72>; #48# major isozyme is CTE-I, only weak expression of PTE-Ia, expression of PTE-Ib, no expression of MTE-I <90>; #48# Acot1 mRNA levels are increased by 90fold in liver by treatment with Wy-14,643. Acot1 mRNA is also increased by 15fold in the liver of hepatocyte nuclear factor 4a (HNF4alpha) knockout animals. Acot1 is under regulation by an interplay between HNF4alpha and PPARalpha <109>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #7# weak expression of Acot7 in male mice <105>) <1,3,4,5,6,7,10,11,12,14,17,20,21,24,27,28,30,31,34,38,39,42,44,45,46,47,48,49,50,55,56,58,60,70,72,78,81,82,84,89,90,105,107,109> liver UBERON:0002107 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034421 curatus Q86TX2 641371 ACOT1 Homo sapiens 9606 Comment/tissue specificity #7,10,12,13,34,45,48,62,64,65# heart (#65# strong expression <107>; #7# expression of isozyme CTE-I and MTE-I <84>; #48# strong expression of MTE-I, expression of CTE-I and PTE-Ia, no expression of PTE-Ib <90>; #10# differential regulation of distinct ACSl isoforms at the transcriptional level <97>; #7# moderate expression in male mice. In female mice, mRNA expression of Acot7 isoforms is highest in brain, lung, kidney, heart and ovary <105>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #62# treatment with a PPARalpha agonist (peroxisome proliferator-activated receptor alpha agonist) increases MTE-1 mRNA, protein expression, and activity and the rate of palmitate export from isolated cardiac mitochondria, suggesting that MTE-I functions to regulate the concentration of long-chain fatty acyl-CoA in the mitochondrial matrix through the generation and export of free fatty acid anions. Thus, upregulation of MTE-I activity may prevent the accumulation of long-chain fatty acyl-CoA in the mitochondrial matrix when the heart is exposed to high levels of fatty acids <108>) <14,37,41,47,49,50,66,81,84,89,90,97,105,107,108> heart BTO:0000562 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034426 curatus Q86TX2 641371 ACOT1 Homo sapiens 9606 Comment/tissue specificity #7,10,12,13,34,45,48,62,64,65# heart (#65# strong expression <107>; #7# expression of isozyme CTE-I and MTE-I <84>; #48# strong expression of MTE-I, expression of CTE-I and PTE-Ia, no expression of PTE-Ib <90>; #10# differential regulation of distinct ACSl isoforms at the transcriptional level <97>; #7# moderate expression in male mice. In female mice, mRNA expression of Acot7 isoforms is highest in brain, lung, kidney, heart and ovary <105>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #62# treatment with a PPARalpha agonist (peroxisome proliferator-activated receptor alpha agonist) increases MTE-1 mRNA, protein expression, and activity and the rate of palmitate export from isolated cardiac mitochondria, suggesting that MTE-I functions to regulate the concentration of long-chain fatty acyl-CoA in the mitochondrial matrix through the generation and export of free fatty acid anions. Thus, upregulation of MTE-I activity may prevent the accumulation of long-chain fatty acyl-CoA in the mitochondrial matrix when the heart is exposed to high levels of fatty acids <108>) <14,37,41,47,49,50,66,81,84,89,90,97,105,107,108> heart UBERON:0000948 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034427 curatus Q86TX2 641371 ACOT1 Homo sapiens 9606 Comment/tissue specificity #7,10,13,34,35,45,48,65# kidney (#13# medulla <73,94>; #65# strong expression <107>; #7# isozymes CTE-I and MTE-I expression <84>; #34# highest content <89>; #48# major isozyme is CTE-I, strong expression of MTE-I, expression of PTE-Ia and PTE-Ib <90>; #7# weak expression of Acot7 in male mice <105>) <11,14,49,50,73,81,84,89,90,94,105,107> kidney BTO:0000671 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034429 curatus Q86TX2 641371 ACOT1 Homo sapiens 9606 Comment/tissue specificity #7,10,13,34,35,45,48,65# kidney (#13# medulla <73,94>; #65# strong expression <107>; #7# isozymes CTE-I and MTE-I expression <84>; #34# highest content <89>; #48# major isozyme is CTE-I, strong expression of MTE-I, expression of PTE-Ia and PTE-Ib <90>; #7# weak expression of Acot7 in male mice <105>) <11,14,49,50,73,81,84,89,90,94,105,107> kidney UBERON:0002113 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034430 curatus Q86TX2 641371 ACOT1 Homo sapiens 9606 Comment/tissue specificity #7,45,48,64,65# muscle (#65# strong expression <107>; #7# low expression of isozyme MTE-I <84>; #48# strong expression of MTE-I, only weak expression of CTE-I, expression of PTE-Ia, no expression of PTE-Ib <90>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #7# weak expression of Acot7 in male mice <105>) <81,84,90,105,107> muscle BTO:0000887 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034432 curatus Q86TX2 641371 ACOT1 Homo sapiens 9606 Comment/tissue specificity #7,45,48,64,65# muscle (#65# strong expression <107>; #7# low expression of isozyme MTE-I <84>; #48# strong expression of MTE-I, only weak expression of CTE-I, expression of PTE-Ia, no expression of PTE-Ib <90>; #64# strong expression. ACOT2 is much more strongly expressed than ACOT1 <107>; #7# weak expression of Acot7 in male mice <105>) <81,84,90,105,107> musculature UBERON:0001015 3.1.2.2 Y Y Pubmed:16940157 BRENDA <107> Hunt, M.C.; Rautanen, A.; Westin, M.A.; Svensson, L.T.; Alexson, S.E.: Analysis of the mouse and human acyl-CoA thioesterase (ACOT) gene clusters shows that convergent, functional evolution results in a reduced number of human peroxisomal ACOTs. FASEB J. (2006) 20, 1855-1864. {Pubmed:16940157} AAP 12/7/2011 1111 3300034433 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #22,26# HEK-293 cell <64,65> HEK-293 cell BTO:0000007 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034438 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #22,26# neutrophil <61,68> neutrophil BTO:0000130 2.3.1.23 Y Y Pubmed:18538854 BRENDA <68> Jackson, S.K.; Abate, W.; Tonks, A.J.: Lysophospholipid acyltransferases: novel potential regulators of the inflammatory response and target for new drug discovery. Pharmacol. Ther. (2008) 119, 104-114. {Pubmed:18538854} AAP 12/7/2011 1111 3300034439 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #26# leukocyte <65> leukocyte BTO:0000751 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034440 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #26# colorectal adenocarcinoma cell <66> colorectal adenocarcinoma cell BTO:0000035 2.3.1.23 Y Y Pubmed:18974965 BRENDA <66> Mansilla, F.; da Costa, K.A.; Wang, S.; Kruh?ffer, M.; Lewin, T.M.; Orntoft, T.F.; Coleman, R.A.; Birkenkamp-Demtroeder, K.: Lysophosphatidylcholine acyltransferase 1 (LPCAT1) overexpression in human colorectal cancer. J. Mol. Med. (2009) 87, 85-97. {Pubmed:18974965} AAP 12/7/2011 1111 3300034441 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #26# A-549 cell <65> A-549 cell BTO:0000018 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034442 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #4,5,6,10,17,18,22,26# lung (#4# adenoma <28>; #17# LPCAT is predominantly expressed in the lung <55>; #18# LPCAT is predominantly expressed in the lung, LPCAT expression in the developing and adult lung, overview <55>; #17# LPCAT1 is predominantly expressed in the lung, in particular in alveolar type II cells, but occurs also in other tissues <53>; #22# highly expressed, detected by Northern blot analysis <57>) <5,6,12,14,22,28,46,50,53,55,57,58,65,68> lung BTO:0000763 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034443 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #4,5,6,10,17,18,22,26# lung (#4# adenoma <28>; #17# LPCAT is predominantly expressed in the lung <55>; #18# LPCAT is predominantly expressed in the lung, LPCAT expression in the developing and adult lung, overview <55>; #17# LPCAT1 is predominantly expressed in the lung, in particular in alveolar type II cells, but occurs also in other tissues <53>; #22# highly expressed, detected by Northern blot analysis <57>) <5,6,12,14,22,28,46,50,53,55,57,58,65,68> lung UBERON:0002048 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034444 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #4,5,6,10,17,18,22,26# lung (#4# adenoma <28>; #17# LPCAT is predominantly expressed in the lung <55>; #18# LPCAT is predominantly expressed in the lung, LPCAT expression in the developing and adult lung, overview <55>; #17# LPCAT1 is predominantly expressed in the lung, in particular in alveolar type II cells, but occurs also in other tissues <53>; #22# highly expressed, detected by Northern blot analysis <57>) <5,6,12,14,22,28,46,50,53,55,57,58,65,68> lung BTO:0000763 2.3.1.23 Y Y Pubmed:18538854 BRENDA <68> Jackson, S.K.; Abate, W.; Tonks, A.J.: Lysophospholipid acyltransferases: novel potential regulators of the inflammatory response and target for new drug discovery. Pharmacol. Ther. (2008) 119, 104-114. {Pubmed:18538854} AAP 12/7/2011 1111 3300034445 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #4,5,6,10,17,18,22,26# lung (#4# adenoma <28>; #17# LPCAT is predominantly expressed in the lung <55>; #18# LPCAT is predominantly expressed in the lung, LPCAT expression in the developing and adult lung, overview <55>; #17# LPCAT1 is predominantly expressed in the lung, in particular in alveolar type II cells, but occurs also in other tissues <53>; #22# highly expressed, detected by Northern blot analysis <57>) <5,6,12,14,22,28,46,50,53,55,57,58,65,68> lung UBERON:0002048 2.3.1.23 Y Y Pubmed:18538854 BRENDA <68> Jackson, S.K.; Abate, W.; Tonks, A.J.: Lysophospholipid acyltransferases: novel potential regulators of the inflammatory response and target for new drug discovery. Pharmacol. Ther. (2008) 119, 104-114. {Pubmed:18538854} AAP 12/7/2011 1111 3300034446 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #5,17,26# placenta <40,50,53,65> placenta BTO:0001078 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034447 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #5,17,26# placenta <40,50,53,65> placenta UBERON:0001987 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034448 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #5,26# HeLa cell <54,65> HeLa cell BTO:0000567 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034449 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #5,26# monocyte <48,49,63,68> monocyte BTO:0000876 2.3.1.23 Y Y Pubmed:18538854 BRENDA <68> Jackson, S.K.; Abate, W.; Tonks, A.J.: Lysophospholipid acyltransferases: novel potential regulators of the inflammatory response and target for new drug discovery. Pharmacol. Ther. (2008) 119, 104-114. {Pubmed:18538854} AAP 12/7/2011 1111 3300034450 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #6,7,17,18,26# spleen (#18# low expression level <55>) <34,41,46,53,55,65> spleen BTO:0001281 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034451 curatus Q8NF37 79888 LPCAT1 Homo sapiens 9606 Comment/tissue specificity #6,7,17,18,26# spleen (#18# low expression level <55>) <34,41,46,53,55,65> spleen UBERON:0002106 2.3.1.23 Y Y Pubmed:19383981 BRENDA <65> Harayama, T.; Shindou, H.; Shimizu, T.: Biosynthesis of phosphatidylcholine by human lysophosphatidylcholine acyltransferase 1. J. Lipid Res. (2009) 50, 1824-1831. {Pubmed:19383981} AAP 12/7/2011 1111 3300034452 curatus Q9NXB9 54898 ELOVL2 Homo sapiens 9606 Comment/tissue specificity #1,6,7,8# liver (#1,6,7,8# enzyme is cloned from a human liver cDNA <5>) <5> liver BTO:0000759 2.3.1.119 Y Y Pubmed:19575253 BRENDA <5> Kitazawa, H.; Miyamoto, Y.; Shimamura, K.; Nagumo, A.; Tokita, S.: Development of a high-density assay for long-Chain Fatty Acyl-CoA elongases. Lipids (2009) 44, 765-773. {Pubmed:19575253} AAP, ASD 12/7/2011 1111 3300034453 curatus Q9NXB9 54898 ELOVL2 Homo sapiens 9606 Comment/tissue specificity #1,6,7,8# liver (#1,6,7,8# enzyme is cloned from a human liver cDNA <5>) <5> liver UBERON:0002107 2.3.1.119 Y Y Pubmed:19575253 BRENDA <5> Kitazawa, H.; Miyamoto, Y.; Shimamura, K.; Nagumo, A.; Tokita, S.: Development of a high-density assay for long-Chain Fatty Acyl-CoA elongases. Lipids (2009) 44, 765-773. {Pubmed:19575253} AAP, ASD 12/7/2011 1111 3300034454 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity #1,6,7,8# liver (#1,6,7,8# enzyme is cloned from a human liver cDNA <5>) <5> liver BTO:0000759 2.3.1.119 Y Y Pubmed:19575253 BRENDA <5> Kitazawa, H.; Miyamoto, Y.; Shimamura, K.; Nagumo, A.; Tokita, S.: Development of a high-density assay for long-Chain Fatty Acyl-CoA elongases. Lipids (2009) 44, 765-773. {Pubmed:19575253} AAP 12/7/2011 1111 3300034456 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity #1,6,7,8# liver (#1,6,7,8# enzyme is cloned from a human liver cDNA <5>) <5> liver UBERON:0002107 2.3.1.119 Y Y Pubmed:19575253 BRENDA <5> Kitazawa, H.; Miyamoto, Y.; Shimamura, K.; Nagumo, A.; Tokita, S.: Development of a high-density assay for long-Chain Fatty Acyl-CoA elongases. Lipids (2009) 44, 765-773. {Pubmed:19575253} AAP 12/7/2011 1111 3300034457 curatus/Chandra Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity #6# neutrophil <84> neutrophil BTO:0000130 2.3.2.2 Y Y ECO:0000006 Pubmed:15943911 BRENDA <84> Sener, A.; Yardimci, T.: Activity determination, kinetic analyses and isoenzyme identification of gamma glutamyltransferase in human neutrophils. J. Biochem. Mol. Biol. (2005) 38, 343-349. {Pubmed:15943911} (c) AAP 12/7/2011 1111 3300034459 curatus/Chandra Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/tissue specificity #6# neutrophil <84> blood UBERON:0000178 2.3.2.2 Y Y ECO:0000006 Pubmed:15943911 BRENDA <84> Sener, A.; Yardimci, T.: Activity determination, kinetic analyses and isoenzyme identification of gamma glutamyltransferase in human neutrophils. J. Biochem. Mol. Biol. (2005) 38, 343-349. {Pubmed:15943911} (c) AAP 12/7/2011 1111 3300034460 curatus Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity #1,5,6,27,30,41,49# brain (#5# most abundant in <12>; #5# low activity <6>; #1# expressed exclusively in brain, adrenal gland and testis <38>; #5# ACSL3 and ACSL6 are the predominant isoforms in brain <50>) <6,12,27,38,40,50,55,60,70,72,79,85,86,87> brain BTO:0000142 6.2.1.3 Y Y Pubmed:16834775 BRENDA <79> Soupene, E.; Kuypers, F.A.: Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol. Biol. (2006) 7, 21. {Pubmed:16834775} AAP, AAP-M, ASD 12/7/2011 1111 3300034461 curatus Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity #1,5,6,27,30,41,49# brain (#5# most abundant in <12>; #5# low activity <6>; #1# expressed exclusively in brain, adrenal gland and testis <38>; #5# ACSL3 and ACSL6 are the predominant isoforms in brain <50>) <6,12,27,38,40,50,55,60,70,72,79,85,86,87> brain UBERON:0000955 6.2.1.3 Y Y Pubmed:16834775 BRENDA <79> Soupene, E.; Kuypers, F.A.: Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol. Biol. (2006) 7, 21. {Pubmed:16834775} AAP, AAP-M, ASD 12/7/2011 1111 3300034462 curatus Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/tissue specificity #16,41# erythrocyte (#16# of Macaca mulatta or Macaca fascicularis infected with Plasmodium knowlesi <19>) <19,79> erythrocyte BTO:0000424 6.2.1.3 Y Y Pubmed:16834775 BRENDA <79> Soupene, E.; Kuypers, F.A.: Multiple erythroid isoforms of human long-chain acyl-CoA synthetases are produced by switch of the fatty acid gate domains. BMC Mol. Biol. (2006) 7, 21. {Pubmed:16834775} AAP, AAP-M, ASD 12/7/2011 1111 3300034463 Faith Q92887 1244 ABCC2 Homo sapiens 9606 Comment/tissue specificity Expressed by polarized cells in liver, kidney and intestine. The highest expression is found in liver. liver UBERON:0002107 Y Y UniProtKB created row for UBERON term AAP, AAP-M, ASD 3300034464 Faith O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. liver UBERON:0002107 Y Y UniProtKB created new row for UBERON term AAP, DGA, AAP-M, ASD 3300034465 Faith O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. prostate gland BTO:0001129 Y Y UniProtKB created row for missing term AAP, DGA, AAP-M, ASD 3300034466 Faith O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. prostate gland UBERON:0002367 Y Y UniProtKB created row for ontology term AAP, DGA, AAP-M, ASD 3300034467 Faith O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. kidney BTO:0000671 Y Y UniProtKB created row for missing ontology term AAP, DGA, AAP-M, ASD 3300034468 Faith O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. kidney UBERON:0002113 Y Y UniProtKB created row for missing ontology term AAP, DGA, AAP-M, ASD 3300034469 Faith O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. small intestine BTO:0000651 Y Y UniProtKB created row for missing ontology term AAP, DGA, AAP-M, ASD 3300034470 Faith O15438 8714 ABCC3 Homo sapiens 9606 Comment/tissue specificity Mainly expressed in the liver. Also expressed in small intestine, colon, prostate, testis, brain and at a lower level in the kidney. small intestine UBERON:0002108 Y Y UniProtKB created row for missing ontology term AAP, DGA, AAP-M, ASD 3300034471 Faith O95255 368 ABCC6 Homo sapiens 9606 Comment/tissue specificity Expressed in kidney and liver. Very low expression in other tissues. kidney UBERON:0002113 Y Y UniProtKB created row to add ontology term AAP, DGA, ASD 3300034472 Faith Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034473 Faith Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:12566991 UniProtKB added row for UBERON term AAP, ASD 3300034474 Faith Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. breast BTO:0000149 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB added row for missing ontology term AAP, DGA, AAP-M 3300034475 Faith Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. breast UBERON:0000310 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB added row for missing ontology term AAP, DGA, AAP-M 3300034476 Faith Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. liver BTO:0000759 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB added row for missing ontology term AAP, DGA, AAP-M 3300034477 Faith Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. liver UBERON:0002107 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB added row for missing ontology term AAP, DGA, AAP-M 3300034478 Faith Q96J66 85320 ABCC11 Homo sapiens 9606 Comment/Involvement in disease Expressed in many tissues. Not expressed in kidney, spleen and colon. Highly expressed in breast cancer. Expressed at moderate levels in normal breast and testis and at very low levels in liver, brain and placenta. breast cancer DOID:1612 Y Y ECO:0000269 PubMed:11483364 PubMed:11591886 UniProtKB AAP, DGA, AAP-M 3300034479 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/Involvement in disease prostate cancer prostate cancer DOID:10283 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 PENTACON <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33951 AAP, ASD 3300034480 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> heart UBERON:0000948 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33942 AAP, ASD 3300034481 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity liver liver BTO:0000759 1.1.1.213 Y Y ECO:0000006 Pubmed:10672042 PENTACON AAP, ASD 3300034482 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> testis BTO:0001363 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33942 #Copied from AKR1C2, anno: 34481 AAP, ASD 3300034483 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> testis UBERON:0000473 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33942 #Copied from AKR1C2, anno: 34481 #Copied from AKR1C2, anno: 34483 AAP, ASD 3300034484 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> small intestine BTO:0000651 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33942 #Copied from AKR1C2, anno: 34481 #Copied from AKR1C2, anno: 34483 #Copied from AKR1C2, anno: 34484 AAP, ASD 3300034485 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> brain BTO:0000142 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33942 #Copied from AKR1C2, anno: 34481 #Copied from AKR1C2, anno: 34483 #Copied from AKR1C2, anno: 34484 #Copied from AKR1C2, anno: 34485 AAP, ASD 3300034486 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> lung BTO:0000763 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33942 #Copied from AKR1C2, anno: 34481 #Copied from AKR1C2, anno: 34483 #Copied from AKR1C2, anno: 34484 #Copied from AKR1C2, anno: 34485 #Copied from AKR1C2, anno: 34486 AAP, ASD 3300034487 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> small intestine UBERON:0002108 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33942 #Copied from AKR1C2, anno: 34481 #Copied from AKR1C2, anno: 34483 #Copied from AKR1C2, anno: 34484 #Copied from AKR1C2, anno: 34485 AAP, ASD 3300034488 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> brain UBERON:0000955 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33942 #Copied from AKR1C2, anno: 34481 #Copied from AKR1C2, anno: 34483 #Copied from AKR1C2, anno: 34484 #Copied from AKR1C2, anno: 34485 #Copied from AKR1C2, anno: 34486 AAP, ASD 3300034489 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity #1,2,3,8# more (#3# indomethacin-sensitive 3alpha-hydroxysteroid dehydrogenase widely distributed in prostate, spleen, heart, testis, small intestine, stomach, lung and brain <5>; #3# low activities found in dog and rabbit liver, no significant activities are detected in extracts of beef, hog, guinea pig, mouse and human liver <7>; #8# wide tissue distribution <16>; #2# no activity in the hepatoma cell line Hep-G2 <24>; #1# the androgen-inactivating enzyme is selectively expressed in female tissue, while it is mostly absent in male tissue, tissue distribution, overview <26>; #2# tissue distribution of AKR1C3, immunohistochemic analysis, overview <36>; #3# tissue distribution of AKR1C9, immunohistochemic analysis, overview <36>; #3# tissue distribution of isozymes, overview <30>) <5,7,16,24,26,30,36> lung UBERON:0002048 1.1.1.213 Y Y ECO:0000033 Pubmed:16547389 BRENDA <16> Matsunaga, T.; Shintani, S.; Hara, A.: Multiplicity of mammalian reductases for xenobiotic carbonyl compounds. Drug Metab. Pharmacokinet. (2006) 21, 1-18. {Pubmed:16547389} #Copied from AKR1C2, anno: 33942 #Copied from AKR1C2, anno: 34481 #Copied from AKR1C2, anno: 34483 #Copied from AKR1C2, anno: 34484 #Copied from AKR1C2, anno: 34485 #Copied from AKR1C2, anno: 34486 #Copied from AKR1C2, anno: 34487 AAP, ASD 3300034490 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. bronchial epithelial cell BTO:0002922 bronchial epithelial cell CL:0002328 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB #Copied from PNPLA8, anno: 33607 AAP 3300034491 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/tissue specificity Expressed in parenchymal tissues including heart, skeletal muscle, placenta, brain, liver and pancreas. Also expressed in bronchial epithelial cells and kidney. Highest expression is observed in skeletal muscle and heart. parenchyma BTO:0001539 Y Y ECO:0000269 PubMed:10744668 PubMed:15695510 PubMed:10833412 PubMed:15629460 UniProtKB #Copied from PNPLA8, anno: 33607 AAP 3300034492 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/Involvement in disease #15,19# non-small cell lung cancer cell <42> lung cancer DOID:1324 1.3.1.20 Y Y ECO:0000006 Pubmed:17266043 PENTACON <42> Wang, H.W.; Lin, C.P.; Chiu, J.H.; Chow, K.C.; Kuo, K.T.; Lin, C.S.; Wang, L.S.: Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin. Int. J. Cancer (2007) 120, 2019-2027. {Pubmed:17266043} #Copied from AKR1C1, anno: 33953 AAP, ASD 3300034493 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. liver UBERON:0002107 Y Y ECO:0000269 PubMed:11013348 UniProtKB #Copied from AKR1C1, anno: 33524 AAP, ASD 3300034494 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:11013348 UniProtKB #Copied from AKR1C1, anno: 33524 AAP, ASD 3300034495 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:11013348 UniProtKB #Copied from AKR1C1, anno: 33524 #Copied from AKR1C1, anno: 34494 AAP, ASD 3300034496 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. mammary gland BTO:0000817 Y Y ECO:0000269 PubMed:11013348 UniProtKB #Copied from AKR1C1, anno: 33524 #Copied from AKR1C1, anno: 34495 AAP, ASD 3300034497 curatus Q04828 1645 AKR1C1 Homo sapiens 9606 Comment/tissue specificity Expressed in all tissues tested including liver, prostate, testis, adrenal gland, brain, uterus, mammary gland and keratinocytes. Highest levels found in liver, mammary gland and brain. mammary gland UBERON:0001911 Y Y ECO:0000269 PubMed:11013348 UniProtKB #Copied from AKR1C1, anno: 33524 #Copied from AKR1C1, anno: 34494 #Copied from AKR1C1, anno: 34496 AAP, ASD 3300034498 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. lung UBERON:0002048 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034499 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. lung BTO:0000763 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034500 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. lung UBERON:0002048 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034501 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. heart UBERON:0000948 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB AAP, ASD 3300034502 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. brain BTO:0000142 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034503 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. brain UBERON:0000955 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034504 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. testis BTO:0001363 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034505 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. testis UBERON:0000473 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034506 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. brain BTO:0000142 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034507 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. brain UBERON:0000955 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034508 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. muscle BTO:0000887 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034509 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. musculature UBERON:0001015 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034510 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. white adipose tissue BTO:0001456 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034511 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. white adipose tissue UBERON:0001347 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 2 > isoform 1 level AAP, ASD 3300034512 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. liver BTO:0000759 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 1 > isoform 2 level AAP, ASD 3300034513 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. liver UBERON:0002107 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 1 > isoform 2 level AAP, ASD 3300034514 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. liver BTO:0000759 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 1 > isoform 2 level AAP, ASD 3300034515 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. liver UBERON:0002107 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 1 > isoform 2 level AAP, ASD 3300034516 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. kidney BTO:0000671 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 1 > isoform 2 level AAP, ASD 3300034517 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 1 > isoform 2 level AAP, ASD 3300034518 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. kidney BTO:0000671 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 1 > isoform 2 level AAP, ASD 3300034519 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB isoform 1 > isoform 2 level AAP, ASD 3300034520 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. heart BTO:0000562 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB AAP, ASD 3300034521 curatus Q15067 51 ACOX1 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels of isoform 1 and isoform 2 detected in testis. Isoform 1 is expressed at higher levels than isoform 2 in liver and kidney while isoform 2 levels are higher in brain, lung, muscle, white adipose tissue and testis. Levels are almost equal in heart. heart UBERON:0000948 Y Y ECO:0000269 PubMed:17603022 PubMed:20195242 UniProtKB AAP, ASD 3300034522 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity Expressed in fetal testes. Expressed in fetal and adult adrenal glands. adrenal gland BTO:0000047 Y Y ECO:0000269 PubMed:21802064 UniProtKB #Copied from AKR1C2, anno: 33583 AAP, ASD 3300034523 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity Expressed in fetal testes. Expressed in fetal and adult adrenal glands. testis UBERON:0000473 fetus BTO:0000449 Y Y ECO:0000269 PubMed:21802064 UniProtKB #Copied from AKR1C2, anno: 33583 AAP, ASD 3300034524 curatus P52895 1646 AKR1C2 Homo sapiens 9606 Comment/tissue specificity Expressed in fetal testes. Expressed in fetal and adult adrenal glands. adrenal gland UBERON:0002369 Y Y ECO:0000269 PubMed:21802064 UniProtKB #Copied from AKR1C2, anno: 33583 #Copied from AKR1C2, anno: 34523 AAP, ASD 3300034525 curatus P13584 1580 CYP4B1 Homo sapiens 9606 Comment/tissue specificity Detected in the liver and lung (at protein level). lung BTO:0000763 Y Y ECO:0000269 PubMed:12695542 UniProtKB AAP, ASD 3300034526 curatus P13584 1580 CYP4B1 Homo sapiens 9606 Comment/tissue specificity Detected in the liver and lung (at protein level). liver UBERON:0002107 Y Y ECO:0000269 PubMed:12695542 UniProtKB AAP, ASD 3300034527 curatus P13584 1580 CYP4B1 Homo sapiens 9606 Comment/tissue specificity Detected in the liver and lung (at protein level). liver BTO:0000759 Y Y ECO:0000269 PubMed:12695542 UniProtKB AAP, ASD 3300034528 curatus Q9HCS2 66002 CYP4F12 Homo sapiens 9606 Comment/tissue specificity Expressed in small intestine, liver, colon and heart. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:11162607 PubMed:11162645 UniProtKB AAP 3300034529 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. mammary gland BTO:0000817 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034531 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. mammary gland UBERON:0001911 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034532 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. trachea UBERON:0003126 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034533 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034534 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034535 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. trachea BTO:0001388 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034536 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. kidney BTO:0000671 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034537 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034538 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. salivary gland BTO:0001203 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034539 curatus P14550 10327 AKR1A1 Homo sapiens 9606 Comment/tissue specificity Widely expressed. Highly expressed in kidney, salivary gland and liver. Detected in trachea, stomach, brain, lung, prostate, placenta, mammary gland, small intestine and lung. salivary gland UBERON:0001044 Y Y ECO:0000269 PubMed:10510318 PubMed:11306097 UniProtKB AAP, ASD 3300034540 curatus Q9Y4D2 747 DAGLA Homo sapiens 9606 Comment/tissue specificity Highly expressed in brain and pancreas. brain BTO:0000142 Y Y ECO:0000269 PubMed:14610053 PubMed:16051747 UniProtKB AAP, ASD 3300034541 Faith O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Functional transporter. Predominant isoform in liver, expression at promoter is regulated by HNF4alpha. liver BTO:0000759 Y Y UniProtKB copied from isoform secondary note AAP, ASD 3300034543 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Functional transporter. Predominant isoform in liver, expression at promoter is regulated by HNF4alpha. liver UBERON:0002107 Y Y UniProtKB copied from isoform secondary note AAP, ASD 3300034544 Faith O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/Involvement in disease E77K; In a breast cancer sample; somatic mutation. breast cancer DOID:1612 VAR_036412 Y Y ECO:0000269 PubMed:16959974 UniProtKB TBD ver_2data value from Isoforms section data value from Isoforms section AAP, ASD 3300034545 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. brain UBERON:0000955 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 3300034546 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. duodenum BTO:0000365 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 3300034547 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/tissue specificity Isoform 1 has it's highest expression in brain, it is the major form expressed in duodenum, kidney, placenta, and skeletal muscle. Isoform 3 predominates in liver. duodenum UBERON:0002114 Y Y ECO:0000269 PubMed:23531488 UniProtKB AAP, ASD 3300034548 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. brain BTO:0000142 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 3300034549 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 3300034550 curatus Q8N6M6 84909 AOPEP Homo sapiens 9606 Comment/tissue specificity Predominantly expressed in pancreas, placenta, liver, testis and heart. Expressed at lower level in brain, lung and kidney. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:15687497 UniProtKB AAP 3300034551 curatus Q9HAU8 57140 RNPEPL1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Expressed at relatively higher levels in heart and skeletal muscle. heart BTO:0000562 Y Y ECO:0000269 PubMed:11017071 UniProtKB AAP 3300034559 Faith Q9HAU8 57140 RNPEPL1 Homo sapiens 9606 Comment/Involvement in disease V247M; In a colorectal cancer sample; somatic mutation. colorectal cancer DOID:9256 VAR_036046 Y Y ECO:0000269 PubMed:16959974 UniProtKB copied from Isoforms section copied from Isoforms section AAP 3300034560 curatus Q92959 6578 SLCO2A1 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Significant expression observed in ling, kidney, spleen, and heart. lung UBERON:0002048 Y Y ECO:0000269 PubMed:22331663 UniProtKB AAP, ASD 3300034561 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #9,42,50# endothelial cell (#42# from lung <134>; #9# of aorta, treatment with angiotensin II results in increased expression of soluble epoxide hydrolase at both the mRNA and protein level <82>) <82,134,141,143> lung UBERON:0002048 3.3.2.10 Y Y ECO:0000033 Pubmed:20339956 BRENDA <143> Xie, W.; Tang, X.; Lu, Q.; Ames, R.S.; Ratcliffe, S.J.; Li, H.: Development of a high throughput cell-based assay for soluble epoxide hydrolase using BacMam technology. Mol. Biotechnol. (2010) 45, 207-217. {Pubmed:20339956} #Copied from EPHX2, anno: 34327 AAP, DGA, ASD 3300034579 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #9,42,50# endothelial cell (#42# from lung <134>; #9# of aorta, treatment with angiotensin II results in increased expression of soluble epoxide hydrolase at both the mRNA and protein level <82>) <82,134,141,143> liver BTO:0000759 3.3.2.10 Y Y ECO:0000033 Pubmed:20339956 PENTACON AAP, DGA, ASD 3300034580 curatus P34913 2053 EPHX2 Homo sapiens 9606 Comment/tissue specificity #9,42,50# endothelial cell (#42# from lung <134>; #9# of aorta, treatment with angiotensin II results in increased expression of soluble epoxide hydrolase at both the mRNA and protein level <82>) <82,134,141,143> liver UBERON:0002107 3.3.2.10 Y Y ECO:0000033 Pubmed:20339956 BRENDA AAP, DGA, ASD 3300034581 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/tissue specificity #3,10,11# monocyte <9,39,40> AML14.3D10/CCCKR3 Clone 16 cell CLO:0001717 4.4.1.20 Y Y ECO:0000006 Pubmed:16980379 PENTACON AAP, DGA, ASD 3300034610 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. spleen BTO:0001281 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034611 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034612 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034613 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. heart BTO:0000562 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034614 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. heart UBERON:0000948 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034615 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. kidney BTO:0000671 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034616 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034617 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. liver BTO:0000759 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034618 curatus Q5T3U5 89845 ABCC10 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is specifically expressed in spleen. Isoform 2 is more widely expressed. liver UBERON:0002107 Y Y ECO:0000269 PubMed:12566991 UniProtKB AAP, ASD 3300034619 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/tissue specificity Detected in adipose tissue, lung, liver, kidney, brain and heart. adipose tissue BTO:0001487 Y Y ECO:0000269 PubMed:11470505 UniProtKB AAP, ASD 3300034642 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. leukocyte BTO:0000751 leukocyte CL:0000738 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034644 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. colon BTO:0000269 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034645 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. colon UBERON:0001155 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034646 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. thymus BTO:0001374 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034647 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. thymus UBERON:0002370 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034648 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. ovary BTO:0000975 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034649 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. female gonad UBERON:0000992 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034650 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034651 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034652 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. brain BTO:0000142 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034653 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. brain UBERON:0000955 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034654 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. placenta BTO:0001078 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034655 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034656 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. spleen BTO:0001281 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034657 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034658 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. kidney BTO:0000671 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034659 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034660 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. liver BTO:0000759 Y Y ECO:0000269 PubMed:15004468 UniProtKB Expressed most abundantly in the kidney, liver, pancreas, prostate and heart, followed by lung, skeletal muscle, testis, small intestine and brain. A low expression level was found in placenta, spleen, thymus, ovary, colon and especially in peripheral blood leukocytes. AAP, ASD 3300034661 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. liver UBERON:0002107 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034662 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034663 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034664 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034665 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034666 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. heart BTO:0000562 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034667 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. heart UBERON:0000948 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034668 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. lung BTO:0000763 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034669 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. lung UBERON:0002048 Y Y ECO:0000269 PubMed:15004468 UniProtKB AAP, ASD 3300034670 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034671 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034672 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. testis BTO:0001363 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034673 curatus Q8N8N7 145482 PTGR2 Homo sapiens 9606 Comment/tissue specificity Widely expressed. testis UBERON:0000473 Y Y ECO:0000269 PubMed:15004468 UniProtKB TBD ver_2 AAP, ASD 3300034674 curatus Q6E213 158835 AWAT2 Homo sapiens 9606 Comment/tissue specificity #2,10,13,14# skin (#10# predominantly <15>; #2# high expression level <15>; #10,13,14# predominant expression <13>; #14# predominant expression of AWAT1 <13>; #10# predominant expression of AWAT2 <13>) <8,13,15> skin of body UBERON:0002097 2.3.1.75 Y Y ECO:0000006 Pubmed:15671038 BRENDA <13> Turkish, A.R.; Henneberry, A.L.; Cromley, D.; Padamsee, M.; Oelkers, P.; Bazzi, H.; Christiano, A.M.; Billheimer, J.T.; Sturley, S.L.: Identification of two novel human acyl-CoA wax alcohol acyltransferases: members of the diacylglycerol acyltransferase 2 (DGAT2) gene superfamily. J. Biol. Chem. (2005) 280, 14755-14764. {Pubmed:15671038} #Copied from AWAT2, anno: 34389 AAP 3300034683 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #43# SNU-354 cell <80> SNU-449 cell BTO:0003188 6.2.1.3 Y Y ECO:0000006 Pubmed:17934335 PENTACON <80> Sung, Y.K.; Park, M.K.; Hong, S.H.; Hwang, S.Y.; Kwack, M.H.; Kim, J.C.; Kim, M.K.: Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. (2007) 39, 477-482. {Pubmed:17934335} #Copied from ACSL4, anno: 34202 AAP, AAP-M, ASD 3300034693 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/tissue specificity #43# SNU-368 cell <80> SNU-475 cell BTO:0003189 6.2.1.3 Y Y ECO:0000006 Pubmed:17934335 PENTACON <80> Sung, Y.K.; Park, M.K.; Hong, S.H.; Hwang, S.Y.; Kwack, M.H.; Kim, J.C.; Kim, M.K.: Regulation of cell growth by fatty acid-CoA ligase 4 in human hepatocellular carcinoma cells. Exp. Mol. Med. (2007) 39, 477-482. {Pubmed:17934335} #Copied from ACSL4, anno: 34203 AAP, AAP-M, ASD 3300034694 curatus P07203 2876 GPX1 Homo sapiens 9606 Comment/tissue specificity #44# adrenal gland (#44# GPx1 is highly expressed in adrenal glands <88>) <88> thyroid gland BTO:0001379 1.11.1.9 Y Y ECO:0000006 Pubmed:17937619 PENTACON <88> Schmutzler, C.; Mentrup, B.; Schomburg, L.; Hoang-Vu, C.; Herzog, V.; Koehrle, J.: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. (2007) 388, 1053-1059. {Pubmed:17937619} #Copied from GPX1, anno: 34217 AAP, DGA, ASD 3300034732 curatus P07203 2876 GPX1 Homo sapiens 9606 Comment/tissue specificity #44# adrenal gland (#44# GPx1 is highly expressed in adrenal glands <88>) <88> thyroid gland UBERON:0002046 1.11.1.9 Y Y ECO:0000006 Pubmed:17937619 PENTACON <88> Schmutzler, C.; Mentrup, B.; Schomburg, L.; Hoang-Vu, C.; Herzog, V.; Koehrle, J.: Selenoproteins of the thyroid gland: expression, localization and possible function of glutathione peroxidase 3. Biol. Chem. (2007) 388, 1053-1059. {Pubmed:17937619} #Copied from GPX1, anno: 34218 AAP, DGA, ASD 3300034733 curatus Q6P1A2 10162 LPCAT3 Homo sapiens 9606 Comment/tissue specificity #22# thymus (#22# highly expressed, detected by Northern blot analysis <57>) <57> thymus UBERON:0002370 2.3.1.23 Y Y ECO:0000006 Pubmed:18781350 BRENDA <57> Kazachkov, M.; Chen, Q.; Wang, L.; Zou, J.: Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling. Lipids (2008) 43, 895-902. {Pubmed:18781350} #Copied from LPCAT3, anno: 34399 AAP 3300034734 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,6,7,8,10,11,25,29,30# liver (#2# moderate expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #11# major form of soluble NADPH-dependent all-trans-retinal dehydrogenase in liver <58>; #25# black and white donors, show similar CBR1 mRNA and protein levels. CBR1 1096G-A polymorphism is common in samples from white donors <78>; #25# CBR1 is prominently expressed in the liver <76>; #29# low expression of CBR3 <76>) <9,11,15,24,29,33,38,39,40,48,54,58,61,74,76,78> pancreas BTO:0000988 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34125 AAP, ASD 3300034737 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #1,2,3,6,7,8,10,11,25,29,30# liver (#2# moderate expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #11# major form of soluble NADPH-dependent all-trans-retinal dehydrogenase in liver <58>; #25# black and white donors, show similar CBR1 mRNA and protein levels. CBR1 1096G-A polymorphism is common in samples from white donors <78>; #25# CBR1 is prominently expressed in the liver <76>; #29# low expression of CBR3 <76>) <9,11,15,24,29,33,38,39,40,48,54,58,61,74,76,78> pancreas UBERON:0001264 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34126 AAP, ASD 3300034738 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #2,6,8,10,25,29,32,33,34# kidney (#8# high expression level <38>; #2# strong expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #32# high expression of CHCR1 at both the mRNA and protein levels <73>; #33# high expression of CHCR2 at both the mRNA and protein levels <73>; #29# low expression of CBR3 <76>) <28,38,39,40,73,76> placenta BTO:0001078 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34128 AAP, ASD 3300034740 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #2,6,8,10,25,29,32,33,34# kidney (#8# high expression level <38>; #2# strong expression of all 3 isozyme in descending order CHCR1, CHCR2, CHCR3 <39>; #32# high expression of CHCR1 at both the mRNA and protein levels <73>; #33# high expression of CHCR2 at both the mRNA and protein levels <73>; #29# low expression of CBR3 <76>) <28,38,39,40,73,76> placenta UBERON:0001987 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 BRENDA <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34129 AAP, ASD 3300034741 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #25,29# stomach (#29# low expression of CBR3 <76>) <76> prostate gland BTO:0001129 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34132 AAP, ASD 3300034742 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #25,29# stomach (#29# low expression of CBR3 <76>) <76> prostate gland UBERON:0002367 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34133 AAP, ASD 3300034743 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #25,29# colon (#29# low expression of CBR3 <76>) <76> ovary BTO:0000975 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34134 AAP, ASD 3300034744 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #25,29# colon (#29# low expression of CBR3 <76>) <76> female gonad UBERON:0000992 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34135 AAP, ASD 3300034745 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #3,5,6,8,25,29,34# lung (#8# ciliated cells, nonciliated bronchiolar cells, Type II alveolar pneumocytes, epithelial cells of the ducts of the bronchial gland <8>; #29# low expression of CBR3 <76>) <3,6,8,10,12,30,54,73,76> spleen UBERON:0002106 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON Low expression; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34136 AAP, ASD 3300034746 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #3,5,6,8,25,29,34# lung (#8# ciliated cells, nonciliated bronchiolar cells, Type II alveolar pneumocytes, epithelial cells of the ducts of the bronchial gland <8>; #29# low expression of CBR3 <76>) <3,6,8,10,12,30,54,73,76> spleen BTO:0001281 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON low expression; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34137 AAP, ASD 3300034747 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #8,10,25,29# heart (#8# high expression level <38>; #29# low expression of CBR3 <76>) <19,38,42,43,49,63,68,76> thymus BTO:0001374 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON low expression level; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34138 AAP, ASD 3300034748 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #8,10,25,29# heart (#8# high expression level <38>; #29# low expression of CBR3 <76>) <19,38,42,43,49,63,68,76> thymus UBERON:0002370 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON low expression; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34139 AAP, ASD 3300034749 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #3,5,6,8,25,29,34# lung (#8# ciliated cells, nonciliated bronchiolar cells, Type II alveolar pneumocytes, epithelial cells of the ducts of the bronchial gland <8>; #29# low expression of CBR3 <76>) <3,6,8,10,12,30,54,73,76> brain BTO:0000142 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON Low expression; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34136 #Copied from CBR1, anno: 34746 AAP, ASD 3300034750 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #3,5,6,8,25,29,34# lung (#8# ciliated cells, nonciliated bronchiolar cells, Type II alveolar pneumocytes, epithelial cells of the ducts of the bronchial gland <8>; #29# low expression of CBR3 <76>) <3,6,8,10,12,30,54,73,76> brain UBERON:0000955 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON low expression; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34137 #Copied from CBR1, anno: 34747 AAP, ASD 3300034751 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #8,10,25,29# heart (#8# high expression level <38>; #29# low expression of CBR3 <76>) <19,38,42,43,49,63,68,76> testis BTO:0001363 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON low expression level; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34138 #Copied from CBR1, anno: 34748 AAP, ASD 3300034752 curatus P16152 873 CBR1 Homo sapiens 9606 Comment/tissue specificity #8,10,25,29# heart (#8# high expression level <38>; #29# low expression of CBR3 <76>) <19,38,42,43,49,63,68,76> testis UBERON:0000473 1.1.1.184 Y Y ECO:0000006 Pubmed:18635746 PENTACON low expression; <76> Kassner, N.; Huse, K.; Martin, H.J.; Goedtel-Armbrust, U.; Metzger, A.; Meineke, I.; Brockmoeller, J.; Klein, K.; Zanger, U.M.; Maser, E.; Wojnowski, L.: Carbonyl reductase 1 is a predominant doxorubicin reductase in the human liver. Drug Metab. Dispos. (2008) 36, 2113-2120. {Pubmed:18635746} #Copied from CBR1, anno: 34139 #Copied from CBR1, anno: 34749 AAP, ASD 3300034753 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity TP expressed in platelets blood platelet BTO:0000132 Y Y ECO:0000033 PubMed:20059330 PENTACON isoform not specified AAP, DGA, ASD 3300034844 curatus P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity TP expressed in platelets blood platelet BTO:0000132 Y Y ECO:0000033 PubMed:20059330 PENTACON isoform not specified AAP, DGA, ASD 3300034845 curatus P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity TP (alpha and beta) expressed in vascular smooth muscle cells vascular smooth muscle cell BTO:0004578 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, DGA, ASD 3300034846 curatus P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity TP (alpha and beta) expressed in vascular smooth muscle cells vascular smooth muscle cell BTO:0004578 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, DGA, ASD 3300034847 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity TP expressed in kidney kidney BTO:0000671 Y Y ECO:0000033 PMID:20059330 PENTACON AAP, DGA, ASD 3300034876 curatus P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity TP expressed in kidney kidney UBERON:0002113 Y Y ECO:0000033 PMID:20059330 PENTACON AAP, DGA, ASD 3300034877 Faith P21731 6915 TBXA2R Homo sapiens 9606 Comment/tissue specificity TP expression detected by RT-PCR in mesangial cell poly(A)+ RNA mesangial cell BTO:0000853 mesangial cell CL:0000650 Y Y ECO:0000006 PubMed:8227091 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681; From review:PubMed:9182072 AAP, DGA, ASD 3300034878 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity FP expressed in uterus uterus BTO:0001424 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, ASD 3300034880 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity FP expressed in uterus uterus UBERON:0000995 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, ASD 3300034881 Faith P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity cDNA for FP isolated from a uterus cDNA library uterus BTO:0001424 Y Y ECO:0000006 PubMed:8300593 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681 AAP, ASD 3300034882 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity cDNA for FP isolated from a uterus cDNA library uterus UBERON:0000995 Y Y ECO:0000006 PubMed:8300593 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681 AAP, ASD 3300034883 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity In situ hybridization with antisense riboprobe showed expression of FP mRNA in eye blood vessels, iris-sphincter, ciliary body, anterior circular muscles, and collagenous connective tissues of the ciliary body. Signals were weak in logitudinal muscles. Choroidal vessels, retinal tissues, and radial muscles did not show any hybridization signal. Northern blot showed FP expression in ciliary muscle cells. vasculature of eye UBERON:0002203 Y Y ECO:0000006 PubMed:11157877 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681 AAP, ASD 3300034886 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity In situ hybridization with antisense riboprobe showed expression of FP mRNA in eye blood vessels, iris-sphincter, ciliary body, anterior circular muscles, and collagenous connective tissues of the ciliary body. Signals were weak in logitudinal muscles. Choroidal vessels, retinal tissues, and radial muscles did not show any hybridization signal. Northern blot showed FP expression in ciliary muscle cells. iris sphincter muscle BTO:0000656 Y Y ECO:0000006 PubMed:11157877 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681 AAP, ASD 3300034887 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity In situ hybridization with antisense riboprobe showed expression of FP mRNA in eye blood vessels, iris-sphincter, ciliary body, anterior circular muscles, and collagenous connective tissues of the ciliary body. Signals were weak in logitudinal muscles. Choroidal vessels, retinal tissues, and radial muscles did not show any hybridization signal. Northern blot showed FP expression in ciliary muscle cells. sphincter pupillae UBERON:0001607 Y Y ECO:0000006 PubMed:11157877 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681 AAP, ASD 3300034888 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity In situ hybridization with antisense riboprobe showed expression of FP mRNA in eye blood vessels, iris-sphincter, ciliary body, anterior circular muscles, and collagenous connective tissues of the ciliary body. Signals were weak in logitudinal muscles. Choroidal vessels, retinal tissues, and radial muscles did not show any hybridization signal. Northern blot showed FP expression in ciliary muscle cells. ciliary body BTO:0000260 Y Y ECO:0000006 PubMed:11157877 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681 AAP, ASD 3300034889 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity In situ hybridization with antisense riboprobe showed expression of FP mRNA in eye blood vessels, iris-sphincter, ciliary body, anterior circular muscles, and collagenous connective tissues of the ciliary body. Signals were weak in logitudinal muscles. Choroidal vessels, retinal tissues, and radial muscles did not show any hybridization signal. Northern blot showed FP expression in ciliary muscle cells. ciliary body UBERON:0001775 Y Y ECO:0000006 PubMed:11157877 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681 AAP, ASD 3300034890 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity In situ hybridization with antisense riboprobe showed expression of FP mRNA in eye blood vessels, iris-sphincter, ciliary body (anterior circular muscles and collagenous connective tissues). Signals were weak in logitudinal muscles (of ciliary body). Choroidal vessels, retinal tissues, and radial muscles did not show any hybridization signal. Northern blot showed FP expression in ciliary muscle cells. ciliary muscle BTO:0000654 Y Y ECO:0000006 PubMed:11157877 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681 AAP, ASD 3300034891 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity In situ hybridization with antisense riboprobe showed expression of FP mRNA in eye blood vessels, iris-sphincter, ciliary body, anterior circular muscles, and collagenous connective tissues of the ciliary body. Signals were weak in logitudinal muscles. Choroidal vessels, retinal tissues, and radial muscles did not show any hybridization signal. Northern blot showed FP expression in ciliary muscle cells. ciliary muscle UBERON:0001605 Y Y ECO:0000006 PubMed:11157877 PENTACON From review:PubMed:20059330; From review:PubMed:19095631; From review:PubMed:15369681 AAP, ASD 3300034892 Faith P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity EP expressed in kidney kidney BTO:0000671 Y Y ECO:0000033 PubMed:20059330 PENTACON isoform not specified AAP, ASD 3300034914 Faith P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from region common to all known EP3 splice variants demonstrated expression of mRNA in cortical and outer medullary collecting duct, medullary thick ascending limb but not inner medullary collecting duct. Labeling of connecting segment cannot be excluded. No labeling of glomeruli or Tamm-Horsfall-positive tubules in cortex. cortical collecting duct BTO:0002643 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472;isoform not specified AAP, ASD 3300034915 curatus P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from region common to all known EP3 splice variants demonstrated expression of mRNA in cortical and outer medullary collecting duct, medullary thick ascending limb but not inner medullary collecting duct. Labeling of connecting segment cannot be excluded. No labeling of glomeruli or Tamm-Horsfall-positive tubules in cortex. outer medullary collecting duct UBERON:0004204 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472;isoform not specified AAP, ASD 3300034916 curatus P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from region common to all known EP3 splice variants demonstrated expression of mRNA in cortical and outer medullary collecting duct, medullary thick ascending limb but not inner medullary collecting duct. Labeling of connecting segment cannot be excluded. No labeling of glomeruli or Tamm-Horsfall-positive tubules in cortex. thick ascending limb of loop of Henle UBERON:0001291 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472;isoform not specified AAP, ASD 3300034918 curatus P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from full length EP1 demonstrated expression of mRNA in cortex, outer medulla, and inner medulla. Hybridization primarily to Tamm-Horsfall-negative tubules, which appeared to be cortical and medullary collecting ducts. Labeling of connecting segment and initial cortical collecting duct in the cortex could not be excluded. No labeling of glomeruli, proximal tubule, or thick ascending limb. cortical collecting duct BTO:0002643 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472 AAP, ASD 3300034921 curatus P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from full length EP1 demonstrated expression of mRNA in cortex, outer medulla, and inner medulla. Hybridization primarily to Tamm-Horsfall-negative tubules, which appeared to be cortical and medullary collecting ducts. Labeling of connecting segment and initial cortical collecting duct in the cortex could not be excluded. No labeling of glomeruli, proximal tubule, or thick ascending limb. medullary collecting duct BTO:0004536 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472 AAP, ASD 3300034922 Faith P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from full length EP4 demonstrated expression of mRNA in kidney cortex and outer medulla. Glomeruli were selectively labeled. Selective labeling of specific segments in the outer cortex was not clearly distinguishable. renal glomerulus BTO:0000530 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472 AAP, ASD 3300034923 curatus P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from full length EP4 demonstrated expression of mRNA in kidney cortex and outer medulla. Glomeruli were selectively labeled. Selective labeling of specific segments in the outer cortex was not clearly distinguishable. renal cortex BTO:0001166 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472 AAP, ASD 3300034924 Faith P43116 5732 PTGER2 Homo sapiens 9606 Comment/tissue specificity EP expressed in vascular smooth muscle cells vascular smooth muscle cell BTO:0004578 vascular associated smooth muscle cell CL:0000359 Y Y C PubMed:20059330 PENTACON AAP, ASD 3300034929 Faith P43116 5732 PTGER2 Homo sapiens 9606 Comment/tissue specificity Staining showed that SM-actin positive (SMC) cells in hyaluronic acid rich areas of atherectomy specimens from the internal carotid artery strongly express the EP2 receptor. carotid artery BTO:0000168 Y Y ECO:0000006 PubMed:14752026 PENTACON Evidence to support Figure 1 in PubMed:20059330 AAP, ASD 3300034930 curatus P43116 5732 PTGER2 Homo sapiens 9606 Comment/tissue specificity Staining showed that SM-actin positive (SMC) cells in hyaluronic acid rich areas of atherectomy specimens from the internal carotid artery strongly express the EP2 receptor. carotid artery segment UBERON:0005396 Y Y ECO:0000006 PubMed:14752026 PENTACON Evidence to support Figure 1 in PubMed:20059330 AAP, ASD 3300034953 curatus P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from region common to all known EP3 splice variants demonstrated expression of mRNA in cortical and outer medullary collecting duct, medullary thick ascending limb but not inner medullary collecting duct. Labeling of connecting segment cannot be excluded. No labeling of glomeruli or Tamm-Horsfall-positive tubules in cortex. cortical collecting duct UBERON:0004203 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472;isoform not specified AAP, ASD 3300034954 curatus P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from region common to all known EP3 splice variants demonstrated expression of mRNA in cortical and outer medullary collecting duct, medullary thick ascending limb but not inner medullary collecting duct. Labeling of connecting segment cannot be excluded. No labeling of glomeruli or Tamm-Horsfall-positive tubules in cortex. medullary collecting duct BTO:0004536 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472;isoform not specified AAP, ASD 3300034955 curatus P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity EP expressed in kidney kidney BTO:0000671 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, ASD 3300034966 curatus P34995 5731 PTGER1 Homo sapiens 9606 Comment/tissue specificity EP expressed in kidney kidney UBERON:0002113 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, ASD 3300034967 curatus P43115 5733 PTGER3 Homo sapiens 9606 Comment/tissue specificity EP expressed in kidney kidney UBERON:0002113 Y Y ECO:0000033 PubMed:20059330 PENTACON isoform not specified AAP, ASD 3300034968 curatus P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity EP expressed in kidney kidney BTO:0000671 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, ASD 3300034969 curatus P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity EP expressed in kidney kidney UBERON:0002113 Y Y ECO:0000033 PubMed:20059330 PENTACON AAP, ASD 3300034970 curatus P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from full length EP4 demonstrated expression of mRNA in kidney cortex and outer medulla. Glomeruli were selectively labeled. Selective labeling of specific segments in the outer cortex was not clearly distinguishable. cortex of kidney UBERON:0001225 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472 AAP, ASD 3300034971 curatus P35408 5734 PTGER4 Homo sapiens 9606 Comment/tissue specificity In situ hybridization with riboprobes generated from full length EP4 demonstrated expression of mRNA in kidney cortex and outer medulla. Glomeruli were selectively labeled. Selective labeling of specific segments in the outer cortex was not clearly distinguishable. renal glomerulus UBERON:0000074 Y Y ECO:0000006 PubMed:8928854 PENTACON From review:PubMed:20059330;From review:PubMed:19095631;From review:PubMed:15369681;From review:PubMed:11264472 AAP, ASD 3300034972 curatus P35354 5743 PTGS2 Homo sapiens 9606 Comment/function Converts arachidonate to prostaglandin H2 (PGH2), a committed step in prostanoid synthesis. Constitutively expressed in some tissues in physiological conditions, such as the endothelium, kidney and brain, and in pathological conditions, such as in cancer. PTGS2 is responsible for production of inflammatory prostaglandins. Up-regulation of PTGS2 is also associated with increased cell adhesion, phenotypic changes, resistance to apoptosis and tumor angiogenesis. In cancer cells, PTGS2 is a key step in the production of prostaglandin E2 (PGE2), which plays important roles in modulating motility, proliferation and resistance to apoptosis. prostaglandin biosynthetic process GO:0001516 Y Y ECO:0000269 PubMed:16373578 UniProtKB N ver_2 AAP, DGA, AAP-M, ASD 5/11/2016 177 3300078746 curatus P35354 5743 PTGS2 Homo sapiens 9606 Comment/miscellaneous Conversion of arachidonate to prostaglandin H2 is mediated by 2 different isozymes: the constitutive PTGS1 and the inducible PTGS2. PGHS1 is expressed constitutively and generally produces prostanoids acutely in response to hormonal stimuli to fine-tune physiological processes requiring instantaneous, continuous regulation (e.g. hemostasis). PGHS2 is inducible and typically produces prostanoids that mediate responses to physiological stresses such as infection and inflammation. arachidonic acid metabolic process GO:0019369 Y Y ECO:0000311 UniProtKB N ver_2 AAP, DGA, AAP-M, ASD 5/11/2016 177 3300078748 curatus P35354 5743 PTGS2 Homo sapiens 9606 Comment/miscellaneous PTGS1 and PTGS2 are the targets of nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin and ibuprofen. Aspirin is able to produce an irreversible inactivation of the enzyme through a serine acetylation. Inhibition of the PGHSs with NSAIDs acutely reduces inflammation, pain, and fever, and long-term use of these drugs reduces fatal thrombotic events, as well as the development of colon cancer and Alzheimer's disease. PTGS2 is the principal isozyme responsible for production of inflammatory prostaglandins. New generation PTGSs inhibitors strive to be selective for PTGS2, to avoid side effects such as gastrointestinal complications and ulceration. acetylsalicylic acid CHEBI:15365 Y Y ECO:0000311 UniProtKB N ver_2 AAP, DGA, AAP-M, ASD 5/11/2016 177 3300078749 curatus P23219 5742 PTGS1 Homo sapiens 9606 Comment/function Converts arachidonate to prostaglandin H2 (PGH2), a committed step in prostanoid synthesis. Involved in the constitutive production of prostanoids in particular in the stomach and platelets. In gastric epithelial cells, it is a key step in the generation of prostaglandins, such as prostaglandin E2 (PGE2), which plays an important role in cytoprotection. In platelets, it is involved in the generation of thromboxane A2 (TXA2), which promotes platelet activation and aggregation, vasoconstriction and proliferation of vascular smooth muscle cells. prostaglandin biosynthetic process GO:0001516 Y Y ECO:0000311 UniProtKB N ver_2 AAP, DGA, AAP-M, ASD 5/11/2016 183 3300078750 curatus P23219 5742 PTGS1 Homo sapiens 9606 Comment/miscellaneous Conversion of arachidonate to prostaglandin H2 is mediated by 2 different isozymes: the constitutive PTGS1 and the inducible PTGS2. PGHS1 is expressed constitutively and generally produces prostanoids acutely in response to hormonal stimuli to fine-tune physiological processes requiring instantaneous, continuous regulation (e.g. hemostasis). PGHS2 is inducible and typically produces prostanoids that mediate responses to physiological stresses such as infection and inflammation. arachidonic acid metabolic process GO:0019369 Y Y ECO:0000311 UniProtKB N ver_2 AAP, DGA, AAP-M, ASD 5/11/2016 183 3300078752 curatus P23219 5742 PTGS1 Homo sapiens 9606 Comment/miscellaneous PTGS1 and PTGS2 are the targets of nonsteroidal anti-inflammatory drugs (NSAIDs) including aspirin and ibuprofen. Aspirin is able to produce an irreversible inactivation of the enzyme through a serine acetylation. Inhibition of the PGHSs with NSAIDs acutely reduces inflammation, pain, and fever, and long-term use of these drugs reduces fatal thrombotic events, as well as the development of colon cancer and Alzheimer's disease. PTGS2 is the principal isozyme responsible for production of inflammatory prostaglandins. New generation PTGSs inhibitors strive to be selective for PTGS2, to avoid side effects such as gastrointestinal complications and ulceration. acetylsalicylic acid CHEBI:15365 Y Y ECO:0000311 UniProtKB N ver_2 AAP, DGA, AAP-M, ASD 5/11/2016 183 3300078753 curatus P78329 8529 CYP4F2 Homo sapiens 9606 Comment/function Omega-hydroxylase that oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids and xenobiotics. Plays a key role in vitamin K catabolism by mediating omega-hydroxylation of vitamin K1 (phylloquinone), and menaquinone-4 (MK-4), a form of vitamin K2. Hydroxylation of phylloquinone and MK-4 probably regulates blood coagulation (PubMed:19297519, PubMed:24138531). Also shows arachidonic acid omega-hydroxylase activity in kidney, by mediating conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), possibly influencing blood pressure control (PubMed:10660572, PubMed:17341693, PubMed:18574070). Also acts as a leukotriene-B(4) omega-hydroxylase by mediating conversion of leukotriene-B(4) (LTB4) to its omega-hydroxylated metabolite 20-hydroxyleukotriene-B(4) (20-OH LTB4) (PubMed:8026587, PubMed:9799565). fatty acid metabolic process GO:0006631 Y Y ECO:0000269 PubMed:10660572 PubMed:17341693 PubMed:18574070 PubMed:19297519 PubMed:24138531 PubMed:8026587 PubMed:9799565 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 158 3300078765 curatus P78329 8529 CYP4F2 Homo sapiens 9606 Comment/tissue specificity Liver. Also present in kidney: specifically expressed in the S2 and S3 segments of proximal tubules in cortex and outer medulla (PubMed:10660572). liver BTO:0000759 Y Y ECO:0000269 PubMed:10492403 PubMed:10660572 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 158 3300078767 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. polymorphonuclear leukocyte BTO:0001026 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 5/11/2016 160 3300078768 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/function Isoform CYP4F3A: Catalyzes the omega-hydroxylation of leukotriene-B(4), a potent chemoattractant for polymorphonuclear leukocytes, it has low activity for arachidonic acid. leukotriene metabolic process GO:0006691 Y Y ECO:0000269 PubMed:11461919 PubMed:8486631 UniProtKB N ver_2 AAP 5/11/2016 160 3300078769 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/function Isoform CYP4F3B: Shows arachidonic acid omega-hydroxylase activity by mediating conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE) (PubMed:11461919, PubMed:16820285). Has a 30-fold higher Km for leukotriene-B(4) compared with CYP4F3A (PubMed:11461919). Also converts eicosapentaenoate (EPA) to 20-hydroxyeicosapentaenoate (20-OH-EPA) (PubMed:16820285). Acts as a polyunsaturated omega-3 fatty acids hydroxylase: mediates conversion of docosahexaenoate (DHA) to 22-hydroxydocosahexaenoate (PubMed:16820285). arachidonic acid metabolic process GO:0019369 Y Y ECO:0000269 PubMed:11461919 PubMed:16820285 PubMed:18577768 UniProtKB N ver_2 AAP 5/11/2016 160 3300078770 curatus P08684 1576 CYP3A4 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599). steroid metabolic process GO:0008202 Y Y ECO:0000269 PubMed:11159812 PubMed:21576599 UniProtKB N ver_2 AAP, DGA, ASD 5/11/2016 187 3300078771 curatus O95255 368 ABCC6 Homo sapiens 9606 Comment/function Isoform 1: May participate directly in the active transport of drugs into subcellular organelles or influence drug distribution indirectly. Transports glutathione conjugates as leukotriene-c4 (LTC4) and N-ethylmaleimide S-glutathione (NEM-GS). Y Y ECO:0000269 PubMed:11880368 UniProtKB N ver_2 AAP, DGA, ASD 5/11/2016 175 3300078782 curatus O95255 368 ABCC6 Homo sapiens 9606 Comment/function Isoform 2: Inhibits TNF-alpha-mediated apoptosis through blocking one or more caspases. Y Y ECO:0000269 PubMed:23912081 UniProtKB N ver_2 AAP, DGA, ASD 5/11/2016 175 3300078783 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/Involvement in disease LTC4 synthase deficiency is associated with a neurometabolic developmental disorder characterized by muscular hypotonia, psychomotor retardation, failure to thrive, and microcephaly. intrinsic asthma DOID:9360 Y Y UniProtKB N ver_2 The deficiency phenotype is MIM:614037. Two cases of the deficiency are described and these patients died at the age of 6 months. For the MIM given, several diseases are discussed: aspirin intolerant asthma (MIM:208550) (patients display increased LTC4S expression and have a promoter polymorphism). I added the second MIM term. HDO does not have a term that captures the 'aspirin' effect in asthma. ICD has various intrinsic asthma terms, none aspirin related AAP, DGA, ASD 5/11/2016 147 3300078785 curatus Q9HBI6 57834 CYP4F11 Homo sapiens 9606 Comment/function Omega-hydroxylase that oxidizes a variety of structurally unrelated compounds, including fatty acids and xenobiotics. Plays a key role in vitamin K catabolism by mediating omega-hydroxylation of vitamin K1 (phylloquinone), and menaquinone-4 (MK-4), a form of vitamin K2. Hydroxylation of phylloquinone and MK-4 probably regulates blood coagulation (PubMed:24138531). Catalyzes omega-hydroxylation of 3-hydroxy fatty acids, such as 3-hydroxypalmitate, 3-hydroxyoleate, 3-hydroxyarachidonate, and 3-hydroxystearate (PubMed:18065749, PubMed:19932081). Oxidizes drugs such as erythromycin, benzphetamine, ethylmorphine, chlorpromazine and imipramine (PubMed:15364545). fatty acid metabolic process GO:0006631 Y Y ECO:0000269 PubMed:15364545 PubMed:18065749 PubMed:19932081 PubMed:24138531 UniProtKB N ver_2 AAP 3/16/2016 141 3300078788 curatus O60733 8398 PLA2G6 Homo sapiens 9606 Comment/Involvement in disease Neurodegeneration with brain iron accumulation 2B (NBIA2B): A neurodegenerative disorder associated with iron accumulation in the brain, primarily in the basal ganglia. It is characterized by progressive extrapyramidal dysfunction leading to rigidity, dystonia, dysarthria and sensorimotor impairment. MIM:610217 pantothenate kinase-associated neurodegeneration DOID:3981 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:16783378 UniProtKB N ver_2 Although this is only one type of the neurodegenerative diseases caused by iron accumulation in the brain it is the closest available HDO term AAP, DGA, ASD 5/11/2016 163 3300078790 curatus O60733 8398 PLA2G6 Homo sapiens 9606 Comment/Involvement in disease Neurodegeneration with brain iron accumulation 2A (NBIA2A): A neurodegenerative disease characterized by pathologic axonal swelling and spheroid bodies in the central nervous system. Onset is within the first 2 years of life with death by age 10 years. MIM:256600 pantothenate kinase-associated neurodegeneration DOID:3981 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:16783378 PubMed:17033970 PubMed:23749988 UniProtKB N ver_2 Although this is only one type of the neurodegenerative diseases caused by iron accumulation in the brain it is the closest available HDO term AAP, DGA, ASD 5/11/2016 163 3300078791 curatus O60733 8398 PLA2G6 Homo sapiens 9606 Comment/Involvement in disease Parkinson disease 14 (PARK14): An adult-onset progressive neurodegenerative disorder characterized by parkinsonism, dystonia, severe cognitive decline, cerebral and cerebellar atrophy and absent iron in the basal ganglia on magnetic resonance imaging. MIM:612953 Parkinson's disease DOID:14330 ICD:332 332.0 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:18570303 UniProtKB N ver_2 AAP, DGA, ASD 5/11/2016 163 3300078792 curatus P39877 5322 PLA2G5 Homo sapiens 9606 Comment/Involvement in disease Fleck retina, familial benign (FRFB): An autosomal recessive condition associated with a distinctive retinal appearance and no apparent visual or electrophysiologic deficits. Affected individuals are asymptomatic, but fundus examination reveals a striking pattern of diffuse, yellow-white, fleck-like lesions extending to the far periphery of the retina but sparing the foveal region. MIM:228980 Retinal flecking SNOMEDCT:247138002 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:22137173 UniProtKB N ver_2 AAP, ASD 5/11/2016 151 3300078793 curatus P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease Cholesteryl ester storage disease (CESD): A mild manifestation of LIPA deficiency, leading to the accumulation of cholesteryl esters and triglycerides in most tissues of the body. It is characterized by late-onset. MIM:278000 Wolman disease DOID:14497 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:8146180 PubMed:9633819 UniProtKB N ver_2 AAP 3/16/2016 157 3300078799 curatus P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease Wolman disease (WOD): A severe manifestation of LIPA deficiency, leading to the accumulation of cholesteryl esters and triglycerides in most tissues of the body. WD occurs in infancy and is nearly always fatal before the age of 1 year. MIM:278000 Wolman disease DOID:14497 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:8146180 UniProtKB N ver_2 AAP 3/16/2016 157 3300078800 curatus Q05469 3991 LIPE Homo sapiens 9606 Comment/Involvement in disease Lipodystrophy, familial partial, 6 (FPLD6): A form of lipodystrophy characterized by abnormal subcutaneous fat distribution. Affected individuals have increased visceral fat, impaired lipolysis, dyslipidemia, hepatic steatosis, systemic insulin resistance, and diabetes. Some patients manifest muscular dystrophy. familial partial lipodystrophy DOID:0050440 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:24848981 UniProtKB N ver_2 AAP, DGA, ASD 4/13/2016 150 3300078801 curatus Q9BYJ1 59344 ALOXE3 Homo sapiens 9606 Comment/function Non-heme iron-containing lipoxygenase which is atypical in that it displays a prominent hydroperoxide isomerase activity and a reduced dioxygenase activity compared to other lipoxygenases. The hydroperoxide isomerase activity catalyzes the isomerization of hydroperoxides, derived from arachidonic and linoleic acid by ALOX12B, into hepoxilin-type epoxyalcohols. The dioxygenase activity requires a step of activation of the enzyme by molecular oxygen. In presence of oxygen, oxygenates polyunsaturated fatty acids, including arachidonic acid, to produce fatty acid hydroperoxides. In the skin, acts downstream of ALOX12B on the linoleate moiety of esterified omega-hydroxyacyl-sphingosine (EOS) ceramides to produce an epoxy-ketone derivative, a crucial step in the conjugation of omega-hydroxyceramide to membrane proteins. Therefore plays a crucial role in the synthesis of corneocytes lipid envelope and the establishment of the skin barrier to water loss. In parallel, it may have a signaling function in barrier formation through the production of hepoxilins metabolites. Plays also a role in adipocyte differentiation through hepoxilin A3 and hepoxilin B3 production which in turn activate PPARG. Through the production of hepoxilins in the spinal cord, it may regulate inflammatory tactile allodynia. isomerase activity GO:0016853 Y Y ECO:0000269 PubMed:12881489 PubMed:17045234 PubMed:20921226 PubMed:20923767 PubMed:21558561 UniProtKB N ver_2 AAP 3/16/2016 134 3300078806 curatus Q9BYJ1 59344 ALOXE3 Homo sapiens 9606 Comment/Involvement in disease Ichthyosis, congenital, autosomal recessive 3 (ARCI3): A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. MIM:242100 congenital ichthyosiform erythroderma DOID:1699 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:11773004 PubMed:16116617 PubMed:19131948 PubMed:19890349 UniProtKB N ver_2 AAP 3/16/2016 134 3300078807 curatus O14734 10005 ACOT8 Homo sapiens 9606 Comment/tissue specificity Detected in a T-cell line (at protein level). Ubiquitous (PubMed:9153233, PubMed:9299485). JURKAT cell BTO:0000661 JURKAT cell CLO:0007043 Y Y ECO:0000269 PubMed:9153233 PubMed:9299485 UniProtKB N ver_2 AAP 4/13/2016 152 3300078816 curatus O14734 10005 ACOT8 Homo sapiens 9606 Comment/function Acyl-coenzyme A (acyl-CoA) thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH (PubMed:9299485, PubMed:9153233, PubMed:15194431). Competes with bile acid CoA:amino acid N-acyltransferase (BAAT) for bile acid-CoA substrate (such as chenodeoxycholoyl-CoA). Shows a preference for medium-length fatty acyl-CoAs (C2 to C20) (PubMed:9299485, PubMed:9153233). Inactive towards substrates with more than C20 aliphatic chains (PubMed:9153233). Involved in the metabolic regulation of peroxisome proliferation (PubMed:15194431). acyl-CoA metabolic process GO:0006637 Y Y ECO:0000269 PubMed:15194431 PubMed:9153233 PubMed:9299485 UniProtKB N ver_2 AAP 4/13/2016 152 3300078817 curatus O14734 10005 ACOT8 Homo sapiens 9606 Comment/subcellular location Predominantly localized in the peroxisome (PubMed:10092594, PubMed:15194431). peroxisome GO:0005777 Y Y ECO:0000269 PubMed:10092594 UniProtKB N ver_2 AAP 4/13/2016 152 3300078820 curatus O14734 10005 ACOT8 Homo sapiens 9606 Comment/subcellular location Peroxisome matrix peroxisomal matrix GO:0005782 SL-0202 Y Y ECO:0000269 PubMed:10092594 UniProtKB N ver_2 AAP 4/13/2016 152 3300078821 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. white adipose tissue BTO:0001456 Y Y ECO:0000311 UniProtKB N ver_2 AAP 4/13/2016 139 3300078822 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. white adipose tissue UBERON:0001347 Y Y ECO:0000311 UniProtKB N ver_2 AAP 4/13/2016 139 3300078823 curatus O00154 11332 ACOT7 Homo sapiens 9606 Comment/tissue specificity Isoform 4 is expressed exclusively in brain. brain BTO:0000142 Y Y ECO:0000269 PubMed:12435388 UniProtKB N ver_2 AAP, ASD 5/11/2016 154 3300078824 curatus Q9NPJ3 55856 ACOT13 Homo sapiens 9606 Comment/function Acyl-CoA thioesterases are a group of enzymes that catalyze the hydrolysis of acyl-CoAs to the free fatty acid and coenzyme A (CoASH), providing the potential to regulate intracellular levels of acyl-CoAs, free fatty acids and CoASH. Has acyl-CoA thioesterase activity towards medium (C12) and long-chain (C18) fatty acyl-CoA substrates. Can also hydrolyze 3-hydroxyphenylacetyl-CoA and 3,4-dihydroxyphenylacetyl-CoA (in vitro). May play a role in controlling adaptive thermogenesis (By similarity). Y Y ECO:0000269 ECO:0000250 : PubMed:16934754 PubMed:19170545 UniProtKB N ver_2 AAP, ASD 5/11/2016 132 3300078826 curatus Q15185 10728 PTGES3 Homo sapiens 9606 Comment/function Cytosolic prostaglandin synthase that catalyzes the oxidoreduction of prostaglandin endoperoxide H2 (PGH2) to prostaglandin E2 (PGE2) (PubMed:10922363). Molecular chaperone that localizes to genomic response elements in a hormone-dependent manner and disrupts receptor-mediated transcriptional activation, by promoting disassembly of transcriptional regulatory complexes (PubMed:11274138, PubMed:12077419). Facilitates HIF alpha proteins hydroxylation via interaction with EGLN1/PHD2, leading to recruit EGLN1/PHD2 to the HSP90 pathway (PubMed:24711448). prostaglandin-E synthase activity GO:0050220 Y Y ECO:0000269 PubMed:10922363 PubMed:11274138 PubMed:12077419 PubMed:24711448 UniProtKB N ver_2 AAP, ASD 5/11/2016 162 3300078831 curatus Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/Involvement in disease A chromosomal aberration involving ACSL6 may be a cause of myelodysplastic syndrome with basophilia. Translocation t(5;12)(q31;p13) with ETV6. myelodysplastic myeloproliferative cancer DOID:4972 Y Y ECO:0000269 PubMed:10502316 UniProtKB N ver_2 AAP, AAP-M, ASD 3/16/2016 150 3300078832 curatus Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/Involvement in disease A chromosomal aberration involving ACSL6 may be a cause of acute myelogenous leukemia with eosinophilia. Translocation t(5;12)(q31;p13) with ETV6. acute myeloid leukemia DOID:9119 Y Y ECO:0000269 PubMed:10502316 UniProtKB N ver_2 AAP, AAP-M, ASD 3/16/2016 150 3300078833 curatus Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/Involvement in disease A chromosomal aberration involving ACSL6 may be a cause of acute eosinophilic leukemia (AEL). Translocation t(5;12)(q31;p13) with ETV6. eosinophilia DOID:999 Y Y ECO:0000269 PubMed:10502316 UniProtKB N ver_2 AAP, AAP-M, ASD 3/16/2016 150 3300078834 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/Involvement in disease Mental retardation, X-linked 63 (MRX63): A disorder characterized by significantly below average general intellectual functioning associated with impairments in adaptive behavior and manifested during the developmental period. Intellectual deficiency is the only primary symptom of non-syndromic X-linked mental retardation, while syndromic mental retardation presents with associated physical, neurological and/or psychiatric manifestations. MIM:300387 non-specific X-linked mental retardation DOID:0050776 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:11889465 UniProtKB N ver_2 ICD:317-319.99 319 ICD:317-319.99 319 AAP, AAP-M, ASD 5/11/2016 166 3300078835 curatus O60488 2182 ACSL4 Homo sapiens 9606 Comment/Involvement in disease Alport syndrome with mental retardation, midface hypoplasia and elliptocytosis (ATS-MR): A X-linked contiguous gene deletion syndrome characterized by glomerulonephritis, sensorineural hearing loss, mental retardation, midface hypoplasia and elliptocytosis. MIM:300194 Alport syndrome DOID:10983 The gene represented in this entry may be involved in disease pathogenesis. Y Y ECO:0000269 PubMed:9480748 UniProtKB N ver_2 The HDO term refers to the autosomal version of the disease. The OMIM term is a better match to the UniProt description. The HDO term refers to the autosomal version of the disease. The OMIM term is a better match to the UniProt description. AAP, AAP-M, ASD 5/11/2016 166 3300078836 curatus Q9H7Z7 80142 PTGES2 Homo sapiens 9606 Comment/function Isomerase that catalyzes the conversion of PGH2 into the more stable prostaglandin E2 (PGE2). prostaglandin-E synthase activity GO:0050220 Y Y ECO:0000269 PubMed:12804604 PubMed:18198127 UniProtKB N ver_2 AAP 5/11/2016 139 3300078852 curatus P04054 5319 PLA2G1B Homo sapiens 9606 Comment/function PA2 catalyzes the calcium-dependent hydrolysis of the 2-acyl groups in 3-sn-phosphoglycerides, this releases glycerophospholipids and arachidonic acid that serve as the precursors of signal molecules. glycerophospholipid biosynthetic process GO:0046474 Y Y ECO:0000269 PubMed:19297324 UniProtKB N ver_2 AAP, ASD 5/11/2016 169 3300078862 curatus Q7Z449 113612 CYP2U1 Homo sapiens 9606 Comment/Involvement in disease Spastic paraplegia 56, autosomal recessive (SPG56): A form of spastic paraplegia, a neurodegenerative disorder characterized by a slow, gradual, progressive weakness and spasticity of the lower limbs. Rate of progression and the severity of symptoms are quite variable. Initial symptoms may include difficulty with balance, weakness and stiffness in the legs, muscle spasms, and dragging the toes when walking. Complicated forms are recognized by additional variable features including spastic quadriparesis, seizures, dementia, amyotrophy, extrapyramidal disturbance, cerebral or cerebellar atrophy, optic atrophy, and peripheral neuropathy, as well as by extra neurological manifestations. In SPG56, upper limbs are often also affected. Some SPG56 patients may have a subclinical axonal neuropathy. hereditary spastic paraplegia DOID:2476 ICD:334.1 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:23176821 UniProtKB N ver_2 AAP 3/16/2016 127 3300078878 curatus Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/miscellaneous Genetic variations in PNPLA2 may influence plasma free fatty acids and triglycerides levels, and fasting glucose concentrations. glucose CHEBI:17234 Y Y ECO:0000269 PubMed:16644682 UniProtKB N ver_2 Actual term would be 'fasting glucose concentrations' but no ontology term found.#ORIGINAL data type: Comment/polymorphism AAP 3/16/2016 112 3300078884 curatus Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/Involvement in disease Genetic variations in PNPLA2 may be associated with risk of diabetes mellitus type 2. type 2 diabetes mellitus DOID:9352 Y Y ECO:0000269 PubMed:16644682 UniProtKB N ver_2 AAP 3/16/2016 112 3300078886 curatus Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/function Catalyzes the initial step in triglyceride hydrolysis in adipocyte and non-adipocyte lipid droplets (PubMed:15550674). Also has acylglycerol transacylase activity. May act coordinately with LIPE/HLS within the lipolytic cascade. Regulates adiposome size and may be involved in the degradation of adiposomes (PubMed:16239926). May play an important role in energy homeostasis. May play a role in the response of the organism to starvation, enhancing hydrolysis of triglycerides and providing free fatty acids to other tissues to be oxidized in situations of energy depletion. Y Y ECO:0000269 PubMed:15364929 PubMed:15550674 PubMed:16239926 UniProtKB N ver_2 AAP 3/16/2016 112 3300078887 curatus Q9NP80 50640 PNPLA8 Homo sapiens 9606 Comment/Involvement in disease Mitochondrial myopathy with lactic acidosis (MMLA): An autosomal recessive disorder characterized by progressive muscle weakness, hypotonia, seizures, poor weight gain, lactic acidosis, and elevated serum pyruvate concentration. Some patients manifest growth failure and moderate neural deafness. lactic acidosis DOID:3650 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:25512002 UniProtKB N ver_2 AAP 4/13/2016 125 3300078890 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/subcellular location Cytosol cytosol GO:0005829 SL-0091 Y Y ECO:0000269 PubMed:10542053 UniProtKB N ver_2 AAP 3/16/2016 158 3300078914 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/subcellular location Cytoskeleton cytoskeleton GO:0005856 SL-0090 Y Y ECO:0000269 PubMed:12704195 UniProtKB N ver_2 AAP 3/16/2016 158 3300078915 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/subcellular location Membrane;Peripheral membrane protein membrane GO:0016020 SL-0162 Y Y ECO:0000269 PubMed:10542053 UniProtKB N ver_2 AAP 3/16/2016 158 3300078916 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/subcellular location Cell membrane plasma membrane GO:0005886 SL-0039 Y Y ECO:0000269 PubMed:10542053 UniProtKB N ver_2 AAP 3/16/2016 158 3300078918 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/function Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids generating a spectrum of bioactive lipid mediators. Converts arachidonic acid to 15S-hydroperoxyeicosatetraenoic acid/(15S)-HPETE. Also acts on linoleic acid to produce 13-hydroxyoctadecadienoic acid/13-HPODE. Has no detectable 8S-lipoxygenase activity but reacts with (8S)-HPETE to produce (8S,15S)-diHPETE. May regulate progression through the cell cycle and cell proliferation. May also regulate cytokine secretion by macrophages and therefore play a role in the immune response. May also regulate macrophage differentiation into proatherogenic foam cells. arachidonate 5-lipoxygenase activity GO:0004051 Y Y ECO:0000269 PubMed:10625675 PubMed:11839751 PubMed:12704195 PubMed:16112079 PubMed:18067895 PubMed:22912809 PubMed:24497644 UniProtKB N ver_2 AAP 3/16/2016 158 3300078920 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. cornea BTO:0000286 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3/16/2016 158 3300078921 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. cornea UBERON:0000964 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3/16/2016 158 3300078922 curatus Q16647 5740 PTGIS Homo sapiens 9606 Comment/Involvement in disease Essential hypertension (EHT): A condition in which blood pressure is consistently higher than normal with no identifiable cause. MIM:145500 essential hypertension DOID:10825 ICD:401 The disease may be caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:12372404 UniProtKB N ver_2 AAP, DGA, AAP-M, ASD 3/16/2016 161 3300078923 curatus Q3MJ16 123745 PLA2G4E Homo sapiens 9606 Comment/function Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position. Y Y ECO:0000250 UniProtKB N ver_2 AAP 3/16/2016 93 3300078924 curatus Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/Involvement in disease Acyl-CoA dehydrogenase family, member 9, deficiency (ACAD9 deficiency): An autosomal recessive metabolic disorder associated with mitochondrial complex I deficiency, resulting in multisystemic and variable manifestations. Clinical features include infantile onset of acute metabolic acidosis, Reye-like episodes (brain edema and vomiting that may rapidly progress to seizures, coma and death), exercise intolerance, hypertrophic cardiomyopathy, liver failure, muscle weakness, and neurologic dysfunction. MIM:611126 mitochondrial disease DOID:0080013 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:17564966 PubMed:20816094 PubMed:20929961 PubMed:21057504 PubMed:22499348 PubMed:23836383 PubMed:23996478 UniProtKB N ver_2 DOID:0060536 mitochondrial complex I deficiency AAP 4/13/2016 138 3300078929 curatus Q9H845 28976 ACAD9 Homo sapiens 9606 Comment/function Required for mitochondrial complex I assembly (PubMed:20816094, PubMed:24158852). Has a dehydrogenase activity on palmitoyl-CoA (C16:0) and stearoyl-CoA (C18:0). It is three times more active on palmitoyl-CoA than on stearoyl-CoA. However, it does not play a primary role in long-chain fatty acid oxidation in vivo (PubMed:20816094, PubMed:24158852). Has little activity on octanoyl-CoA (C8:0), butyryl-CoA (C4:0) or isovaleryl-CoA (5:0). mitochondrial respiratory chain complex I GO:0005747 Y Y ECO:0000269 PubMed:20816094 PubMed:24158852 UniProtKB N ver_2 AAP 4/13/2016 138 3300078930 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/Involvement in disease Spinocerebellar ataxia 38 (SCA38): A form of spinocerebellar ataxia, a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA38 is an autosomal dominant form characterized by adult-onset of slowly progressive gait ataxia accompanied by nystagmus. Brain MRI shows cerebellar atrophy. spinocerebellar ataxia DOID:1441 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:25065913 UniProtKB N ver_2 AAP 4/13/2016 126 3300078941 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/subcellular location Dendrite dendrite GO:0030425 SL-0283 Y Y ECO:0000269 PubMed:25065913 UniProtKB N ver_2 AAP 4/13/2016 126 3300078942 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/subcellular location In Purkinje cells, the protein localizes to the soma and proximal portion of the dendritic tree. cerebellar Purkinje cell BTO:0001011 Y Y ECO:0000269 PubMed:25065913 UniProtKB N ver_2 AAP 4/13/2016 126 3300078943 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/function Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Condensing enzyme that acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6) acyl-CoA. May participate to the production of monounsaturated and of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. unsaturated fatty acyl-CoA CHEBI:51006 Y Y ECO:0000255 ECO:0000269 HAMAP-Rule:MF_03205 PubMed:10970790 PubMed:20937905 UniProtKB N ver_2 AAP 4/13/2016 126 3300078944 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. adrenal gland UBERON:0002369 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 AAP 4/13/2016 126 3300078945 curatus Q96SL4 2882 GPX7 Homo sapiens 9606 Comment/Involvement in disease Barrett esophagus (BE): A condition characterized by a metaplastic change in which normal esophageal squamous epithelium is replaced by a columnar and intestinal-type epithelium. Patients with Barrett esophagus have an increased risk of esophageal adenocarcinoma. The main cause of Barrett esophagus is gastroesophageal reflux. The retrograde movement of acid and bile salts from the stomach into the esophagus causes prolonged injury to the esophageal epithelium and induces chronic esophagitis, which in turn is believed to trigger the pathologic changes. MIM:614266 Barrett's esophagus DOID:9206 The disease is caused by mutations affecting the gene represented in this entry. The pathologic mechanisms leading to Barrett esophagus involve GPX7 dysfunction that results in higher levels of hydrogen peroxide and ROS-induced oxidative stress and DNA damage in esophageal cells. Y Y ECO:0000269 PubMed:22157330 UniProtKB N ver_2 AAP, ASD 3/16/2016 134 3300078948 curatus Q9H4A9 64174 DPEP2 Homo sapiens 9606 Comment/function Probable metalloprotease which hydrolyzes leukotriene D4 (LTD4) into leukotriene E4 (LTE4). Y Y ECO:0000250 UniProtKB N ver_2 AAP 3/16/2016 112 3300078951 curatus Q9UJ14 2686 GGT7 Homo sapiens 9606 Comment/function Cleaves glutathione conjugates. Y Y ECO:0000250 UniProtKB N ver_2 AAP 5/11/2016 133 3300078952 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Eye. eye BTO:0000439 Y Y ECO:0000269 PubMed:18587449 UniProtKB N ver_2 AAP, ASD 3/16/2016 146 3300078953 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/tissue specificity Eye. eye UBERON:0000970 Y Y ECO:0000269 PubMed:18587449 UniProtKB N ver_2 AAP, ASD 3/16/2016 146 3300078954 curatus P43088 5737 PTGFR Homo sapiens 9606 Comment/function Receptor for prostaglandin F2-alpha (PGF2-alpha). The activity of this receptor is mediated by G proteins which activate a phosphatidylinositol-calcium second messenger system. Initiates luteolysis in the corpus luteum (By similarity). Isoforms 2 to 7 do not bind PGF2-alpha but are proposed to modulate signaling by participating in variant receptor complexes; heterodimers between isoform 1 and isoform 5 are proposed to be a receptor for prostamides including the synthetic analog bimatoprost. Y Y ECO:0000269 ECO:0000250 : PubMed:18587449 UniProtKB N ver_2 AAP, ASD 3/16/2016 146 3300078955 curatus P35610 6646 SOAT1 Homo sapiens 9606 Comment/function Catalyzes the formation of fatty acid-cholesterol esters, which are less soluble in membranes than cholesterol. Plays a role in lipoprotein assembly and dietary cholesterol absorption. In addition to its acyltransferase activity, it may act as a ligase. Y Y UniProtKB N ver_2 AAP, ASD 4/13/2016 155 3300078956 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/Involvement in disease Isolated congenital nail clubbing (ICNC): A rare genodermatosis characterized by enlargement of the nail plate and terminal segments of the fingers and toes, resulting from proliferation of the connective tissues between the nail matrix and the distal phalanx. It is usually symmetrical and bilateral (in some cases unilateral). In nail clubbing usually the distal end of the nail matrix is relatively high compared to the proximal end, while the nail plate is complete but its dimensions and diameter more or less vary in comparison to normal. There may be different fingers and toes involved to varying degrees. Some fingers or toes are spared, but the thumbs are almost always involved. MIM:119900 Hereditary clubbing SNOMEDCT:239055005 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:18805827 UniProtKB N ver_2 AAP, ASD 5/11/2016 169 3300078977 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/Involvement in disease Hypertrophic osteoarthropathy, primary, autosomal recessive, 1 (PHOAR1): A disease characterized by digital clubbing, periostosis, acroosteolysis, painful joint enlargement, and variable features of pachydermia that include thickened facial skin and a thickened scalp. Other developmental anomalies include delayed closure of the cranial sutures and congenital heart disease. MIM:259100 primary hypertrophic osteoarthropathy DOID:14283 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:18500342 UniProtKB N ver_2 AAP, ASD 5/11/2016 169 3300078978 curatus P15428 3248 HPGD Homo sapiens 9606 Comment/Involvement in disease Cranioosteoarthropathy (COA): A form of osteoarthropathy characterized by swelling of the joints, digital clubbing, hyperhidrosis, delayed closure of the fontanels, periostosis, and variable patent ductus arteriosus. Pachydermia is not a prominent feature. MIM:259100 primary hypertrophic osteoarthropathy DOID:14283 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:18500342 UniProtKB N ver_2 AAP, ASD 5/11/2016 169 3300078979 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, retinoid and xenobiotics. Preferentially oxidizes 17beta-estradiol to the carcinogenic 4-hydroxy derivative, and a variety of procarcinogenic compounds to their activated forms, including polycyclic aromatic hydrocarbons. Promotes angiogenesis by removing cellular oxygenation products, thereby decreasing oxidative stress, release of antiangiogenic factor THBS2, then allowing endothelial cells migration, cell adhesion and capillary morphogenesis. These changes are concommitant with the endothelial nitric oxide synthase activity and nitric oxide synthesis. Plays an important role in the regulation of perivascular cell proliferation, migration, and survival through modulation of the intracellular oxidative state and NF-kappa-B expression and/or activity, during angiogenesis. Contributes to oxidative homeostasis and ultrastructural organization and function of trabecular meshwork tissue through modulation of POSTN expression. liver BTO:0000759 Y Y ECO:0000269 PubMed:10426814 PubMed:15258110 PubMed:22888116 PubMed:23821647 UniProtKB N ver_2 AAP, ASD 5/11/2016 186 3300078981 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease Glaucoma 3, primary congenital, A (GLC3A): An autosomal recessive form of primary congenital glaucoma (PCG). PCG is characterized by marked increase of intraocular pressure at birth or early childhood, large ocular globes (buphthalmos) and corneal edema. It results from developmental defects of the trabecular meshwork and anterior chamber angle of the eye that prevent adequate drainage of aqueous humor. MIM:231300 primary congenital glaucoma DOID:0050593 ICD:743.21 The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Y Y ECO:0000269 PubMed:10227395 PubMed:10655546 PubMed:11184479 PubMed:11527932 PubMed:11980847 PubMed:12036985 PubMed:12525557 PubMed:14635112 PubMed:14640114 PubMed:15255109 PubMed:15342693 PubMed:15475877 PubMed:16490498 PubMed:16735994 PubMed:9463332 PubMed:9497261 UniProtKB N ver_2 AAP, ASD 5/11/2016 186 3300078982 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease Peters anomaly (PETAN): Consists of a central corneal leukoma, absence of the posterior corneal stroma and Descemet membrane, and a variable degree of iris and lenticular attachments to the central aspect of the posterior cornea. MIM:604229 eye disease DOID:5614 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:11403040 UniProtKB N ver_2 No HDO term, except more gener """"eye disease"""" AAP, ASD 5/11/2016 186 3300078983 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease Glaucoma, primary open angle (POAG): A complex and genetically heterogeneous ocular disorder characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. In some cases, POAG shows digenic inheritance involving mutations in CYP1B1 and MYOC genes. MIM:137760 primary open angle glaucoma DOID:1070 ICD:365.11 Disease susceptibility is associated with variations affecting the gene represented in this entry. CYP1B1 mutations have been reported to pose a significant risk for early-onset POAG and also modify glaucoma phenotype in patients who do not carry a MYOC mutation (PubMed:15342693). Y Y ECO:0000269 PubMed:11774072 PubMed:15342693 PubMed:16688110 PubMed:16862072 UniProtKB N ver_2 AAP, ASD 5/11/2016 186 3300078984 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease Glaucoma 1, open angle, A (GLC1A): A form of primary open angle glaucoma (POAG). POAG is characterized by a specific pattern of optic nerve and visual field defects. The angle of the anterior chamber of the eye is open, and usually the intraocular pressure is increased. However, glaucoma can occur at any intraocular pressure. The disease is generally asymptomatic until the late stages, by which time significant and irreversible optic nerve damage has already taken place. MIM:137750 open-angle glaucoma DOID:1067 ICD:365.1 365.10 365.13 The gene represented in this entry acts as a disease modifier. Digenic mutations in CYP1B1 and MYOC have been found in a family segregating both primary adult-onset and juvenile forms of open angle glaucoma (PubMed:11774072). All affected family members with mutations in both MYOC and CYP1B1 had juvenile glaucoma, whereas those with only the MYOC mutation had the adult-onset form (PubMed:11774072). Y Y ECO:0000269 PubMed:11774072 UniProtKB N ver_2 AAP, ASD 5/11/2016 186 3300078985 curatus P24752 38 ACAT1 Homo sapiens 9606 Comment/Involvement in disease 3-ketothiolase deficiency (3KTD): An inborn error of isoleucine catabolism characterized by intermittent ketoacidotic attacks associated with unconsciousness. Some patients die during an attack or are mentally retarded. Urinary excretion of 2-methyl-3-hydroxybutyric acid, 2-methylacetoacetic acid, triglylglycine, butanone is increased. It seems likely that the severity of this disease correlates better with the environmental or acquired factors than with the ACAT1 genotype. MIM:203750 beta-ketothiolase deficiency DOID:14723 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:1346617 PubMed:1715688 PubMed:7728148 PubMed:9744475 UniProtKB N ver_2 AAP, DGA, ASD 5/11/2016 177 3300078988 curatus O75342 242 ALOX12B Homo sapiens 9606 Comment/Involvement in disease Ichthyosis, congenital, autosomal recessive 2 (ARCI2): A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. MIM:242100 congenital ichthyosiform erythroderma DOID:1699 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:11773004 PubMed:16116617 PubMed:19131948 PubMed:19890349 UniProtKB N ver_2 AAP 1/20/2016 146 3300078991 curatus O75342 242 ALOX12B Homo sapiens 9606 Comment/function Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids generating a spectrum of bioactive lipid mediators. Mainly converts arachidonic acid to (12R)-hydroperoxyeicosatetraenoic acid/(12R)-HPETE and minor stereoisomers. In the skin, acts upstream of ALOXE3 on the lineolate moiety of esterified omega-hydroxyacyl-sphingosine (EOS) ceramides to produce an epoxy-ketone derivative, a crucial step in the conjugation of omega-hydroxyceramide to membrane proteins. Therefore plays a crucial role in the synthesis of corneocytes lipid envelope and the establishment of the skin barrier to water loss. May also play a role in the regulation of the expression of airway mucins. arachidonic acid metabolic process GO:0019369 Y Y ECO:0000269 PubMed:21558561 PubMed:22441738 PubMed:9618483 UniProtKB N ver_2 AAP 1/20/2016 146 3300078992 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. blood plasma BTO:0000131 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3/16/2016 172 3300078996 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/function Central enzyme in the extracellular metabolism of plasma lipoproteins. Synthesized mainly in the liver and secreted into plasma where it converts cholesterol and phosphatidylcholines (lecithins) to cholesteryl esters and lysophosphatidylcholines on the surface of high and low density lipoproteins (HDLs and LDLs) (PubMed:10329423, PubMed:19065001, PubMed:26195816). The cholesterol ester is then transported back to the liver. Has a preference for plasma 16:0-18:2 or 18:O-18:2 phosphatidylcholines (PubMed:8820107). Also produced in the brain by primary astrocytes, and esterifies free cholesterol on nascent APOE-containing lipoproteins secreted from glia and influences cerebral spinal fluid (CSF) APOE- and APOA1 levels. Together with APOE and the cholesterol transporter ABCA1, plays a key role in the maturation of glial-derived, nascent lipoproteins. Required for remodeling high-density lipoprotein particles into their spherical forms (PubMed:10722751). Y Y ECO:0000269 PubMed:10329423 PubMed:10722751 PubMed:14636062 PubMed:19065001 PubMed:26195816 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3/16/2016 172 3300078997 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease Lecithin-cholesterol acyltransferase deficiency (LCATD): A disorder of lipoprotein metabolism characterized by inadequate esterification of plasmatic cholesterol. Two clinical forms are recognized: complete LCAT deficiency and fish-eye disease. LCATD is generally referred to the complete form which is associated with absence of both alpha and beta LCAT activities resulting in esterification anomalies involving both HDL (alpha-LCAT activity) and LDL (beta-LCAT activity). It causes a typical triad of diffuse corneal opacities, target cell hemolytic anemia, and proteinuria with renal failure. MIM:245900 Norum disease DOID:1391 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:11423760 PubMed:12957688 PubMed:15994445 PubMed:16051254 PubMed:16216249 PubMed:1681161 PubMed:1859405 PubMed:2370048 PubMed:7607641 PubMed:7711728 PubMed:8318557 PubMed:8432868 PubMed:8807342 PubMed:9007616 PubMed:9741700 UniProtKB N ver_2 AAP, DGA 3/16/2016 172 3300078998 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/Involvement in disease Fish-eye disease (FED): A disorder of lipoprotein metabolism due to partial lecithin-cholesterol acyltransferase deficiency that affects only alpha-LCAT activity. FED is characterized by low plasma HDL and corneal opacities due to accumulation of cholesterol deposits in the cornea ('fish-eye'). MIM:136120 Norum disease DOID:1391 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:1516702 PubMed:1571050 PubMed:15994445 PubMed:1737840 PubMed:21901787 PubMed:8620346 PubMed:9261271 UniProtKB N ver_2 AAP, DGA 3/16/2016 172 3300078999 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/subcellular location Secreted into blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Produced in astrocytes and secreted into cerebral spinal fluid (CSF). astrocyte BTO:0000099 astrocyte CL:0000127 Y Y UniProtKB N ver_2 AAP, DGA 3/16/2016 172 3300079000 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. brain BTO:0000142 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 5/11/2016 137 3300079004 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 5/11/2016 137 3300079005 curatus P11712 1559 CYP2C9 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics (PubMed:25994031). This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan (PubMed:25994031). liver BTO:0000759 Y Y ECO:0000269 PubMed:25994031 UniProtKB N ver_2 AAP, DGA, ASD 4/13/2016 184 3300079006 curatus Q6NT55 126410 CYP4F22 Homo sapiens 9606 Comment/Involvement in disease Ichthyosis, congenital, autosomal recessive 5 (ARCI5): A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. MIM:604777 Autosomal recessive ichthyosis SNOMEDCT:402772005 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:16436457 UniProtKB N ver_2 AAP 3/16/2016 115 3300079007 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. liver BTO:0000759 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3/16/2016 126 3300079019 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/function Converts lysophosphatidic acid (LPA) into phosphatidic acid by incorporating an acyl moiety at the sn-2 position of the glycerol backbone. Acts on LPA containing saturated or unsaturated fatty acids C15:0-C20:4 at the sn-1 position using C18:1-CoA as the acyl donor. Also acts on lysophosphatidylethanolamine using oleoyl-CoA, but not arachidonoyl-CoA, and lysophosphatidylinositol using arachidonoyl-CoA, but not oleoyl-CoA. Activity toward lysophosphatidylglycerol not detectable. lysophosphatidic acid acyltransferase activity GO:0042171 Y Y ECO:0000269 PubMed:21173190 UniProtKB N ver_2 AAP 3/16/2016 126 3300079020 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/subcellular location Endoplasmic reticulum membrane;Multi-pass membrane protein endoplasmic reticulum membrane GO:0005789 SL-0097 Y Y ECO:0000269 PubMed:1873652 UniProtKB N ver_2 AAP 3/16/2016 126 3300079023 curatus O15120 10555 AGPAT2 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in adipose tissue, pancreas and liver. liver BTO:0000759 Y Y ECO:0000269 PubMed:21873652 UniProtKB N ver_2 AAP 3/16/2016 148 3300079034 curatus O15120 10555 AGPAT2 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in adipose tissue, pancreas and liver. liver UBERON:0002107 Y Y ECO:0000269 PubMed:21873652 UniProtKB N ver_2 AAP 3/16/2016 148 3300079035 curatus O15120 10555 AGPAT2 Homo sapiens 9606 Comment/Involvement in disease Congenital generalized lipodystrophy 1 (CGL1): An autosomal recessive disorder characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes. MIM:608594 congenital generalized lipodystrophy DOID:0050585 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:11967537 UniProtKB N ver_2 AAP 3/16/2016 148 3300079036 curatus P18054 239 ALOX12 Homo sapiens 9606 Comment/pathway Lipid metabolism; hydroperoxy eicosatetraenoic acid biosynthesis. arachidonic acid metabolic process GO:0019369 UPA00881 Y Y PubMed:16638750 UniProtKB N ver_2 AAP, DGA, AAP-M 5/11/2016 177 3300079041 curatus P18054 239 ALOX12 Homo sapiens 9606 Comment/Involvement in disease Esophageal cancer (ESCR): A malignancy of the esophagus. The most common types are esophageal squamous cell carcinoma and adenocarcinoma. Cancer of the esophagus remains a devastating disease because it is usually not detected until it has progressed to an advanced incurable stage. esophagus squamous cell carcinoma DOID:3748 Disease susceptibility may be associated with variations affecting the gene represented in this entry. Gln at position 261 may confer interindividual susceptibility to esophageal cancer (PubMed:17460548). Y Y ECO:0000269 PubMed:17460548 UniProtKB N ver_2 AAP, DGA, AAP-M 5/11/2016 177 3300079042 curatus P18054 239 ALOX12 Homo sapiens 9606 Comment/Involvement in disease Colorectal cancer (CRC): A complex disease characterized by malignant lesions arising from the inner wall of the large intestine (the colon) and the rectum. Genetic alterations are often associated with progression from premalignant lesion (adenoma) to invasive adenocarcinoma. Risk factors for cancer of the colon and rectum include colon polyps, long-standing ulcerative colitis, and genetic family history. MIM:114500 colorectal cancer DOID:9256 Disease susceptibility may be associated with variations affecting the gene represented in this entry. Gln at position 261 may confer interindividual susceptibility to colorectal cancer (PubMed:17460548). Y Y ECO:0000269 PubMed:17151091 UniProtKB N ver_2 AAP, DGA, AAP-M 5/11/2016 177 3300079043 curatus P18054 239 ALOX12 Homo sapiens 9606 Comment/function Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids generating a spectrum of bioactive lipid mediators. Mainly converts arachidonic acid to (12S)-hydroperoxyeicosatetraenoic acid/(12S)-HPETE but can also metabolize linoleic acid. Has a dual activity since it also converts leukotriene A4/LTA4 into both the bioactive lipoxin A4/LXA4 and lipoxin B4/LXB4. Through the production of specific bioactive lipids like (12S)-HPETE it regulates different biological processes including platelet activation. It also probably positively regulates angiogenesis through regulation of the expression of the vascular endothelial growth factor. Plays a role in apoptotic process, promoting the survival of vascular smooth muscle cells for instance. May also play a role in the control of cell migration and proliferation. arachidonic acid metabolic process GO:0019369 Y Y ECO:0000269 PubMed:16638750 PubMed:22237009 PubMed:23578768 PubMed:8250832 PubMed:9751607 UniProtKB N ver_2 AAP, DGA, AAP-M 5/11/2016 177 3300079048 curatus P18054 239 ALOX12 Homo sapiens 9606 Comment/tissue specificity Expressed in vascular smooth muscle cells. vascular smooth muscle cell BTO:0004578 Y Y ECO:0000269 PubMed:23578768 UniProtKB N ver_2 AAP, DGA, AAP-M 5/11/2016 177 3300079049 curatus Q14032 570 BAAT Homo sapiens 9606 Comment/Involvement in disease Familial hypercholanemia (FHCA): A disorder characterized by elevated serum bile acid concentrations, itching, and fat malabsorption. MIM:607748 The disease may be caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Y Y ECO:0000269 PubMed:12704386 UniProtKB N ver_2 no relevant DOID term AAP, ASD 4/13/2016 131 3300079053 curatus Q99685 11343 MGLL Homo sapiens 9606 Comment/function Converts monoacylglycerides to free fatty acids and glycerol. Hydrolyzes the endocannabinoid 2-arachidonoylglycerol, and thereby contributes to the regulation of endocannabinoid signaling, nociperception and perception of pain (By similarity). Regulates the levels of fatty acids that serve as signaling molecules and promote cancer cell migration, invasion and tumor growth (PubMed:20079333). Y Y ECO:0000269 ECO:0000250 PubMed:20079333 UniProtKB:O35678 UniProtKB N ver_2 AAP, ASD 3/16/2016 145 3300079055 curatus P16050 246 ALOX15 Homo sapiens 9606 Comment/Involvement in disease Disease susceptibility may be associated with variations affecting the gene represented in this entry. Met at position 560 may confer interindividual susceptibility to coronary artery disease (CAD) (PubMed:17959182). coronary artery disease DOID:3393 Y Y ECO:0000269 PubMed:17959182 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 169 3300079059 curatus P16050 246 ALOX15 Homo sapiens 9606 Comment/subcellular location Cytosol cytosol GO:0005829 SL-0091 Y Y ECO:0000269 PubMed:17052953 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 169 3300079060 curatus P16050 246 ALOX15 Homo sapiens 9606 Comment/subcellular location Lipid droplet lipid particle GO:0005811 SL-0154 Y Y ECO:0000269 PubMed:1952863 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 169 3300079061 curatus P16050 246 ALOX15 Homo sapiens 9606 Comment/subcellular location Cell membrane;Peripheral membrane protein plasma membrane GO:0005886 SL-0039 Y Y ECO:0000269 PubMed:17052953 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 169 3300079062 curatus P16050 246 ALOX15 Homo sapiens 9606 Comment/function Non-heme iron-containing dioxygenase that catalyzes the stereo-specific peroxidation of free and esterified polyunsaturated fatty acids generating a spectrum of bioactive lipid mediators. Converts arachidonic acid into 12-hydroperoxyeicosatetraenoic acid/12-HPETE and 15-hydroperoxyeicosatetraenoic acid/15-HPETE. Also converts linoleic acid to 13-hydroperoxyoctadecadienoic acid. May also act on (12S)-hydroperoxyeicosatetraenoic acid/(12S)-HPETE to produce hepoxilin A3. Probably plays an important role in the immune and inflammatory responses. Through the oxygenation of membrane-bound phosphatidylethanolamine in macrophages may favor clearance of apoptotic cells during inflammation by resident macrophages and prevent an autoimmune response associated with the clearance of apoptotic cells by inflammatory monocytes. In parallel, may regulate actin polymerization which is crucial for several biological processes, including macrophage function. May also regulate macrophage function through regulation of the peroxisome proliferator activated receptor signaling pathway. Finally, it is also involved in the cellular response to IL13/interleukin-13. In addition to its role in the immune and inflammatory responses, may play a role in epithelial wound healing in the cornea maybe through production of lipoxin A4. May also play a role in endoplasmic reticulum stress response and the regulation of bone mass. arachidonic acid metabolic process GO:0019369 Y Y ECO:0000269 PubMed:17052953 PubMed:21831839 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 169 3300079065 curatus P16050 246 ALOX15 Homo sapiens 9606 Comment/tissue specificity Detected in monocytes and eosinophils (at protein level). Expressed in airway epithelial cells. eosinophil BTO:0000399 Y Y ECO:0000269 PubMed:21831839 PubMed:9414270 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 169 3300079066 curatus P20292 241 ALOX5AP Homo sapiens 9606 Comment/Involvement in disease Ischemic stroke (ISCHSTR): A stroke is an acute neurologic event leading to death of neural tissue of the brain and resulting in loss of motor, sensory and/or cognitive function. Ischemic strokes, resulting from vascular occlusion, is considered to be a highly complex disease consisting of a group of heterogeneous disorders with multiple genetic and environmental risk factors. MIM:601367 cerebrovascular disease DOID:6713 ICD:430-438.99 437.9 Disease susceptibility is associated with variations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:14770184 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 141 3300079067 curatus P20292 241 ALOX5AP Homo sapiens 9606 Comment/Involvement in disease Genetic variations in ALOX5AP may be associated with susceptibility to myocardial infarction. Involvement in myocardial infarction is however unclear: according to some authors (PubMed:14770184), a 4-SNP haplotype in ALOX5AP confers risk of myocardial infarction, while according to other (PubMed:17304054) ALOX5AP is not implicated in this condition. myocardial infarction DOID:5844 Y Y ECO:0000269 PubMed:14770184 UniProtKB N ver_2 Genetic variations in ALOX5AP may be associated with susceptibility to myocardial infarction. Involvement in myocardial infarction is however unclear: according to some authors (PubMed:14770184), a 4-SNP haplotype in ALOX5AP confers risk of myocardial infarction, while according to other (PubMed:17304054) ALOX5AP is not implicated in this condition. AAP, DGA, ASD 3/16/2016 141 3300079068 curatus Q7L5N7 54947 LPCAT2 Homo sapiens 9606 Comment/function Possesses both acyltransferase and acetyltransferase activities. Activity is calcium-dependent. Involved in platelet-activating factor (PAF) biosynthesis by catalyzing the conversion of the PAF precursor, 1-O-alkyl-sn-glycero-3-phosphocholine (lyso-PAF) into 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF). Also converts lyso-PAF to 1-O-alkyl-2-acyl-sn-glycero-3-phosphocholine (PC), a major component of cell membranes and a PAF precursor. Under resting conditions, acyltransferase activity is preferred. Upon acute inflammatory stimulus, acetyltransferase activity is enhanced and PAF synthesis increases. Also catalyzes the conversion of 1-acyl-sn-glycero-3-phosphocholine to 1,2-diacyl-sn-glycero-3-phosphocholine. platelet activating factor production GO:0002390 Y Y ECO:0000269 PubMed:20363836 PubMed:21498505 UniProtKB N ver_2 AAP 4/13/2016 117 3300079079 curatus Q9NXB9 54898 ELOVL2 Homo sapiens 9606 Comment/function Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C20:4(n-6) acyl-CoA. Condensing enzyme that catalyzes the synthesis of polyunsaturated very long chain fatty acid (C20- and C22-PUFA). May participate to the production of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. unsaturated fatty acyl-CoA CHEBI:51006 Y Y ECO:0000255 ECO:0000269 HAMAP-Rule:MF_03202 PubMed:12371743 PubMed:20937905 UniProtKB N ver_2 AAP, ASD 3/16/2016 116 3300079086 curatus O94956 11309 SLCO2B1 Homo sapiens 9606 Comment/function Mediates the Na(+)-independent transport of organic anions such as taurocholate, the prostaglandins PGD2, PGE1, PGE2, leukotriene C4, thromboxane B2 and iloprost. Y Y ECO:0000250 UniProtKB N ver_2 AAP, ASD 4/13/2016 144 3300079110 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/function Cleaves the gamma-glutamyl bond of extracellular glutathione (gamma-Glu-Cys-Gly), glutathione conjugates, and other gamma-glutamyl compounds. The metabolism of glutathione releases free glutamate and the dipeptide, cysteinyl-glycine, which is hydrolyzed to cysteine and glycine by dipeptidases. In the presence of high concentrations of dipeptides and some amino acids, can also catalyze a transpeptidation reaction, transferring the gamma-glutamyl moiety to an acceptor amino acid to form a new gamma-glutamyl compound. Initiates extracellular glutathione (GSH) breakdown, provides cells with a local cysteine supply and contributes to maintain intracellular GSH level. It is part of the cell antioxidant defense mechanism. Isoform 3 seems to be inactive. glutathione metabolic process GO:0006749 Y Y ECO:0000269 PubMed:20622017 PubMed:24047895 PubMed:7673200 PubMed:7759490 PubMed:8095045 PubMed:8827453 UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 182 3300079113 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/Involvement in disease Glutathionuria (GLUTH): Autosomal recessive disease. MIM:231950 gamma-Glutamyltransferase deficiency SNOMEDCT:78586005 The disease is caused by mutations affecting the gene represented in this entry. Y Y UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 182 3300079114 curatus P19440 2678 GGT1 Homo sapiens 9606 Comment/subcellular location Cell membrane;Single-pass type II membrane protein plasma membrane GO:0005886 SL-0039 Y Y UniProtKB N ver_2 AAP, DGA, ASD 3/16/2016 182 3300079115 curatus Q6P531 124975 GGT6 Homo sapiens 9606 Comment/function Cleaves glutathione conjugates. Y Y ECO:0000250 UniProtKB N ver_2 AAP 3/16/2016 98 3300079116 curatus P47712 5321 PLA2G4A Homo sapiens 9606 Comment/Involvement in disease PLA2G4A mutations resulting in phospholipase A2 deficiency have been found in a patient affected by recurrent episodes of multiple complicated ulcers of the small intestine, not due to cyclooxygenase inhibitors use. Disease features also include platelet dysfunction, and globally decreased eicosanoid synthesis (PubMed:18451993). gastric ulcer DOID:10808 Y Y PubMed:18451993 UniProtKB N ver_2 Intestinal ulcers resulting from phospholipase and eicosanoid production deficiency. Only relevant HDO term found. AAP, ASD 5/11/2016 174 3300079118 curatus O15120 10555 AGPAT2 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in adipose tissue, pancreas and liver. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:21873652 UniProtKB N ver_2 AAP 3300079133 curatus O15120 10555 AGPAT2 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in adipose tissue, pancreas and liver. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:21873652 UniProtKB N ver_2 AAP 3300079134 curatus O15120 10555 AGPAT2 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in adipose tissue, pancreas and liver. adipose tissue BTO:0001487 Y Y ECO:0000269 PubMed:21873652 UniProtKB N ver_2 AAP 3300079135 curatus O15120 10555 AGPAT2 Homo sapiens 9606 Comment/tissue specificity Expressed predominantly in adipose tissue, pancreas and liver. adipose tissue UBERON:0001013 Y Y ECO:0000269 PubMed:21873652 UniProtKB N ver_2 AAP 3300079136 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. adipose tissue UBERON:0001013 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079137 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. leukocyte BTO:0000751 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079138 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. adipose tissue BTO:0001487 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079139 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079140 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079141 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. colon BTO:0000269 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079142 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. colon UBERON:0001155 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079143 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. thymus BTO:0001374 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079144 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079145 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. thymus UBERON:0002370 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079146 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079147 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. testis BTO:0001363 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079148 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. testis UBERON:0000473 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079149 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. ovary BTO:0000975 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079150 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. right ovary UBERON:0002118 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079151 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. heart UBERON:0000948 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079152 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. placenta BTO:0001078 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079153 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079154 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079155 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079156 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. kidney BTO:0000671 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079157 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079158 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079159 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079160 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. lung BTO:0000763 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079161 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. lung UBERON:0002048 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079162 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. spleen BTO:0001281 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079163 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079164 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. brain BTO:0000142 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079165 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. brain UBERON:0000955 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079166 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. heart BTO:0000562 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079167 curatus Q9NUQ2 55326 AGPAT5 Homo sapiens 9606 Comment/tissue specificity Widely expressed. liver UBERON:0002107 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 AAP 3300079168 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. liver BTO:0000759 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79019 AAP 3300079169 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. adipose tissue UBERON:0001013 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79137 AAP 3300079170 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. leukocyte BTO:0000751 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79138 AAP 3300079171 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. adipose tissue BTO:0001487 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79139 AAP 3300079172 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. small intestine BTO:0000651 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79140 AAP 3300079173 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. small intestine UBERON:0002108 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79141 AAP 3300079174 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. colon BTO:0000269 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79142 AAP 3300079175 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. colon UBERON:0001155 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79143 AAP 3300079176 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. thymus BTO:0001374 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79144 AAP 3300079177 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79145 AAP 3300079178 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. thymus UBERON:0002370 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79146 AAP 3300079179 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79147 AAP 3300079180 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. testis BTO:0001363 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79148 AAP 3300079181 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. testis UBERON:0000473 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79149 AAP 3300079182 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. ovary BTO:0000975 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79150 AAP 3300079183 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. right ovary UBERON:0002118 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79151 AAP 3300079184 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. heart UBERON:0000948 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79152 AAP 3300079185 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. placenta BTO:0001078 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79153 AAP 3300079186 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. placenta UBERON:0001987 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79154 AAP 3300079187 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. skeletal muscle BTO:0001103 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79155 AAP 3300079188 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79156 AAP 3300079189 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. kidney BTO:0000671 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79157 AAP 3300079190 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79158 AAP 3300079191 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. pancreas BTO:0000988 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79159 AAP 3300079192 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. pancreas UBERON:0001264 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79160 AAP 3300079193 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. lung BTO:0000763 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79161 AAP 3300079194 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. lung UBERON:0002048 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79162 AAP 3300079195 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. spleen BTO:0001281 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79163 AAP 3300079196 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. spleen UBERON:0002106 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79164 AAP 3300079197 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. brain BTO:0000142 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79165 AAP 3300079198 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. brain UBERON:0000955 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79166 AAP 3300079199 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. heart BTO:0000562 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79167 AAP 3300079200 curatus Q9NRZ5 56895 AGPAT4 Homo sapiens 9606 Comment/tissue specificity Widely expressed with highest levels in skeletal muscle, followed by heart, liver, prostate and thymus. liver UBERON:0002107 Y Y ECO:0000269 PubMed:16620771 PubMed:21173190 UniProtKB N ver_2 #Copied from AGPAT5, anno: 79168 AAP 3300079201 curatus P16050 246 ALOX15 Homo sapiens 9606 Comment/tissue specificity Detected in monocytes and eosinophils (at protein level). Expressed in airway epithelial cells. epithelial cell BTO:0000414 Y Y ECO:0000269 PubMed:21831839 PubMed:9414270 UniProtKB N ver_2 AAP, DGA, ASD 3300079202 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. spinal cord BTO:0001279 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079203 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. spinal cord UBERON:0002240 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079204 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. ovary BTO:0000975 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079205 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. right ovary UBERON:0002118 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079206 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. lymph node BTO:0000784 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079207 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. lymph node UBERON:0000029 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079208 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. hair BTO:0001501 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079209 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. strand of hair UBERON:0001037 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079210 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079211 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079212 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. lung BTO:0000763 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079213 curatus O15296 247 ALOX15B Homo sapiens 9606 Comment/tissue specificity Expressed in hair, prostate, lung, ovary, lymph node, spinal cord and cornea. lung UBERON:0002048 Y Y ECO:0000269 PubMed:10542053 PubMed:11350124 PubMed:9177185 UniProtKB N ver_2 AAP 3300079214 curatus Q9BYJ1 59344 ALOXE3 Homo sapiens 9606 Comment/Involvement in disease Ichthyosis, congenital, autosomal recessive 3 (ARCI3): A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. MIM:242100 Congenital ichthyosiform erythroderma SNOMEDCT:254156001 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:11773004 PubMed:16116617 PubMed:19131948 PubMed:19890349 UniProtKB N ver_2 AAP 3300079215 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease Peters anomaly (PETAN): Consists of a central corneal leukoma, absence of the posterior corneal stroma and Descemet membrane, and a variable degree of iris and lenticular attachments to the central aspect of the posterior cornea. MIM:604229 Irido-corneo-trabecular dysgenesis SNOMEDCT:204153003 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:11403040 UniProtKB N ver_2 No HDO term, except more gener """"eye disease"""" AAP, ASD 3300079216 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, retinoid and xenobiotics. Preferentially oxidizes 17beta-estradiol to the carcinogenic 4-hydroxy derivative, and a variety of procarcinogenic compounds to their activated forms, including polycyclic aromatic hydrocarbons. Promotes angiogenesis by removing cellular oxygenation products, thereby decreasing oxidative stress, release of antiangiogenic factor THBS2, then allowing endothelial cells migration, cell adhesion and capillary morphogenesis. These changes are concommitant with the endothelial nitric oxide synthase activity and nitric oxide synthesis. Plays an important role in the regulation of perivascular cell proliferation, migration, and survival through modulation of the intracellular oxidative state and NF-kappa-B expression and/or activity, during angiogenesis. Contributes to oxidative homeostasis and ultrastructural organization and function of trabecular meshwork tissue through modulation of POSTN expression. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10426814 PubMed:15258110 PubMed:22888116 PubMed:23821647 UniProtKB N ver_2 AAP, ASD 3300079217 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/Involvement in disease Glaucoma 3, primary congenital, A (GLC3A): An autosomal recessive form of primary congenital glaucoma (PCG). PCG is characterized by marked increase of intraocular pressure at birth or early childhood, large ocular globes (buphthalmos) and corneal edema. It results from developmental defects of the trabecular meshwork and anterior chamber angle of the eye that prevent adequate drainage of aqueous humor. MIM:231300 Congenital glaucoma SNOMEDCT:392371002 ICD:743.21 The disease is caused by mutations affecting distinct genetic loci, including the gene represented in this entry. Y Y ECO:0000269 PubMed:10227395 PubMed:10655546 PubMed:11184479 PubMed:11527932 PubMed:11980847 PubMed:12036985 PubMed:12525557 PubMed:14635112 PubMed:14640114 PubMed:15255109 PubMed:15342693 PubMed:15475877 PubMed:16490498 PubMed:16735994 PubMed:9463332 PubMed:9497261 UniProtKB N ver_2 AAP, ASD 3300079218 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. heart BTO:0000562 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079219 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. brain UBERON:0000955 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079220 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. lung UBERON:0002048 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079221 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. liver BTO:0000759 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079222 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. skeletal muscle BTO:0001103 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079223 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. skeletal muscle tissue UBERON:0001134 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079224 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. kidney UBERON:0002113 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079225 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. kidney BTO:0000671 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079226 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. spleen BTO:0001281 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079227 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. liver UBERON:0002107 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079228 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. lung BTO:0000763 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079229 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. placenta UBERON:0001987 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079230 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. placenta BTO:0001078 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079231 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. brain BTO:0000142 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079232 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. heart UBERON:0000948 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079233 curatus P33261 1557 CYP2C19 Homo sapiens 9606 Comment/miscellaneous Genetic variation in CYP2C19 is responsible for poor drug metabolism [MIM:609535]. Individuals can be characterized as either extensive metabolizers (EM) or poor metabolizers (PM). The PM phenotype is inherited in an autosomal recessive manner, with the EM phenotype comprising both homozygous dominant and heteroyzgote genotypes. There are marked interracial differences in the frequency of this polymorphism. Poor metabolizers represent 2-5% of Caucasians, 13-23% of Asian populations, and as many as 38-79% of individuals of some of the islands of Polynesia and Micronesia. Different alleles of CYP2C19 are known: CYP2C19*1A CYP2C19*1B, CYP2C19*1C, CYP2C19*2A (CYP2C19m1 or CYP2C19m1A), CYP2C19*2B (CYP2C19m1B), CYP2C19*2C (CYP2C19*21), CYP2C19*3A (CYP2C19m2), CYP2C19*3B (CYP2C19*20), CYP2C19*4 (CYP2C19m3), CYP2C19*5A (CYP2C19m4), CYP2C19*5B, CYP2C19*6, CYP2C19*7, CYP2C19*8, CYP2C19*9, CYP2C19*10, CYP2C19*11 CYP2C19*12, CYP2C19*13, CYP2C19*14 CYP2C19*15, CYP2C19*16, CYP2C19*18, CYP2C19*19. Defective CYP2C19*2 and CYP2C19*3 alleles are characterized by a splice mutation and a stop codon, respectively, and account for most of the PM alleles. The sequence shown is that of allele CYP2C19*1B. MIM:608902 Y Y ECO:0000269 PubMed:12464799 UniProtKB N ver_2 AAP, DGA, ASD 3300079234 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. testis UBERON:0000473 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079235 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. thymus UBERON:0002370 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079236 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. thymus BTO:0001374 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079237 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. ovary BTO:0000975 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079239 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. colon UBERON:0001155 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079240 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. testis BTO:0001363 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079242 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. prostate gland UBERON:0002367 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079243 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. small intestine UBERON:0002108 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079244 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. right ovary UBERON:0002118 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079245 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. small intestine BTO:0000651 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079246 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. colon BTO:0000269 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079248 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. spleen UBERON:0002106 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079249 curatus Q16678 1545 CYP1B1 Homo sapiens 9606 Comment/tissue specificity Expressed in many tissues. prostate gland BTO:0001129 heart, brain, placenta, lung, liver, skeletal muscle, kidney, spleen, thymus, prostate, testis, ovary, small intestine, colon, and peripheral blood leukocytes Y Y ECO:0000269 PubMed:8175734 UniProtKB UPDATE ver_2 Changes in: EVID1,EVID Expressed in many tissues AAP, ASD 3300079250 curatus P11712 1559 CYP2C9 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics (PubMed:25994031). This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan (PubMed:25994031). liver UBERON:0002107 Y Y ECO:0000269 PubMed:25994031 UniProtKB N ver_2 AAP, DGA, ASD 3300079251 curatus P11712 1559 CYP2C9 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics (PubMed:25994031). This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan (PubMed:25994031). fatty acid metabolic process GO:0006631 Y Y ECO:0000269 PubMed:25994031 UniProtKB N ver_2 AAP, DGA, ASD 3300079252 curatus P11712 1559 CYP2C9 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics (PubMed:25994031). This enzyme contributes to the wide pharmacokinetics variability of the metabolism of drugs such as S-warfarin, diclofenac, phenytoin, tolbutamide and losartan (PubMed:25994031). steroid metabolic process GO:0008202 Y Y ECO:0000269 PubMed:25994031 UniProtKB N ver_2 AAP, DGA, ASD 3300079253 curatus P10635 1565 CYP2D6 Homo sapiens 9606 Comment/miscellaneous Genetic variations in CYP2D6 are the cause of poor drug metabolism CYP2D6-related [MIM:608902]. The CYP2D6 gene is highly polymorphic. CYP2D6 activity ranges widely within a population comprising ultrarapid (UM), extensive (EM), intermediate (IM) and poor (PM) metabolizer phenotypes. UM and PM are those most at risk for treatment failure or dose-dependent drug toxicity, respectively. Of the Caucasian populations of Europe and North America, 5%-10% are of the PM phenotype and are unable to metabolize the antihypersensitive drug debrisoquine and numerous other drugs. Different alleles are known, including CYP2D6*1 (PubMed:15768052), CYP2D6*2 (PubMed:25469868), CYP2D6*6B/6C (PubMed:7868129), CYP2D6*7 also known CYP2D6E (PubMed:7845481), CYP2D6*9 also known CYP2D6C (PubMed:1844820), CYP2D6*10 also known CYP2D6J (PubMed:8287064, PubMed:25469868), CYP2D6*12 (PubMed:8655150), CYP2D6*14 (PubMed:10064570), CYP2D6*17 also known CYP2D6Z (PubMed:8971426), CYP2D6*41B (PubMed:15768052), CYP2D6*45A (PubMed:15768052), CYP2D6*45B (PubMed:15768052), CYP2D6*46 (PubMed:15768052), CYP2D6*87 (PubMed:25469868), CYP2D6*88 (PubMed:25469868), CYP2D6*89 (PubMed:25469868), CYP2D6*90 (PubMed:25469868), CYP2D6*91 (PubMed:25469868), CYP2D6*93 (PubMed:25469868), C CYP2D6*94 (PubMed:25469868), CYP2D6*97 (PubMed:25469868) and CYP2D6*98 (PubMed:25469868). Isozymes CYP2D6.45 (Lys-155, Cys-296 and Thr-486) and CYP2D6.46 (His-26, Lys-155, Cys-296 and Thr-486) are functional (PubMed:15768052). MIM:608902 Y Y ECO:0000269 PubMed:10064570 PubMed:15768052 PubMed:16352597 PubMed:1844820 PubMed:25469868 PubMed:7845481 PubMed:7868129 PubMed:8655150 PubMed:8971426 UniProtKB N ver_2 AAP, DGA, ASD 3300079254 curatus P08684 1576 CYP3A4 Homo sapiens 9606 Comment/function Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599). fatty acid metabolic process GO:0006631 Y Y ECO:0000269 PubMed:11159812 PubMed:21576599 UniProtKB N ver_2 AAP, DGA, ASD 3300079255 curatus P78329 8529 CYP4F2 Homo sapiens 9606 Comment/tissue specificity Liver. Also present in kidney: specifically expressed in the S2 and S3 segments of proximal tubules in cortex and outer medulla (PubMed:10660572). liver UBERON:0002107 Y Y ECO:0000269 PubMed:10492403 PubMed:10660572 UniProtKB N ver_2 AAP, DGA, ASD 3300079256 curatus P78329 8529 CYP4F2 Homo sapiens 9606 Comment/tissue specificity Liver. Also present in kidney: specifically expressed in the S2 and S3 segments of proximal tubules in cortex and outer medulla (PubMed:10660572). renal proximal tubule BTO:0001498 Y Y ECO:0000269 PubMed:10492403 PubMed:10660572 UniProtKB N ver_2 AAP, DGA, ASD 3300079257 curatus P78329 8529 CYP4F2 Homo sapiens 9606 Comment/tissue specificity Liver. Also present in kidney: specifically expressed in the S2 and S3 segments of proximal tubules in cortex and outer medulla (PubMed:10660572). proximal tubule UBERON:0004134 Y Y ECO:0000269 PubMed:10492403 PubMed:10660572 UniProtKB N ver_2 AAP, DGA, ASD 3300079258 curatus P78329 8529 CYP4F2 Homo sapiens 9606 Comment/function Omega-hydroxylase that oxidizes a variety of structurally unrelated compounds, including steroids, fatty acids and xenobiotics. Plays a key role in vitamin K catabolism by mediating omega-hydroxylation of vitamin K1 (phylloquinone), and menaquinone-4 (MK-4), a form of vitamin K2. Hydroxylation of phylloquinone and MK-4 probably regulates blood coagulation (PubMed:19297519, PubMed:24138531). Also shows arachidonic acid omega-hydroxylase activity in kidney, by mediating conversion of arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE), possibly influencing blood pressure control (PubMed:10660572, PubMed:17341693, PubMed:18574070). Also acts as a leukotriene-B(4) omega-hydroxylase by mediating conversion of leukotriene-B(4) (LTB4) to its omega-hydroxylated metabolite 20-hydroxyleukotriene-B(4) (20-OH LTB4) (PubMed:8026587, PubMed:9799565). steroid metabolic process GO:0008202 Y Y ECO:0000269 PubMed:10660572 PubMed:17341693 PubMed:18574070 PubMed:19297519 PubMed:24138531 PubMed:8026587 PubMed:9799565 UniProtKB N ver_2 AAP, DGA, ASD 3300079259 curatus Q6NT55 126410 CYP4F22 Homo sapiens 9606 Comment/Involvement in disease Ichthyosis, congenital, autosomal recessive 5 (ARCI5): A form of autosomal recessive congenital ichthyosis, a disorder of keratinization with abnormal differentiation and desquamation of the epidermis, resulting in abnormal skin scaling over the whole body. The main skin phenotypes are lamellar ichthyosis (LI) and non-bullous congenital ichthyosiform erythroderma (NCIE), although phenotypic overlap within the same patient or among patients from the same family can occur. Lamellar ichthyosis is a condition often associated with an embedment in a collodion-like membrane at birth; skin scales later develop, covering the entire body surface. Non-bullous congenital ichthyosiform erythroderma characterized by fine whitish scaling on an erythrodermal background; larger brownish scales are present on the buttocks, neck and legs. MIM:604777 congenital ichthyosis DOID:1695 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:16436457 UniProtKB N ver_2 AAP 3300079260 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. leukocyte BTO:0000751 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079261 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. bone marrow BTO:0000141 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079262 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. bone marrow UBERON:0002371 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079263 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. liver BTO:0000759 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079264 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. liver UBERON:0002107 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079265 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. kidney BTO:0000671 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079266 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. kidney UBERON:0002113 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079267 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. trachea BTO:0001388 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079268 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. trachea UBERON:0003126 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079269 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. gastrointestinal tract BTO:0000511 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079270 curatus Q08477 4051 CYP4F3 Homo sapiens 9606 Comment/tissue specificity Isoform CYP4F3A is expressed in the polymorphonuclear leukocytes as well as leukocytes and bone marrow. Isoform CYP4F3B is selectively expressed in liver and kidney and is also the predominant CYP4F isoform in trachea and tissues of the gastrointestinal tract. gastrointestinal system UBERON:0005409 Y Y ECO:0000269 PubMed:11461919 UniProtKB N ver_2 AAP 3300079271 Jenn P19440 2678 GGT1 Homo sapiens 9606 Comment/Involvement in disease Glutathionuria (GLUTH): Autosomal recessive disease. MIM:231950 amino acid metabolic disorder DOID:9252 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 UniProtKB N ver_2 AAP, DGA, ASD 3300079273 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. testis UBERON:0000473 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3300079275 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3300079276 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. testis BTO:0001363 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3300079277 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. cerebrospinal fluid UBERON:0001359 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3300079278 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. liver BTO:0000759 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3300079279 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3300079280 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. brain BTO:0000142 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3300079281 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. cerebrospinal fluid BTO:0000237 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3300079282 curatus P04180 3931 LCAT Homo sapiens 9606 Comment/tissue specificity Detected in blood plasma (PubMed:3458198, PubMed:8820107, PubMed:10222237). Detected in cerebral spinal fluid (at protein level) (PubMed:10222237). Detected in liver (PubMed:3797244, PubMed:3458198). Expressed mainly in brain, liver and testes. blood plasma UBERON:0001969 Y Y ECO:0000269 PubMed:10222237 PubMed:3458198 PubMed:3797244 PubMed:8820107 UniProtKB N ver_2 AAP, DGA 3300079283 curatus Q16873 4056 LTC4S Homo sapiens 9606 Comment/Involvement in disease LTC4 synthase deficiency is associated with a neurometabolic developmental disorder characterized by muscular hypotonia, psychomotor retardation, failure to thrive, and microcephaly. Aspirin-sensitive asthma with nasal polyps SNOMEDCT:233686006 Y Y UniProtKB N ver_2 The deficiency phenotype is MIM:614037. Two cases of the deficiency are described and these patients died at the age of 6 months. For the MIM given, several diseases are discussed: aspirin intolerant asthma (MIM:208550) (patients display increased LTC4S expression and have a promoter polymorphism). I added the second MIM term. HDO does not have a term that captures the 'aspirin' effect in asthma. ICD has various intrinsic asthma terms, none aspirin related AAP, DGA, ASD 3300079284 curatus P39877 5322 PLA2G5 Homo sapiens 9606 Comment/Involvement in disease Fleck retina, familial benign (FRFB): An autosomal recessive condition associated with a distinctive retinal appearance and no apparent visual or electrophysiologic deficits. Affected individuals are asymptomatic, but fundus examination reveals a striking pattern of diffuse, yellow-white, fleck-like lesions extending to the far periphery of the retina but sparing the foveal region. MIM:228980 retinal disease DOID:5679 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:22137173 UniProtKB N ver_2 AAP, ASD 3300079285 curatus Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/miscellaneous Genetic variations in PNPLA2 may influence plasma free fatty acids and triglycerides levels, and fasting glucose concentrations. fatty acid CHEBI:35366 Y Y ECO:0000269 PubMed:16644682 UniProtKB N ver_2 Actual term would be 'fasting glucose concentrations' but no ontology term found.#ORIGINAL data type: Comment/polymorphism AAP 3300079286 curatus Q96AD5 57104 PNPLA2 Homo sapiens 9606 Comment/miscellaneous Genetic variations in PNPLA2 may influence plasma free fatty acids and triglycerides levels, and fasting glucose concentrations. triglyceride CHEBI:17855 Y Y ECO:0000269 PubMed:16644682 UniProtKB N ver_2 Actual term would be 'fasting glucose concentrations' but no ontology term found.#ORIGINAL data type: Comment/polymorphism AAP 3300079287 curatus Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/Involvement in disease A chromosomal aberration involving ACSL6 may be a cause of myelodysplastic syndrome with basophilia. Translocation t(5;12)(q31;p13) with ETV6. Myelodysplastic syndrome SNOMEDCT:128623006 Y Y ECO:0000269 PubMed:10502316 UniProtKB N ver_2 AAP, AAP-M, ASD 3300079291 curatus Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/Involvement in disease A chromosomal aberration involving ACSL6 may be a cause of myelodysplastic syndrome with basophilia. Translocation t(5;12)(q31;p13) with ETV6. Basophilia SNOMEDCT:65209002 Y Y ECO:0000269 PubMed:10502316 UniProtKB N ver_2 AAP, AAP-M, ASD 3300079292 curatus Q9UKU0 23305 ACSL6 Homo sapiens 9606 Comment/Involvement in disease A chromosomal aberration involving ACSL6 may be a cause of acute myelogenous leukemia with eosinophilia. Translocation t(5;12)(q31;p13) with ETV6. Acute myeloid leukemia SNOMEDCT:17788007 Y Y ECO:0000269 PubMed:10502316 UniProtKB N ver_2 AAP, AAP-M, ASD 3300079293 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/function Isoform 2 does not exhibit any catalytic activity toward 20:3n-6, but it may enhance FADS2 activity (By similarity). Isoform 1 is a component of a lipid metabolic pathway that catalyzes biosynthesis of highly unsaturated fatty acids (HUFA) from precursor essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3). Catalyzes the desaturation of dihomo-gamma-linoleic acid (DHGLA) (20:3n-6) and eicosatetraenoic acid (20:4n-3) to generate arachidonic acid (AA) (20:4n-6) and eicosapentaenoic acid (EPA)(20:5n-3), respectively. icosatetraenoic acid CHEBI:36033 Y Y ECO:0000250 ECO:0000269 PubMed:10601301 PubMed:10769175 UniProtKB N ver_2 AAP, ASD 3300079294 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/function Isoform 2 does not exhibit any catalytic activity toward 20:3n-6, but it may enhance FADS2 activity (By similarity). Isoform 1 is a component of a lipid metabolic pathway that catalyzes biosynthesis of highly unsaturated fatty acids (HUFA) from precursor essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3). Catalyzes the desaturation of dihomo-gamma-linoleic acid (DHGLA) (20:3n-6) and eicosatetraenoic acid (20:4n-3) to generate arachidonic acid (AA) (20:4n-6) and eicosapentaenoic acid (EPA)(20:5n-3), respectively. alpha-linolenic acid CHEBI:27432 Y Y ECO:0000250 ECO:0000269 PubMed:10601301 PubMed:10769175 UniProtKB N ver_2 AAP, ASD 3300079295 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/function Isoform 2 does not exhibit any catalytic activity toward 20:3n-6, but it may enhance FADS2 activity (By similarity). Isoform 1 is a component of a lipid metabolic pathway that catalyzes biosynthesis of highly unsaturated fatty acids (HUFA) from precursor essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3). Catalyzes the desaturation of dihomo-gamma-linoleic acid (DHGLA) (20:3n-6) and eicosatetraenoic acid (20:4n-3) to generate arachidonic acid (AA) (20:4n-6) and eicosapentaenoic acid (EPA)(20:5n-3), respectively. all-cis-icosa-8,11,14-trienoic acid CHEBI:53486 Y Y ECO:0000250 ECO:0000269 PubMed:10601301 PubMed:10769175 UniProtKB N ver_2 AAP, ASD 3300079296 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. heart UBERON:0000948 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079297 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. liver BTO:0000759 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079298 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. liver UBERON:0002107 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079299 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. adrenal gland BTO:0000047 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079300 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. adrenal gland UBERON:0002369 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079301 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. heart BTO:0000562 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079302 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. brain BTO:0000142 fetus BTO:0000449 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079303 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. brain UBERON:0000955 fetus BTO:0000449 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079304 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. liver BTO:0000759 fetus BTO:0000449 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079305 curatus O60427 3992 FADS1 Homo sapiens 9606 Comment/tissue specificity Widely expressed, with highest levels in liver, brain, adrenal gland and heart. Highly expressed in fetal liver and brain. liver UBERON:0002107 fetus BTO:0000449 Y Y ECO:0000269 PubMed:10601301 PubMed:10769175 PubMed:10860662 UniProtKB N ver_2 AAP, ASD 3300079306 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. adrenal gland UBERON:0002369 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 AAP 3300079307 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. cerebellum UBERON:0002037 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 AAP 3300079308 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. testis BTO:0001363 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 AAP 3300079309 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. brain UBERON:0000955 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 weakly expressed AAP 3300079310 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. lung BTO:0000763 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 weakly expressed AAP 3300079311 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. lung UBERON:0002048 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 weakly expressed AAP 3300079312 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. cerebellum BTO:0000232 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 AAP 3300079313 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. testis UBERON:0000473 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 AAP 3300079314 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. prostate gland BTO:0001129 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 weakly expressed AAP 3300079315 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. prostate gland UBERON:0002367 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 weakly expressed AAP 3300079316 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/tissue specificity Ubiquitous. Highly expressed in the adrenal gland and testis. Weakly expressed in prostate, lung and brain. Expressed in the cerebellum. brain BTO:0000142 Y Y ECO:0000269 PubMed:10970790 PubMed:20937905 PubMed:25065913 UniProtKB N ver_2 weakly expressed AAP 3300079317 curatus Q9NYP7 60481 ELOVL5 Homo sapiens 9606 Comment/function Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Condensing enzyme that acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6) acyl-CoA. May participate to the production of monounsaturated and of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. gamma-linolenoyl-CoA CHEBI:15508 Y Y ECO:0000255 ECO:0000269 HAMAP-Rule:MF_03205 PubMed:10970790 PubMed:20937905 UniProtKB N ver_2 AAP 3300079318 curatus Q9NXB9 54898 ELOVL2 Homo sapiens 9606 Comment/function Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C20:4(n-6) acyl-CoA. Condensing enzyme that catalyzes the synthesis of polyunsaturated very long chain fatty acid (C20- and C22-PUFA). May participate to the production of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. arachidonoyl-CoA CHEBI:15514 Y Y ECO:0000255 ECO:0000269 HAMAP-Rule:MF_03202 PubMed:12371743 PubMed:20937905 UniProtKB N ver_2 AAP, ASD 3300079319 curatus P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease Wolman disease (WOD): A severe manifestation of LIPA deficiency, leading to the accumulation of cholesteryl esters and triglycerides in most tissues of the body. WD occurs in infancy and is nearly always fatal before the age of 1 year. MIM:278000 Wolman's disease SNOMEDCT:82500001 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:8146180 UniProtKB N ver_2 AAP 3300079320 curatus P38571 3988 LIPA Homo sapiens 9606 Comment/Involvement in disease Cholesteryl ester storage disease (CESD): A mild manifestation of LIPA deficiency, leading to the accumulation of cholesteryl esters and triglycerides in most tissues of the body. It is characterized by late-onset. MIM:278000 Wolman's disease SNOMEDCT:82500001 The disease is caused by mutations affecting the gene represented in this entry. Y Y ECO:0000269 PubMed:8146180 PubMed:9633819 UniProtKB N ver_2 AAP 3300079321 curatus Q96SL4 2882 GPX7 Homo sapiens 9606 Comment/Involvement in disease Barrett esophagus (BE): A condition characterized by a metaplastic change in which normal esophageal squamous epithelium is replaced by a columnar and intestinal-type epithelium. Patients with Barrett esophagus have an increased risk of esophageal adenocarcinoma. The main cause of Barrett esophagus is gastroesophageal reflux. The retrograde movement of acid and bile salts from the stomach into the esophagus causes prolonged injury to the esophageal epithelium and induces chronic esophagitis, which in turn is believed to trigger the pathologic changes. MIM:614266 Barrett's esophagus SNOMEDCT:302914006 The disease is caused by mutations affecting the gene represented in this entry. The pathologic mechanisms leading to Barrett esophagus involve GPX7 dysfunction that results in higher levels of hydrogen peroxide and ROS-induced oxidative stress and DNA damage in esophageal cells. Y Y ECO:0000269 PubMed:22157330 UniProtKB N ver_2 AAP, ASD 3300079322 curatus O00154 11332 ACOT7 Homo sapiens 9606 Comment/tissue specificity Isoform 4 is expressed exclusively in brain. brain UBERON:0000955 Y Y ECO:0000269 PubMed:12435388 UniProtKB N ver_2 AAP, ASD 3300079323 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. kidney BTO:0000671 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079326 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. kidney UBERON:0002113 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079327 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. uterus BTO:0001424 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079328 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. uterus BTO:0001424 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079329 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. liver UBERON:0002107 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079330 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. liver BTO:0000759 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079331 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. brain BTO:0000142 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079332 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. brain UBERON:0000955 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079333 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. spleen UBERON:0002106 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079334 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. spleen BTO:0001281 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079335 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. lung BTO:0000763 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079336 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. lung UBERON:0002048 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079337 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. skeletal muscle BTO:0001103 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079338 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. skeletal muscle tissue UBERON:0001134 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079339 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. testis BTO:0001363 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079340 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. testis UBERON:0000473 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079341 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. stomach BTO:0001307 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079342 curatus Q8WXI4 26027 ACOT11 Homo sapiens 9606 Comment/tissue specificity Isoform 1 is predominantly expressed in skeletal muscle, liver, testis, stomach, spleen, lung and brain. Isoform 2 is predominantly expressed in kidney, uterus, hibernoma and white adipose tissue. stomach UBERON:0000945 Y Y ECO:0000311 UniProtKB N ver_2 AAP 3300079343